VAERS Reports EN 6201

VAERS 2700608

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 82,0
Geschlecht: M
Eingang: 24.10.2023
Impfdatum: 02.03.2021
Beginn: 21.01.2022
Tage bis Beginn: 325,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Death Dyspnoea Endotracheal intubation Syncope Walking distance test abnormal

Symptomtext

Presented with syncope; required oxygen 3 liters/minute to maintain his sats above 90%; started on remdesivir and Decadron. Also, rec'd Vit C, Vit D3, lovenox, zinc; Rec'd 3 days of remdesivir; patient feels significantly better and wants to go home; walk study required 3 L of O2 to maintain his sats above 90%; home oxygen will be arranged for the patient prior to discharge. Readmitted on 10/18 with increasing SOB and rec'd further steroids and toci, eventually intubated and then family chose comfort care. Pt died on 10/26/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2687708

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 71,0
Geschlecht: M
Eingang: 28.09.2023
Impfdatum: 24.02.2021
Beginn: 19.12.2021
Tage bis Beginn: 298,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Cardiac failure acute Death Decreased appetite Dyspnoea General physical health deterioration Left ventricular failure Metabolic encephalopathy Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

presented to ED with progressive generalized weakness, dyspnea and anorexia over several weeks; +Covid-19 pneumonia and acute hypoxemic resp failure; treated with dexamethasone and remdesivir along with oxygen support and empiric abx (ceftriaxone+azithromycin). Abx were discontinued after 5 days. His condition improved with treatment but deteriorated after he completed 10-day course of dexamethasone. Hospitalization was complicated by acute metabolic encephalopathy and acute on chronic HFrEF. Respiratory failure with hypoxia and encephalopathy progressed quickly during the last 3 days of hospitalization which required sedation and BiPAP therapy. Family decided to transition to comfort care only on day 15. BiPAP was discontinued for comfort. Pt died on day 16.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 15,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2674185

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 83,0
Geschlecht: F
Eingang: 21.08.2023
Impfdatum: 24.02.2021
Beginn: 18.01.2022
Tage bis Beginn: 328,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury COVID-19 Cardiac arrest Dyspnoea Endotracheal intubation Hypoxia Klebsiella infection Staphylococcal sepsis

Symptomtext

PMH of COPD on 3L NC baseline, pAF on eliquis, CVA, T2DM, OSA on CPAP, and HFpEF. To ER complaining of several days of worsening SOB. On EMS arrival, she was found to be profoundly hypoxic with sats of 48% The pt was found to have COVID, MSSA and klebs PNA, she was on appropriate abx, had worsening AKI nephro was following. pt rec'ed remdisivir, steroids, antibiotics. intubated on 2/6/22; The pt had a progressively worsening clinical course. Ultimately pt had cardiac arrest, and during ACLS the family told staff "let her go" -> pt was transitioned to end of life care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 19,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2662098

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 27.07.2023
Impfdatum: 13.02.2021
Beginn: 19.12.2022
Tage bis Beginn: 674,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Vaccine breakthrough infection

Symptomtext

Covid Breakthrough Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: PTSD, FTT, GERD, BPH, OAB, IBS, HTN, HLD, Schizoaffective disorder
Andere Medikamente: Vit B, Tylenol, ASA, Atropine, Dexamethasone, Senna, Lithium, Loratadine, Melatonin, Meloxicam, Olanzapine, Tamsulosin, Zinc
Allergien: Erythromycin
Vorherige Impfungen: -

VAERS 2649822

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 50,0
Geschlecht: F
Eingang: 27.06.2023
Impfdatum: 05.03.2021
Beginn: 27.07.2022
Tage bis Beginn: 509,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Arterial catheterisation Blood bicarbonate decreased Blood lactic acid Blood pH decreased Cardiac arrest Endotracheal intubation Haematocrit decreased Haemoglobin decreased Hypertransaminasaemia Hypotension Hypoxia Intensive care Lactic acidosis Leukocytosis Mental status changes Pulse absent Pulseless electrical activity Pupil fixed

Symptomtext

Dose 3: Pfizer Monovalent 12+: 01/15/2022- lot # not provided. Patient is a 52 year old female with history of CKD IV on IHD, Wounds secondary to calciphylaxis, DM 11, GERD, HTN who presents from rehab facility due to hypotension and AMS onset earlier this day. Patient has had long course since last July resulting ultimately resulting in CKD HD due to obstructive uropathy requiring chronic foley changed every month by nursing staff, multiple wounds due to calciphylaxis which became acutely infected previously who presented today again for AMS. Patient found to have lactic acidosis in addition to profound hypotension requiring vasopressor support. Currently undergoing fluid resuscitation and septic work up. She will be started on broad spectrum antibiotics and admitted to the MICU. Patient became unresponsive and hypotensive maxed on levo and vaso overnight. Patient was intubated for hypoxia and an arterial line was placed. Patient on levo 0.05, vaso 0.08, and epi gtt started. Patient found to have HCO3 of 7 and pH 6.9, given 2 amps of bicarb and started on bicarb gtt. Lactic acid 13.1 this AM. Leukocytosis worse this AM. H/H down to 6.7, one unit of PRBC ordered. Mild transaminitis this AM. Pupils now fixed and dilated. While assessing the patient, she lost a pulse and was PEA, given two amps of bicarb, 2 of epi, and 1 of calcium given and ROSC achieved. Patient was made a DNR and went asystole.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Anemia, Asthma, Lung nodule, Diabetes, Hypertension
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2649365

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 82,0
Geschlecht: M
Eingang: 26.06.2023
Impfdatum: 24.02.2021
Beginn: 29.11.2022
Tage bis Beginn: 643,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient received 3rd dose of COVID-19 vaccine (Pfizer. Lot #051B22A) on 08/03/2022. COVID-19 + on 11/29/2022, deceased 12/09/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Anemia Anxiety Atrial fibrillation BPH (benign prostatic hYPerplasia) COPD {chronic obstructive pulmonary disease) Dementia Depression DOE (dyspnea on exertion) Femoral artery aneurysm, left GERO (gastroesophageaf reflux disease) Insomnia Pacemaker PVO (peripheral vascular disease)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2646923

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6201

kritisch

Staat: MO
Alter: 57,0
Geschlecht: M
Eingang: 19.06.2023
Impfdatum: 22.02.2021
Beginn: 02.08.2021
Tage bis Beginn: 161,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Asthenia Cerebellar stroke Cerebrovascular accident Computerised tomogram Laboratory test Magnetic resonance imaging

Symptomtext

Multiple debilitating strokes in the cerebellum and cerebrum.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 30,0
Labordaten: Multiple MRIs, CT scans, and others
Aktuelle Erkrankungen: Diabetes Meletus Type 2
Vorgeschichte: None
Andere Medikamente: Adderall
Allergien: None
Vorherige Impfungen: -

VAERS 2645187

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

kritisch

Staat: FL
Alter: 77,0
Geschlecht: M
Eingang: 14.06.2023
Impfdatum: 26.02.2021
Beginn: 19.08.2022
Tage bis Beginn: 539,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction Anticoagulant therapy COVID-19 COVID-19 pneumonia Cardiomyopathy Cough Diuretic therapy Dyspnoea Echocardiogram abnormal Ejection fraction decreased Pneumonia viral Pulmonary oedema SARS-CoV-2 test positive Troponin increased Vaccine breakthrough infection

Symptomtext

BREAKTHROUGH COVID: FULLY VACCINATED WITH BOOSTER BY PFIZER, COVID POSITIVE. 79-year-old gentleman who presented with complaint of cough, shortness of breath. Found to have pulmonary edema. Echo revealed cardiomyopathy. Patient had elevated troponins consistent with NSTEMI. He was started on heparin drip, IV diuresis. Cardiology was consulted. They recommend ischemic workup outpatient in light of patient's positive COVID status. Regarding COVID viral pneumonia, patient placed on oral Decadron and Albuterol, Symbicort, anticoagulation. Fortunately he had no significant hypoxia during his stay. Pt now has an ejection fracture of 20%-25%.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: UNKNONWN
Vorgeschichte: CAD, AFIB, CHF
Andere Medikamente: UNKNOWN
Allergien: PENICILLINS, GLUTEN
Vorherige Impfungen: -

VAERS 2635875

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6201

kritisch

Staat: OH
Alter: 71,0
Geschlecht: M
Eingang: 15.05.2023
Impfdatum: 21.02.2021
Beginn: 10.12.2021
Tage bis Beginn: 292,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Cerebrovascular accident

Symptomtext

Left pontine CVA 11/15/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Primary osteoarthritis of right knee; Renal stone; Erectile dysfunction; Paronychia, toe, right; Patellofemoral disorder; Chest pain; Hammer toe of right foot - S/P Repair
Andere Medikamente: acetaminophen; aspirin; betamethasone valerate; Vitamin D3; Diclofenac sodium; hydrocodone- acetaminophen; Lisinopril; naloxone; tadafil; Tamsulosin
Allergien: Prednisolone - Gets severe hiccup when receives steroid injections; Lyrica - Dizzy/vertigo; NSAIDS - Has CKD-2; Tetanus-Diphtheria Toxoids Td - Nausea and Vomiting. fever
Vorherige Impfungen: -

VAERS 2612972

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NY
Alter: 80,0
Geschlecht: M
Eingang: 11.04.2023
Impfdatum: 24.09.2022
Beginn: 11.12.2022
Tage bis Beginn: 78,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Alanine aminotransferase increased Aspartate aminotransferase increased Blood creatinine increased Blood gases Blood urea increased C-reactive protein increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic obstructive pulmonary disease Condition aggravated Cough Dyspnoea Glomerular filtration rate decreased Hypertransaminasaemia Liver function test increased

Symptomtext

12/11/2022- Presents to ED, worsening SOB and cough. Afebrile. 02 mid 90's on 6L NCL (4L and cpap at HS baseline). Covid + test. CXR-b/l infiltrates . ABG 7.47/38/63/27 6L 02 via NC. Dexamethasone, hold remdesivir d/t elevated LFT's-AST 63 and ALT 66, transaminases 60's trending down. IV vanco and cefepime. Admit Acute on chronic hypoxemic respiratory failure b/l covid pna causing copd exacerbation. eGFR 27. WBC 15.8. AKI creat 2.4. BUN 87 . recently d/c 12/9 after 5 weeks stay COPD exacerbation and CAP. 12/12/-2022- cefepime d/c start meropenem. Pseudomonas. 12/19/2022-On 8L o2 via NC sat above 90's. IV decadron and meropenem. procalcitonin 0.10 and crp 1.3 d/c vanco. 12/27/2022- Transaminitis resolving, WBC 1

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 16,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD on chronic 02 4L, CAD s/p CABG, AS s/p TAVR, OSA and CHF
Andere Medikamente: -
Allergien: None
Vorherige Impfungen: -

VAERS 2605935

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 29.03.2023
Impfdatum: 20.02.2021
Beginn: 01.09.2022
Tage bis Beginn: 558,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Computerised tomogram head normal Confusional state Cough Death Fall General physical health deterioration Head injury Hypoxia SARS-CoV-2 test positive

Symptomtext

3RD COVID VACCINE GIVEN 10/16/21, PFIZER, #FF2593; pt to ED with confusion after falling at home and hitting his head; CT of head is negative; found to be positive for COVID in ED with coughing and hypoxia; O2 supplementation; given ABX and Dexamethasone; DNI; pt's condition continued to decline; transitioned to comfort measures and passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: ATRIAL FIBRILLATION-ON WARFARIN, TAVR
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2605024

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 92,0
Geschlecht: F
Eingang: 28.03.2023
Impfdatum: 06.03.2021
Beginn: 11.02.2023
Tage bis Beginn: 707,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Blood sodium increased COVID-19 Condition aggravated Dementia Alzheimer's type Dysphagia Hypernatraemia Hypophagia Metabolic encephalopathy Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

Patient is a 94 y.o. female with past medical history of dementia, depression, hyperlipidemia who presented from Alzheimer's facility on 2/11/2023 with acute hypoxic respiratory failure secondary to COVID. Given her worsening Alzheimer's, family elected for comfort care and hospice. Now end of life care. Plan to return to facility with hospice. Acute hypoxic respiratory failure COVID-19 positive swab 2/11/23 - Presented with significant hypoxia with O2 sats of 65% on arrival. COVID-19 positive on arrival here, but supposedly was positive in December 2022 at memory care unit - completed remdesivir and steroids - Required BiPAP and heated high flow O2, and now on nasal cannula 2 L - CCM followed, now comfort care. Hypernatremia - as high as 147, and Suspect secondary to poor oral intake - Sodium normalized as of 2/14 Dysphagia, oropharynegeal - speech recommending pureed with thin for comfort feeds Alzheimer's dementia Acute metabolic encephalopathy - Nonverbal at baseline. Previously on Namenda and rivastigmine - plan to return to memory unit with hospice - cont comfort measures

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2599572

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NY
Alter: 75,0
Geschlecht: M
Eingang: 20.03.2023
Impfdatum: 16.09.2022
Beginn: 13.11.2022
Tage bis Beginn: 58,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Atrial fibrillation Blood gases COVID-19 Chest X-ray abnormal Chills Dyspnoea Glomerular filtration rate Oxygen saturation decreased Respiratory tract congestion SARS-CoV-2 test positive Sepsis White blood cell count increased

Symptomtext

11/13/2022-Presents to ED, increased sob and low o2, 88% RA at home. Chest congestion and has chills. Covid + test. eGFR 45. WBC- 16.7. HR-129 a fib with RVR, RR 20. ABG-7.4/42.6/56/ o2 90 on RA. Acute resp failure with hypoxia s/t covid 19. Sepsis. CXR- possible infitrate. Start Zosyn, dexamethasone, remdesivir and vanco. Started on 2L NC. 11/16/2022-Tolerating RA, continue IV remdesivir and decadron. IV ceftriaxone. D/d home after completion of remdesivir. 11/18/2022-Remdesivir completed. tolerating RA. WBC-12.4 egfr >60. D/C home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CHf and hx of triple bypass. Afib, CAD, DM,
Andere Medikamente: -
Allergien: Iodine and shellfish
Vorherige Impfungen: -

VAERS 2594640

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 82,0
Geschlecht: F
Eingang: 10.03.2023
Impfdatum: 22.02.2021
Beginn: 01.09.2022
Tage bis Beginn: 556,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Aphasia COVID-19 Cerebral haemorrhage Cerebral mass effect Death Gaze palsy Intraventricular haemorrhage SARS-CoV-2 test positive

Symptomtext

3RD DOSE PFIZER COVID VACCINE GIVEN 11/10/21, #FF2587; 9/7/22 pt to hospital with a sudden onset of aphasia and rightward gaze; found to have acute right frontal lobe IPH and right ventricle IVHJ with mass effect, right-left midline shift; also found to be positive for COVID; family transitioned pt to comfort measures and GIP hospice where pt passed away

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DEMENTIA, COPD, MAI INFECTION
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2590328

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 92,0
Geschlecht: M
Eingang: 02.03.2023
Impfdatum: 24.02.2021
Beginn: 01.08.2022
Tage bis Beginn: 523,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Asymptomatic COVID-19 Death Fall SARS-CoV-2 test positive

Symptomtext

3RD DOSE COVID VACCINE, PFIZER, GIVEN 11/18/21, #FG3527; 4TH DOSE COVID VACCINE, PFIZER, GIVEN 4/26/22, #FM9992; 8/28/22 pt brought to hospital after a fall in assisted living facility; found to be positive for COVID; asymptomatic; no O2 supplementation needed; dc'd to Health and Rehab Center on 8/30/22 where he passed away 2 wks later

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DMT2, HTN, HLD, BPH, SENILE DEGENERATION OF THE BRAIN
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2579734

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 79,0
Geschlecht: F
Eingang: 10.02.2023
Impfdatum: 19.02.2021
Beginn: 12.10.2022
Tage bis Beginn: 600,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and expired.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 14,0
Labordaten: Positive COVID test on 9/28/2022.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2578134

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 08.02.2023
Impfdatum: 09.02.2021
Beginn: 01.07.2022
Tage bis Beginn: 507,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Aspiration Asymptomatic COVID-19 Computerised tomogram head normal Death Dysphagia Encephalopathy SARS-CoV-2 test positive

Symptomtext

Pt brought to ED; found to be positive for COVID; from respiratory perspective pt was asymptomatic; encephalopathy; CT head was negative; dysphagia; aspirating when eating; family chose to allow comfort feeds and changed status to comfort care; dc'd to Hospice where pt passed away (facility and state withheld.)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DEMENTIA, HTN, COPD, IRON DEFICIENCY ANEMIA, GERD
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2577962

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 87,0
Geschlecht: F
Eingang: 08.02.2023
Impfdatum: 21.02.2021
Beginn: 01.08.2022
Tage bis Beginn: 526,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asthenia COVID-19 Death Hyperhidrosis Hypotension Lethargy SARS-CoV-2 test positive White blood cell count increased

Symptomtext

3RD COVID DOSE, MODERNA, GIVEN 11/22/21, LOT #027H21B; Pt tested positive for COVID on 8/5/21 in Hospital; no cough, no dyspnea, on RA, lungs clear; dc'd to SNF on 8/10/22; weakness; suffered hypotension with diaphoresis, weakness, slightly lethargic; elevated WBC; requested UA but unable to obtain, gave pt a shot of Rocephin; pt transitioned to DNR/DNI, comfort measures only; he passed away in the SNF (Center for Rehab and Healing.)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DEMENTIA, DM, HTN, ADULT FAILURE TO THRIVE
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2575155

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 82,0
Geschlecht: F
Eingang: 03.02.2023
Impfdatum: 01.03.2021
Beginn: 01.08.2022
Tage bis Beginn: 518,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction Anticoagulant therapy Atrial fibrillation COVID-19 Death Dyspnoea General physical health deterioration SARS-CoV-2 test positive

Symptomtext

3RD DOSE COVID VACCINE GIVEN 11/15/21, LOT #30155BA; pt to ED with SOB; O2 supplementation; had a positive COVID test on 8/18/22; tested positive as well in hospital; admitted; given Dexamethasone, Remdesivir, Albuterol Inhaler; pt is DNR without aggressive interventions; NSTEMI - heparin given; A Fibrillation with RVR - medication given; pt's condition worsened and she passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DEMENTIA
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2569361

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6201

kritisch

Staat: FL
Alter: -
Geschlecht: U
Eingang: 27.01.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Chest pain Dyspnoea Pulmonary embolism

Symptomtext

Chest pain, shortness of breath 1/20 Pulmonary embolisms 1/22 ER, 1/23-1/24 hospital stay, on eliquis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2567802

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 82,0
Geschlecht: M
Eingang: 25.01.2023
Impfdatum: 21.03.2021
Beginn: 13.08.2022
Tage bis Beginn: 510,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Positive COVID test on 7/29/2022.
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2558573

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 12.01.2023
Impfdatum: 27.02.2021
Beginn: 30.07.2022
Tage bis Beginn: 518,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Death Pneumonia aspiration SARS-CoV-2 test positive

Symptomtext

3RD DOSE PFIZER COVID VACCINE GIVEN 12/7/21, LOT #FJ1620; pt had a positive COVID test on 7/30/22; brought to hospital and admitted to Hospice for end of life care; comfort measures; pt had previous aspiration pneumonia as well; acute hypoxic respiratory failure; pt passed away in the hospital under hospice care

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DEMENTIA, ADULT FAILURE TO THRIVE
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2557643

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 95,0
Geschlecht: M
Eingang: 11.01.2023
Impfdatum: 06.06.2022
Beginn: 02.11.2022
Tage bis Beginn: 149,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia Body temperature increased Bronchitis COVID-19 COVID-19 pneumonia Cough SARS-CoV-2 test positive

Symptomtext

Patient brought to the ED via EMS on 11/2 for weakness and a cough that began three days prior. Additionally, he was found by EMS to have O2 sats 88-90% on room air and a temperature of 101.3F. The day prior to ED arrival, patient reports he tested positive for COVID. He additionally was tested for COVID-19 by PCR in the ED and tested positive. Patient admitted to the hospital 11/2 - 11/14 with acute respiratory failure with hypoxia secondary to COVID-19 pneumonia; this resolved during his admission. Additionally, he was diagnosed with acute bronchitis. Patient has received the primary COVID vaccine series and two boosters.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2536776

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 84,0
Geschlecht: F
Eingang: 19.12.2022
Impfdatum: 23.02.2021
Beginn: 01.06.2022
Tage bis Beginn: 463,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Cardiac pacemaker insertion Death Dyspnoea General physical health deterioration SARS-CoV-2 test positive

Symptomtext

PFIZER COVID VACCINE #3 GIVEN 10/13/21, LOT #FE3590; pt admitted to hospital with worsening dyspnea x 2 months; had a permanent pacemaker placed 1 month prior to admission; dyspnea has been worse since placement; found to be positive for COVID; administered "standard treatment for COVID" per medical report; ABX given; pt condition worsened; DNR; pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 22,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CHF, HTN, HLD, ASTHMA, ATRIAL FIBRILLATION, PULMONARY HTN, SICK SINUS SYNDROME
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2536760

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 89,0
Geschlecht: F
Eingang: 19.12.2022
Impfdatum: 17.02.2021
Beginn: 01.06.2022
Tage bis Beginn: 469,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Chest X-ray normal Computerised tomogram head normal Death Fall General physical health deterioration Pneumonia aspiration Respiratory failure SARS-CoV-2 test positive Shock Skin laceration Suture insertion

Symptomtext

PFIZER COVID VACCINE #3 GIVEN 11/17/21, LOT #FF8839; pt admitted to hospital from ED for recurrent falls; laceration to scalf required stapling; CT of brain was negative for acute intracranial abnormalities; CXR also showed no acute abnormalities; husband not comfortable having her at home due to falling; while getting ready for dc from hospital, pt tested positive for COVID; initially there were no O2 requirements; developed aspiration pneumonia; condition worsened; respiratory failure and shock; pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 25,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN, SVT, HYPOTHYROIDISM, ANEMIA, GERD, OSTEOARTHRITIS
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2527822

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

kritisch

Staat: IN
Alter: 88,0
Geschlecht: F
Eingang: 09.12.2022
Impfdatum: 03.03.2021
Beginn: 07.12.2022
Tage bis Beginn: 644,0
Dosis: 2
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acetabulum fracture Activated partial thromboplastin time shortened Acute kidney injury Acute myocardial infarction Alanine aminotransferase normal Anaemia Anion gap Anticoagulant therapy Aspartate aminotransferase normal Basophil count normal Basophil percentage Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium normal Blood chloride normal Blood creatinine increased Blood culture negative

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on December 07, 2022 16:03 EST Verified By: MD on December 07, 2022 16:03 EST Encounter Info: Hospital, Inpatient, 12/07/22 - * Final Report * History of Present Illness/Subjective 90-year-old woman past medical history of anemia, CKD stage III, peripheral vascular disease, hypertension, hyperlipidemia, coronary artery disease, diabetes mellitus, hypothyroidism, and GERD. She presented after a fall, now with multiple fractures. Orthopedic surgery consulted, no surgical intervention. was being treated for Klebsiella uti with ceftriaxone. blood cultures were negative she was at Paoli Hospital, pending placement, today during rounds, she was found to be not feeling well and looked slightly pale and cyanotic. Although bedside saturation was normal . troponin EKG and chest x-ray was ordered. Her troponin were found to be elevated. She did not complain of chest pain or heaviness. EKG did not show any dynamic changes in comparison to the previous ekgs. the patient was started on NSTEMI treatment. Cardiology on board I do not see any previous cardiac work-up or stress testing in the charts Patient has slight leukocytosis, chronic stable anemia resolving AKI on CKD, troponin of 2699. Review of Systems 13 point review of system negative except for whats mentioned in my HPI Physical Exam/Objective Vital Signs (most recent and range for last 24 hours) None reported this timeframe Patient Weight Patient Height None Reported Constitutional: pale Eyes: PERRLA, EOMI, normal conjunctiva, no scleral icterus ENMT: Moist oral mucosa Neck: Supple, non-tender, intact range of motion Respiratory: Lungs CTAB Cardiovascular: Regular rate and rhythm Gastrointestinal: Soft, non-tender, non-distended Musculoskeletal: No joint swelling, no deformity, intact ROM Integumentary: Intact, warm, dry no rashes Neurologic: Alert & Oriented x 3, Psychiatric: Cooperative, appropriate mood and affect Assessment/Plan 1. NSTEMI (non-ST elevated myocardial infarction) I21.4 - trend trops Q6, - Serial ekg q6 -heparin drip -s/l aspirin and Plavix loading - aspirin and plavix daily - cardiology consult -nitroglycerin prn - pain control if needed Orders: Sodium Chloride 0.9% 1,000 mL, Total Volume (mL) = 1,000, IV, 12/07/22 9:48:00 EST, for 1 Days, 12/08/22 9:47:00 EST, 42 mL/hr, Clinical Weight Bed Request (Decision to Admit) Electrocardiogram Level of Care Troponin-I High Sensitivity 1. Sepsis secondary to UTI A41.9 Ceftriaxone for one more day for klebsiella UTI 2. Fall with injury W19.XXXA 3. Hip fracture, left S72.002A Conservative management, Per Ortho on call, Dr, "I reviewed the images. Would recommend non operative treatment with protective weight bearing with walker and pain control. Would repeat X-ray of pelvis and inlet/outlet view in 7-10 days. Can't see her old dexa results but some vit d and calcium would help for insufficiency type fractures" - restarted anticoagulation -Calcium and vitamin D have been added to patient's regimen . 4. Left acetabular fracture S32.402A no surgical intervention per ortho for DC to rehab After resolution of acute issues 5. Fracture of left inferior pubic ramus S32.592A no surgical intervention per ortho for DC to rehab After resolution of acute issues 6. Anemia D64.9 chronic and stable, normocytic, no active signs of bleeding, continue to trend 7. CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min N18.30 Stable relative to baseline, avoid nephrotoxins as possible and continue to trend 8. PVD (peripheral vascular disease) I73.9 on Xarelto, but currently on heparin drip for NSTEMI. 9. HTN (hypertension) I10 Relatively normotensive and stable, continue to trend, continue home regimen with titration as appropriate 10. HLD (hyperlipidemia) E78.5 stable on current statin regimen, screening lipid profile pending 11. Coronary artery disease I25.10 H/o of CAD 12. DM2 (diabetes mellitus, type 2) E11.9 Continue subcutaneous sliding scale and carb controlled diet for tight glycemic control. Initiate baseline basal/bolus regimen as indicated by home clinical course with appropriate titration 13. Hypothyroidism E03.9 continue home dosing of levothyroxine Due to a high probability of clinically significant, life threatening deterioration, the patient required my highest level of preparedness to intervene emergently and I personally spent 35-70 minutes minutes of critical care time directly and personally managing the patient. This critical care time included obtaining a history, examining the patient, pulse oximetry, ordering and reviewing the studies, arranging urgent treatment with development of a management plan, evaluation of the patient?s response to treatment, frequent reassessment, and discussions with other clinicians. The critical care time was performed to assess and manage the high probability of imminent, life-threatening deterioration that could result in multi-organ failure. It was exclusive of separately billable procedures and treating other patients and teaching time. Please see the MDM section and the rest of this note for further information on patient assessment and treatment. Code Status None Recorded Chronic Problem List Atherosclerosis of artery of left upper extremity Shoulder arthritis Shoulder strain Subclavian artery stenosis Procedure/Surgical History ?Bone density scan (12/31/2018) ?Pressure relieved in eye (2011) ?Pressure relieved in eye (2009) ?Repair of hole in retina (2006) ?EGD with biopsy (09/08/2005) ?Colonoscopy (07/13/2004) ?Gallbladder (2004) ?Hip replacement (2001) ?Stents in heart (2001) ?Cataract (1999) ?Cesarean section (1961) ?Cesarean section (1958) ?Cesarean section (1954) ?Carotid Stent Medications Home Medications (19) Active atorvastatin 20 mg, Orally, Daily clopidogrel 75 mg, Orally, Daily Colace 100 mg oral capsule 100 mg = 1 Capsule, Orally, BID furosemide 20 mg, Orally, Daily gabapentin 100 mg oral capsule 100 mg = 1 Capsule, Orally, Daily gemfibrozil 600 mg, Orally, BID isosorbide mononitrate 60 mg, Orally, QAM Lantus (glucostabilizer) 38 Units, Subcutaneous, At Bedtime, 38-40 units levothyroxine 112 mCg, Orally, Daily Nitrostat 0.4 mg sublingual tablet 0.4 mg = 1 Tablet, PRN, Sublingually, Q5min Novolog See Instructions, 14 units in morning, 15 at noon, 4-6 in evening oxybutynin 5 mg, Orally, Daily pantoprazole. 40 mg, Orally, Daily Refresh 1 Drop, Eyes, Both, BID Restasis Restasis 0.05% ophthalmic emulsion 1 Bottle, Eyes, Both, Q12H, 1 drop each eye sodium bicarbonate 325 mg, Orally, BID Xarelto 2.5 mg oral tablet 2.5 mg = 1 Tablet, Orally, BID Zioptan 0.0015% ophthalmic solution 1 Drop, Eyes, Both, Every PM Active Scheduled Inpatient Medications Dextrose 10% in Water 500 mL IV PRN - See Comments Sodium Chloride 0.9% 1,000 mL IV 42 mL/hr Heparin PREMIX + Sodium Chloride 0.45% IV Per Nomogram 1,514.7059 Units/kg/hr One-Time Medications Given 12/06/22 00:00:00 TO 12/07/22 16:03:03 None Reported PRN Medications (0600 - 0559) from 12/06 - 12/07 None Reported Allergies TRENtal sulfa drugs Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Home/Environment Lives with Alone. Substance Abuse Denies Tobacco Tobacco Use: Never (less than 100 in lifetime). Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 12.2 k/cumm High (12/07/22 15:12:00) RBC: 2.41 million/cumm Low (12/07/22 15:12:00) Hgb: 7.7 GM/dL Low (12/07/22 15:12:00) Hct: 23.2 % Low (12/07/22 15:12:00) MCV: 96 fL (12/07/22 15:12:00) MCH: 31.9 pg (12/07/22 15:12:00) MCHC: 33.1 GM/dL (12/07/22 15:12:00) RDW: 14.1 % (12/07/22 15:12:00) Platelet: 311 k/cumm (12/07/22 15:12:00) MPV: 7.5 fL (12/07/22 15:12:00) Neutrophils %: 90 % (12/07/22 06:13:00) Lymphocytes %: 2 % (12/07/22 06:13:00) Monocytes %: 6 % (12/07/22 06:13:00) Eosinophils %: 1 % (12/07/22 06:13:00) Basophils %: 1 % (12/07/22 06:13:00) Absolute Neutrophil: 10.1 k/cumm High (12/07/22 06:13:00) Absolute Lymphocyte: 0.2 k/cumm Low (12/07/22 06:13:00) Absolute Monocyte: 0.6 k/cumm (12/07/22 06:13:00) Absolute Eosinophil: 0.2 k/cumm (12/07/22 06:13:00) Absolute Basophil: 0.1 k/cumm (12/07/22 06:13:00) Chemistry: Sodium SerPl QN: 136 mmol/L (12/07/22 06:13:00) Potassium SerPl QN: 4.1 mmol/L (12/07/22 06:13:00) Chloride SerPl QN: 105 mmol/L (12/07/22 06:13:00) Carbon Dioxide SerPl QN: 20 mmol/L Low (12/07/22 06:13:00) Anion Gap: 11 mmol/L (12/07/22 06:13:00) BUN SerPl QN: 42 mg/dL High (12/07/22 06:13:00) Creatinine SerPl QN: 1.39 mg/dL High (12/07/22 06:13:00) Estimated GFR (CKD-EPI, no race): 36 mL/min/1.73m2 Low (12/07/22 06:13:00) Estimated CRCL (CG): 24 mL/min Low (12/07/22 06:13:00) Glucose SerPl QN: 74 mg/dL (12/07/22 06:13:00) Calcium Total SerPl QN: 9.2 mg/dL (12/07/22 06:13:00) Alkaline Phos SerPl QN: 116 Units/L (12/07/22 06:13:00) ALT SerPl QN: 10 Units/L (12/07/22 06:13:00) AST SerPl QN: 22 Units/L (12/07/22 06:13:00) Bilirubin Total SerPl QN: 0.3 mg/dL (12/07/22 06:13:00) Total Protein SerPl QN: 6.1 GM/dL Low (12/07/22 06:13:00) Albumin SerPl QN: 3 GM/dL Low (12/07/22 06:13:00) Troponin-I High Sensitivity: 2699 ng/L High (12/07/22 12:50:00) Gluc-Strip, POC: 72 mg/dL (12/07/22 11:28:00) Coagulation: aPTT: 24 seconds (12/07/22 15:12:00) Micro - Last 7 days Blood CX: NEG (12/01/22 23:17:00) Blood CX: NEG (12/01/22 23:17:00) Urine CX: POS Critical (12/01/22 16:46:00) Diagnostics Radiology Results - Last 24 hours Across Visits 12/07/2022 15:50 - XR Chest PA or AP Portable Impression: There is mild vascular congestion and possibly edema.There is large hiatal hernia.Visualized cardiac silhouette size appears enlarged, accentuated bylow lung volumes. Pericardial effusion is not excluded. Signature Line Electronically Signed on 12/07/22 16:03 EST ________________________________________________________ MD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2520111

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 86,0
Geschlecht: F
Eingang: 30.11.2022
Impfdatum: 05.03.2021
Beginn: 01.07.2022
Tage bis Beginn: 483,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Death Dyspnoea Headache Neck pain Oxygen saturation decreased Productive cough SARS-CoV-2 test positive

Symptomtext

pt sent to ED from a walk in clinic for low O2 saturation; increasing SOB, productive cough, headache, neck pain; O2 supplementation; positive for COVID; given Dexamethasone and Remdesivir; pt slowly worsening; DNR; family wanted to take pt home; she passed away at home

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1043690

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: ID
Alter: 75,0
Geschlecht: M
Eingang: 21.11.2022
Impfdatum: 20.02.2020
Beginn: 21.02.2020
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autopsy Cardiac arrest Death Sudden death Ventricular fibrillation

Symptomtext

Heart stopped. Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Sudden death
Hospital-Tage: -
Labordaten: Autopsy. 2/202
Aktuelle Erkrankungen: -
Vorgeschichte: A fib
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2511082

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 75,0
Geschlecht: F
Eingang: 17.11.2022
Impfdatum: 01.06.2022
Beginn: 02.09.2022
Tage bis Beginn: 93,0
Dosis: 2
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute myocardial infarction Arthralgia Breast cancer metastatic COVID-19 Confusional state Death Enterobacter sepsis Mental status changes Pyrexia SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated 4 times with the Pfizer product, having received vaccine on 01/28/2021, 02/18/2021, 08/26/2021 and 06/01/2022. They presented to emergency department on 09/01/2022 for shoulder pain and were discharged with medication. They presented to emergency department again on 09/02/2022 via EMS for fever and change in mental status/new confusion. They tested positive for COVID-19 on 09/02/2022 (upon hospital admission). They had a highly complex medical history and were on chemotherapy for multiple metastasized cancer. They were found to be septic due to Enterobacter and in acute renal failure. They also had suffered a non-ST elevated myocardial infarction. The individual was revised to DNR due to poor prognosis and they died in hospital on 09/04/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 2,0
Labordaten: Positive COVID-19 tests on 09/02/2022 and 09/03/2022 despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes Mellitus Type II (described as "uncontrolled"), Breast Cancer metastatic to Bone and Liver, Lung Cancer, Hypothyroid, History of Anal Cancer, Chronic Deep Vein Thrombosis, Interstitial Lung Disease, Chronic Anemia, Basal Cell carcinoma of the skin, Congestive Heart Failure, past history of embolus in the femoral artery, Obesity, Former Smoker (Quit 19 years ago)
Andere Medikamente: -
Allergien: Regadenoson, Abemaciclib, Ace Inhibitors, IV Contrast (none of these have reactions listed)
Vorherige Impfungen: -

VAERS 2509702

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

kritisch

Staat: IN
Alter: 68,0
Geschlecht: M
Eingang: 16.11.2022
Impfdatum: 24.02.2021
Beginn: 21.03.2022
Tage bis Beginn: 390,0
Dosis: 2
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anion gap Asthenia Balance disorder Basophil count decreased Basophil percentage decreased Blood calcium normal Blood chloride normal Blood creatinine increased Blood glucose normal Blood potassium normal Blood sodium normal Blood urea normal Brain natriuretic peptide normal Carbon dioxide increased Chest X-ray normal Computerised tomogram head normal Condition aggravated Creatinine renal clearance

Symptomtext

\Document Type: ED Physician Progress Note Document Subject: ED Progress Note Performed By: on March 16, 2022 20:45 Verified By: MD on March 21, 2022 19:13 Encounter Info: Hospital, Observation, 03/16/22 - 03/18/22 * Final Report * Basic Information Time Seen: 03/16/2022 20:33 Chief Complaint Numbness/tingling (Complaint of), Weakness (Complaint of) History of Present Illness The pt is a 69 y/o male who presents to the ED via PV c/o stroke-like symptoms onset 10:30 PM yesterday. The pt reports that he noticed his stroke like symptoms this morning after he awoke. The pt endorses the following: L arm paresthesia, L arm weakness, and poor balance. The pt states that he has a relevant PMHx of blood clots in his arms, but is not on any blood thinners at the moment. Review of Systems Constitutional: No fevers, no chills, no sweats Eyes: No changes in vision Ears, Nose, Mouth, Throat: No ear pain, no nasal congestion, no sore throat Respiratory: No shortness of breath, no cough, no wheeze Cardiovascular: No chest pain, no palpitations, no edema Gastrointestinal: No abdominal pain, no nausea, no vomiting, no diarrhea, no constipation Genitourinary: No frequency, no urgency, no dysuria, no hematuria Hematologic/Lymphatic: No bruising, no enlarged lymph nodes Allergic/Immunologic: No hives Endocrine: No cold intolerance, no heat intolerance, no polyuria, no polydipsia Musculoskeletal: No arthralgia, no myalgia Skin: No rash, no pruritus Neurological: No headache, + L-arm weakness, no numbness+L-arm Paresthesia, +poor balance Psychiatric: No anxiety, no depression Physical Exam/Objective Vitals & Measurements last 24 hours VITAL SIGNS Temp C: 36.7 DegC Heart Rate: 67 bpm Resp Rate: 18 br/min BP #1: 226 / 111 mmHg SpO2 (%): 98 % O2 Device: Room air Height CM: 175.3 cm Weight KG: 76.4 kg Ideal Body Weight: 70.74 kg NIH Stroke Scale Level of consciousness alert = 0 Current month and age answers both correctly = 0 Opens and closes eyes/grip release hand obeys both correctly = 0 Best gaze normal = 0 Visual field testing no visual field loss = 0 Facial paresis normal symmetric movement = 0 Motor function of L arm normal = 0 Motor function of R arm normal = 0 Motor function of L leg normal = 0 Motor function of R leg normal = 0 Limb ataxia no ataxia = 0 Sensory normal = 0 Best language no aphasia = 0 Dysarthria normal aticulation = 0 Extinction and inattention normal = 0 Total Score: 4 Medical Decision Making Documents Reviewed: ED nurse, prior records Diagnostic Results: Labs: Reviewed Imaging: Reviewed Condition Stable Scribe Attestation I, acting as scribe for Dr. at 03/16/22 20:45:03 Signed by Scribe, at 03/16/22 20:45:03 I, MD, attest that the scribes documentation has been prepared under my direction in person and by me in its entirety. I confirm that the note above accurately reflects the work, treatment, procedures, and medical decision-making performed by me. chart edited and reviewed Assessment/Plan GERD (gastroesophageal reflux disease) Hypertensive emergency Prostate cancer Pulmonary emboli Sleep apnea TIA (transient ischemic attack) Patient Education High Blood Pressure (Hypertension), Discharge Instructions TIA: Transient Ischemic Attack Follow Up With When Contact Information MD, 03/22/2022 09:45 AM Hospital Additional Instructions: Appointment is with Dr. Chronic Problem List Actinic keratoses Back pain Blood pressure elevated without history of HTN Encounter for long-term (current) use of medications GERD (gastroesophageal reflux disease) Lipid screening Myalgia and myositis Obesity Prostate cancer Pulmonary emboli Sleep apnea Procedure/Surgical History ?basal cell carcinoma removal of right shoulder ?prostate ca 2013 ?shaved disc lumbar approx age 2007 Medications No qualifying data available Allergies Zofran (Unknown) sulfa drugs (Unknown) Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Home/Environment married Substance Abuse Denies Tobacco Tobacco Use: Never (less than 100 in lifetime). Family History Car accident: Mother. Lab Results Hemogram-Platelets-WBC Differential FS LATEST RESULTS HISTORICAL RESULTS WBC 03/16/22 20:36 8.8 12/23/20 7.9 RBC 03/16/22 20:36 5.35 12/23/20 5.39 Hgb 03/16/22 20:36 15.2 12/23/20 15.7 Hct 03/16/22 20:36 43.0 12/23/20 44.7 MCV 03/16/22 20:36 80 Low 12/23/20 83 MCH 03/16/22 20:36 28.3 12/23/20 29.1 MCHC 03/16/22 20:36 35.3 12/23/20 35.1 RDW 03/16/22 20:36 14.4 12/23/20 13.8 Platelet 03/16/22 20:36 186 12/23/20 155 MPV 03/16/22 20:36 9.4 12/23/20 9.5 Neutrophils % 03/16/22 20:36 64 12/23/20 72 Lymphocytes % 03/16/22 20:36 24 12/23/20 18 Monocytes % 03/16/22 20:36 8 12/23/20 8 Eosinophils % 03/16/22 20:36 3 12/23/20 2 Basophils % 03/16/22 20:36 0 12/23/20 1 Absolute Neutrophil 03/16/22 20:36 5.6 12/23/20 5.7 Absolute Lymphocyte 03/16/22 20:36 2.1 12/23/20 1.4 Absolute Monocyte 03/16/22 20:36 0.7 12/23/20 0.6 Absolute Eosinophil 03/16/22 20:36 0.3 12/23/20 0.2 Absolute Basophil 03/16/22 20:36 0.0 12/23/20 0.0 Routine Coagulation Studies FS LATEST RESULTS PT 03/16/22 20:36 12.2 INR 03/16/22 20:36 1.03 Routine Serum/Plasma Chemistry Tests FS LATEST RESULTS HISTORICAL RESULTS Sodium SerPl QN 03/16/22 20:36 140 12/23/20 140 Potassium SerPl QN 03/16/22 20:36 3.5 12/23/20 4.2 Chloride SerPl QN 03/16/22 20:36 103 12/23/20 104 Carbon Dioxide SerPl QN 03/16/22 20:36 29 12/23/20 31 High Anion Gap 03/16/22 20:36 8 12/23/20 5 BUN SerPl QN 03/16/22 20:36 14 12/23/20 12 Creatinine SerPl QN 03/16/22 20:36 1.21 12/23/20 1.25 Estimated GFR (CKD-EPI) 03/16/22 20:36 61 12/23/20 59 Low Estimated CRCL (CG) 03/16/22 20:36 60 12/23/20 59 Glucose SerPl QN 03/16/22 20:36 91 12/23/20 94 Calcium Total SerPl QN 03/16/22 20:36 9.0 12/23/20 9.0 Troponin-I High Sensitivity 03/16/22 20:36 5 BNP Pl QN 03/16/22 20:36 38 Diagnostic Results CT Head W/o IV Contrast 03/16/22 22:00:17 IMPRESSION: 1. Chronic findings as above without acute intracranial abnormality. If continued clinical concern for stroke, MRI may be of value. Thank you for consulting our team of subspecialty radiologists. Healthcare providers wishing to discuss this case further can contact the Emergency Radiology Room. Electronically Signed by: Signed By: MD ************************************************** XR Chest PA or AP Portable 03/16/22 21:59:11 IMPRESSION: 1. No acute findings in the chest. Thank you for consulting our team of subspecialty radiologists. Healthcare providers wishing to discuss this case further can contact the Emergency Radiology Room. Electronically Signed by: Signed By: MD Signature Line Electronically Signed on 03/17/22 00:23 ________________________________________________________ Electronically Signed on 03/21/22 19:13 ________________________________________________________ MD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2508729

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 82,0
Geschlecht: M
Eingang: 15.11.2022
Impfdatum: 27.02.2021
Beginn: 20.08.2022
Tage bis Beginn: 539,0
Dosis: 3
Route/Site: SYR / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia COVID-19 COVID-19 pneumonia Death Fall SARS-CoV-2 test positive Subarachnoid haemorrhage Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual received the Moderna product on 11/05/2021 and the Pfizer product on 02/06/2021 and 02/27/2021. They tested positive for COVID-19 via antigen test on 08/20/2022. They presented to emergency department on 08/21/2022 with general weakness and unwitnessed fall. They were admitted to hospital on 08/21/2022. They were diagnosed with COVID-19 pneumonia and found to have an acute subarachnoid hemorrhage. Due to poor prognosis, they were transitioned to comfort care and remained hospitalized until their death on 08/26/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 5,0
Labordaten: Positive COVID-19 antigen test on 08/20/2022 despite being vaccinated
Aktuelle Erkrankungen: -
Vorgeschichte: Lewy Body Dementia, History of A-Fib I found rhabdomyolysis mentioned in the emergency department notes but nowhere else.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2504543

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 10.11.2022
Impfdatum: 23.02.2021
Beginn: 01.07.2022
Tage bis Beginn: 493,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 COVID-19 pneumonia Death Encephalopathy Respiratory failure SARS-CoV-2 test positive

Symptomtext

PFIZER COVID VACCINE #3 GIVEN 8/17/21, LOT # FD8448; pt had a positive COVID test on 6/13/22; pt passed away at home; COD: refractory combined encephalopathy, respiratory failure, COVID - 19 pneumonia; PCP not known; no other medical records

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2501870

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NY
Alter: 77,0
Geschlecht: F
Eingang: 08.11.2022
Impfdatum: 19.05.2022
Beginn: 23.06.2022
Tage bis Beginn: 35,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Blood gases COVID-19 COVID-19 pneumonia Computerised tomogram head abnormal Computerised tomogram thorax abnormal Cough Fibrin D dimer increased Leukopenia Lung consolidation Pleural effusion SARS-CoV-2 test positive White blood cell count decreased

Symptomtext

6/24/2022-Presents to ED, + home covid test and coughing. Covid + test. ABG-7.46/34.1/32/24.4. CT chest bibasilar mild consolidation and minimal plueral effusions. 2L NC 96%.HR-113. Ordered dexamthasone, CAP coverage IV azithromycin , Rocephin and Remdesivir. Intial bp was 76/45 bolus given, now 89/50, patients baseline. MAP is around 63-65, started on levophed and fluids were d/c questionable HF. WBC 3.1 was 6.1 6 days prior, leukopenia immunotherapy in the setting of multiple myeloma. D Dimer 1125, CT was negative for PE. Admit acute hypoxic rep distress s/t to Covid pna. 6/26/2022- D/C remdesivir, no longer hypoxic. VSS. WBC 4.3. 6/28/2022-Continues on RA for 02, completed IV azithromycin and Rocephin course. VSS. D/CLevophed map around 70's. D/C Home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Multiple myeloma, heart murmur
Andere Medikamente: -
Allergien: Adhesive, Iodine and Latex
Vorherige Impfungen: -

VAERS 2491451

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 81,0
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: 04.03.2021
Beginn: 25.10.2021
Tage bis Beginn: 235,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure C-reactive protein increased COVID-19 Pneumonia

Symptomtext

The patient is a 82 y female who was admitted on 10/25/2021 pmhx htn, breast cancer, copd, former smoker, was admitted for acute hypoxic respiratory failure due to covid 19 infection, she was placed on respiratory protocol, decadron, abx, remdesivir. acute hypoxic respiratory resolved, covid 19 infections, pneumonia improved. Pt is medically stable will be discharged home stable condition, resume home medications, follow up pcp.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: CRP non cardiac 7.00
Aktuelle Erkrankungen: -
Vorgeschichte: 1985 History of breast lump/mass excision Date Unknown Arthritis Date Unknown Cancer (HCC) Date Unknown Cataract Date Unknown COPD (chronic obstructive pulmonary disease) (HCC) Date Unknown Heart murmur Date Unknown HTN (hypertension) Date Unknown Pneumonia, unspecified organism
Andere Medikamente: acidophillus/lactobacillus (FLORANEX/LACTINEX GEQ) chew tablet albuterol (VENTOLIN HFA) 108 (90 BASE) MCG/ACT HFA inhaler amLODIPine (NORVASC) 5 MG tablet aspirin EC (ECOTRIN) 325 MG tablet calcium-vitamin D (CALTRATE 600 PLUS D) 600-40
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2483960

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 99,0
Geschlecht: F
Eingang: 20.10.2022
Impfdatum: 14.02.2021
Beginn: 01.06.2022
Tage bis Beginn: 472,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asthenia Cardiovascular disorder Cerebrovascular accident Coronary artery disease Coronavirus infection Death Dementia Multiple organ dysfunction syndrome

Symptomtext

pt passed away at home; cause of death: multi-organ failure, general debility stroke, cardiovascular disease, dementia, coronary artery disease, coronavirus infection; name of PCP not listed; no other medical information

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2483009

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 86,0
Geschlecht: F
Eingang: 19.10.2022
Impfdatum: 25.02.2021
Beginn: 30.12.2021
Tage bis Beginn: 308,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Acute respiratory failure Asthenia COVID-19 Chills Death Pyrexia SARS-CoV-2 test positive

Symptomtext

pt was in the hospital, local Medical Center, from 12/30/2021 - 01/1/2022 with acute on chronic respiratory failure; positive for COVID, NSTEMI; pt had been weak, with fever and chills prior to admission; placed on steroids, O2 supplementation; pt continued to improve and she went home where she passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 14,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2478391

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 72,0
Geschlecht: M
Eingang: 14.10.2022
Impfdatum: 25.02.2021
Beginn: 16.08.2021
Tage bis Beginn: 172,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory distress syndrome Bradycardia COVID-19 Cough Death Dyspnoea Endotracheal intubation Haemodialysis Hypotension Hypoxia Infection Life support Mechanical ventilation Pulse absent Renal impairment Respiratory failure Resuscitation SARS-CoV-2 test positive

Symptomtext

pt had a positive COVID test on 8/16/21; was prescribed a Medrol Dosepak and Azithromycin; 8/20/21 pt to ED with increasing cough, SOB, hypoxia - O2 saturation 77% on RA; given O2 supplementation; developed worsening infection and sepsis with respiratory failure and ARDS; Decadron; required intubation with mechanical ventilation; not a Remdesivir candidate due to renal dysfunction; during hemodialysis, pt developed bradycardia hypotension and arrested; CPR, ACLS protocol performed; pulse returned then pt arrested again; ROSC; pt's family changed status to DNR and he passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2468106

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 77,0
Geschlecht: F
Eingang: 04.10.2022
Impfdatum: 26.02.2021
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Dyspnoea Fatigue Hypoxia Pulmonary embolism Thrombosis

Symptomtext

Pulmonary Embolus; Significantly hypoxic; fatigue; shortness of breath; blood clots/The clots are old, not acute; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 79-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Feb2021 as dose 2, single (Lot number: EN6201) at the age of 77 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "High BP" (unspecified if ongoing). Patient did not have any known allergies. The patient took concomitant medications. Vaccination history included: BNT162b2 (Dose 1, single, lot number=EL9261, vaccine location: Right arm), administration date: 05Feb2021, when the patient was 77-year-old, for COVID-19 immunization. The following information was reported: PULMONARY EMBOLISM (hospitalization, disability, medically significant, life threatening), outcome "recovering", described as "Pulmonary Embolus"; HYPOXIA (hospitalization, disability, medically significant, life threatening), outcome "recovering", described as "Significantly hypoxic"; FATIGUE (hospitalization, disability, life threatening), outcome "recovering"; DYSPNOEA (hospitalization, disability, life threatening), outcome "recovering", described as "shortness of breath"; THROMBOSIS (hospitalization, disability, medically significant, life threatening), outcome "recovering", described as "blood clots/The clots are old, not acute". The patient was hospitalized for pulmonary embolism, hypoxia, fatigue, dyspnoea, thrombosis (start date: 22Sep2022, discharge date: 26Sep2022, hospitalization duration: 4 day(s)). The events "pulmonary embolus", "significantly hypoxic", "fatigue", "shortness of breath" and "blood clots/the clots are old, not acute" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of pulmonary embolism, hypoxia, fatigue, dyspnoea, thrombosis. Clinical Course: The patient did not have covid Prior vaccination. The patient was not tested with covid post vaccination. Patient did not receive any other vaccine in four weeks. The patient had Pulmonary Embolus, bilateral pulmonary embolic disease, albeit relatively small clot burden. Significantly hypoxic. The clots are old, not acute. Recognized a slow decline after receiving Covid Vaccine. Fatigue, shortness of breath for well over a year. Shortness of breath worsened throughout the year and months. Room air oxygen was 70%. No risk factors at all for blood clots, except for Pfizer vaccine. The patient went to emergency room on 22Sep2022. Admitted from PE in both lungs and severe Hypoxia. Flown to a hirer level of care on 24Sep2022. Release to recover at home on 26Sep2022. AE resulted in: [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage]. The patient took Heparin, O2, Blood Thinners and Air Lifted as the treatment of the events.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood pressure high
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2465563

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 72,0
Geschlecht: M
Eingang: 30.09.2022
Impfdatum: 09.05.2022
Beginn: 27.09.2022
Tage bis Beginn: 141,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia Body temperature increased COVID-19 Chemotherapy Chronic obstructive pulmonary disease Lung neoplasm malignant Pneumonia SARS-CoV-2 test positive Sepsis

Symptomtext

Patient brought to the ED via EMS on 9/27 for weakness. He tested positive for COVID on 9/22 by home test. Of note, the patient currently has lung cancer and restarted chemotherapy 4 days ago after 3 months off from previous chemo. He also had a temperature at home of 100.8 F. Patient was placed on supplemental oxygen, and had another COVID test done in the ED which was positive. He was admitted from 9/27-9/28. Discharge diagnoses include acute hypoxic respiratory failure with left lower lobe pneumonia, COPD exacerbation; sepsis; and COVID-19. Patient has received the COVID vaccine and two booster shots.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical history of large cell neuroendocrine carcinoma involving the right lung with associated mets to liver, bone, and brain s/p multiple chemo and radiation.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2454724

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 91,0
Geschlecht: F
Eingang: 22.09.2022
Impfdatum: 22.02.2021
Beginn: 01.01.2022
Tage bis Beginn: 313,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death

Symptomtext

PFIZER COVID VACCINE #3 GIVEN 9/8/21, LOT #FC3182; patient passed away at home with COD: complications of COVID 19; no medical records on this patient; PCP unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2451140

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge EN 6201

kritisch

Staat: NY
Alter: 74,0
Geschlecht: M
Eingang: 19.09.2022
Impfdatum: 03.03.2021
Beginn: 02.04.2022
Tage bis Beginn: 395,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Cerebrovascular accident

Symptomtext

Stroke

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2440817

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NY
Alter: 85,0
Geschlecht: F
Eingang: 12.09.2022
Impfdatum: 22.02.2021
Beginn: 14.02.2022
Tage bis Beginn: 357,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Aortic stenosis Asthenia Blood creatinine increased Blood gases Blood urea increased Bronchitis COVID-19 COVID-19 pneumonia Cardiac arrest Cardiac failure Cardiac failure acute Chest X-ray abnormal Creatinine renal clearance decreased Death Dyspnoea Glomerular filtration rate decreased Haemoglobin decreased

Symptomtext

2/14/2022-Presents to weakness and SOB. Covid + test. Recently treated for bronchitis Jan 2022 with amox. 2L NC 95% sat. Afebrile. CXR: Mod right pleural effusion. Hgb 7.1 dropped to 6.5 1 unit PRBC. Admit acute decompensated HF with preserved EF in setting of severe aortic stenosis Covid 19 pneumonia. 2/15/2022- Remdesivir, Decadron and azithromycin started. Ferritin 12.5 iron supplements started. Troponinemia (downtrending) s/t demand ischemia Trop:0.053,0.059 and 0.069. 2/17/2022-AKI worsening, BUN was 71 and 1.4 (baseline creatnine 0.7-1) remdesivir d/c low creatnine clearance. 2/19/2022-AKI worsening with diuresis. Lasix held. Placed on Bipap 16/6 45%. CXR:Worsening bilateral infiltrates 2/19/2022- ABG: 7.154/85.6/73/30.1/95. Need for TAVR held due to acuity. 2/21/2022-Started baricitinib, aztreonam and Vanco continue decadron. 2/21/2022-Sating WDL on Bipap 45%. expiratory wheeze and rhonci noted through night r lung. 2/22/2022-Continues on Bipap, BP range -110/60-118/71 sattng 95% HR range 110-150 a fib. WBC-21.3. TPN started. DNR/DNI on file. Creatnine of 1.3, BUN 105 EGFR 41. Platelets decrease to 50 from 60. ABG: 7.34/60.8/88/33/98 on bipap 2/24/2022- Amiodarone dtt running @ 16.67 ml~/hr HR 60-80's. Continues in Bipap tolerates short period of HFNC. Palliative following family wishes to continue aggressive care. 3/1/2022- WBC-9.4. Platelets 100. BUN 82. Went into sinus brady due to worsening hypoxia leading to asystole. DNR/DNI. Time of death 1941.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 15,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, CHR, A fib, HTN, hx of strokes and Restless leg syndrome,
Andere Medikamente: -
Allergien: alendronate Sodium, Doxycycline, Iodine, gabapentin, Keflex an
Vorherige Impfungen: -

VAERS 2424084

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 30.08.2022
Impfdatum: 17.02.2021
Beginn: 01.03.2022
Tage bis Beginn: 377,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure COVID-19 Death Hypoxia Intensive care Oxygen saturation decreased Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

PFIZER COVID VACCINE #3 GIVEN 9/23/21, LOT #FC3182; 3/2/22 pt had a positive COVID test from a health care facility; 3/7/22 pt started requiring O2 supplementation at home, ordered by PCP (name unknown); 3/10/22 pt seen in cardiac clinic, told to return to hospital d/t worsening hypoxia; started on steroids and dc'd to home on Decadron 3/15/22; 3/17/22 pt to hospital again with O2 desaturation during the night; requiring 35L @70%; admitted ICU with AHRF; DNR/DNI; transitioned to BiPAP; O2 saturation continued to fall; pt made comfort care and passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HFrEF, NICM, Pulmonary Hypertension, A. Fib, HTN, CKD stage III
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2400204

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: GA
Alter: 58,0
Geschlecht: F
Eingang: 27.08.2022
Impfdatum: 12.10.2021
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Cardiomegaly Chest X-ray abnormal Circulatory collapse Dyspnoea Blood test Chest discomfort Chest pain Computerised tomogram coronary artery Fall Fatigue Myocardial infarction Pulmonary thrombosis Palpitations Scan Syncope Scan brain Sluggishness

Symptomtext

No adverse event; This case is invalid due to no adverse event, as assessed by License Partner. This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from License Party. The reporter is the patient. Information was received from a Consumer/other non health professional concerning a 59 Year(s) old Female patient, who received Suspect product APIXABAN for PE (5 milligram(s) from 12-Oct- 2021 2 every 1 Day), lot number:ACA5998P; Suspect product COVID-19 VACCINE for Product used for unknown indication (from 05-Mar-2021), lot numbers: EN5318 and EN6201. On an unknown date, the patient experienced no adverse event(no adverse event) which was considered not serious. The outcome of the event is unknown. The status of APIXABAN medication is unknown. The status of COVID-19 VACCINE medication is unknown. Medical history and concurrent conditions included Blood pressure. Concomitant medication included METOPROLOL. Relevant Laboratory & other Diagnostic Tests On an unknown date, X-RAY: Found out there are blood clots in my lungs, both lungs are full of blood clot., SCAN: Result not provided. The reporter did not provide a causal assessment for event no adverse event to product APIXABAN. The reporter did not provide a causal assessment for event no adverse event to product COVID-19 VACCINE. Tracking of Changes: 23-Jul- 2022: Initial information was received. Follow up (29Jul2022): This is a spontaneous follow up report received from contactable reporter(s) (Consumer or other non HCP) from License Party. Follow up received on 29-Jul-2022 with the following updates: New suspect such as COVID-19 Vaccine was added. Follow-up (10Aug2022): This is a follow up spontaneous report from a contactable consumer. This consumer (Patient) reported in response to Non HCP letter sent which included that: Updated Information included: Patient's weight updated. Lab data captured. Dosage slider #02 added. Dosage slider #01 updated for concomitant medication "Metoprolol". Follow-up attempts are completed. No further information is expected. Follow up (10Aug2022): This is a spontaneous follow up report received from contactable reporter(s) (Consumer or other non HCP) from License Party. Follow up received on 10-Aug-2022 with the following updates: All the reported events were deleted as they were occurred on 12-Oct-2021 (before the start of Eliquis) and the case was made invalid as no adverse event. It was reported that the patient started to take Eliquis since 12-Oct-2021 as the patient collapsed when exercising last year. The patient was rushed to the hospital to find out that both lungs was filled with blood clots in the process of travelling to patient's heart. The patient had to have emergency surgery to keep the bloods from travelling to her heart. The patient never had a problem with blood clots until she took the Pfizer Vaccine. Hence, the case was made Invalid. BMS Comment: This patient was hospitalized due to multiple events after receiving apixaban therapy. Based on the limited information available regarding therapy dates, events onset dates, action taken with the suspect, relevant medical history, treatment given and outcome of the events, it cannot be ascertained with the reasonable possibility that the suspect could have contributed to the events thrombosis, syncope, circulatory collapse, cardiomegaly, pulmonary thrombosis and dyspnea. ELIQUIS is under agreement.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: Test Name: Scan; Result Unstructured Data: Test Result:Result not provided; Test Name: X-RAY; Result Unstructured Data: Test Result:Found out there are blood clots in my lungs, both; Comments: lungs are full of blood clot
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood pressure; Comments: None
Andere Medikamente: METOPROLOL
Allergien: -
Vorherige Impfungen: -

VAERS 2418406

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: F
Eingang: 23.08.2022
Impfdatum: 01.03.2021
Beginn: 01.03.2022
Tage bis Beginn: 365,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Inappropriate schedule of product administration SARS-CoV-2 test positive Unresponsive to stimuli

Symptomtext

pt lives in Unknown, Quality Center for Rehab and Healing; 3/3/22 pt had a positive COVID test in the center; O2 via NC; pt found unresponsive on 3/12/22, pt expired

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: malignant neoplasm left bronchus, COPD, DMT2, CKD, dementia, paroxysmal Atrial Fibrillation
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2415929

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TN
Alter: 99,0
Geschlecht: F
Eingang: 19.08.2022
Impfdatum: 04.03.2021
Beginn: 14.02.2022
Tage bis Beginn: 347,0
Dosis: 2
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Dyspnoea Fall Gait inability General physical health deterioration Loss of personal independence in daily activities Positive airway pressure therapy SARS-CoV-2 test positive Urinary tract infection

Symptomtext

The patient was hospitalized in February 2022 d/t a fall at home, and urinary tract infection. She tested positive for Covid-19 during rehab stay and was returned to the hospital. She required assistance with eating and was non ambulatory and was placed in a nursing facility. She developed SOB with saturation in 70s on 03/09/2022 and was hospitalized again. She continued to decline and has required high flow oxygen and bipap. The family ultimately chose comfort focused care with Hospice Patient expired on 03/17/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2415804

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 71,0
Geschlecht: F
Eingang: 19.08.2022
Impfdatum: 17.03.2021
Beginn: 01.01.2022
Tage bis Beginn: 290,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory distress syndrome Anticoagulant therapy COVID-19 Cough Death Deep vein thrombosis Dyspnoea Endotracheal intubation Fatigue Gastrointestinal haemorrhage General physical health deterioration Hypoxia Intensive care Life support Nausea Positive airway pressure therapy Pyrexia Respiratory disorder

Symptomtext

PFIZER COVID VACCINE #3 GIVEN 11/12/21, LOT #FF2593; 1/8/22 pt had a positive COVID test at Medical Center and was given monoclonal antibodies; 1/27/22 pt to ED and admitted with fever, fatigue, SOB, cough, nausea and vomiting; ARDS; given Decadron, Baricitinib, empiric ABX, O2 supplement; worsening hypoxemia; toggled between BiPAP and Vapotherm; respiratory status continued to worsen; transferred to ICU; intubated RLE DVT, anticoagulation therapy until a GI bleed, then placed IVC filter; pt's condition did not improve, worsened; family decided to withdraw all life support and pt expired in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 42,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN, HYPOTHYROIDISM
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2412409

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 68,0
Geschlecht: F
Eingang: 16.08.2022
Impfdatum: 24.05.2022
Beginn: 15.07.2022
Tage bis Beginn: 52,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Cough Headache Interchange of vaccine products Pain Respiratory failure SARS-CoV-2 test positive

Symptomtext

Patient seen in the ED on 7/15 after testing positive for COVID at home. She reported coughing, headaches, and body aches. COVID-19 PCR swab also done in the ED and was positive. Patient did not feel safe being discharged home, so she was admitted from 7/15-7/18 and diagnosed with acute on chronic hypoxic respiratory failure due to COVID-19. She is vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2412278

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 16.08.2022
Impfdatum: 24.02.2021
Beginn: 01.01.2022
Tage bis Beginn: 311,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Critical illness Death Dyspnoea Endotracheal intubation Enteral nutrition Intensive care Lung disorder Lung infiltration Mechanical ventilation Positive airway pressure therapy SARS-CoV-2 test positive Sedative therapy

Symptomtext

PFIZER COVID #3 VACCINE GIVEN 9/30/21, LOT #FE3592; pt had a positive COVID test on 1/24/22 at the clinic; saw PCP and was given Molnupipavr x 5 days; SOB worsened along with cough; pt to ED 2/1/22; O2 supplement placed; continued to worsen; ABX given; transferred to ICU in critical condition; placed on BiPAP; pulmonary fibrotic changes and multifocal infiltrates notes on CXR; intubated; sedated; ventilated; tube feedings; corticosteroids; failed weaning (O2) trial; DNR; Severe COVID pneumonia; pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 21,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, smokes cigars
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2401389

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 87,0
Geschlecht: M
Eingang: 04.08.2022
Impfdatum: 23.02.2021
Beginn: 01.09.2021
Tage bis Beginn: 190,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Asthenia COVID-19 Death Dyspnoea SARS-CoV-2 test positive

Symptomtext

pt had a positive COVID test on 9/24/21; was weak and had increasing SOB; 9/30/21 pt went to hosp; O2 saturation 70%; placed on O2; pt's condition did not improve; 10/5/21 dc'd to hospice facility with terminal dx; DNR; pt passed away in hospice

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2399153

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

kritisch

Staat: IN
Alter: 70,0
Geschlecht: M
Eingang: 02.08.2022
Impfdatum: 22.11.2021
Beginn: 29.04.2022
Tage bis Beginn: 158,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram pulmonary abnormal Anticoagulant therapy Dyspnoea Pulmonary embolism

Symptomtext

injection dates 11/22/21, 2/23/21, 3/19/21 pulmonary embolism, became short of breath on the morning of admission, presented to the ER and found to have a right sided PE. He was treated appropriately and admitted to hospital for further treatment and evaluation. taking Eliquis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: chest cta
Aktuelle Erkrankungen: -
Vorgeschichte: htn, parkinsonism
Andere Medikamente: ?MiraLax 17 GM Packet 1 packet mixed with 8 ounces of fluid Orally BID ?Aspir-81 81 MG Tablet Delayed Release 1 tablet Orally Once a day ?Metoprolol Succinate ER 200 MG Tablet Extended Release 24 Hour 1/2 tablet Orally Once a day ?
Allergien: Amantadine HCl: psychosis Mirapex: psychosis
Vorherige Impfungen: -

VAERS 2399153

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

kritisch

Staat: IN
Alter: 70,0
Geschlecht: M
Eingang: 02.08.2022
Impfdatum: 22.11.2021
Beginn: 29.04.2022
Tage bis Beginn: 158,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram pulmonary abnormal Anticoagulant therapy Dyspnoea Pulmonary embolism

Symptomtext

injection dates 11/22/21, 2/23/21, 3/19/21 pulmonary embolism, became short of breath on the morning of admission, presented to the ER and found to have a right sided PE. He was treated appropriately and admitted to hospital for further treatment and evaluation. taking Eliquis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: chest cta
Aktuelle Erkrankungen: -
Vorgeschichte: htn, parkinsonism
Andere Medikamente: ?MiraLax 17 GM Packet 1 packet mixed with 8 ounces of fluid Orally BID ?Aspir-81 81 MG Tablet Delayed Release 1 tablet Orally Once a day ?Metoprolol Succinate ER 200 MG Tablet Extended Release 24 Hour 1/2 tablet Orally Once a day ?
Allergien: Amantadine HCl: psychosis Mirapex: psychosis
Vorherige Impfungen: -

VAERS 2396373

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 80,0
Geschlecht: F
Eingang: 29.07.2022
Impfdatum: 01.11.2021
Beginn: 03.07.2022
Tage bis Beginn: 244,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 Cough Escherichia bacteraemia Fall SARS-CoV-2 test positive Septic shock Vaccine breakthrough infection

Symptomtext

Patient with history of COPD. She was brought into the ED on 7/3 by EMS for weakness and a fall. She additionally reported a cough. She was hypoxic per the paramedics and was placed on supplemental O2. COVID-19 PCR test was done in the ED which was positive. Patient admitted from 7/3-7/12, discharge diagnoses included septic shock secondary to E. coli bacteremia and acute hypoxic respiratory failure secondary to COVID infection, among others. This meets criteria for vaccine breakthrough case review.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2370540

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 70,0
Geschlecht: F
Eingang: 15.07.2022
Impfdatum: 24.02.2021
Beginn: 01.08.2021
Tage bis Beginn: 158,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Atrial fibrillation Bradycardia COVID-19 Death Encephalopathy Endotracheal intubation General physical health deterioration Hypoxia Inappropriate schedule of product administration Klebsiella infection Positive airway pressure therapy Pulseless electrical activity Respiratory failure Resuscitation SARS-CoV-2 test positive Sepsis Shock Urinary tract infection

Symptomtext

pt had a positive COVID test on 8/18/21; 9/1/21 pt transferred from Medical Center to another Medical Center for respiratory failure, COVID, acute encephalopathy, Klebsiella UTI, sepsis, A Fib with RVR; had been given dexamethasone; on BiPAP when transferred; condition worsened requiring intubation; worsening shock and hypoxia; suffered bradycardic PEA; meds and CPR administered; family decided on no CPR and pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HYPOTHYROIDISM, HTN, A FIB ON CHRONIC ANTICOAGULATION MEDICATION, CKD STAGE 4-5
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2370247

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 15.07.2022
Impfdatum: 21.01.2021
Beginn: 11.03.2022
Tage bis Beginn: 414,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Death

Symptomtext

Narrative: Patient passed away due to COVID-19. He was on hospice and had received the COVID-19 vaccine,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2367384

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NY
Alter: 83,0
Geschlecht: F
Eingang: 13.07.2022
Impfdatum: 18.10.2021
Beginn: 15.04.2022
Tage bis Beginn: 179,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Atelectasis Blood pressure systolic decreased COVID-19 Cardiac failure congestive Chest pain Computerised tomogram thorax abnormal Condition aggravated Dyspnoea Electrocardiogram normal Hypophagia Hypotension Lung disorder Nausea Troponin increased Vomiting White blood cell count increased

Symptomtext

4/15/2022- Presents to ED via EMS, c/o 1 week history of N/V , SOB , chest pain and decreased PO intake. Troponin 0.408 Seen by Card: review of EKG no ST elevation or STEMI chest CT: Patchy peripheral airspace densities subsegmental atelectasis Admit: Acute respiratory failure Covid 19 and CHF exacerbation. Start remdesivir, Ceftriaxone, doxycyline and heparin. 4/17/2022- Improving, SOb remains. WBC 11. Requiring 1.5 L o2 via NC. VVS BP 103/59. 4/18/2022- Hypotensive event systolic dropped to low 70's. Bolus given 100/62. 4/20/22- BP remains stable 97/60, continues on 1.5 L NC. 4/21/2022- VSS stable. 1.5 L NC 98% sat. WBC 8.9 Discharge to home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Mitral valve clipping x 2, chronic anticoagulation Eliquis, A Fib, CHF, DM type 2, HX of CVA and HTN
Andere Medikamente: -
Allergien: iodine, PCN and Cipro
Vorherige Impfungen: -

VAERS 2366013

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 12.07.2022
Impfdatum: 24.02.2021
Beginn: 01.08.2021
Tage bis Beginn: 158,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Acute respiratory failure COVID-19 Condition aggravated Death Dyspnoea Fatigue Hyperlipidaemia Hypertension Hypertensive urgency Intensive care Renal impairment Respiratory disorder SARS-CoV-2 test positive

Symptomtext

pt states he had a positive COVID test on 8/18/21 and was told by his dr (name not in medical record) to self-isolate; since then he has progressive fatigue and SOB; EMS brought him to ED on 8/23/21; positive for COVID; O2 saturations in the 80s; placed on O2 supplementation; AHRF, hypertensive urgency, AKI, hyperlipemia; hypertension treated also given decadron, vitamins, zinc; transferred to ICU; respiratory status worsened; given Tocilizumab; renal function worsened; pt made a DNR; poor prognosis; comfort care and placed into inpatient hospice where he passed away

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 14,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2359825

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 76,0
Geschlecht: F
Eingang: 06.07.2022
Impfdatum: 27.02.2021
Beginn: 06.10.2021
Tage bis Beginn: 221,0
Dosis: 2
Route/Site: SYR / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury COVID-19 COVID-19 pneumonia Cellulitis Death Multiple organ dysfunction syndrome SARS-CoV-2 test positive Sepsis Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 02/06/2021 and 02/27/2021. There is a third dose in the state immunization system, but it has an administered date of 04/06/2022 which is after this person's death so it is likely this is an error. The individual tested positive for COVID-19 on 10/06/2021 at an out-of-state hospital. They had been hospitalized from 10/04/2021 to 10/19/2021. They were then re-admitted on 10/22/2021. They experienced complications of COVID-19 pneumonia, acute kidney injury, multiple organ failure, sepsis, and cellulitis. They were placed on comfort cares and died on 10/28/2021. Specific state issued the death certificate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 21,0
Labordaten: Positive COVID-19 test on 10/06/2021 despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Renal Failure, Congestive Heart Failure, Type II Diabetes, Obesity, A-Fib, Hypertension, long term issues with open wounds/skin breakdown/wounds not healing
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2320517

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 91,0
Geschlecht: F
Eingang: 15.06.2022
Impfdatum: 25.02.2021
Beginn: 01.01.2022
Tage bis Beginn: 310,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 COVID-19 pneumonia Death Dyspnoea SARS-CoV-2 test positive

Symptomtext

PFIZER COVID VACCINE #3 GIVEN 11/18/22, LOT #32030BD; 1/12/22 pt had a positive COVID test ordered. 1/16/22 pt had a second positive COVID test at Medical Center, dc'd from hospital to another Hospital on 1/19/22; COVID PNA for dyspnea; pt passed away in the hospice facility on 1/23/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CVA, A FIB, HTN, CKD STAGE III
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2313467

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TN
Alter: 78,0
Geschlecht: F
Eingang: 08.06.2022
Impfdatum: 25.02.2021
Beginn: 28.12.2021
Tage bis Beginn: 306,0
Dosis: 2
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Computerised tomogram thorax abnormal Death Endarterectomy Interstitial lung disease Oxygen saturation decreased Pain SARS-CoV-2 test positive

Symptomtext

Patient had recent endarterectomy presented to ED with c/o of stating her oxygen has been dropping. Patient has mild pain on left side, in ED CT showed severe bilateral multifocal mixed interstitial alvelolar PNA. Patient was placed on NC oxygen. Patient was admitted to hospital services. On 12/28/2021, rapid response called, family requested hospice services. Covid-19 PCR came back positive on 12/29/2021. Patient expired on 12/30/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2305328

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 01.06.2022
Impfdatum: 27.02.2021
Beginn: 01.07.2021
Tage bis Beginn: 124,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cardiac arrest Cardio-respiratory arrest Chest X-ray abnormal Confusional state Death Hypoxia Intentional medical device removal by patient Oxygen saturation decreased Pneumonia Positive airway pressure therapy Respiratory failure Resuscitation Systemic candida White blood cell count increased

Symptomtext

9/10/21 pt dc'd from hosp after hypoxic respiratory failure; 9/11/21 pt back to the hosp with confusion and hypoxia from SNF; pt was removing BiPAP in SNF and O2 sats were 71%; admitted with chronic hypoxic respiratory failure; placed on 4L via NC; elevated WBC; placed on BiPAP; CXR showed pneumonia pattern; given antibiotic; candidemia; given antifungal regime; pt experienced asystole, code blue called, CPR done; pt is a DNI; ROSC achieved for a brief period but oxygenation was poor; pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DMT2
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2305154

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 01.06.2022
Impfdatum: 18.02.2021
Beginn: 01.02.2022
Tage bis Beginn: 348,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Death Endotracheal intubation Hypotension Multiple organ dysfunction syndrome Respiratory failure SARS-CoV-2 test positive Sepsis

Symptomtext

Pfizer COVID vaccine #3 given 10/06/2021, lot #30158A; pt had a positive COVID test on 2/22/22; 4/25/22 pt admitted to hospital with another positive COVID test, as a transfer from medical center; pt in respiratory failure, intubated; sepsis; hypotension; O2 sats 86% on 6 L via NC; on ABX, steroids; multi-organ failure; transitioned to comfort care/hospice; pt died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: non-Hodgkin's lymphoma
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2303498

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TN
Alter: 77,0
Geschlecht: F
Eingang: 31.05.2022
Impfdatum: 12.02.2021
Beginn: 21.02.2022
Tage bis Beginn: 374,0
Dosis: 2
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Atrial fibrillation COVID-19 Cardiac failure congestive Chronic kidney disease Chronic left ventricular failure Confusional state Death Diabetes mellitus Mental status changes Metabolic encephalopathy Oxygen saturation decreased Pneumonia aspiration Respiratory failure SARS-CoV-2 test positive Vomiting

Symptomtext

Patient brought to ED shortly after testing positive for Covid-19 d/t increased confusion, vomiting, and decreasing oxygen saturation. Patient was admitted to hospital services with acute hypoxemic respiratory failure secondary to covid-9. Patient was unable to be on BiPap with vomiting. Patient started on Bronchodilator, dexamethasone and remdesivir and Baricitinib. Patient expired on 02/21/2022 with diagnosis of acute metabolic encephalopathy, Afib, AMS, aspiration PNA, CKD, Covid-19 virus infection, chronic combined systolic and diastolic CHF, Diabetes, Respiratory failure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2303341

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 31.05.2022
Impfdatum: 23.02.2021
Beginn: 01.10.2021
Tage bis Beginn: 220,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 COVID-19 pneumonia Death Dyspnoea SARS-CoV-2 test positive

Symptomtext

pt tested positive for COVID on 10/24/21; 10/25/21 family brought pt to hosp requesting care, stating they were unable to care for him any longer; dx with COVID pneumonia; some dyspnea but not requiring O2 supplementation; started on ABX; began to prepare to transition him to hospice care; DNR; 10/29/21 dc'd pt to Hospice where he passed away; DC and med records sent to vaers website

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: FTT, ESRD on dialysis, DM, HTN, CAD, GERD, hyperlipidemia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2294458

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 77,0
Geschlecht: M
Eingang: 25.05.2022
Impfdatum: 18.02.2021
Beginn: 01.08.2021
Tage bis Beginn: 164,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

pt died at hospice; positive COVID test on 8/30/21 from medical center; DC and med records sent per request.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: ESRD, DMT2, gangrene
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2283266

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 92,0
Geschlecht: F
Eingang: 18.05.2022
Impfdatum: 18.02.2021
Beginn: 11.10.2021
Tage bis Beginn: 235,0
Dosis: 2
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 COVID-19 pneumonia Death Dyspnoea Pancytopenia Pyrexia SARS-CoV-2 test positive Septic shock Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 01/28/2021 and 02/18/2021. They presented to emergency department on 10/11/2021 with primary concerns of shortness of breath and fever which had been happening for about 2 days (symptom onset approx. 10/09/2021). They were admitted to hospital on 10/11/2021 and tested positive for COVID-19 upon admission. They experienced complications of COVID-19 pneumonia, septic shock, and pancytopenia. They remained hospitalized until their death on 10/16/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 5,0
Labordaten: Positive COVID-19 tests x2 on 10/11/2021 despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Metastatic Brest Cancer, Past history of squamous cell skin cancer, past history of basal cell carcinoma, hypertension, Hypothyroidism, Previous myocardial infarction, paroxysmal A-Fib
Andere Medikamente: Chemotherapy for metastatic breast cancer
Allergien: -
Vorherige Impfungen: -

VAERS 2278860

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 78,0
Geschlecht: M
Eingang: 16.05.2022
Impfdatum: 20.02.2021
Beginn: 29.09.2021
Tage bis Beginn: 221,0
Dosis: 2
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 COVID-19 pneumonia Coagulopathy Death Dyspnoea Encephalopathy Gastrointestinal haemorrhage Respiratory failure SARS-CoV-2 test positive Shock Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 01/30/2021 and 02/20/2021. They tested positive for COVID-19 on 09/29/2021 and again on 10/02/2021. They presented to emergency department via EMS on 10/06/2021 with a primary concern of shortness of breath. They were admitted to hospital same day. The individual was found to be having complications and co-occurring conditions including coagulopathy, encephalopathy, COVID-19 pneumonia, hypoxic respiratory failure, shock, and a Gastrointestinal Bleed. They remained hospitalized until their death on 10/12/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: Positive COVID-19 test on 09/29/2021 and 10/02/2021 (x2) despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Congestive Heart Failure, End-Stage Renal Disease, Gout, Hypertension, Obstructive Sleep Apnea, COPD, Waldenstrom macroglobulinemia, IgM monoclonal gammopathy, past history of Deep Vein Thrombosis, Implantable Cardioverter-Defibrillator in place, atrial flutter,
Andere Medikamente: -
Allergien: Amiodarone (reaction: rash)
Vorherige Impfungen: -

VAERS 2273140

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 69,0
Geschlecht: M
Eingang: 09.05.2022
Impfdatum: 22.02.2021
Beginn: 08.02.2022
Tage bis Beginn: 351,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chronic obstructive pulmonary disease Death Dyspnoea Metapneumovirus infection Pneumonia Respiratory failure SARS-CoV-2 test positive

Symptomtext

Narrative: Hospitalization - pt admitted on 1/9/22 for SOB. Prolonged hospital course for PNA, human metapneumovirus, COPD exacerbation. Found to be COVID-19 positive on 2/8/22 (while admitted), fully vaccinated (not boosted). Patient died on 2/15/22 of hypoxic respiratory failure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2266513

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 74,0
Geschlecht: M
Eingang: 06.05.2022
Impfdatum: 18.02.2021
Beginn: 16.09.2021
Tage bis Beginn: 210,0
Dosis: 2
Route/Site: SYR / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Dyspnoea Malaise SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 01/28/2021 and 02/18/2021. They became symptomatic on approx 09/11/2021 with shortness of breath. They tested positive for COVID-19 on 09/16/2021, at the hospital. They were in palliative care at a care facility since May 2021. They died on 09/21/2021. I see an admit/discharge for the hospital indicated below for 09/08/2021-09/21/2021 but clinical notes dated 09/21/2021 indicate the induvial was receiving care at the care facility indicted in the address portion of this form on the day of their death (09/21/2021).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 13,0
Labordaten: Positive COVID-19 test on 09/16/2021 despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Systolic heart failure, ischemic heart disease, Type 2 Diabetes Mellitus (with insulin pump), Coronary Artery Disease, Obstructive Sleep Apnea, Hyperlipidemia, Chronic Kidney Disease (Stage III), Stented Coronary Artery, Hypothyroidism, Morbid Obesity, Acromegaly (history of partial pituitary adenectomy), Dementia, Bladder Cancer, Testosterone Deficiency, Depression, Chronic Back Pain, Peripheral Vascular Disease The individual a resident of the care center indicated in the Address portion since May 2021, a few months prior to the adverse event.
Andere Medikamente: -
Allergien: Penicillin (reaction: severe wheezing)
Vorherige Impfungen: -

VAERS 2263559

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: PA
Alter: 19,0
Geschlecht: F
Eingang: 04.05.2022
Impfdatum: 16.02.2021
Beginn: 01.03.2021
Tage bis Beginn: 13,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Antineutrophil cytoplasmic antibody positive Autopsy Bronchoscopy abnormal Chest X-ray abnormal Computerised tomogram thorax abnormal Cough Death Fatigue Granulomatosis with polyangiitis Nasal congestion Pulmonary mass Sinus pain

Symptomtext

In the spring after her vaccination, patient developed increased nasal congestion and sinus pain. She was seen in the summer of 2021 by both an Allergist and an ENT for what was thought to be worsening allergies. They all missed that she had Wegener's GPA. She was treated by multiple providers with antibiotics and allergy medication, but she did not have a sinus infection. She developed a cough and fatigue in September 2021. She was treated with steroids along with a 2nd course of antibiotics, and then a 3rd antibiotic without any lab testing. She died on October 12, 2021 at hospital after having a bronchoscopy. She was not diagnosed with Wegener's GPA until after she passed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 4,0
Labordaten: She was seen at urgent care on Saturday 10/9/21 and then hospitalized. CT and CXR showed cavitary lesions. Her pANCA was positive. Her autopsy confirmed Wegener's GPA.
Aktuelle Erkrankungen: -
Vorgeschichte: allergies as above
Andere Medikamente: -
Allergien: season, cats, dogs, pollen, dust mites
Vorherige Impfungen: -

VAERS 2261827

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NY
Alter: 74,0
Geschlecht: M
Eingang: 03.05.2022
Impfdatum: 24.09.2021
Beginn: 05.01.2022
Tage bis Beginn: 103,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Alanine aminotransferase increased Aspartate aminotransferase increased Asthenia Bacteraemia Blood culture positive Body temperature increased C-reactive protein increased COVID-19 COVID-19 pneumonia Chills Cough Dizziness Echocardiogram normal Hypervolaemia Liver function test Pneumonia SARS-CoV-2 test positive

Symptomtext

1/3/2022- Arrived at ER, c/o weakness, dizziness, chills and cough. T-100.7 .WBC-14. CRP-13.9 Covid + test. O2 sat 88% placed on 4L o2 via NC, maintaining O2 around mid 90's. Admit with acute hypoxic respiratory failure with sepsis and bilateral Covid-19 pneumonia. Started on IV decadron, baricitinib and remdesivir. IV Ceftriaxone and Doxycycline. 1/6/2022- D/C decadron-volume overload. Continue baricitinib, remdesivir and Doxycycline. Positive Blood culture Beta-hemolytic strep B, ceftriaxone ordered. D/C Vancomycin. 1/7/2022- WBC 10.8. CRP 5.7, afrebile and no supplemental oxygen needed. 1/10/2022- LFT's- AST 61 ALT 92, CRP 3.1. WBC-17.2 1/12/2022- WBC down to 16.3 Continue IV antibiotics for bacteremia.TEE co 1/12/2022- TEE completed-unremarkable. 1/13/2022- WBC down to 11.4 and CRP was 3.1. Continue Rocephin for 4 weeks. Discharged to home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Asthma, HTN,Hyperlipidemia, Type 2 DM, OSA, Morbid obesity, A-Fib
Andere Medikamente: -
Allergien: Iodine and shellfish
Vorherige Impfungen: -

VAERS 2261730

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 82,0
Geschlecht: F
Eingang: 03.05.2022
Impfdatum: 24.02.2021
Beginn: 01.01.2022
Tage bis Beginn: 311,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury COVID-19 Chronic obstructive pulmonary disease Condition aggravated Cough Death Dyspnoea Dyspnoea exertional General physical health deterioration Intensive care Oropharyngeal pain Pneumonia Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

pt had an earlier hosp admission 1 wk before this hospitalization, dx with pneumonia and COPD exacerbation, was dc'd to home; 1/13/22 back to ED with c/o worsening SOB especially with exertion; sore throat, non-productive cough, states O2 sats at home in the 80s; found to be positive for COVID; treated with ABX, steroids, O2 supplementation; pt's status worsened; transferred to ICU; AKI; increase in O2 needs; placed on BiPAP; family made pt DNR/DNI; pt expired in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 16,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, chronic hypoxic respiratory failure
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2260591

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 74,0
Geschlecht: F
Eingang: 02.05.2022
Impfdatum: 25.02.2021
Beginn: 29.10.2021
Tage bis Beginn: 246,0
Dosis: 2
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Bradycardia COVID-19 Death Decubitus ulcer Dysarthria Hypotension Hypothermia Hypoxia Pneumonia SARS-CoV-2 test positive Sepsis Staphylococcal infection Unresponsive to stimuli Urinary tract infection Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 02/04/2021 and 02/25/2021. They were brought to Emergency Department via ambulance after experiencing "garbled speech" which was concerning. Paramedics determined the individual was hypoxia (O2 at 69%), hypothermic, bradycardic, and hypotensive. They were unresponsive upon arrival to Emergency Department. They were admitted and tested positive for COVID-19 upon admission. They were found to be experiencing multiple complications and conditions in addition to the chronic conditions listed earlier in this form. They were found to have pneumonia, multiple decubiti, hypothermia (body temperature 36 C), an MRSA Urinary Tract Infection, and be septic. The individual's condition did not improve and they were transitioned to comfort cares only on 10/30/2021. They remained hospitalized until their death on 10/31/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 2,0
Labordaten: Positive COVID-19 test on 10/29/2021 despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Metastatic Breast Cancer to Bone; A-Fib; Obstructive Sleep Apnea, Chronic Kidney Disease, Hypotension; Hypothyroidism,
Andere Medikamente: -
Allergien: Penicillin (reaction: hives)
Vorherige Impfungen: -

VAERS 2260293

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 87,0
Geschlecht: F
Eingang: 02.05.2022
Impfdatum: 22.02.2021
Beginn: 26.04.2022
Tage bis Beginn: 428,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Cough Death of relative Malaise Nausea Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

First thing is COVID-19 infection. the Patient's husband recently died, and her whole immediate family developed COVID-19 after the funeral. She started to have symptoms yesterday. And she tested positive this morning. This is a home test. The patient has a sore throat and slight cough. She is not short of breath. She has not had fevers. She does have some nausea.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death of relative
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2254753

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 77,0
Geschlecht: M
Eingang: 27.04.2022
Impfdatum: 25.02.2021
Beginn: 01.01.2022
Tage bis Beginn: 310,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Asthenia COVID-19 Chronic kidney disease Confusional state Death Dyspnoea General physical health deterioration Hypoxia Intensive care Paracentesis Positive airway pressure therapy Productive cough SARS-CoV-2 test positive Tachypnoea Ventricular tachycardia

Symptomtext

pt had a positive COVID test on 1/17/22 and has been seeing a Home Health Nurse (name of agency not known); EMS brought pt to hospital on 1/24/22 with an increase in SOB, weakness, wet cough, tachypnea, and confusion; pt was hypoxic on RA; admitted; O2 supplementation; AKI on CKD; dexamethasone; placed on BiPAP; paracentesis performed; pt's condition worsened; wife decided to make pt DNR/DNI; pt worsened and went into V Tach; admitted to ICU where pt expired.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2254711

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 69,0
Geschlecht: F
Eingang: 27.04.2022
Impfdatum: 17.03.2021
Beginn: 21.09.2021
Tage bis Beginn: 188,0
Dosis: 1
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 COVID-19 pneumonia Cough Death Diarrhoea Dyspnoea Nausea Pulmonary embolism Pulse absent Pyrexia Respiratory distress Resuscitation SARS-CoV-2 test positive Vaccine breakthrough infection Vomiting

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 02/24/2021 and 03/17/2021. They were brought to emergency department on 09/21/2021 in respiratory distress. They reported about a week of fever, cough, shortness of breath, nausea, vomiting, and diarrhea. Laying down flat made shortness of breath worse. They were admitted to hospital same day and tested positive for COVID-19 upon admission on 09/21/2021. They were diagnosed with COVID-19 pneumonia and to have a pulmonary embolism. They were in process of being prepped for intubation when pulse was suddenly lost. The family opted to discontinue CPR and death was called on 09/21/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 1,0
Labordaten: Positive COVID-19 test on 09/21/2021 despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: The individual was having work-ups done and evaluated, trying to get a diagnosis for chronic back pain that was not explained by any obvious cause.
Andere Medikamente: -
Allergien: Soy (GI Intolerance) Lactose (GI Intolerance) Lactase (GI Intolerance) Alcohol (reaction: other, not specified)
Vorherige Impfungen: -

VAERS 2231815

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 74,0
Geschlecht: M
Eingang: 13.04.2022
Impfdatum: 10.03.2021
Beginn: 08.10.2021
Tage bis Beginn: 212,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury COVID-19 COVID-19 pneumonia Death Dyspnoea Respiratory failure SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 02/18/2021 and 03/10/2021. They tested positive for COVID-19 via PCR test on 10/08/2021. They presented to emergency department on 10/16/2021 with primary complaint of shortness of breath. They were admitted to hospital on 10/16/2021. They experienced complications of COVID-19 pneumonia, an acute kidney injury, and hypoxic respiratory failure. They remained hospitalized until their death on 10/24/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: Positive COVID-19 test on 10/08/2021 despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Diastolic Congestive Heart Failure, History of Cerebrovascular Accident (without residual deficits); Uncontrolled Type II Diabetes (no long term current insulin use); Hypertension; Benign Prostatic Hyperplasia with Nocturia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2231157

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 51,0
Geschlecht: M
Eingang: 13.04.2022
Impfdatum: 23.12.2021
Beginn: 01.12.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction COVID-19 Cardio-respiratory arrest Chest pain Death Dyspnoea Electrocardiogram abnormal Intensive care Productive cough Resuscitation SARS-CoV-2 test positive Stent placement Ventricular fibrillation Ventricular tachycardia

Symptomtext

pt brought to ED with c/o chest pain; states has had SOB, productive cough x 1 wk; found to be positive for COVID; O2 supplementation; EKG showed inferior STEMI; prepped for cath lab; 2 stents placed; admitted to ICU; continued to have chest pain despite additional O2; code blue called later and pt developed a pulseless VT then VF; ROSC was never achieved with continued CPR; pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN, CHF, DM
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2228484

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 69,0
Geschlecht: F
Eingang: 12.04.2022
Impfdatum: 27.02.2021
Beginn: 01.01.2022
Tage bis Beginn: 308,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Anticoagulant therapy Asthenia COVID-19 Cerebral haemorrhage Computerised tomogram head abnormal Cough Death Dyspnoea Hemiparesis Hyporesponsive to stimuli Hypoxia Intensive care SARS-CoV-2 test positive

Symptomtext

pt states she had a positive COVID test on 1/16/22; came to ED on 1/19/22 with SOB, weakness, cough; found to be hypoxic; O2 supplementation; admitted and given dexamethasone and started on Lovenox; on 1/23/22 a code FAST was called due to pt being less responsive and right sided weakness; transferred to CCU; head CT scan showed intraparenchymal hemorrhage, possible deep vessel aneurysm; family requested no interventions; transitioned to comfort care; pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2220997

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WA
Alter: 59,0
Geschlecht: M
Eingang: 07.04.2022
Impfdatum: 19.02.2021
Beginn: 22.02.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram Angiogram pulmonary Catheter placement Computerised tomogram abdomen Deep vein thrombosis Pulmonary embolism Scan with contrast Stent placement Thrombectomy Thrombolysis Ultrasound Doppler abnormal Venogram abnormal

Symptomtext

1. Acute bilateral pulmonary emboli. 2. Extensive left lower extremity deep vein thrombosis. 3. Status post catheter insertion into left lower extremity with tPA thrombolysis and thrombectomy. 4. Status post venogram and stent placement into left iliac to common femoral artery

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: Venous duplex ultrasound of the left lower extremity. CT angiogram of the lungs. CT venogram. IR angiogram procedure. CT abdomen and pelvis with IV contrast
Aktuelle Erkrankungen: None.
Vorgeschichte: Rheumatoid arthritis, pre-diabetes
Andere Medikamente: diclofenac 75mg daily as needed. unsure if was taking Kevzara 200mg/1.14ml solution
Allergien: none
Vorherige Impfungen: -

VAERS 2218293

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 77,0
Geschlecht: M
Eingang: 06.04.2022
Impfdatum: 21.02.2021
Beginn: 01.01.2022
Tage bis Beginn: 314,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Asthenia COVID-19 Cardio-respiratory arrest Death Endotracheal intubation General physical health deterioration Hyperkalaemia Intensive care Resuscitation Sepsis Wound infection

Symptomtext

pt admitted to hosp from ED with generalized weakness; found to be positive for COVID; O2 supplementation; pt experienced cardiorespiratory arrest; CPR; intubated; transferred ICU; family then made pt DNR; AKI with hyperkalemia; sepsis from multiple infected chronic wounds - pt not stable enough to have surgery on wounds; pt's condition worsened requiring 3 vasopressors; transitioned to comfort care; pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2218115

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TN
Alter: 78,0
Geschlecht: M
Eingang: 06.04.2022
Impfdatum: 26.02.2021
Beginn: 31.12.2021
Tage bis Beginn: 308,0
Dosis: 2
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Inappropriate schedule of product administration

Symptomtext

Information unavailable. Patient died at home. Covid 19 listed as a cause of death on death certificate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2216072

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 92,0
Geschlecht: M
Eingang: 05.04.2022
Impfdatum: 28.09.2021
Beginn: 28.01.2022
Tage bis Beginn: 122,0
Dosis: 2
Route/Site: SYR / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Pneumonia Respiratory failure SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 01/28/2021, 02/17/2021, and 09/28/2021. The first doses were administered at the facility specified above. The third dose was administered at the Clinic. It is not known if the individual had a specific symptom onset, but tested positive for COVID-19 on 01/28/2022. They were also admitted to hospital on 01/28/2022. They experienced complications of pneumonia and respiratory failure. They were transitioned to comfort care only and died on 02/05/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: Positive COVID-19 test despite being vaccinated and boosted.
Aktuelle Erkrankungen: -
Vorgeschichte: Hypothyroidism, A-Fib
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2211537

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 37,0
Geschlecht: F
Eingang: 01.04.2022
Impfdatum: 04.03.2021
Beginn: 01.08.2021
Tage bis Beginn: 150,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram Heavy menstrual bleeding Pulmonary embolism Thrombosis Ultrasound scan

Symptomtext

In August 2021, my period became very very heavy which is not normal for me. Then in March 2022 I developed a blot clot in my right lower leg that broke off and went up into both of my lungs causing bilateral pulmonary embolisms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: Ultrasound, CT scans (3/13/2022)
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2206456

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 75,0
Geschlecht: F
Eingang: 30.03.2022
Impfdatum: 23.02.2021
Beginn: 29.03.2022
Tage bis Beginn: 399,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Dyspnoea SARS-CoV-2 test positive Upper respiratory tract infection

Symptomtext

Pt has a history of CAD, status post CABG, history of lung cancer status post lobectomy, diabetes, and obesity. She has had 8 days of increased work of breathing at which time she states she caught a URI. She is COVID positive and admitted with acute hypoxic respiratory failure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2204042

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 29.03.2022
Impfdatum: 23.02.2021
Beginn: 16.09.2021
Tage bis Beginn: 205,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 COVID-19 pneumonia Chest tube insertion Death Dialysis Dyspnoea Endotracheal intubation General physical health deterioration Oxygen saturation decreased Pneumothorax Renal failure Tachypnoea

Symptomtext

pt had an earlier hospitalization from 9/14/21 - 9/15/21 with a diagnosis of COVID; was dc'd to home and instructed to receive antibody infusions the following day; pt unable to receive infusions due to low O2 sats; sent to the hospital; readmitted with developing COVID pneumonia; pt with SOB, tachypnea; admitted; O2 supplementation; pt had a pneumothorax and had a right thoracostomy tube placed; pt's condition worsened; given decadron and baricitinib; intubated; renal failure with 1 dialysis; pt's condition deteriorated more and he expired in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 14,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: A FIB, HTN, SICK SINUS SYNDROME WITH PACEMAKER, MI WITH 3 STENTS, NEUROPATHY BILATERAL LEGS
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2198621

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: AR
Alter: 82,0
Geschlecht: M
Eingang: 25.03.2022
Impfdatum: 12.02.2021
Beginn: 24.03.2022
Tage bis Beginn: 405,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Pt received x3 doses of covid vaccine and was admitted to the hospital o 3/24/22 with covid and died on 3/25.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 2,0
Labordaten: Positive covid test on 3/24/22
Aktuelle Erkrankungen: Unknown
Vorgeschichte: At risk for sleep apnea, barretts esophagus, dementia, depression, HTN, and hypercholesterolemia
Andere Medikamente: Unknown
Allergien: None
Vorherige Impfungen: -

VAERS 2193025

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 85,0
Geschlecht: M
Eingang: 22.03.2022
Impfdatum: 17.03.2021
Beginn: 04.01.2022
Tage bis Beginn: 293,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acquired diaphragmatic eventration Acute respiratory failure Alanine aminotransferase increased Albumin globulin ratio Allen's test Anion gap Aspartate aminotransferase increased Base excess Basophil count decreased Basophil percentage decreased Blood albumin normal Blood alkaline phosphatase normal Blood bicarbonate increased Blood bilirubin normal Blood calcium normal Blood chloride decreased Blood creatinine normal Blood culture

Symptomtext

1/4/22 86-year-old male with a history of ILD with chronic respiratory failure presented with acute on chronic hypoxemic respiratory failure secondary to COVID-19 pneumonia. He declined rapidly. We were unable to achieve SPO2 greater than 80 to 100% FiO2 with nonrebreather. Family did not wish to escalate care further and preferred to proceed with comfort focused care. Spoke with daughter, POA, and she informed me that the plan was to maintain full treatment until family could arrive. Family arrived on 1/5 and we initiated comfort focused treatment. Hospice was consulted. Consents were signed for inpatient scatter bed. Patient to be discharged/readmitted to scatter bed. Hospice following His symptoms were treated. He appeared to remain comfortable. The patient expired secondary to acute on chronic hypoxemic respiratory failure secondary to covid 19 pneumonia in the setting of advanced interstitial lung disease @ 0203 hours 1/7/2022 REVIEW OF SYSTEMS Review of Systems Constitutional: Negative for chills and fever. HENT: Negative for sore throat and neck pain. Eyes: Negative for visual disturbance. Respiratory: Positive for cough and shortness of breath. Negative for chest tightness. Cardiovascular: Negative for chest pain and leg swelling. Gastrointestinal: Negative for abdominal pain, diarrhea, nausea and vomiting. Genitourinary: Negative. Musculoskeletal: Positive for myalgias. Skin: Negative for rash. Neurological: Negative for dizziness, syncope and headaches. Psychiatric/Behavioral: Negative for agitation and behavioral problems. CBC W/DIFF - Abnormal White Blood Count 6.16 4.5 - 11.0 10*3/uL Red Blood Count 4.50 4.5 - 5.9 10*6/uL Hemoglobin 13.4 (*) 13.5 - 17.5 g/dL Hematocrit 43.0 41.0 - 53.0 % Mean Corpuscular Volume 95.6 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 29.8 26.0 - 34.0 pg Mean Corpuscular HGB Conc 31.2 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 12.9 12.0 - 16.8 % Platelet Count 160 140 - 440 10*3/uL Mean Platelet Volume 11.3 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 71.2 45 - 80 % Lymphocyte % 14.3 (*) 15 - 50 % Monocyte % 13.8 0 - 15 % Eosinophil% 0.0 0 - 7 % BASO% 0.2 0 - 2 % Immature Granulocyte% 0.5 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 4.39 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 0.88 0.7 - 5.5 10*3/uL Monocyte Absolute 0.85 0.0 - 1.7 10*3/uL EOS-Absolute 0.00 0.0 - 0.8 10*3/uL Basophil Abs 0.01 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.03 0.00 - 0.10 10*3/uL COMPREHENSIVE METABOLIC PANEL (CMP) - Abnormal Sodium 138 136 - 145 mmol/L Potassium 4.6 3.5 - 5.1 mmol/L Chloride 94 (*) 98 - 107 mmol/L Carbon Dioxide 30 (*) 22 - 29 mmol/L Anion Gap 14 (*) 5 - 13 (arb'U) Glucose 97 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 26 8 - 26 mg/dL Creatinine-Blood 1.20 (*) 0.73 - 1.18 mg/dL BUN/Creatinine Ratio 21.7 RATIO Estimated GFR 57 (*) >60 /1.73 m2 Estimated GFR if (Privacy) >60 >60 /1.73 m2 Total Protein 6.3 6.2 - 8.0 g/dL Albumin 3.6 3.2 - 4.6 g/dL Globulin 2.7 1.5 - 4.5 g/dL Albumin/Globulin Ratio 1.3 1.1 - 2.5 RATIO Calcium 9.0 8.4 - 10.2 mg/dL Total Bilirubin 0.7 0.2 - 1.2 mg/dL AST/SGOT 88 (*) 5 - 34 U/L ALT/SGPT 67 (*) 0 - 55 U/L Alkaline Phosphatase 57 40 - 150 U/L TROPONIN - Abnormal Troponin 0.039 (*) 0.000 - 0.034 ng/mL ARTERIAL BLOOD GAS - Abnormal Allen Test POSITIVE (arb'U) Temperature-ABG 37.0 37.0 Cel pH-ABG 7.45 7.35 - 7.45 PH PCO2-ABG 47 35 - 48 mm(Hg) PO2-ABG 56 (*) 83 - 108 mm(Hg) HCO3-ABG 33 (*) 22 - 30 mmol/L TC02-ABG 34 (*) 22 - 30 mmol/L Base Excess-ABG 7.5 (*) 0 - 3 mmol/L O2 Sat-ABG 90.6 (*) 95.0 - 98.0 % FIO2-ABG 60.0 20 - 100 % CULTURE, BLOOD CULTURE, BLOOD B-TYPE NATRIURETIC PEPTIDE B-Type Natriuretic Peptide 111.2 4 - 254 pg/mL LACTIC ACID Lactic Acid 1.3 0.7 - 2.0 mmol/L 1/4/22 Chest xray IMPRESSION: Right greater than left patchy infiltrate which could represent pulmonary edema and/or multifocal pneumonia superimposed on chronic volume loss and scarring of the prominently elevated right lung base/hemidiaphragm

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 1,0
Labordaten: 1/4/22 COVID-19 Result Detected
Aktuelle Erkrankungen: -
Vorgeschichte: history of metastatic prostate cancer, restrictive lung disease, Chronic Resp failure, Diastolic Dysfunction, HTN, Obesity Anxiety o Arthritis OSTEO/FEET o Cancer (CMS/HCC) PROSTATE o Compression fracture of L1 lumbar vertebra (CMS/HCC) o Compression fracture of L3 lumbar vertebra o Compression fracture of L5 lumbar vertebra o Compression fracture of T12 vertebra (CMS/HCC) o Depression o Difficulty walking use of cane for ambulation o ED (erectile dysfunction) o GERD (gastroesophageal reflux disease) o H/O prostatectomy 1993 o History of cholecystectomy 1992 o History of hip surgery 1998 hip replacement right hip o Hyperlipidemia o Hypertension o Kidney stone o Metastasis to bone (CMS/HCC) 11/6/2017 o Midline low back pain o Neuropathy N/T BILAT FEET o Pathologic fracture Pathologic fx probably secondary to prostate cancer of T11, T12, L1, L3, L5 and possibly L4. o Renal insufficiency
Andere Medikamente: albuterol-ipratropium 0.5-2.5 mg/3 mL nebulizer albuterol-ipratropium 0.5-2.5 mg/3 mL nebulizer Take 1 ampule by nebulization every 4 (four) hours as needed for Wheezing or Shortness of Air Dx: R06.02, R06.2, J44.1. ALPRAZolam 0.25 MG tab
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2189755

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MO
Alter: 67,0
Geschlecht: F
Eingang: 21.03.2022
Impfdatum: 12.03.2021
Beginn: 25.02.2022
Tage bis Beginn: 350,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

ADMITTED TO HOSPITAL

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2188318

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WA
Alter: 70,0
Geschlecht: F
Eingang: 18.03.2022
Impfdatum: 07.02.2021
Beginn: 14.03.2022
Tage bis Beginn: 400,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Intensive care SARS-CoV-2 test positive

Symptomtext

Patient received Pfizer COVID vaccine on 1/17/21 and 2/7/21. Patient tested positive for COVID at her AFH on 3/14/22 and was transferred to our inpatient facility with ambulance. Main admission diagnosis: acute hypoxemic respiratory failure due to COVID-19. Patient was in CCU from 3/14/22 to 3/16/22 and currently in med/surg unit from 3/16/22. Earliest anticipated discharge is 3/21/22 pending caregiver availability.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: COVID status positive 3/14/22 at AFH (external result).
Aktuelle Erkrankungen: -
Vorgeschichte: AFH resident with a history of dementia, COPD/asthma, HFpEF, CKD 3, prior issues with PE and PNA
Andere Medikamente: acetaminophen, albuterol inh, atorvastatin, budesonide/formoterol inh, buspirone, duloxetine, fluticasone nasal sp, furosemide, melatonin, memantine, methadone, nitroglycerin sl, pantoprazole, polyethylene glycol, pregabalin, tiotropium inh
Allergien: aspirin, epinephrine
Vorherige Impfungen: -

VAERS 2184160

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 17.03.2022
Impfdatum: 25.02.2021
Beginn: 30.01.2022
Tage bis Beginn: 339,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death Inappropriate schedule of product administration

Symptomtext

VAERS reporting as required by law, death occurred on 01/30/2022. Pfizer COVID 19 vaccines completed on 2/3/2021 and 2/25/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2128449

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TN
Alter: 78,0
Geschlecht: M
Eingang: 15.03.2022
Impfdatum: 13.02.2021
Beginn: 06.03.2021
Tage bis Beginn: 21,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Intensive care SARS-CoV-2 test positive

Symptomtext

Patient passed away from COVID

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Afib, CHF, watchman device, HTN, CAD, T2DM,
Andere Medikamente: Cetirizine 10mg PO Qdaily Amiodarone 100mg PO Qdaily Atorvastatin 20mg PO QHS Carvedilol 3.125mg PO BID Lisinopril 2.5mg PO QDaily Omega-3 Fatty Acids/Fish Oil 1,000mg PO Qdaily Spironolactone 12.5mg PO Qdaily Aspirin 81mg PO BID KCl 10 mE
Allergien: codeine, oxycodone
Vorherige Impfungen: -

VAERS 2128449

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TN
Alter: 78,0
Geschlecht: M
Eingang: 15.03.2022
Impfdatum: 13.02.2021
Beginn: 06.03.2021
Tage bis Beginn: 21,0
Dosis: 1
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Intensive care SARS-CoV-2 test positive

Symptomtext

Patient passed away from COVID

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Afib, CHF, watchman device, HTN, CAD, T2DM,
Andere Medikamente: Cetirizine 10mg PO Qdaily Amiodarone 100mg PO Qdaily Atorvastatin 20mg PO QHS Carvedilol 3.125mg PO BID Lisinopril 2.5mg PO QDaily Omega-3 Fatty Acids/Fish Oil 1,000mg PO Qdaily Spironolactone 12.5mg PO Qdaily Aspirin 81mg PO BID KCl 10 mE
Allergien: codeine, oxycodone
Vorherige Impfungen: -

VAERS 2172601

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 11.03.2022
Impfdatum: 12.03.2021
Beginn: 01.04.2021
Tage bis Beginn: 20,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Arterial occlusive disease Echocardiogram Fatigue Hidradenitis Hypersomnia Myocardial infarction Nasopharyngitis Pain in extremity Swelling

Symptomtext

HEART ATTACK /open heart surgery and was in the hospital for the surgery; ARTERIES WERE 95 TO 99 PERCENT BLOCKED; ARM HURT; TIRED; SLEPT ABOUT 25 TO 30 HOURS; small bump; COLDS; HIDRADENITIS SUPPURATIVA FLARE; This case was reported by a consumer via other manufacturer and described the occurrence of heart attack in a 62-year-old female patient who received Herpes zoster (Hz/su + AS01B) for prophylaxis. Co-suspect products included TOZINAMERAN (BIONTECH-PFIZER COVID-19 VACCINE INJECTION) (batch number EN6201, expiry date June 2021) for prophylaxis and TOZINAMERAN (BIONTECH-PFIZER COVID-19 VACCINE INJECTION) (batch number ER8732, expiry date unknown) for prophylaxis. Previously administered products included Penicillin. Concurrent medical conditions included diabetes, neuropathy, blood pressure high, allergy to molds, penicillin allergy, drug allergy and drug allergy. Concomitant products included adalimumab (Humira), acetylsalicylic acid (Aspirin (Baby)), metformin, glimepiride, gabapentin, metoprolol, ascorbic acid (Vitamin C), cyanocobalamin (Vitamin B12), atorvastatin, iron, clopidogrel, losartan and amlodipine. On an unknown date, the patient received Hz/su + AS01B. On 12th March 2021, the patient received the 1st dose of BIONTECH-PFIZER COVID-19 VACCINE INJECTION (intramuscular). On 2nd April 2021, the patient received the 2nd dose of BIONTECH-PFIZER COVID-19 VACCINE INJECTION (intramuscular). On 15th April 2021, unknown after receiving Hz/su + AS01B, the patient experienced heart attack (serious criteria hospitalization and GSK medically significant) and hidradenitis suppurativa. In April 2021, the patient experienced arterial occlusion (serious criteria hospitalization and clinically significant/intervention required). On an unknown date, the patient experienced pain in arm, tiredness, sleep excessive, local swelling and cold. On 15th April 2021, the outcome of the heart attack was recovered/resolved. On an unknown date, the outcome of the arterial occlusion, pain in arm, tiredness, sleep excessive, local swelling and cold were unknown and the outcome of the hidradenitis suppurativa was recovered/resolved. It was unknown if the reporter considered the heart attack, arterial occlusion, pain in arm, tiredness, sleep excessive, hidradenitis suppurativa, local swelling and cold to be related to Hz/su + AS01B. Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient was not a tobacco or alcohol user. Concomitant products also included Vitamin D as supplement and Venofer. On an unknown date the patient received Shingles vaccine and her arm hurt, slept about 25 to 30 hours, was tired and had colds. The patient received second dose COVID-19 Vaccine and was tired, slept about 25 to 30 hours after second vaccine of Covid. In April 2021, the patient experienced arteries that were 95 to 99 percent blocked. On 15th April 2021, the patient experienced heart attack and hidradenitis suppurativa flare and the heart attack resolved the same day. The patient had an open-heart surgery or triple coronary artery bypass graft last on 21st April 2021 due to three arteries that were 95 to 99 percent blocked. Approximately, from 15th April 2021 up to 11th May 2021, she was in the hospital for the surgery and she also had a rehab for her heart. The patient had a flare of Hidradenitis suppurativa under her arms without Humira. The patient could now use electric razor and was considering deodorant. The patient sometimes used antibacterial soap, hibacleanse. The patient stopped Humira therapy for one month during time of heart surgery, following heart attack in May 2021 and risk of infection, she was off of Humira for three months and then restarted it after risk was no longer. In October 2021, the patient received 3rd dose of Pfizer Biontech Covid-19 vaccine intramuscularly. In January 2022, the patient experienced hidradenitis suppurativa flare, in 2022, the hidradenitis suppurativa flare resolved. The patient had great positive response since taking Humira and had only one flare up in Jan 2022 that started as small bump and was all clear. She was tired and slept about 25 to 30 hours after second vaccine of Covid. The patient statute that the fatigue happened when she got colds and she did not get sick often if she slept well when first getting sick. She did not have the expiration date of second dose of COVID-19 vaccination because it was not on the vaccination card. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 26,0
Labordaten: Test Date: 202104; Test Name: Echocardiogram; Result Unstructured Data: (Test Result:three arteries that were 95 to 99 percent blocked,Unit:unknown,Normal Low:,Normal High:)
Aktuelle Erkrankungen: Allergy to molds; Blood pressure high; Diabetes; Drug allergy; Neuropathy; Penicillin allergy
Vorgeschichte: -
Andere Medikamente: HUMIRA; ASPIRIN (BABY); METFORMIN; GLIMEPIRIDE; GABAPENTIN; METOPROLOL; VITAMIN C; VITAMIN B12; ATORVASTATIN; IRON; CLOPIDOGREL; LOSARTAN; AMLODIPINE; Hz/su + AS01B;
Allergien: -
Vorherige Impfungen: -

VAERS 2170890

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 66,0
Geschlecht: F
Eingang: 10.03.2022
Impfdatum: 24.02.2021
Beginn: 13.12.2021
Tage bis Beginn: 292,0
Dosis: 2
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 Death Malaise SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of COVID-19 breakthrough disease after which death occurred. The individual was vaccinated with the Pfizer product on 02/03/2021 and 02/24/2021. They became symptomatic approx 12/06/2021 and tested positive for COVID-19 twice on 12/13/2021. They presented to Emergency Dept on 12/06/2021, 12/16/2021, 12/18/2021, and 12/20/2021. After the emergency dept visit on 12/20/2021, they were admitted to hospital. They were transitioned to palliative care and remained hospitalized until their death on 01/04/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 15,0
Labordaten: Positive COVID-19 tests x2 despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Schizophrenia, Severe Protein Malnutrition, Hyponatremia, Anxiety Disorder. The individual was a resident of a facility for people with disabilities at the time of the adverse event.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2170871

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IN
Alter: 81,0
Geschlecht: M
Eingang: 10.03.2022
Impfdatum: 21.01.2021
Beginn: 24.10.2021
Tage bis Beginn: 276,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction Angiogram Catheterisation cardiac Computerised tomogram abdomen Computerised tomogram head Computerised tomogram thorax Echocardiogram Embolic stroke Magnetic resonance imaging abdominal Magnetic resonance imaging head Renal infarct

Symptomtext

embolic stroke, embolic left renal infarction, non ST elevation myocardial infarction

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 3,0
Labordaten: head CT, 2D echo, brain MRI, abd MRI, TEE, left heart cath, chest/abd/pelvic CT, renal CTA
Aktuelle Erkrankungen: n/a
Vorgeschichte: high cholesterol, hypertension, COPD, CAD, NSTEMI in 2018, TIA
Andere Medikamente: alprazolam 0.25 mg tablet 12.5 - 25 mg PO BID PRN 10/24/21 10/24/21 budesonide-formoterol HFA 160 2 puff INHALATION DAILY 10/24/21 10/24/21 mcg-4.5 mcg/actuation aerosol inhaler (Symbicort) escitalopram oxalate 10 mg tablet 10 m
Allergien: Amlodipine: suicidal Sulfa Antibiotics Carvedilol: nightmares
Vorherige Impfungen: -

VAERS 2168892

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 74,0
Geschlecht: M
Eingang: 09.03.2022
Impfdatum: 08.10.2021
Beginn: 12.01.2022
Tage bis Beginn: 96,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Acute respiratory failure Alanine aminotransferase normal Albumin globulin ratio Anion gap Aspartate aminotransferase normal Basophil count decreased Basophil percentage decreased Blood albumin decreased Blood alkaline phosphatase increased Blood bilirubin increased Blood calcium decreased Blood chloride increased Blood creatinine increased Blood glucose normal Blood potassium normal Blood sodium normal Blood urea increased

Symptomtext

1/24/22 Chief Complaint Patient presents with o HOT o Respiratory Distress Per EMS called resp distress, low-mid 80s on10L pt diagnosed with covid on 1/11. Pt increased WOB. hx of colon ca. 75 yr/o male who presents with abdominal and chest pain. He was recently diagnosed with Covid. His wife says that he has been confused since Thursday of last week. His O2 sats have been low at home. He was complaining of abdominal and chest pain and EMS was called to transport the patient to our facility. He was vaccinated against Covid, including a booster. Admission Diagnoses: Acute respiratory failure due to COVID-19 Hospital Problems: Principal Problem: Acute respiratory failure due to COVID-19 Active Problems: S/P thoracic aortic aneurysm repair (4/19/2012) Chronic anticoagulation (3/12/2015) CKD (chronic kidney disease) (5/20/2018) Malignant neoplasm of urinary bladder Discharge Diagnoses: Acute hypoxic respiratory failure secondary to COVID-19 PNA Sepsis, POA Acute on CKD III Hx of bladder cancer Hospital Course: 75 y/o male with hx of bladder cancer, who was vaccinated against COVID-19, was admitted to the hospital for acute hypoxic respiratory failure secondary to COVID-19 PNA. He was placed on high flow oxygen and started on IV Abx and IV steroids. On the evening of 1/25, he kept pulling off his oxygen and made it clear to me that he didn't want to fight anymore. I talked to him and called his wife. We discussed options of continuing aggressive medical care with DNR order vs transitioning to comfort care. Patient said he just wanted comfort care. He was started on prn IV dilaudid and versed. His family arrived, he was kept comfortable, and passed away at 14:45 on 1/26/2022. Cause of death is acute hypoxic respiratory failure secondary to COVID-19 PNA.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: 1/12/22 COVID Result IPOC PCR Detected Abnormal CBC w/Diff Collection Time: 01/24/22 8:34 PM Result Value Ref Range White Blood Count 15.15 (H) 4.5 - 11.0 10*3/uL CBC w/Diff Collection Time: 01/24/22 8:34 PM Result Value Ref Range White Blood Count 15.15 (H) 4.5 - 11.0 10*3/uL Red Blood Count 3.90 (L) 4.5 - 5.9 10*6/uL Hemoglobin 11.5 (L) 13.5 - 17.5 g/dL Hematocrit 36.9 (L) 41.0 - 53.0 % Mean Corpuscular Volume 94.6 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 29.5 26.0 - 34.0 pg Mean Corpuscular HGB Conc 31.2 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 14.6 12.0 - 16.8 % Platelet Count 140 140 - 440 10*3/uL Mean Platelet Volume 10.0 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 90.4 (H) 45 - 80 % Lymphocyte % 3.4 (L) 15 - 50 % Monocyte % 3.0 0 - 15 % Eosinophil% 2.2 0 - 7 % BASO% 0.1 0 - 2 % Immature Granulocyte% 0.9 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 13.69 (H) 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 0.51 (L) 0.7 - 5.5 10*3/uL Monocyte Absolute 0.46 0.0 - 1.7 10*3/uL EOS-Absolute 0.34 0.0 - 0.8 10*3/uL Basophil Abs 0.02 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.13 (H) 0.00 - 0.10 10*3/uL Comprehensive Metabolic Panel (CMP) Collection Time: 01/24/22 8:34 PM Result Value Ref Range Sodium 136 136 - 145 mmol/L Potassium 3.7 3.5 - 5.1 mmol/L Chloride 109 (H) 98 - 107 mmol/L Carbon Dioxide 13 (L) 22 - 29 mmol/L Anion Gap 14 (H) 5 - 13 (arb'U) Glucose 104 (H) 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 40 (H) 8 - 26 mg/dL Creatinine-Blood 2.41 (H) 0.73 - 1.18 mg/dL BUN/Creatinine Ratio 16.6 RATIO Estimated GFR 26 (L) >60 /1.73 m2 Estimated GFR if (Privacy) 32 (L) >60 /1.73 m2 Total Protein 7.1 6.2 - 8.0 g/dL Albumin 3.2 3.2 - 4.6 g/dL Globulin 3.9 1.5 - 4.5 g/dL Albumin/Globulin Ratio 0.8 (L) 1.1 - 2.5 RATIO Calcium 8.0 (L) 8.4 - 10.2 mg/dL Total Bilirubin 1.1 0.2 - 1.2 mg/dL AST/SGOT 21 5 - 34 U/L ALT/SGPT 10 0 - 55 U/L Alkaline Phosphatase 148 40 - 150 U/L Troponin Collection Time: 01/24/22 8:34 PM Result Value Ref Range Troponin 0.011 0.000 - 0.034 ng/mL B-Type Natriuretic Peptide Collection Time: 01/24/22 8:34 PM Result Value Ref Range B-Type Natriuretic Peptide 123.8 4 - 254 pg/mL Protime-INR Collection Time: 01/24/22 8:35 PM Result Value Ref Range Prothrombin Time 25.0 (H) 10.3 - 13.3 s INR 2.1 INR 1/24/22 CT Chest Wo Contrast IMPRESSION: Paraseptal and centrilobular emphysema. Scattered reticular and ground glass opacities likely infectious. INCIDENTAL FINDINGS: A few scattered calcified pulmonary nodules. Calcified mediastinal and hilar lymph nodes, likely remote granulomatous infection. No pleural effusion or pneumothorax. Calcified granuloma within the spleen and liver. Gallbladder is surgically absent.
Aktuelle Erkrankungen: -
Vorgeschichte: Anticoagulated on Coumadin chronic following aneurysm repair o Anxiety and depression o Arthritis o Arthritis HANDS, FEET KNEES o Asthma o Bladder cancer (CMS/HCC) o Blood transfusion 2009 BLADDER CANCER WITH CHEMO o Bruises easily o Cancer (CMS/HCC) o Decreased range of motion LEFT SHOULDER o GERD (gastroesophageal reflux disease) o Gout o H/O heat stroke 08/2017 o Hearing loss o History of concussion 2010 NECK SPRAIN /MVA o HIT (heparin-induced thrombocytopenia) (CMS/HCC) 2006 FOLLOWING KNEE SURGERY o Insomnia o Kidney stones PASSED WITHOUT INTERVENTION o Left shoulder pain X1 MONTH/FALL AT HOME o Neuropathy FEET o Obesity o Pneumonia 08/2017 MULTIPLE o PONV (postoperative nausea and vomiting) HAS DONE WELL WITH SCOPALAMINE PATCH o Restless leg syndrome o Seasonal allergies o Sepsis (CMS/HCC) 3/2018 from UTI o Slow to wake up after anesthesia o Snoring o Urinary tract infection MULTIPLE
Andere Medikamente: albuterol HFA (VENTOLIN HFA) 108 (90 Base) MCG/ACT inhaler albuterol HFA (VENTOLIN HFA) 108 (90 Base) MCG/ACT inhaler Inhale 2 puffs into the lungs every 6 (six) hours as needed o dexamethasone (DECADRON) 2 MG tablet Take 1 tablet by mouth
Allergien: Heparin, plastic tape, adhesive, Advil, sulfa antibiotics, amb ativan, bactrim, benadryl, codeine, diphehydramine, lunesta, morphine, restoril, temazepam, xanax, zolpidem
Vorherige Impfungen: -

VAERS 2168577

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 73,0
Geschlecht: M
Eingang: 09.03.2022
Impfdatum: 23.02.2021
Beginn: 05.01.2022
Tage bis Beginn: 316,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time Acute kidney injury Acute respiratory failure Alanine aminotransferase increased Albumin globulin ratio decreased Angiogram pulmonary abnormal Aspartate aminotransferase increased Atrial fibrillation Bacteraemia Blood albumin decreased Blood creatinine increased Blood culture positive Blood gases abnormal Blood glucose normal Blood lactic acid Blood pH increased Blood sodium decreased Brain natriuretic peptide increased

Symptomtext

1/2/22 Short of breath. This started around Christmas. It is gradually worsening. Coughing. Had a negative at home Covid test. The coughing is severe. Shortness of breath is moderate to severe. Gradually worsening. Productive at times. He has no chest pain pressure or tightness. No pain with taking a breath. No personal or family history of clots or dissection or heart disease. No abdominal pain. No back pain. No swelling or pain in the arms or the legs. No trauma. No headaches or neck pain. No fevers. Review of Systems Constitutional: Positive for activity change, appetite change, chills and fatigue. Negative for fever. HENT: Positive for congestion. Review of Systems Negative for nosebleeds, neck pain and neck stiffness. Eyes: Negative for visual disturbance. Respiratory: Positive for cough and shortness of breath. Negative for chest tightness. Cardiovascular: Negative for chest pain and leg swelling. Gastrointestinal: Negative for abdominal pain, diarrhea, nausea and vomiting. Genitourinary: Negative for difficulty urinating and dysuria. Musculoskeletal: Negative for back pain and gait problem. Skin: Negative for rash. Neurological: Negative for dizziness, tingling and headaches. Hematological: Does not bruise/bleed easily. Psychiatric/Behavioral: Negative for agitation. 1/24/22 REASON FOR HOSPITALIZATION COVID-19 pneumonia causing hypoxemia acute respiratory failure FINAL DIAGNOSES 1. Acute respiratory failure with hypoxemia secondary to COVID-19 pneumonia and pulmonary embolus 2. large pulmonary emboli and bilateral lower DVTs 3. Bacteremia--causing severe sepsis 4. A. fib with RVR 5. History of hypertension 6. Acute kidney injury 7. Severe sepsis with organ failure kidney and respiratory 74yo gentleman with a PMH of HTN, HLD, GERD, and arthritis who was admitted on 1/3 for acute respiratory failure wit hypoxia 2/2 PE and pneumonia.. Patient was intubated on 1/9/2022. Continue Decadron and remdesivir, baricitinib (start date 1/7). Completed Unasyn and azithromycin. Patient started displaying leukocytosis had positive blood cultures on 1/18/2022 was started restarted on cefepime and switched to Unasyn and now on Zosyn ID was consulted. Patient had his central line replaced on 1/20/2022. Patient's oxygen requirements increased to 85%. He is showing kidney failure with his creatinine elevated this morning further at 2.59. Family and patient's wife have decided to make him comfort care only once all family has arrived. The following morning family had all catheter to stated decided on terminal extubation patient was extubated and passed peacefully On 1/24/2022 at 11:25 AM

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 22,0
Labordaten: CBC W/DIFF - Abnormal; Notable for the following components: Result Value White Blood Count 12.29 (*) Red Blood Count 3.61 (*) Hemoglobin 12.0 (*) Hematocrit 35.8 Result Value White Blood Count 12.29 (*) Red Blood Count 3.61 (*) Hemoglobin 12.0 (*) Hematocrit 35.8 (*) Neutrophils % 90.8 (*) Lymphocyte % 3.6 (*) Neutrophil Abs 11.16 (*) Lymphocyte-Absolute 0.44 (*) Immature Granulocyte Abs 0.12 (*) All other components within normal limits COMPREHENSIVE METABOLIC PANEL (CMP) - Abnormal; Notable for the following components: Sodium 135 (*) Glucose 162 (*) Albumin 2.9 (*) Albumin/Globulin Ratio 0.7 (*) AST/SGOT 54 (*) ALT/SGPT 91 (*) All other components within normal limits B-TYPE NATRIURETIC PEPTIDE - Abnormal; Notable for the following components: B-Type Natriuretic Peptide 766.4 (*) All other components within normal limits TROPONIN - Abnormal; Notable for the following components: Troponin 0.200 (*) All other components within normal limits ARTERIAL BLOOD GAS - Abnormal; Notable for the following components: pH-ABG 7.47 (*) PO2-ABG 62 (*) O2 Sat-ABG 91.9 (*) All other components within normal limits COVID FLU RSV PCR PANEL LACTIC ACID PARTIAL THROMBOPLASTIN TIME CBC W/DIFF 1/5/22 COVID-19 Result Detected Abnormal 1/3/22 XR Chest 1 Vw IMPRESSION: Bilateral pattern multifocal airspace disease may relate to multifocal pneumonia, bronchitis or atypical/viral pneumonia with the trace bilateral pleural effusions CT Angiogram Chest For PE IMPRESSION: 1. Positive study for pulmonary embolism. 2. There is bilateral patchy ground-glass opacity and some dependent predominant consolidation in both lungs. Differential diagnostic considerations include edema and infectious/inflammatory pneumonitis including viral pneumonia Additional information for Item 12: o Hyperlipidemia o Hypertension
Aktuelle Erkrankungen: -
Vorgeschichte: Arthritis knees o Fever blister takes Valacyclovir as needed o GERD (gastroesophageal reflux disease)
Andere Medikamente: Prilosec, Altace, Valtrex
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2165664

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 08.03.2022
Impfdatum: 24.02.2021
Beginn: 24.12.2021
Tage bis Beginn: 303,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Decreased appetite Dyspnoea Hypoglycaemia Malaise Productive cough Renal failure Respiratory disorder SARS-CoV-2 test positive

Symptomtext

pt admitted to hospital with SOB, not feeling well, hypoglycemia; poor appetite; positive for COVID: increase in dyspnea with productive cough; renal insufficiency; given ABX, remdesivir, dexamethasone; DNR/DNI; respiratory status worsened and pt was made comfort care; he died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 15,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: bladder CA, CAD, dementia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2165325

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 89,0
Geschlecht: M
Eingang: 08.03.2022
Impfdatum: 20.02.2021
Beginn: 16.11.2021
Tage bis Beginn: 269,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anticoagulant therapy Atrial fibrillation COVID-19 Chronic obstructive pulmonary disease Death of relative Decreased appetite Depression Hypertension Hypophagia Lethargy SARS-CoV-2 test positive Unresponsive to stimuli

Symptomtext

Admission 11/16/21; admitted to the hospital with afib, copd, and hypertension; pt recently dx w/COVID; pt treated for afib with RVR with Cardizem drip and heparin drip; pt became more lethargic and unresponsive; pt depressed after passing of wife and stopped taking all medications, not eating or drinking fluids. Family requested hospice care and was discharge to swing bed and started on comfort measures. pt tested positive for COVID outside facility on 11/09/2021; pt found unresponsive on the morning of 11/17/2021 by nurse.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death of relative
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2165191

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TN
Alter: 89,0
Geschlecht: F
Eingang: 08.03.2022
Impfdatum: 21.02.2021
Beginn: 22.09.2021
Tage bis Beginn: 213,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Arthralgia Asthenia Back pain Contusion Death Dyspnoea Dyspnoea exertional Fatigue Gait inability Oedema Skin discolouration

Symptomtext

pt died at home; notes from HCP on 07/29/21; PMH: kidney disease stage 3, congestive heart failure, hypertension, osteoarthritis, depression, anxiety, falls, urinary incontinence; allergic to all steroids and bendryl pt complained of generalized weakness and unable to ambulate; fatigue, skin color changes from previous bruising to bilateral lower extremities; bilateral hearing aids, shortness of breath, chronic dyspnea on exertion, edema, back pain, achy joints vital signs: temp 97.2, spo2 98% at rest, BP 142/74, pulse 62

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1857450

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 89,0
Geschlecht: F
Eingang: 08.03.2022
Impfdatum: 20.02.2021
Beginn: 11.11.2021
Tage bis Beginn: 264,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Cystitis Death Dementia Hydronephrosis COVID-19 SARS-CoV-2 test positive Metabolic encephalopathy Sepsis Septic shock Urinary tract infection

Symptomtext

Admission date 11/11/2021. HPI: Hospice admission; pt admitted to the hospital for sepsis secondary to cystitis and transitioned to hospice. Hx of hypertension, hypothyroid, rheumatoid arthritis. Allergy Hx: egg, sulfa, adhesive, erythromycin base, procaine DX: septic shock, uti, hyronephrosis, acute kidney injury, metabolic encephalopathy, dementia Comfort care measures employed. Pt passed away 11/14/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1857450

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 89,0
Geschlecht: F
Eingang: 08.03.2022
Impfdatum: 20.02.2021
Beginn: 11.11.2021
Tage bis Beginn: 264,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Cystitis Death Dementia Hydronephrosis COVID-19 SARS-CoV-2 test positive Metabolic encephalopathy Sepsis Septic shock Urinary tract infection

Symptomtext

Admission date 11/11/2021. HPI: Hospice admission; pt admitted to the hospital for sepsis secondary to cystitis and transitioned to hospice. Hx of hypertension, hypothyroid, rheumatoid arthritis. Allergy Hx: egg, sulfa, adhesive, erythromycin base, procaine DX: septic shock, uti, hyronephrosis, acute kidney injury, metabolic encephalopathy, dementia Comfort care measures employed. Pt passed away 11/14/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2155522

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 79,0
Geschlecht: M
Eingang: 03.03.2022
Impfdatum: 07.10.2021
Beginn: 22.01.2022
Tage bis Beginn: 107,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Acute respiratory failure Aggression Alanine aminotransferase normal Anion gap Anticoagulation drug level above therapeutic Aspartate aminotransferase normal Asthenia Basophil count Blood albumin decreased Blood alkaline phosphatase normal Blood bicarbonate increased Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood creatinine decreased Blood glucose normal Blood lactic acid

Symptomtext

1/22/22 80 yr/o male who presents to the Emergency Department complaining of vomiting blood. Patient is unable to provide any history at this time as he has garbled speech and is combative. Per report EMS was called for the patient either coughing or vomiting blood. He noticed his oxygen levels were low in route. His daughter arrived shortly after began my evaluation at the bedside. She provides majority of the history. She states that he was diagnosed with cancer of his gastroesophageal junction at the end of November. He subsequently developed COVID which he was exposed at the end of December and was in the hospital at an outside facility until the 16th of this month with COVID-pneumonia. He was discharged home on 2 L of oxygen which the daughter states was adequate when he was awake and sitting upright but at night his oxygen would drop and she would have to turn it up to 4 to 5 L. States over the past 2 days he has been complaining of feeling nauseous and not wanting to eat and feeling weak. She states today he was able to take 2 of his morning medications but when attempting to take more he declined stating he did not feel like he could swallow. She states shortly thereafter he began regurgitating a pink-colored fluid. She did not note any cough when this was occurring and states it appeared to be "reflux". This prompted her to call EMS. He has had episodes of regurgitation in the past but has never been discolored. She is not aware of any black or tarry stools. She does note he did not take his Lasix this morning and she has noticed some intermittent swelling of his ankles. She notes that she is the second designee for his medical power of attorney his wife being the first. She is unsure if he has an advanced directive or living well. She will attempt to obtain these or get a hold of the patient's wife so we can discuss his wishes. Physical Exam Constitutional: Appearance: He is underweight. He is ill-appearing. HENT: Head: Comments: There is bright red saliva present in the patient's mouth and face. Neck: Thyroid: No thyroid mass. Cardiovascular: Rate and Rhythm: Normal rate. Rhythm irregular. Pulses: Radial pulses are 1+ on the right side and 1+ on the left side. Pulmonary: Comments: Mildly tachypneic, there is rhonchi at the right middle and lower lobes. Chest: Chest wall: No deformity or crepitus. Abdominal: General: Abdomen is flat. Bowel sounds are decreased. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. Musculoskeletal: Cervical back: Neck supple. Skin: General: Skin is warm. Capillary Refill: Capillary refill takes less than 2 seconds. Coloration: Skin is pale. Neurological: Mental Status: He is easily aroused. He is lethargic and confused. GCS: GCS eye subscore is 3. GCS verbal subscore is 2. GCS motor subscore is 6. Psychiatric: Behavior: Behavior is uncooperative. Hospital Problems: Principal Problem: Acute blood loss anemia (1/22/2022) Active Problems: Pneumonia of both lower lobes due to infectious organism Hemoptysis Discharge Diagnoses: Acute blood loss anemia, hemorrhagic shock, septic shock, sepsis due to aspiration pneumonia, acute respiratory failure with hypoxia, coagulopathy, acute renal failure likely due to ATN Hospital Course: Patient was admitted with impression of acute blood loss anemia due to upper GI bleeding likely from known esophageal cancer exacerbated by anticoagulation on Coumadin with supratherapeutic INR. INR was reversed with Kcentra and IV vitamin K, he received blood product and IV fluids. He was treated for aspiration pneumonia with Zosyn and required intubation for hypoxia and airway protection. Intensivist and GI service manage alongside, however patient's hemodynamic stability declined and he required up to 4 vasopressors. His course was further complicated by AKI suspected to be due to ATN in setting of hypotension/anemia. Patient's family opted to make patient comfort care. Patient expired at 13:14.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: 1/22/22 COVID-19 Result Detected Abnormal Laboratory Results: Recent Results (from the past 24 hour(s)) CBC w/Diff Collection Time: 01/22/22 9:56 AM Result Value Ref Range White Blood Count 17.89 (H) 4.5 - 11.0 10*3/uL Red Blood Count 2.78 (L) 4.5 - 5.9 10*6/uL Hemoglobin 8.2 (L) 13.5 - 17.5 g/dL Hematocrit 25.9 (L) 41.0 - 53.0 % Mean Corpuscular Volume 93.2 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 29.5 26.0 - 34.0 pg Mean Corpuscular HGB Conc 31.7 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 15.1 12.0 - 16.8 % Platelet Count 403 140 - 440 10*3/uL Mean Platelet Volume 9.0 8.4 - 12.4 fL Diff Type CBC w/Manual Differential (arb'U) Neutrophils % 88.2 (H) 45 - 80 % Lymphocyte % 3.6 (L) 15 - 50 % Monocyte % 5.5 0 - 15 % Eosinophil% 2.7 0 - 7 % Nucleated RBC % 0 0 /100(WBC) Absolute Neutrophil Count 15.78 (H) 1.5 - 7.5 /uL Neutrophil Abs 15.78 (H) 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 0.64 (L) 0.7 - 5.5 10*3/uL Monocyte Absolute 0.98 0.0 - 1.7 10*3/uL EOS-Absolute 0.48 0.0 - 0.8 10*3/uL Poikilocytosis 2+ (A) None Seen (arb'U) Anisocytosis 1+ (A) None Seen (arb'U) Microcytosis 1+ (A) None Seen (arb'U) Acanthocytes 2+ (A) None Seen (arb'U) Platelet Estimate Adequate Adequate (arb'U) Comprehensive Metabolic Panel(CMP) Collection Time: 01/22/22 9:56 AM Result Value Ref Range Sodium 140 136 - 145 mmol/L Potassium 4.4 3.5 - 5.1 mmol/L Chloride 106 98 - 107 mmol/L Carbon Dioxide 28 22 - 29 mmol/L Anion Gap 6 5 - 13 (arb'U) Glucose 101 (H) 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 28 (H) 8 - 26 mg/dL Creatinine-Blood 0.50 (L) 0.73 - 1.18 mg/dL BUN/Creatinine Ratio 56.0 RATIO Estimated GFR >60 >60 /1.73 m2 Estimated GFR if African-American >60 >60 /1.73 m2 Total Protein 4.8 (L) 6.2 - 8.0 g/dL Albumin 2.3 (L) 3.2 - 4.6 g/dL Globulin 2.5 1.5 - 4.5 g/dL Albumin/Globulin Ratio 0.9 (L) 1.1 - 2.5 RATIO Calcium 7.8 (L) 8.4 - 10.2 mg/dL Total Bilirubin 0.9 0.2 - 1.2 mg/dL AST/SGOT 28 5 - 34 U/L ALT/SGPT 15 0 - 55 U/L Alkaline Phosphatase 77 40 - 150 U/L B-Type Natriuretic Peptide Collection Time: 01/22/22 9:56 AM Result Value Ref Range B-Type Natriuretic Peptide 217.4 4 - 254 pg/mL Troponin Collection Time: 01/22/22 9:56 AM Result Value Ref Range Troponin 0.037 (H) 0.000 - 0.034 ng/mL Protime-INR Collection Time: 01/22/22 9:56 AM Result Value Ref Range Prothrombin Time >110.0 (H) 10.3 - 13.3 s INR >11.0 (HH) INR .Partial Thromboplastin Time Collection Time: 01/22/22 9:56 AM Result Value Ref Range Partial Thromboplastin Time 55.6 (H) 25.1 - 36.5 s Type and Screen Collection Time: 01/22/22 10:07 AM Result Value Ref Range ABO/Rh(D) A Positive Antibody Screen Negative Crossmatch Expiration 01/25/2022,2359 Arterial Blood Gas Collection Time: 01/22/22 10:07 AM Result Value Ref Range Allen Test POSITIVE (arb'U) Temperature-ABG 37.0 37.0 Cel pH-ABG 7.49 (H) 7.35 - 7.45 PH PCO2-ABG 39 35 - 48 mm(Hg) PO2-ABG 60 (L) 83 - 108 mm(Hg) HCO3-ABG 30 22 - 30 mmol/L TC02-ABG 31 (H) 22 - 30 mmol/L Base Excess-ABG 6.1 (H) 0 - 3 mmol/L O2 Sat-ABG 93.7 (L) 95.0 - 98.0 % FIO2-ABG 100.0 20 - 100 % Digoxin Collection Time: 01/22/22 10:29 AM Result Value Ref Range Digoxin 0.50 (L) 0.8 - 1.8 ng/mL Lactic Acid Collection Time: 01/22/22 10:51 AM Result Value Ref Range Lactic Acid 2.7 (H) 0.7 - 2.0 mmol/L Lactic Acid Collection Time: 01/22/22 12:08 PM Result Value Ref Range Lactic Acid 2.0 0.7 - 2.0 mmol/L Protime-INR Collection Time: 01/22/22 12:39 PM Result Value Ref Range Prothrombin Time 25.6 (H) 10.3 - 13.3 s INR 2.2 INR CBC w/Diff Collection Time: 01/22/22 12:39 PM Result Value Ref Range White Blood Count 28.64 (H) 4.5 - 11.0 10*3/uL Red Blood Count 2.87 (L) 4.5 - 5.9 10*6/uL Hemoglobin 8.5 (L) 13.5 - 17.5 g/dL Hematocrit 27.4 (L) 41.0 - 53.0 % Mean Corpuscular Volume 95.5 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 29.6 26.0 - 34.0 pg Mean Corpuscular HGB Conc 31.0 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 15.0 12.0 - 16.8 % Platelet Count 546 (H) 140 - 440 10*3/uL Mean Platelet Volume 9.0 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 87.4 (H) 45 - 80 % Lymphocyte % 5.9 (L) 15 - 50 % Monocyte % 4.5 0 - 15 % Eosinophil% 0.7 0 - 7 % BASO% 0.2 0 - 2 % Immature Granulocyte% 1.3 (H) 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 25.04 (H) 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 1.70 0.7 - 5.5 10*3/uL Monocyte Absolute 1.30 0.0 - 1.7 10*3/uL EOS-Absolute 0.19 0.0 - 0.8 10*3/uL Basophil Abs 0.05 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.36 (H) 0.00 - 0.10 10*3/uL 1/22/22 XR Chest 1 Vw IMPRESSION: Placement of enteric tube with tip projecting over the distal thoracic esophagus, recommend advancement for more optimal positioning. Placement of endotracheal tube in satisfactory position. Moderate to severe right greater than left airspace disease and effusions concerning for pulmonary edema and/or multifocal pneumonia.
Aktuelle Erkrankungen: -
Vorgeschichte: Adenocarcinoma of duodenum 11/10/2021 o Adenocarcinoma of gastroesophageal junction 11/10/2021 o Anemia o Anemia 6/11/2014 o Atrial fibrillation o BPH (benign prostatic hypertrophy) o CAD (coronary artery disease) o CPAP (continuous positive airway pressure) dependence o H/O mitral valve repair o Hyperlipidemia o IFG (impaired fasting glucose) o Iron deficiency anemia 4/13/2015 o Left bundle-branch block o Mitral insufficiency o Normocytic anemia 3/27/2017 o Obstructive sleep apnea o Rectal bleeding 6/13/2016 o Sleep apnea o Throat cancer (CMS/HCC) 01/2021 o Tricuspid regurgitation o Unspecified intestinal malabsorption 8/31/2015 o Vitamin D deficiency
Andere Medikamente: atorvastatin (LIPITOR) 10 MG tablet Take 10 mg by mouth daily. digoxin (LANOXIN) 0.125 MG tablet Take 1 tablet (125 mcg total) by mouth daily. diltiazem (CARDIZEM CD) 240 MG 24 hr capsule 1 by mouth twice a day 7/17/13 ferrous sulfat
Allergien: Benzocaine
Vorherige Impfungen: -

VAERS 2155009

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 78,0
Geschlecht: M
Eingang: 03.03.2022
Impfdatum: 23.02.2021
Beginn: 13.01.2022
Tage bis Beginn: 324,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time shortened Acute left ventricular failure Acute respiratory failure Agitation Alanine aminotransferase normal Albumin globulin ratio Angiogram pulmonary abnormal Anion gap Aspartate aminotransferase normal Basophil count decreased Basophil percentage decreased Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood creatinine normal Blood glucose normal

Symptomtext

1/13/22 79 yr/o male with history of HTN, DM, HLD, CVA, vascular dementia who presents with cough and shortness of breath. Symptoms worsening over the last several days. Patient was diagnosed with COVID-19 9 days ago. Patient's been on Tessalon Perles but no inhalers or steroids. Patient was noted to have oxygen saturations below 80% on home pulse ox monitor. EMS was called and they reported pulse ox values 88 to 89% on room air. Patient denies chest pain, body aches, fatigue, fever, chills, nausea vomiting or diarrhea. Physical Exam Constitutional: NAD, well-developed appearance. HENT: Non-cephalic, atraumatic. Bilateral external ears normal Eyes: Extraocular movements intact Cardiovascular: Normal rate and rhythm, normal heart sounds without murmurs. Distal pulses normal. Pulmonary: Pulmonary effort is normal. No distress. Normal breath wounds without wheeze, rales, or rhonchi. Abdominal: Soft. Non-tender. Non-distended. Normal bowel sounds. No guarding or rebound. Musculoskeletal: Normal range of motion of the extremities. Normal ROM of the neck, supple. Skin: Skin is warm and dry. No rash. Neurological: AAOx3. No focal neurologic deficit. MAES. Psychiatric: Speech normal. Behavior normal. 1/17/22: Summary: Diagnoses: Acute hypoxic respiratory failure secondary to COVID-pneumonia Acute on chronic diastolic CHF Cardiac arrest Coronary artery disease status post CABG and stent Arterial occlusions of the right and left posterior tibial arteries Hypertension Hyperlipidemia Type 2 diabetes Obesity IBS Anxiety Depression Dementia with agitation Obstructive sleep apnea History of squamous cell cancer HPI and Hospital Course: Patient was a 79 yr/o male with PMH of CAD s/p CABG and stent, HTN, HLD, T2DM, obesity, IBS, anxiety, depression, cardiomyopathy, TIA/CVA, cognitive disorder, OSA (non compliant with CPAP), dementia, and squamous cell skin cancer who presented for shortness of breath. Reportedly tested positive for COVID 9-10 days ago. Per EMS, patient's O2 sat were 88-89% on RA and then decreased to 82% when walking. Per chart review he has been vaccinated for covid with Pfizer, not clear on booster. Patient on admission was noted to be hypoxic and required 2 L nasal cannula. CRP is elevated at 13.9. Pro-Cal was low. CT chest angiogram neg for PE but showed diffuse bilateral PNA, consistent with Covid 19 PNA. Suspect acute hypoxic respiratory failure secondary to COVID-19 pneumonia. Was treated with Decadron, remdesivir, and vitamins c/d and zinc. Since patient was afebrile with no leukocytosis with low procal was monitored off antibiotics due to low suspicion for secondary bacterial pneumonia. Patient had worsening oxygenation and repeat chest x-ray showed significant interval increase in bilateral airspace disease. BNP was noted to be mildly elevated and patient was given dose of IV Lasix. Patient was also significantly agitated that was not able to be redirected which did not improve with Seroquel and patient required IM Geodon. Per nursing patient was progressively more restless and was removing oxygen. Reportedly patient went into ventricular tachycardia and later into V. fib with cardiac arrest. Patient had defibrillation with shock delivered and then was noted to be in PEA. Patient was intubated during code. Multiple rounds of epi were given during code. It was discussed with patient daughter his overall poor prognosis due to prolonged arrest. Patient's daughter decided to withdraw care and patient died on 1/17/2022 at 0128.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: 1/14/22 COVID-19 Result Detected Abnormal CBC W/DIFF - Abnormal Result Value Ref Range White Blood Count 7.43 4.5 - 11.0 10*3/uL Red Blood Count 3.86 (*) 4.5 - 5.9 10*6/u CBC W/DIFF - Abnormal Red Blood Count 3.86 (*) 4.5 - 5.9 10*6/uL Hemoglobin 11.2 (*) 13.5 - 17.5 g/dL Hematocrit 35.5 (*) 41.0 - 53.0 % Mean Corpuscular Volume 92.0 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 29.0 26.0 - 34.0 pg Mean Corpuscular HGB Conc 31.5 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 12.7 12.0 - 16.8 % Platelet Count 180 140 - 440 10*3/uL Mean Platelet Volume 10.9 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 65.0 45 - 80 % Lymphocyte % 19.2 15 - 50 % Monocyte % 13.1 0 - 15 % Eosinophil% 1.9 0 - 7 % BASO% 0.1 0 - 2 % Immature Granulocyte% 0.7 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 4.83 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 1.43 0.7 - 5.5 10*3/uL Monocyte Absolute 0.97 0.0 - 1.7 10*3/uL EOS-Absolute 0.14 0.0 - 0.8 10*3/uL Basophil Abs 0.01 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.05 0.00 - 0.10 10*3/uL COMPREHENSIVE METABOLIC PANEL (CMP) - Abnormal Sodium 138 136 - 145 mmol/L Potassium 3.9 3.5 - 5.1 mmol/L Chloride 105 98 - 107 mmol/L Carbon Dioxide 25 22 - 29 mmol/L Anion Gap 8 5 - 13 (arb'U) Glucose 195 (*) 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 12 8 - 26 mg/dL Creatinine-Blood 0.77 0.73 - 1.18 mg/dL BUN/Creatinine Ratio 15.6 RATIO Estimated GFR >60 >60 /1.73 m2 Estimated GFR if African-American >60 >60 /1.73 m2 Total Protein 5.7 (*) 6.2 - 8.0 g/dL Albumin 2.9 (*) 3.2 - 4.6 g/dL Globulin 2.8 1.5 - 4.5 g/dL Albumin/Globulin Ratio 1.0 (*) 1.1 - 2.5 RATIO Calcium 8.9 8.4 - 10.2 mg/dL Total Bilirubin 0.4 0.2 - 1.2 mg/dL AST/SGOT 25 5 - 34 U/L ALT/SGPT 22 0 - 55 U/L Alkaline Phosphatase 63 40 - 150 U/L B-TYPE NATRIURETIC PEPTIDE B-Type Natriuretic Peptide 76.4 4 - 254 pg/mL TROPONIN Troponin 0.013 0.000 - 0.034 ng/mL PROTIME-INR Prothrombin Time 11.8 10.3 - 13.3 s INR 1.0 INR PARTIAL THROMBOPLASTIN TIME Partial Thromboplastin Time 29.3 25.1 - 36.5 s 1/13/22 XR Chest 1 Vw FINDINGS: A single portable AP view of the chest was obtained. There are increased diffuse bilateral interstitial and airspace opacities. No large pleural effusion or evidence of pneumothorax. Postoperative changes related to coronary artery bypass grafting with a stable cardiomediastinal silhouette. No acute bony abnormality is demonstrated. IMPRESSION: There are increased diffuse bilateral interstitial and airspace opacities, which could be related to COVID-19 pneumonia given that the patient recently tested positive. Pulmonary edema could have a similar appearance. CT Angiogram Chest For PE 1/13/22 IMPRESSION: 1. Respiratory motion artifacts. 2. Negative for pulmonary embolism 3. Diffuse bilateral pneumonia, consistent with Covid 19 pneumonia 1/16/22 XR Chest 1 Vw IMPRESSION: Significant interval increase in the bilateral airspace disease
Aktuelle Erkrankungen: -
Vorgeschichte: Anxiety o Arthritis OA o Back pain o CAD (coronary artery disease) o Cardiomyopathy o Cerebrova o Cardiomyopathy o Cerebrovascular disease o Cognitive disorder 7/15 mmse 26/30-pt s/p cva-fh alzheimers o Dementia o Depression o Diabetes mellitus type II, non insulin dependent o Diarrhea 06/2019 chronic o Dyslipidemia o HTN (hypertension) o Hyperlipidemia o IBS (irritable bowel syndrome) o Muscle weakness (generalized) o Obesity o Sleep apnea o Squamous cell skin cancer 02/2019 o Stroke 11/13,8/14-thalamic cva 8/14 o TIA (transient ischemic attack)
Andere Medikamente: aspirin-dipyridamole 25-200 MG Additional information for Item 9: aspirin-dipyridamole 25-200 MG Commonly known as: AGGRENOX atorvastatin 40 MG tablet dicyclomine 10 MG capsule diphenoxylate-atropine 2.5-0.025 MG donepezil 10 MG tablet ergo
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 2151266

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 79,0
Geschlecht: F
Eingang: 01.03.2022
Impfdatum: 24.02.2021
Beginn: 26.02.2022
Tage bis Beginn: 367,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Death Emotional distress Hyporesponsive to stimuli Hypotension Inappropriate schedule of product administration Pyrexia Respiratory failure SARS-CoV-2 test positive

Symptomtext

Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccine on 2/03/21 and 2/24/21. Admitted 2/6/22 Covid+ for acute on chronic hypoxic respiratory failure 2/2 COVID PNA. Code status DNR on admission. Advanced pulmonary fibrosis on 9L O2 at baseline. O2 requirements continued to increase needing Airvo. Became less responsive, hypotensive, febrile and showed signs of distress. TX'd w/remdesivir, baricitinib, solumedrol, nystatin, bactrim, and Zosyn. Transitioned to comfort care and expired 2/26/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 20,0
Labordaten: 2/06/22: This sample was analyzed using the SARS assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, Interstitial pulmonary disease, pulmonary fibrosis, HX of GI bleed, pulmonary HTN, HTN, HLD, GERD, Breast CX, RA, diverticulitis
Andere Medikamente: alendronate, vitamin C, atorvastatin, vitamin D3, furosemide, multivitamin, oregano oil, pantoprazole, pirfenidone, prednisone, spironolactone
Allergien: Opsumit
Vorherige Impfungen: -

VAERS 2114186

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IN
Alter: 73,0
Geschlecht: M
Eingang: 15.02.2022
Impfdatum: 03.03.2021
Beginn: 26.01.2022
Tage bis Beginn: 329,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Activated partial thromboplastin time shortened Acute myocardial infarction Alanine aminotransferase increased Albumin globulin ratio decreased Ammonia normal Analgesic drug level therapeutic Angiogram pulmonary abnormal Anion gap Arteriosclerosis Arteriosclerosis coronary artery Aspartate aminotransferase increased Asthenia Atelectasis Bacterial test Basophil count decreased Basophil percentage Bilirubin urine Blood albumin normal

Symptomtext

1/26/22 The patient is a pleasant 74 yr/o male presenting to the ED with fall and cough. Patient states that last night he was trying to get out of bed and slid out of bed because he was generally weak and unable to get up. He apparently was lying on the floor for several hours. He did not hit his head and states he did not lose consciousness. He is on Coumadin at this time for history of left lower extremity DVT. He is not complaining of any particular pain on my exam but states that he has been having a cough with dyspnea over the past approximately 1 week. No hemoptysis. He denies having a fever. States he is up-to-date on COVID-19 vaccinations. He has chronic left lower extremity edema from his DVT. Review of Systems Constitutional: Negative for activity change, chills and fever. HENT: Negative for ear pain, congestion, sore throat, neck pain and ear discharge. Eyes: Negative for pain, discharge and redness. Respiratory: Positive for cough. Negative for chest tightness, shortness of breath and wheezing. Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal distention, abdominal pain, constipation, diarrhea, nausea and vomiting. Genitourinary: Negative for decreased urine volume, difficulty urinating, dysuria, flank pain, hematuria and urgency. Musculoskeletal: Negative for back pain and arthralgias. Skin: Negative for color change and pallor. Neurological: Negative for dizziness, seizures, weakness, numbness and headaches. CBC w/Diff Collection Time: 01/26/22 6:17 PM Result Value Ref Range White Blood Count 3.85 (L) 4.5 - 11.0 10*3/uL Red Blood Count 4.45 (L) 4.5 - 5.9 10*6/uL Hemoglobin 13.0 (L) 13.5 - 17.5 g/dL Hematocrit 38.9 (L) 41.0 - 53.0 % Mean Corpuscular Volume 87.4 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 29.2 26.0 - 34.0 pg Mean Corpuscular HGB Conc 33.4 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 15.1 12.0 - 16.8 % Platelet Count 119 (L) 140 - 440 10*3/uL Mean Platelet Volume 11.1 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 70.0 45 - 80 % Lymphocyte % 16.4 15 - 50 % Monocyte % 12.5 0 - 15 % Eosinophil% 0.3 0 - 7 % BASO% 0.5 0 - 2 % Immature Granulocyte% 0.3 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 2.70 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 0.63 (L) 0.7 - 5.5 10*3/uL Monocyte Absolute 0.48 0.0 - 1.7 10*3/uL EOS-Absolute 0.01 0.0 - 0.8 10*3/uL Basophil Abs 0.02 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.01 0.00 - 0.10 10*3/uL Partial Thromboplastin Time Collection Time: 01/26/22 6:17 PM Result Value Ref Range Partial Thromboplastin Time 38.8 (H) 25.1 - 36.5 s Protime-INR Collection Time: 01/26/22 6:17 PM Result Value Ref Range Prothrombin Time 25.2 (H) 10.3 - 13.3 s INR 2.1 INR CMP Collection Time: 01/26/22 6:17 PM Result Value Ref Range Sodium 136 136 - 145 mmol/L Potassium 4.8 3.5 - 5.1 mmol/L Chloride 109 (H) 98 - 107 mmol/L Carbon Dioxide 16 (L) 22 - 29 mmol/L Anion Gap 11 5 - 13 (arb'U) Glucose 158 (H) 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 25 8 - 26 mg/dL Creatinine-Blood 1.35 (H) 0.73 - 1.18 mg/dL BUN/Creatinine Ratio 18.5 RATIO Estimated GFR 52 (L) >60 /1.73 m2 Estimated GFR if race >60 >60 /1.73 m2 Total Protein 7.5 6.2 - 8.0 g/dL Albumin 3.8 3.2 - 4.6 g/dL Globulin 3.7 1.5 - 4.5 g/dL Albumin/Globulin Ratio 1.0 (L) 1.1 - 2.5 RATIO Calcium 10.0 8.4 - 10.2 mg/dL Total Bilirubin 1.8 (H) 0.2 - 1.2 mg/dL AST/SGOT 64 (H) 5 - 34 U/L ALT/SGPT 57 (H) 0 - 55 U/L Alkaline Phosphatase 125 40 - 150 U/L Magnesium Collection Time: 01/26/22 6:17 PM Result Value Ref Range Magnesium 1.8 1.6 - 2.6 mg/dL CK Collection Time: 01/26/22 6:17 PM Result Value Ref Range CK 436 (H) 30 - 200 U/L Troponin Collection Time: 01/26/22 6:17 PM Result Value Ref Range Troponin 0.206 (HH) 0.000 - 0.034 ng/mL Ammonia Collection Time: 01/26/22 6:17 PM Result Value Ref Range Ammonia 45 <72 umol/L Toxicology Screen Collection Time: 01/26/22 6:17 PM Result Value Ref Range Acetaminophen <18.0 <18.0 ug/mL Ethylalcohol <10 <10 mg/dL Salicylate <5.0 2.0 - 20.0 mg/dL Urinalysis Collection Time: 01/26/22 6:26 PM Result Value Ref Range Color-Urine Yellow Clarity-Urine Clear Specific Gravity Urine 1.023 1.005 - 1.030 (arb'U) pH-Urine 5.5 5.0 - 9.0 (pH) Protein-Urine 50 (A) Negative mg/dL Glucose-Urine Negative Negative mg/dL Ketone-Urine Negative Negative mg/dL Bilirubin-Urine Negative Negative mg/dL Occult Blood-Urine 3+ (A) Negative (arb'U) Nitrite-Urine Negative Negative (arb'U) Urobilinogen-Urine Normal Normal (EhrlichU)/dL Leukocyte Esterase-Urine Negative Negative (arb'U) Source-Urine Urine Midstream Reflex Microscopic? Microscopic performed RBC-Urine 143 (H) 0 - 2 (HPF) WBC-Urine 3 0 - 3 (HPF) Squamous Epithelial-Urine 1 0 - 4 (HPF) Bacteria-Urine None Seen None Seen (HPF) Mucus-Urine TRACE (A) None Seen (LPF) Toxicology Screen, urine Collection Time: 01/26/22 6:26 PM Result Value Ref Range Amphetamines-Urine Scrn Negative Negative Barbiturates-Urine Screen Negative Negative Benzodiazepines-Urine Screen Negative Negative Cannabinoids-Urine Screen Negative Negative Cocaine-Urine Screen Negative Negative Opiates-Urine Screen Negative Negative Lactic Acid Collection Time: 01/26/22 7:22 PM Result Value Ref Range Lactic Acid 1.5 0.7 - 2.0 mmol/L XR Chest 1 Vw 1/26/22 IMPRESSION: 1. Hazy increased density in the lungs bilaterally may be mild edema or infiltrate CT Angiogram Chest For PE 1/26/22 IMPRESSION: 1. Limited exam secondary to motion artifact. Heterogeneous enhancement of bilateral pulmonary arteries and veins favored to be related to timing of the contrast bolus and mixing of contrast and motion artifact. No central pulmonary embolus and no convincing peripheral embolus on this limited exam. Correlation with Doppler venous ultrasound and d-dimer levels is recommended. 2. Emphysema. 3. Noncalcified nodule in the left upper lobe measures 3 mm and not seen on the prior exam. Recommend attention on follow-up. 4. Focal atelectasis or infiltrate in the left lung base. 5. Atherosclerotic vascular calcification and coronary artery calcification without aortic dissection. 1/29/22 Discharge: Hospital Course: The patient is a 74 year old male with past medical history of dm, dvt, chronic anticoagulation with coumadin, cirrhosis admitted for viral sepsis, covid 19. Please see h and p for details. The following issues were addressed: 1. Viral sepsis (temp 100.6, heart rate 110), poa - blood cultures no growth to date - afebrile >24 hours 2. Covid 19 infection - vaccinated - cta chest shows no pe - covid pos 1/26/22 - procal neg - continue supportive care - needs repeat imaging as outpatient with pcp to ensure resolution 3. Acute on stage 3 ckd - 2/2 dehydration - creatinine 1.2 on 8/16/21 - creatinine 1.35 on admission - creatinine 1.2 today - needs cmp 1/31/22 with pcp 4. Elevated troponin (peak troponin 0.206) - suspect non mi elevation in setting of covid - ekg shows no acute changes - trend flat 5. Rhabdomyolysis (peak ck 1449) - initial ck 436 - ck downtrending, 651 today - status post iv fluids - needs ck 1/31/22 with pcp 6. Transaminitis 2/2 rhabdomyolysis, covid 19, cirrhosis - alt/ast 41/49 on 6/15/21 - alt/ast 57/64 on admission - alt/ast 44/76 today - needs cmp 1/31/22 with pcp 7. Pancytopenia - wbc/hgb/plt 2.98/11.1/102 on 6/15/21 - wbc/hgb/plt 3.85/13/119 on admission - wbc/hgb/plt 2.35/11.1/97 today - needs cbc 1/31/22 with pcp 8. DM2 - hemoglobin a1c 6.8 - continue metformin, levemir - may need further adjustment of medications as outpatient with pcp 9. Chronic back pain - continue gabapentin 10. Status post fall - ct head shows no acute intracranial abnormality - ct cervical spine shows no fracture - seen by PT 11. Lung nodule - cta chest shows 3 mm left upper lobe nodule - outpatient follow up with pcp 12. DVT - continue chronic anticoagulation with coumadin as outlined below - inr 2.1 on admission - inr 1.6 today - needs inr 1/31/22 with pcp 13. Obesity - bmi 36.07 - dietary and lifestyle modifications 14. Cirrhosis 2/2 nash - on rifaximin, spironolactone at time of admission 2/13/22 Readmission: 74 yr old M with PMH of HTN, T2DM, CKD, NASH cirrhosis, CVA, OSA (wears CPAP), obesity, and chronic back pain who presents for bloody stools. Patient reports that he woke up this morning and had a bowel movement which was dark red blood mixed with his stool. States that he had an additional episode around 8 AM that looks similar. Reports some associated nausea and dry heaves with one episode of clear emesis. Reports resolution of nausea or vomiting and denies abdominal pain. Denies hematemesis, hemoptysis, or melena. Denies NSAIDs use. Denies fevers, chills, chest pain, shortness of breath, cough, sputum production, diarrhea, or urinary complaints. Patient reports being diagnosed with a LLE DVT about 6 months ago and being started on Coumadin. Reports that rash over left shin secondary to DVT and reports improvement in rash after being started on Coumadin. Patient also takes daily aspirin.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 3,0
Labordaten: 1/26/22 COVID-19 Result Detected Abnormal 2/14/22 COVID-19 Result Detected Abnormal
Aktuelle Erkrankungen: -
Vorgeschichte: Anemia ohn Iron supplement o Blood transfusion without reported diagnosis o Cervical arthritis injection pain clinic o Cirrhosis o Colon polyp o CPAP (continuous positive airway pressure) dependence o Degenerative disc disease, cervical o Demand ischemia 11/21/2017 In the setting of anemia and GIB o Depression with anxiety o Diabetes 1.5, managed as type 2 o Diabetes mellitus niddm o Gastric bleed 2016 o Generalized osteoarthritis o H/O gastric bypass 1980s o HTN (hypertension) o Hypertension o Insomnia o Kidney stones o NAFLD (nonalcoholic fatty liver disease) o NASH (nonalcoholic steatohepatitis) o Obesity o OSA (obstructive sleep apnea) o Sleep apnea bipap o Spinal stenosis in cervical region o Stroke found on CT old no residual problems o Vascular headache o Vitamin D deficiency
Andere Medikamente: ASPIRIN 81 PO diphenhydrAMINE 25 mg capsule Commonly known as: BENADRYL Ferrous Sulfate 5 MG/20ML Liqd gabapentin 100 MG capsule Commonly known as: NEURONTIN TAKE 2 CAPSULES BY MOUTH 3 TIMES DAILY . insulin detemir 100 UNIT/ML
Allergien: Bumex, Celebrex, Lipitor, Lisinopril, Norvasc, Tricor, Vioxx, Zocor
Vorherige Impfungen: -

VAERS 2113219

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 80,0
Geschlecht: M
Eingang: 15.02.2022
Impfdatum: 27.02.2021
Beginn: 01.10.2021
Tage bis Beginn: 216,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asthenia Atrial fibrillation COVID-19 Chest X-ray abnormal Death Dizziness Dyspnoea Hypervolaemia Positive airway pressure therapy Productive cough Pulmonary embolism SARS-CoV-2 test positive

Symptomtext

pt brought to hospital with c/o weakness, dizziness, SOB, productive cough; states was positive for COVID 1 month prior; experienced A Fib, bilateral pulmonary embolism, and fluid overload on chest xray; placed on BiPAP; pt's condition worsened and family transitioned pt to comfort care and dc'd all life-sustaining measures (BiPAP, antibiotics, IV fluids); pt died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 19,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CAD, HTN, hyperlipidemia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2102162

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 89,0
Geschlecht: F
Eingang: 10.02.2022
Impfdatum: 02.10.2021
Beginn: 12.01.2022
Tage bis Beginn: 102,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Activated partial thromboplastin time shortened Acute respiratory failure Alanine aminotransferase increased Albumin globulin ratio Anion gap Aspartate aminotransferase increased Asthenia Atrial fibrillation Basophil count decreased Basophil percentage decreased Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin normal Blood chloride normal Blood creatinine increased Blood glucose normal Blood lactic acid Blood potassium decreased

Symptomtext

:Pt is a 89 yr/o female who presents with shortness of breath for past two days. Pt has had a cough, sneezing/tearing from eyes, body aches, and fever. Pt took home covid swab and was positive. Pt oxygen levels have been dropping despite her 2 liters continuous. Pt has had covid vaccine. No HA, sore throat, CP, abdominal pain, V/D, dysuria, or rash. Pt does bruise easily due to being on Eliquis. Pt has had covid vaccine. Review of Systems Constitutional: Negative for chills and fever. HENT: Positive for congestion and rhinorrhea. Negative for sore throat. Eyes: Negative for discharge. Respiratory: Positive for cough and shortness of breath. Cardiovascular: Negative for chest pain. Review of Systems Gastrointestinal: Negative for diarrhea and vomiting. Genitourinary: Negative for dysuria. Musculoskeletal: Positive for myalgias. Neurological: Negative for headaches. Hematological: Does not bruise/bleed easily 1/12/22 TT Echo: Physician Conclusions Any valve disease noted in the report is non-rheumatic unless otherwise specifically noted. Summary: 1. Normal biventricular chamber size and systolic function. LVEF 50 to 55%. 2. The patient is status post bioprosthetic aortic valve (#26 Evolut pro plus) with normal function.Mean gradient 8 mmHg, dimensionless index 0.52. 3. Moderate mitral annular calcification with mild to moderate mitral regurgitation. 4. Moderate tricuspid valve regurgitation. 5. RVSP estimated at 42 mmHg. 6. Dilated IVC consistent with elevated right-sided filling pressures. Findings Left Ventricle: The left ventricular chamber size, wall thickness, and systolic function are within normal limits. There are no regional wall motion abnormalities observed. Indeterminate diastolic filling pattern due to mitral annular calcification. The ejection fraction biplane was calculated at 51%. Left Atrium: Moderately dilated left atrium. Right Ventricle: The right ventricular chamber size and systolic function are within normal limits. Right Atrium: The right atrial chamber size appears normal. Aortic Valve: s/p TAVR with Evolut Pro plus 26 mm. The peak instantaneous gradient of the aortic valve is 16 mmHg. The mean gradient of the aortic valve is 8. mmHg. The aortic valve area by VTI, is calculated at 1.5 cm2.There is normal function in from the bioprosthetic aortic valve. There is no evidence of aortic valve stenosis. There is no paravalvular regurgitation appreciated. Dimensionless index is 0.52. Mitral Valve: Moderate mitral annular calcification.There is mild to moderate mitral regurgitation. There is no evidence of mitral valve stenosis. Tricuspid Valve: The tricuspid valve is normal in structure and function. There is Moderate tricuspid regurgitation. Right ventricular systolic pressure of 42 mmHg. Pulmonic Valve: The pulmonic valve is not adequately visualized but Doppler appears normal. Trivial pulmonic insufficiency. Pericardial: There is no evidence of pericardial effusion. Aorta/Great Vessels: Aortic root dimension within normal limits. There is no dilatation of the ascending aorta. The IVC appears to be dilated. CBC w/Diff Collection Time: 01/12/22 12:32 PM Result Value Ref Range White Blood Count 4.03 (L) 4.5 - 11.0 10*3/uL Red Blood Count 3.96 (L) 4.0 - 5.2 10*6/uL Hemoglobin 10.8 (L) 12.0 - 16.0 g/dL Hematocrit 35.9 (L) 36.0 - 46.0 % Mean Corpuscular Volume 90.7 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 27.3 26.0 - 34.0 pg Mean Corpuscular HGB Conc 30.1 (L) 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 15.4 12.0 - 16.8 % Platelet Count 143 140 - 440 10*3/uL Mean Platelet Volume 11.0 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 65.4 45 - 80 % Lymphocyte % 22.8 15 - 50 % Monocyte % 10.2 0 - 15 % Eosinophil% 0.2 0 - 7 % BASO% 0.2 0 - 2 % Immature Granulocyte% 1.2 (H) 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 2.63 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 0.92 0.7 - 5.5 10*3/uL Monocyte Absolute 0.41 0.0 - 1.7 10*3/uL EOS-Absolute 0.01 0.0 - 0.8 10*3/uL Basophil Abs 0.01 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.05 0.00 - 0.10 10*3/uL Comprehensive Metabolic Panel(CMP) Collection Time: 01/12/22 12:32 PM Result Value Ref Range Sodium 141 136 - 145 mmol/L Potassium 3.1 (L) 3.5 - 5.1 mmol/L Chloride 101 98 - 107 mmol/L Carbon Dioxide 28 22 - 29 mmol/L Anion Gap 12 5 - 13 (arb'U) Glucose 95 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 55 (H) 10 - 20 mg/dL Creatinine-Blood 1.79 (H) 0.55 - 1.02 mg/dL BUN/Creatinine Ratio 30.7 RATIO Estimated GFR 27 (L) >60 /1.73 m2 Estimated GFR if (Privacy) 32 (L) >60 /1.73 m2 Total Protein 5.9 (L) 6.2 - 8.0 g/dL Albumin 3.1 (L) 3.2 - 4.6 g/dL Globulin 2.8 1.5 - 4.5 g/dL Albumin/Globulin Ratio 1.1 1.1 - 2.5 RATI Calcium 8.9 8.4 - 10.2 mg/dL Total Bilirubin 0.4 0.2 - 1.2 mg/dL AST/SGOT 55 (H) 5 - 34 U/L ALT/SGPT 52 0 - 55 U/L Alkaline Phosphatase 90 40 - 150 U/L B-Type Natriuretic Peptide Collection Time: 01/12/22 12:32 PM Result Value Ref Range B-Type Natriuretic Peptide 155.3 4 - 254 pg/mL Troponin Collection Time: 01/12/22 12:32 PM Result Value Ref Range Troponin 0.205 (HH) 0.000 - 0.034 ng/mL Partial Thromboplastin Time Collection Time: 01/12/22 12:32 PM Result Value Ref Range Partial Thromboplastin Time 33.0 25.1 - 36.5 s Protime-INR Collection Time: 01/12/22 12:32 PM Result Value Ref Range Prothrombin Time 13.6 (H) 10.3 - 13.3 s INR 1.2 INR Lactic Acid Collection Time: 01/12/22 12:33 PM Result Value Ref Range Lactic Acid 1.5 0.7 - 2.0 mmol/L 1/12/22 XR Chest 1 Vw CONCLUSION: No acute abnormality 1/17/22 Hospital Course: Patient presented to the ER with shortness of breath and weakness. She was known covid +. She was found to have acute on chronic hypoxic respiratory failure and was admitted for further management. Issues addressed this admission are detailed below. Acute hypoxic respiratory failure secondary to COVID-19 PNA On remdesivir and dexamethasone. Was increased to high flow on 1/13 and started on baricitinib but it was discontinued due to worsening leukopenia. Pt now stable on 2 liters oxygen with exertion Chronic diastolic heart failure cont torsemide Afib New diagnosis could be illness related and transient. Has been back in sinus. Already on beta blocker and AC. echo with preserved EF. F/u with cardio outpt Mild asymptomatic bradycardia Pt noted to have dips in heart rate to 50s and occassionaly 40's. Happens at rest and is asymptomatic. Recommend observatoin. If worsens may need to decrease beta blocker. Leukopenia/tcp appears to be related to baricitinib, improving with discontinuation. Recommend repeat cbc when Essential hypertension bp has been climbing on steroids. At one point prior to admission was on losartan but family unsure why it was discontinued. Recommend monitoring bp at home if persists may need further treatment. Acquired hypothyroidism Synthroid H/o DVT on eliquis, repeat dopplers with no clot 1/26/22 PCP F/u: 89 yr/o female who presents here for hospital follow-up after admission from 1/12/2022-1/17/2022 with COVID-19 infection and shortness of breath. Patient have respiratory discomfort before admission and was diagnosed with acute on chronic respiratory failure. Acute hypoxic respiratory failure secondary to COVID-19 PNA and has received remdesivir and dexamethasone. She was treated with high flow oxygen. She was started on baricitinib but it was discontinued due to worsening leukopenia. But her symptoms improved. She is currently not on oxygen when she came to the office. She still gets short of breath easily. Chronic diastolic heart failure she is doing well with the beta-blocker bisoprolol and diuretic with torsemide. No complaining of dizziness. She does have some leg swelling. Complaining of neck pain. She is sleeping with one pillow. She was also diagnosed with atrial fibrillation. She is not a candidate for anticoagulation with bleeding. She does not have any palpitation. Leukopenia/tcp appears to be related to baricitinib.I will obtain blood work again today. Hypertension she is doing well on the current regimen. Complaining of burning in the mouth. She does have poor taste. She was brought to the office by her son and history obtained from both patient and son. The following portions of the patient's history were reviewed and updated as appropriate: allergies, current medications, past family history, past medical history, past social history, past surgical history and problem list.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: 1/12/22 COVID-19 Result Detected Abnormal
Aktuelle Erkrankungen: -
Vorgeschichte: Anesthesia complication 10/2017 oct 2017 - had delirum post op o Arthritis all over o Bilateral edema of lower 1/12/22 o Bilateral edema of lower extremity off/ on o CHF (congestive heart failure) (CMS/HCC) o Chronic diastolic CHF (congestive heart failure) (CMS/HCC) 6/8/2021 o Chronic renal insufficiency, stage III (moderate) (CMS/HCC) followed by PCP o Colon cancer (CMS/HCC) 2010 has 12 inches of colon removed--no chemo/radiation o Complication of anesthesia o Constipation treated PRN o COPD (chronic obstructive pulmonary disease) (CMS/HCC) treated with meds o Coronary artery disease o Delirium, induced by drug 10/2017 combative, confused o DVT (deep venous thrombosis) (CMS/HCC) 9/14,3/2017 Admission to (Privacy) restarted after recurrent PE and DVT 3/2017 o Exercise intolerance o Fractures 08/18/2017 Comp Fx T5, broken ribs o HLD (hyperlipidemia) treated with medication o HTN (hypertension) treated with medication o Hypothyroidism treated with medication o Long term current use of anticoagulant therapy o Osteoporosis treated with medications o PE (pulmonary thromboembolism) (CMS/HCC) 9/14,3/2017 Dr. (Privacy) Admission to (Privacy), did not tolerate anticoagulation due to hematuria but restarted after recurrent PE and DVT 3/2017 o Pneumonia 2019 Hospitalized & on vent x 3-4- days o Renal cyst 10/2014 Anticoagulation was discontinued after PE and DVT-v resolved o Restless leg treatedb PRN o Skin breakdown bruises easily - large bruise right wrist. abraisions on right wrist, and rt hand d/t blood thinners o Sleep apnea pt does not use CPAP o Snoring o Vertebral compression fracture (CMS/HCC) 10/03/2017 Comp Fx T7, T8 o Vertebral compression fracture (CMS/HCC) 11/30/2017 Comp Fx T6, T10, T12
Andere Medikamente: albuterol-ipratropium (DUO-NEB) 0.5-2.5 mg/3 mL nebulizer albuterol-ipratropium (DUO-NEB) 0.5-2.5 mg/3 mL nebulizer Take 1 ampule by nebulization 4 (four) times daily. 300 mL 11 o apixaban (ELIQUIS) 5 MG tablet Take 1 tablet by mouth 2 (tw
Allergien: Bumex, Sulfa antibiotics, Xarelto, Norvasc, Trazodone
Vorherige Impfungen: -

VAERS 2102040

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 84,0
Geschlecht: M
Eingang: 10.02.2022
Impfdatum: 13.02.2021
Beginn: 31.01.2022
Tage bis Beginn: 352,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time shortened Acute respiratory failure Alanine aminotransferase normal Albumin globulin ratio decreased Allen's test Angiogram pulmonary abnormal Anion gap Anogenital warts Anticoagulant therapy Aspartate aminotransferase increased Atelectasis Back pain Base excess negative Basophil count normal Basophil percentage Blood albumin decreased Blood alkaline phosphatase normal Blood bicarbonate normal

Symptomtext

1/31/22 The patient presents for shortness of breath. He tested positive for Covid yesterday. EMS reported O2 sats in the 70s when they transported the patient today. The patient tells me his shortness of breath has been chronic but worse over the last 3 weeks. He has had a cough but no fever and no chest pain. On my assessment, he is awake and alert. Skin color is normal. There is no scleral icterus. He is nontoxic-appearing Pt states he is always short of breath but has worsen since fall on Saturday. Pt has hx of falling for unknown reasons. Pt has been worked up for this. Pt fell Saturday where he broke ribs on his right side. Pt was seen at local hospital. Pt went home and had home health nurse do a covid swab on him which was positive. Pt has had vaccine but not booster. Pt has had a cough. Pt denies fever, sore throat, HA, sneezing/tearing from eyes, body aches, V/D, dysuria, or rash. Pt does bruise easily due to being on aspirin. Pt does smoke. Pt has hx of COPD. No home oxygen. Pt denies hitting head or other injuries from fall. Review of Systems Constitutional: Negative for fever. HENT: Negative for sore throat and sneezing. Eyes: Negative for discharge. Respiratory: Positive for cough and shortness of breath. Cardiovascular: Positive for chest pain (ribs). Gastrointestinal: Negative for diarrhea, nausea and vomiting. Genitourinary: Negative for dysuria. Musculoskeletal: Positive for back pain (posterior ribs). Skin: Positive for color change. Neurological: Negative for headaches. Hematological: Bruises/bleeds easily. 2/2/22 Hospital Course: From admission HPI: "85 y/o male with hx of COPD/emphysema, DM II, HTN, and a recent fall causing right sided rib fractures, presents to ED for evaluation of increasing SOB and cough. Of note, patient is vaccinated and boostered, but did test + for COVID-19 last week. He doesn't wear oxygen at home. Denies fevers or chills. He still has pain in right lateral chest wall." The following issues were addressed: 1) Acute hypoxic respiratory failure 2/2 community-acquired PNA: - COVID-19 positive but infiltrates on CT chest appear more consistent with bacterial PNA that what we typically see with COVID-19. - s/p IV abx, discharge on PO to complete course - s/p IV dexamethasone for COVID, home on PO to complete 10 day total course - weaned off oxygen, does not qualify for home O2 per 6 min walk - WBC chronically elevated. 2) Prior R rib fractures: - pain seems to be improving 3) Uncontrolled T2DM with steroid-induced hyperglycemia: - resume metformin - A1c 6.0 so typically well controlled at home 4) Groin lesions: - appear consistent with condyloma acuminata, unclear chronicity - can f/u with PCP after discharge, she can pursue biopsy or removal if desired 5) Tobacco abuse: - requests Rx for nicotine patch

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: 1/31/22 COVID-19 Result Detected Abnormal 1/31/22 TTE findings:Findings Left Ventricle The ejection fraction biplane was calculated at 66%. Left ventricle size is normal. Normal left ventricular wall thickness. Left Atrium The left atrial chamber size appears normal. Right Ventricle Mild to moderately dilated right ventricle. Right Atrium The right atrial chamber size appears normal. Aortic Valve Structurally normal aortic valve. The aortic valve leaflets were not well visualized. Mitral Valve The mitral valve is not well visualized. Structurally normal mitral valve. Tricuspid Valve Tricuspid valve is structurally normal. Tricuspid valve was not well visualized. Pulmonic Valve The pulmonic valve was not well visualized . Pericardium There is no evidence of pericardial effusion. Great Vessels Aortic root dimension within normal limits. CBC w/Diff Collection Time: 01/31/22 9:56 AM Result Value Ref Range White Blood Count 19.41 (H) 4.5 - 11.0 10*3/uL Red Blood Count 4.11 (L) 4.5 - 5.9 10*6/uL Hemoglobin 13.1 (L) 13.5 - 17.5 g/dL Hematocrit 39.8 (L) 41.0 - 53.0 % Mean Corpuscular Volume 96.8 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 31.9 26.0 - 34.0 pg Mean Corpuscular HGB Conc 32.9 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 13.8 12.0 - 16.8 % Platelet Count 195 140 - 440 10*3/uL Mean Platelet Volume 9.4 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 80.4 (H) 45 - 80 % Lymphocyte % 5.9 (L) 15 - 50 % Monocyte % 11.9 0 - 15 % Eosinophil% 0.3 0 - 7 % BASO% 0.5 0 - 2 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 15.61 (H) 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 1.15 0.7 - 5.5 10*3/uL Monocyte Absolute 2.31 (H) 0.0 - 1.7 10*3/uL EOS-Absolute 0.06 0.0 - 0.8 10*3/uL Basophil Abs 0.09 0.0 - 0.2 10*3/uL Poikilocytosis 1+ (A) None Seen (arb'U) Platelet Estimate Adequate Adequate (arb'U) Immature Granulocyte% 1.0 0.0 - 1.0 % Immature Granulocyte Abs 0.19 (H) 0.00 - 0.10 10*3/uL Comprehensive Metabolic Panel(CMP) Collection Time: 01/31/22 9:56 AM Result Value Ref Range Sodium 137 136 - 145 mmol/L Potassium 3.9 3.5 - 5.1 mmol/L Chloride 103 98 - 107 mmol/L Carbon Dioxide 22 22 - 29 mmol/L Anion Gap 12 5 - 13 (arb'U) Glucose 130 (H) 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 22 8 - 26 mg/dL Creatinine-Blood 0.78 0.73 - 1.18 mg/dL BUN/Creatinine Ratio 28.2 RATIO Estimated GFR >60 >60 /1.73 m2 Estimated GFR if African-American >60 >60 /1.73 m2 Total Protein 6.7 6.2 - 8.0 g/dL Albumin 3.3 3.2 - 4.6 g/dL Globulin 3.4 1.5 - 4.5 g/dL Albumin/Globulin Ratio 1.0 (L) 1.1 - 2.5 RATIO Calcium 9.0 8.4 - 10.2 mg/dL Total Bilirubin 0.7 0.2 - 1.2 mg/dL AST/SGOT 37 (H) 5 - 34 U/L ALT/SGPT 18 0 - 55 U/L Alkaline Phosphatase 62 40 - 150 U/L B-Type Natriuretic Peptide Collection Time: 01/31/22 9:56 AM Result Value Ref Range B-Type Natriuretic Peptide 24.4 4 - 254 pg/mL Troponin Collection Time: 01/31/22 9:56 AM Result Value Ref Range Troponin 0.011 0.000 - 0.034 ng/mL Partial Thromboplastin Time Collection Time: 01/31/22 9:56 AM Result Value Ref Range Partial Thromboplastin Time 23.9 (L) 25.1 - 36.5 s Protime-INR Collection Time: 01/31/22 9:56 AM Result Value Ref Range Prothrombin Time 12.8 10.3 - 13.3 s INR 1.1 INR Arterial Blood Gas Collection Time: 01/31/22 11:00 AM Result Value Ref Range Allen Test POSITIVE (arb'U) pH-ABG 7.40 7.35 - 7.45 PH PCO2-ABG 40 35 - 48 mm(Hg) PO2-ABG 71 (L) 83 - 108 mm(Hg) HCO3-ABG 25 (H) 18 - 23 mmol/L TC02-ABG 26 (H) 19 - 24 mmol/L Base Excess-ABG 0.0 0.0 - 3.0 mmol/L O2 Sat-ABG 94.8 (L) 95.0 - 98.0 % XR Chest 1 Vw: IMPRESSION: 1. Increasing blunting of both costophrenic angles likely increasing small-to-moderate bilateral pleural effusions and associated atelectasis CT Angiogram Chest For PE IMPRESSION: 1. No evidence of pulmonary embolus. 2. Small right pleural effusion. This is potentially a chronic finding. 3. Bilateral lower lobe airspace opacities suspicious for pneumonia. The pattern is not specifically suggestive of Covid 19 pneumonia. 4. Indeterminate 13 mm short axis subcarinal lymph node which could be reactive. Metastatic disease not excluded. Attention on CT follow-up in 3 months is recommended if this is not a known stable finding based on prior outside imaging studies. 5. Emphysema. 6. Coronary artery disease
Aktuelle Erkrankungen: -
Vorgeschichte: Chronic back pain o Chronic left hip pain x 1 year plus o COPD (chronic obstructive pulmonary disease) o Diabetes mellitus type 2 dx 2017 o Enlarged prostate o Family history of blood clots sister-DVT, IVC filter placed o History of bronchitis 1/14/2016 o History of chicken pox as child had shingles shot o History of falling r/t hip o Hyperlipidemia o Hypertension o Pneumonia 01/15/2018 diagnosis about 2 weeks ago o Smoker
Andere Medikamente: Albuterol Sulfate (PROAIR HFA IN) Inhale into the lungs. o albuterol-ipratropium (DUO-NEB) 0.5-2.5 mg/3 mL nebulizer Take 1 ampule by nebulization Every 4 hours as needed. (short of breath). o amLODIPine (NORVASC) 5 mg tablet Take 1 table
Allergien: Clindamycin
Vorherige Impfungen: -

VAERS 2099100

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 82,0
Geschlecht: M
Eingang: 09.02.2022
Impfdatum: 18.02.2021
Beginn: 07.02.2022
Tage bis Beginn: 354,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Angiogram COVID-19 pneumonia Chest pain Computerised tomogram thorax abnormal

Symptomtext

Hospitalized for chest pain NSTEMI requiring angiogram done, Remdesivir 5 day course.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 2,0
Labordaten: CT scan showed results consistent with COVID pneumonia
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2098996

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: F
Eingang: 09.02.2022
Impfdatum: 18.02.2021
Beginn: 07.03.2021
Tage bis Beginn: 17,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction

Symptomtext

Inferior STEMI. ED Visit and Hospital Admission. This visit was within 6 weeks of receiving the COVID vaccine,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2095804

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 42,0
Geschlecht: M
Eingang: 08.02.2022
Impfdatum: 27.01.2021
Beginn: 07.02.2022
Tage bis Beginn: 376,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Diarrhoea Dyspnoea

Symptomtext

Pt arrives to the ED with shortness of breath and 4 days of diarrhea. Pt has a history of DM type 2 and obstructive sleep apnea. Pt was found to have acute hypoxic respiratory failure in the presence of COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2095483

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: FL
Alter: 79,0
Geschlecht: M
Eingang: 08.02.2022
Impfdatum: 23.02.2021
Beginn: 07.01.2022
Tage bis Beginn: 318,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

ADMITTED TO HOSPITAL

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2092425

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 07.02.2022
Impfdatum: 20.02.2021
Beginn: 21.09.2021
Tage bis Beginn: 213,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Asthenia COVID-19 Death Decreased appetite Dementia Dysphagia Exposure to SARS-CoV-2 Gait inability General physical health deterioration SARS-CoV-2 test positive

Symptomtext

pr brought to ED with increasing weakness and unable to walk; dementia; decrease in appetite; swallowing impaired; wife tested positive for COVID and is unable to care for him; pt tested positive for COVID; wife states he's been steadily declining over the past month; there has not been any SOB, and pt is breathing on RA and well hydrated; pt's condition worsened and he was made comfort care; pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2647101

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MD
Alter: 90,0
Geschlecht: F
Eingang: 04.02.2022
Impfdatum: 23.03.2021
Beginn: 08.04.2021
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

NO NEGATIVE OUTCOME AFTER RESIDENT RECEIVED 2 DOSES OF COVID VACCINE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: anemia, dysphagia, history of falls, age related osteoporosis
Vorgeschichte: protein calorie malnutrition,COPD,displacedIntertrochanteric fracture right femur, wedge compression fracture of t-7 wedge compression fracture of T-8 T-9 T-10 Patient died in house under hospice care
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 2215717

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 04.02.2022
Impfdatum: 24.02.2021
Beginn: 08.01.2022
Tage bis Beginn: 318,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Aortic arteriosclerosis Atelectasis Blood lactic acid increased COVID-19 Cardioversion Chest X-ray abnormal Chronic obstructive pulmonary disease Condition aggravated Intensive care Laboratory test Mental status changes Pneumonia Procalcitonin Pulmonary congestion Pulmonary vascular disorder Pyrexia SARS-CoV-2 test positive

Symptomtext

Narrative: Admitted: JAN 8,2022 Discharged: Jan 14,2022 85 y/o M with PMH BPH, HLD, HTN, dementia, insomnia, b/l hearing loss, CKD, COPD (2018 via CT w/ emphysema), seizure, stroke/meningioma, blind secondary to glaucoma and cataracts presented to the Emergency Department with altered mental status, acute hypoxic respiratory failure, COVID+ despite vaccination x 2 and required ICU care. #Acute hypoxic respiratory failure, Covid positive, h/o COPD (improving): On admission on 1/8/22 patient tested positive for COVID and was febrile with a procalcitonin of 4. Patient initially requiring 4 L nasal cannula in ED. Started on CAP coverage in ED, ceftriaxone and azithromycin. Given concern for sepsis, patient required ICU care. He was broadened out from CAP to Vanc/Zosyn; Remdesevir, Dexamethasone 6mg daily. Infectious workup done and was negative aside from pulmonary source. Patient showed improvement with downtrend in lactate and was weaned to Room Air. He was then transferred to floor and transitioned back to ceftriaxone and azithromycin. He completed 7 day course of antibiotics, 5 days of remdesivir, and 10 days of dexamethsone 6mg daily. Discharged in stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: Date Test Name Result 01/08/2022@16:15 COVID-19 PCR (FLUVID CEPH) DETECTED Exam Date/Time 01/08/2022 17:10 Procedure Name CHEST-1 VIEW (AP/PA) Impression Mild prominence of bilateral perihilar interstitial markings, suggesting pulmonary vascular congestion. Report X-RAY EXAM CHEST 1 VIEW HISTORY: Seizure COMPARISON: 6/15/2021 TECHNIQUE: Single frontal view of the chest, submitted to program for interpretation. FINDINGS: Lungs: Expiratory lung volumes with crowding of the bronchovascular structures. Mild prominence of bilateral perihilar and interstitial markings. Mild bibasilar atelectasis. Pleura: No significant pleural effusion or pneumothorax. Mediastinum: Grossly unchanged. Calcified plaque of the aorta. Catheters and Medical Devices: Cardioversion paddles overlying the mid chest. Bones: Grossly unchanged.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2088140

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WA
Alter: 73,0
Geschlecht: F
Eingang: 04.02.2022
Impfdatum: 20.02.2021
Beginn: 02.02.2022
Tage bis Beginn: 347,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Cardiogenic shock Encephalopathy Endotracheal intubation Gastrointestinal haemorrhage Intensive care SARS-CoV-2 test positive Ventricular fibrillation

Symptomtext

Patient received Pfizer COVID vaccine on 1/29/21 and 2/20/21. On 2/2/22, patient had v. fib arrest at home (intubated in the field) and admitted to our CCU with acute hypoxic respiratory failure, acute encephalopathy, cardiogenic shock, and GI bleed. Patient was also tested positive for COVID during admission. As of today (2/4/22), patient is still admitted in CCU intubated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: COVID status positive 2/3/22.
Aktuelle Erkrankungen: -
Vorgeschichte: cardiomyopathy, diabetes, hypertension, mitral valve replacement [on chronic anticoagulation with warfarin], atrial fibrillation, Parkinson's disease, and mild COPD
Andere Medikamente: albuterol inh, atorvastain, carbidopa/levodopa, donepezil, ferrous sulfate, furosemide, gabapentin, insulin glargine inj, losartan, metformin, metoprolol er, oxycodone prn, spironolactone, tramadol, warfarin
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2085121

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 86,0
Geschlecht: F
Eingang: 03.02.2022
Impfdatum: 27.02.2021
Beginn: 02.02.2022
Tage bis Beginn: 340,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 pneumonia Dyspnoea

Symptomtext

1. Shortness of breath 2. Acute respiratory failure with hypoxia 3. Pneumonia due to COVID-19 virus 4. History of COPD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2075519

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CT
Alter: 69,0
Geschlecht: M
Eingang: 31.01.2022
Impfdatum: 09.02.2021
Beginn: 19.02.2021
Tage bis Beginn: 10,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Laboratory test Myocardial infarction Pulmonary embolism Stent placement

Symptomtext

(2) pulmonary embolisms, heart attack 3 days after vaccine. Medications to break up clots, plus 2 stents.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 5,0
Labordaten: Lots.
Aktuelle Erkrankungen: None
Vorgeschichte: Heart palpitations
Andere Medikamente: Metformin, omeprazole, losartan, aspirin
Allergien: None
Vorherige Impfungen: -

VAERS 2072012

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 28.01.2022
Impfdatum: 05.03.2021
Beginn: 06.12.2021
Tage bis Beginn: 276,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Cough Culture urine positive Death Dyspnoea Endotracheal intubation Infection Oxygen saturation decreased Pain Positive airway pressure therapy Pyrexia SARS-CoV-2 test positive Urinary tract infection Urinary tract infection fungal

Symptomtext

12/06/2021: admitted with cough, fever for 5 days with all over body aches and pain now SOB. Sx gradually worsening since that time. ER found to have COVID positive. Pt has been vaccinated with 2 doses of Pfizer (2/12/21 and 3/5/21). 12/07/2021-12/15/2021: treated with dexamethasone 6 mg x 10 doses (last dose 12/15), Remdesivir (last dose on 12/10), and supp oxygen. Patient is also on azithromycin and Rocephin for possible pneumonia. 12/15/2021: Patient's oxygen continued to drop to low 70s while on high flow with NRB. Start BIPAP. 12/18/2021: start cefepime, micafungin, and Zyvox for secondary infection. Pt has UTI and yeast in urine culture. 12/21/2021-12/23/21: Patient's RR was not sustainable and had to be intubated. Patient was sedated. Transition to comfort care. 12/23/2021: Patient was extubated and deceased.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 18,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2072012

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 28.01.2022
Impfdatum: 05.03.2021
Beginn: 06.12.2021
Tage bis Beginn: 276,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Cough Culture urine positive Death Dyspnoea Endotracheal intubation Infection Oxygen saturation decreased Pain Positive airway pressure therapy Pyrexia SARS-CoV-2 test positive Urinary tract infection Urinary tract infection fungal

Symptomtext

12/06/2021: admitted with cough, fever for 5 days with all over body aches and pain now SOB. Sx gradually worsening since that time. ER found to have COVID positive. Pt has been vaccinated with 2 doses of Pfizer (2/12/21 and 3/5/21). 12/07/2021-12/15/2021: treated with dexamethasone 6 mg x 10 doses (last dose 12/15), Remdesivir (last dose on 12/10), and supp oxygen. Patient is also on azithromycin and Rocephin for possible pneumonia. 12/15/2021: Patient's oxygen continued to drop to low 70s while on high flow with NRB. Start BIPAP. 12/18/2021: start cefepime, micafungin, and Zyvox for secondary infection. Pt has UTI and yeast in urine culture. 12/21/2021-12/23/21: Patient's RR was not sustainable and had to be intubated. Patient was sedated. Transition to comfort care. 12/23/2021: Patient was extubated and deceased.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 18,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2068801

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IL
Alter: 74,0
Geschlecht: M
Eingang: 27.01.2022
Impfdatum: 04.03.2021
Beginn: 24.11.2021
Tage bis Beginn: 265,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory failure COVID-19 pneumonia Death Lethargy Malaise Positive airway pressure therapy

Symptomtext

pt developed COVID symptoms of a severity which required hospitalization

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: Assessment and Plan 1. Covid pneumonia ?-Status post remdesivir ?-Status post Actemra --Continue Decadron 2. Acute hypoxic respiratory --Patient on BiPAP --At this point the patient has worsened to the point that he will now require intubation. --- Long discussion with wife repeatedly today regarding his prognosis. Explained that if the patient is intubated the likelihood of coming off the ventilator is very very small. On the other hand also explained that he is very uncomfortable on BiPAP. I explained that unfortunately outcome may be the same whether we intubate him or not in terms of his likely passing, however we should consider his comfort his overall wishes. Wife is still deciding on course of action. 3.AKI ??Patient to begin CRRT Subjective Wife is sitting outside pt's room speaking with intensivist and RN about plan to place an HD cath for emergent hemodialysis. Wife delayed intubation yesterday. RN endorses the pt is so lethargic today he is declining an offer to hold bipap for some po. Skipped oral meds mostly for the past 24hrs. Wife did not feel like talking though she expressed frustration her son and his wife were not coming to see the pt despite her relaying the seriousness of her husband's condition. She declined the offer for us to reach out separately and asked us to no longer speak to her about them as we walked her to the chapel to spend some quiet time alone. Pt expired on 12/9/21
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: Past Medical History - DM - CAD - TIA - Ulcerative colitis - Afib
Andere Medikamente: UNKNOWN
Allergien: CEFAZOLIN, NIACIN
Vorherige Impfungen: -

VAERS 2065703

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 91,0
Geschlecht: M
Eingang: 26.01.2022
Impfdatum: 25.02.2021
Beginn: 27.08.2021
Tage bis Beginn: 183,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Atrial fibrillation COVID-19 COVID-19 pneumonia Colectomy Computerised tomogram abdomen abnormal Death Endotracheal intubation General physical health deterioration Intensive care Intestinal anastomosis Intestinal perforation Respiratory failure SARS-CoV-2 test positive Sepsis Small intestinal obstruction Surgery

Symptomtext

pt admitted to hospital after CT scan of abdomen showed small bowel obstruction perforation; pt also tested positive for COVID; surgery required - right colectomy with ileocolic anastomosis; pt intubated and transferred to ICU; course of treatment complicated by A Fib, respiratory failure; AKI, COVID pneumonia and sepsis; pt was eventually able to be extubated but his condition worsened and he required intubation; required vasopressors; condition deteriorated and pt was transitioned to comfort care; pt died in the hosp

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2062947

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MO
Alter: 62,0
Geschlecht: F
Eingang: 25.01.2022
Impfdatum: 26.02.2021
Beginn: 15.11.2021
Tage bis Beginn: 262,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 Feeling abnormal Hypocalcaemia Hypomagnesaemia Intensive care Mechanical ventilation Pneumonia Pneumonia bacterial Pneumonia streptococcal Positive airway pressure therapy SARS-CoV-2 test positive Superinfection Urine analysis abnormal Vitamin D decreased

Symptomtext

admitted 11/15 for acute respiratory failure requiring BiPAP 2/2 COVID with superimposed Strep pneumonia. Patient was initially admitted to hospital and discharged on oral Azithromycin, Augmentin and Prednisone. She stated that, however, she started feeling worse the following week and was found by cleaning lady over the weekend sat at 72%, and EMS was called. Patient Tested positive for Covid on 11/15. Admitted to ICU for acute hypoxic respiratory failure requiring NIPPV. Started on Remdesivir (11/15- 11/20), Dexamethasone IV (stop date 11/24). Urine positive for Strep Pneumonia 11/15. Patient was initially started on Zosyn but was subsequently de-escalated to Levaquin 750 mg (stop date 11/25) for community-acquired superimposed bacterial pneumonia. Patient continued to improve and transferred to step down on 11/19. PT/OT evaluated the patient recommended SNF. Plan to continue to wean oxygen as tolerated. She at the time of discharge is requiring BIPAP overnight and her baseline 5L during the day. Her hospital course was complicated by hypocalcemia and hypomagnesemia. Workup for her hypocalcemia demonstrated only a low Vitamin D which was also replaced. She is being discharged on Ca, Mg, and Vit D replacement.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 18,0
Labordaten: COVID+ 11/15/21
Aktuelle Erkrankungen: -
Vorgeschichte: PMH HTN, obesity, COPD (5L baseline with SpO2 88%), OSA (CPAP), DM2 (insulin), CKD, hx thyroid cancer s/p thyroidectomy 1992, hx lung cancer s/p radiation & chemo 2016 and has spread to both lungs on immunotherapy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2054567

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: ME
Alter: 58,0
Geschlecht: F
Eingang: 21.01.2022
Impfdatum: 30.12.2021
Beginn: 13.01.2022
Tage bis Beginn: 14,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Basal ganglia haemorrhage Cerebral haemorrhage Computerised tomogram head abnormal Hemiparesis Hydrocephalus International normalised ratio normal Intraventricular haemorrhage Platelet count normal Ventricular drainage

Symptomtext

Presented 1/13 with left sided weakness. Found to have acute right basal ganglia intracerebral hemorrhage with interventricular hemorrhage and hydrocephalus. Course complicated by worsening hydrocephalus needing external ventricular drain placement.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 8,0
Labordaten: CT brain 1/13/22, 1/14/22, 1/15/22, 1/16/22, 1/20/22, 1/21/22: all with evolving right basal ganglia hemorrhage which was stable. 1/20 scan revealed worsening hydrocephalus prompting placement of EVD. 1/22/22 showed improved hydrocephalus with drain in place. INR 1.0 1/13/22 Platelets 255 1/13/22
Aktuelle Erkrankungen: none
Vorgeschichte: hyperlipidemia
Andere Medikamente: atorvastatin 20mg
Allergien: mustard, mustard oil
Vorherige Impfungen: -

VAERS 2054049

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 21.01.2022
Impfdatum: 23.02.2021
Beginn: 25.06.2021
Tage bis Beginn: 122,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 pneumonia Cough Death Dyspnoea Intensive care

Symptomtext

6/30/21 pt to hospital with acute respiratory failure and COVID pneumonia; (previous hospitalization at another hospital on 6/25/21 for COVID pneumonia); c/o severe SOB, weakness, cough; treated with steroids, remdesivir, Actemra, Decadron, pt transferred to ICU when O2 requirements increased; pt's condition worsened and he decided to stop aggressive therapy including O2 therapy; DNR; comfort measures; pt died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, HTN, prostate CA
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1536271

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 21.01.2022
Impfdatum: 20.03.2021
Beginn: 16.07.2021
Tage bis Beginn: 118,0
Dosis: 1
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 pneumonia Death COVID-19 Cardioversion Chest X-ray abnormal Cough Dialysis Dyspnoea Endotracheal intubation Intensive care Renal impairment Resuscitation SARS-CoV-2 test positive Ventricular tachycardia

Symptomtext

pt diagnosed positive for COVID on 7/16/21; 7/23/21 pt brought to ED via EMS; c/o increasing SOB, cough; O2 sats 60% on RA; placed on NRB mask (15L); chest xray showed COVID pneumonia; transferred to ICU; required intubation; developed worsening renal function; started dialysis; few hours into dialysis, pt sustained pulseless Ventricular tachycardia requiring CPR, shocking and med; after 20 mins of CPR, pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 13,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CAD, HTN, GERD, hyperlipidemia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2043650

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 73,0
Geschlecht: F
Eingang: 18.01.2022
Impfdatum: 12.03.2021
Beginn: 11.08.2021
Tage bis Beginn: 152,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Malaise Pneumonia Renal failure SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of COVID-19 breakthrough disease after which a death occurred. The individual was vaccinated with the Pfizer product on 02/19/2021 and 03/12/2021. They became symptomatic for COVID-19 disease on 08/11/2021 and tested positive via both antigen and PCR on the same day. They were admitted to the hospital on 08/16/2021 and experienced complications of pneumonia and renal failure. They remained hospitalized until their death on 08/19/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: Positive COVID-19 tests x2 despite being fully vaccinated: one PCR and one antigen test collected on the same .
Aktuelle Erkrankungen: -
Vorgeschichte: Type II Diabetes, Obesity
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2043116

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 18.01.2022
Impfdatum: 15.02.2021
Beginn: 09.01.2022
Tage bis Beginn: 328,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Brain natriuretic peptide increased COVID-19 Cardiac arrest Cardio-respiratory arrest Chest X-ray normal Computerised tomogram head normal Cough Death Diarrhoea Dizziness Dizziness postural Echocardiogram abnormal Endotracheal intubation Fall Hyperhidrosis Hypophagia Left ventricular hypertrophy

Symptomtext

Deceased 01/10/2022; Hospitalized 01/09/2022; COVID-19 positive 01/09/2022; fully vaccinated Discharge Provider: MD Primary Care Physician at Discharge: MD Admission Date: 1/9/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Dizziness [R42] AKI (acute kidney injury) (HCC) [N17.9] Elevated brain natriuretic peptide (BNP) level [R79.89] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 67 year old female with a past medical history of NICM (EF 30%), HTN, T2DM, who presents following a syncopal episode while at home. Patient reports URI symptoms that have been ongoing for for the last week and half with an associated cough. She had decreased oral intake as well as increasing dizziness prior to presentation. She would get a room spinning sensation upon standing and noted having a witnessed LOC while at home. After falling, she was noted to have a postictal state for approximately 2-3 minutes as well as losing bladder control. Based off of this history, orthostatic hypotension in the setting of COVID-19 and seizure disorder were high in the differential. In the ED, she was noted to be hemodynamically stable and appeared well on room air. Her dizziness occurs primarily with positional changes. Orthostatic blood pressures were noted to be positive in the emergency department. Due to her fall, CT head was performed which showed no acute intracranial abnormality. CXR was obtained with no sings of vascular congestion noted. She was found to have an AKI which is likely secondary to poor oral intake in the setting of her COVID-19 infection. BNP and Troponin were noted to be elevated and cardiology was contacted to discuss the patient further. Without any chest pain, ACS was thought to be unlikely and her second troponin was found to be downtrending. Her BNP and troponin were also thought to be elevated in the setting of her acute kidney injury. For further work up of her syncopal episode, Echocardiogram was ordered to investigate further for possible structural changes. CT chest without contrast and bilateral lower extremity ultrasound was ordered to rule out DVT and possible PE. Neurology was consulted to work up possible seizure as her cause of her LOC. EEG was ordered as well as MRI brain and MRA head and neck. Echocardiogram resulted showing poor visualization with mild left ventricular hypertrophy and moderate right ventricular systolic dysfunction. In the evening of 1/10/2022, patient was noted to have an unwitnessed fall while attempting to go to the bathroom. Upon evaluation, the patient was noted to having diarrhea, diaphoresis with vomiting in relation to getting up from bed. Work up was beginning to occur after her fall until there was a noted significant event with a code blue being called secondary to a PEA arrest. Chest compressions were started immediately and attempts were made to obtain ROSC. The patient was intubated with her airway being secured. Echocardiogram was attempted bedside with poor visualization but there were signs of a moderate pericardial effusion noted. Cardiology was contacted who attempted a bedside pericardiocentesis without success. CPR was performed for 50mins and she continued to remain pulseless with echocardiogram showing no cardiac activity. Ultimately, Dr. called the code. Patient had a death exam performed by Dr. with time of death called at 6:08pm on 1/10/2022. Family was contacted throughout the code blue and was updated as events developed. ME was contacted who declined the case for autopsy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Chronic systolic congestive heart failure (HCC) Cardiomyopathy (HCC) Essential hypertension Coronary artery calcification seen on CT scan COVID-19
Andere Medikamente: Biotin 10 MG CAPS carvedilol (COREG) 12.5 MG tablet Ferrous Sulfate (IRON) 325 (65 Fe) MG TABS FIBER ADULT GUMMIES PO furosemide (LASIX) 40 MG tablet ketoconazole (NIZORAL) 2 % shampoo metformin-XR (GLUCOPHAGE-XR) 500 MG 24 hr tablet Multip
Allergien: NKA
Vorherige Impfungen: -

VAERS 2042824

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 86,0
Geschlecht: F
Eingang: 18.01.2022
Impfdatum: 18.02.2021
Beginn: 14.01.2022
Tage bis Beginn: 330,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Asthenia COVID-19 Computerised tomogram thorax abnormal Lung opacity Pulmonary embolism

Symptomtext

Hospitalized with COVID 19, weakness , small PE of undetermined significance and ground glass opacities on CT chest Remdesivir x 5 days. Pt had Pfizer 3rd dose 9/28/2021 lot number FC3183

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2040458

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 73,0
Geschlecht: M
Eingang: 17.01.2022
Impfdatum: 12.10.2021
Beginn: 17.11.2021
Tage bis Beginn: 36,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cardiac failure Cerebrovascular accident Computerised tomogram Dizziness Echocardiogram Ejection fraction Electrocardiogram Magnetic resonance imaging Mobility decreased Myocarditis Supraventricular tachycardia

Symptomtext

Acute CVA with some permanent loss of left arm functionality. Heart Failure with evidence of myocarditis. 51% LV ejection fraction. Frequent Supraventricular Tachycardia events resulting in dizziness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 1,0
Labordaten: MRI - 11/17/2021, Echocardiology -11/17/2021, CT Scan - 11/17/2021, continuous 14-day EKG
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Terazosin
Allergien: none
Vorherige Impfungen: -

VAERS 2032089

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 88,0
Geschlecht: M
Eingang: 13.01.2022
Impfdatum: 26.02.2021
Beginn: 11.08.2021
Tage bis Beginn: 166,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Chest X-ray abnormal Death Dyspnoea Endotracheal intubation General physical health deterioration Hypoxia Interstitial lung disease Positive airway pressure therapy Productive cough Sepsis

Symptomtext

pt admitted to hosp with increasing SOB, productive cough; found to be hypoxemic; chest x ray shows diffuse parenchymal disease; placed on BiPAP; given antibiotics, decadron, remdesivir; acute renal failure; sepsis; intubated due to worsening condition; discussed with family the plan of care and family decided to extubate pt; pt died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: A Fib, peptic ulcer disease
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2027883

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 86,0
Geschlecht: F
Eingang: 12.01.2022
Impfdatum: 18.02.2021
Beginn: 11.01.2022
Tage bis Beginn: 327,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19

Symptomtext

COVID-19 virus infection; Acute hypoxemic respiratory failure

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2529554

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 88,0
Geschlecht: M
Eingang: 05.01.2022
Impfdatum: 11.02.2021
Beginn: 07.04.2021
Tage bis Beginn: 55,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Device dependence Dysphagia Feeding tube user Muscular weakness Pneumonia

Symptomtext

Narrative: Patient was not previously Covid positive and did not have any predisposing fators(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 86 and had at least one year history of progressive muscle weakness and dysphagia requiring tube feed dependency. On 3/22/21 he went to the ER with pneumonia which he eventually passed away from on 4/7/2021. Comorbidities include chronic afib, HTN, HLD, CKD, asthma/COPD.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2529552

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 72,0
Geschlecht: M
Eingang: 05.01.2022
Impfdatum: 11.02.2021
Beginn: 28.03.2021
Tage bis Beginn: 45,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Condition aggravated Death Diagnostic aspiration Malnutrition Neoplasm malignant Squamous cell carcinoma

Symptomtext

Narrative: Patient died after COVID vaccine dose #1 01/20 pt presents to ED with left neck swelling x 1 month, weight loss, coughing, left AMA before being seen by provider 02/10 seen by PCP for initial visit and sent to ED to evaluate neck mass, dizziness and neck pain upon standing, depressed and forgetful, hypophonia; CT HEAD/NECK showed neck mass, likely malignant, admitted 02/12 COVID vaccine dose #1 02/13 discharged from hospital, FNA showed advanced squamous cell carcinoma in neck 03/07 admitted to hospital due to malnourishment 03/10 pt enrolled in hospice care 03/28 pt passed away Death likely due to aggressive malignant carcinoma and not related to COVID vaccine. Patient was hospitalized before and after vaccination for comorbidities. Did not experience ADR at time of vaccination. Was never diagnosed with COVID infection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: 02/10/21 CT head/neck: 31 mm mass centered in the LEFT palatine tonsil, highly suspicious for malignancy. This invades the tongue base and resultant atrophy of the ipsilateral tongue. Extensive nodal metastases in the ipsilateral LEFT neck. The largest conglomerate measures up to 60 mm in diameter. It encases the left carotid arteries with 360 degrees of contact, highly suggestive of mural invasion. There are large calcific plaques in the contralateral RIGHT internal carotid artery calcific plaques resulting in at least 50% narrowing.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2541733

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 88,0
Geschlecht: M
Eingang: 04.01.2022
Impfdatum: 17.02.2021
Beginn: 25.04.2021
Tage bis Beginn: 67,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac failure Cardiogenic shock Chest pain Condition aggravated Death Dyspnoea Lactic acidosis Multiple organ dysfunction syndrome Myocardial infarction Respiratory failure

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was admitted to ED on 4/24/21 with chest pain that radiated down left arm with shortness of breath. Over hospital stay, patient experienced HF exacerbation with hypoxic respiratory failure, multi-organ failure, and lactic acidosis. Patient eventually underwent cardiogenic shock from a heart attack. Patient was transitioned to comfort care and later passed away on 4/25/21. Patient had comorbidities including CAD s/p 4 stents, HFrEF, CKD4, AFib, T2DM, HTN, IDA.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2536290

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 79,0
Geschlecht: M
Eingang: 04.01.2022
Impfdatum: 18.02.2021
Beginn: 10.05.2021
Tage bis Beginn: 81,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Malnutrition Weight decreased

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for carcinoma of floor of mouth, COPD, malignant neoplasm of colon, ocular HTN, hyperlipidemia, hx of cerebrovascular accident, abnormal imaging of lung, nicotine dependence. Pt has a Smoking pack year of 100. Pt was scheduled for a g tube placement on 5/13 due to malnutrition and weight loss. Deceased on 5/10 under hospice care with no cause of death listed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2536257

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 69,0
Geschlecht: M
Eingang: 04.01.2022
Impfdatum: 09.02.2021
Beginn: 13.05.2021
Tage bis Beginn: 93,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Hepatocellular carcinoma

Symptomtext

Narrative: Death on 5/13/2021 approximately 3 months after 2nd dose of Pfizer vaccine. 68-year-old patient admitted to hospital for hospice/end of life care on 04/15. Newly diagnosed with hepatocellular carcinoma, with very limited treatment options, declining further life-prolonging therapy. No indication that death was due to vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2533913

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 79,0
Geschlecht: M
Eingang: 04.01.2022
Impfdatum: 16.02.2021
Beginn: 22.02.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Asthenia Cerebrovascular accident Computerised tomogram head abnormal Death Mobility decreased

Symptomtext

Narrative: Patient had a stroke 18 hours after admission to the hospital which was 5.5 days after his second Pfizer vaccination. He had multiple stroke risk factors and was non-adherent with medications for 4-5 days prior to stroke, and poorly adherent prior to that. He was admitted to the hospital on 2/21/21 for an episode of weakness when going to the bathroom in the night on 2/20/21 and being unable to get up. Brought by ambulance to the hospital. Patient suffered another stroke while in rehab in April and passed away 4/24/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: CT scan showing R MCA stroke
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2529628

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 04.01.2022
Impfdatum: 05.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 12,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Details surrounding death on 3/17/21 not known. Pulmonary Note dated 2/17/21 detailed condition getting worse w/ increasing shortness of breath. He had a 40 PPY smoking history with interstitial lung disease, HTN, ITP, PVD. He required 3 L of oxygen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2552130

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 03.01.2022
Impfdatum: 10.02.2021
Beginn: 20.04.2021
Tage bis Beginn: 69,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for neurocognitive disorder, coronary atherosclerosis, gout, essential hypertension, T2DM, dyslipidemia, agent orange exposure, tetraplegia d/t lesion at c5-7. Deceased 4/20/2021 but no cause of death reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2500407

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 17.02.2021
Beginn: 16.05.2021
Tage bis Beginn: 88,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Amyotrophic lateral sclerosis Death Dysphagia Dyspnoea Feeding disorder Gastrostomy Pneumonia Positive airway pressure therapy Weight decreased

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 71 years old with past medical history of IBS, Iron Deficiency Anemia, Hyperlipidemia, Hypothyroidism, Coronary Arteriosclerosis, Hematuria, Obesity, Benign Hypertension, Foot Pain, Mood Disorder. Per last few days Patient was having food nutrition through G-tube. Also had BIPAP mask full time with oxygen through g-tube, also within past few days he was losing weight. Patient last visit to ER notes developed sob and swallowing difficulties in 6.2020. He was unable to eat and peg tube was placed in Sept 2020. For the ALS treatment patient was getting Radicava via PICC line to slow progression of ALS. He continued IV treatment and was admitted to hospital from 4/8 to 4/15 for pneumonia and SOB. Patient was enrolled for a home and functional assessment, remote monitoring, and care coordination. Cause of death of patient is noted as progression of ALS. Patient was deceased on 5/16/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2500322

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 25.02.2021
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Patient received one dose of the covid vaccine. Unclear cause of death. PMH included CAD, end stage asbestos lung disease. Limited details overall in chart. reporting per facility instructions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2500240

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 62,0
Geschlecht: F
Eingang: 02.01.2022
Impfdatum: 25.02.2021
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Dyspnoea

Symptomtext

Narrative: Patient received two doses of covid vaccine. Patient with PMH of pulmonary fibrosis 2/2 organizing pneumonia on chronic immunosuppression. Patient was admitted for worsening breathing and after family meeting decidedly to change patient to DNR/DNI. Patient passed with no other documentation of death relating to other causes. Reporting per facility instructions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2498945

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

kritisch

Staat: -
Alter: 77,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 17.02.2021
Beginn: 09.05.2021
Tage bis Beginn: 81,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Chronic kidney disease Death Duodenal ulcer Dyspnoea Dyspnoea exertional Endoscopy upper gastrointestinal tract abnormal Gastric haemorrhage Gastrointestinal haemorrhage Oesophagitis Peptic ulcer Respiratory failure

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient is a 75 yo male with PMH of CAD s/p CABG 1999, HFpEF, CKD stage 4 (baseline Cr 4), hypertension, severe COPD/emphysema on supplemental oxygen at 3-4L at home vnc, and s/p nephroureterectomy in 2005 who presented with several weeks of shortness of breath on exertion, previous smoker, cancer of the ureter status post left nephroureterectomy. Per notes from 5.7 patient was admitted to acute hosp on 3.31 due to shortness of breath. Patient developed GI bleed, and upper endoscopy PUD with multiple duodenal and gastric bleed and severe esophagitis. Pt. was transferred to local hospital LTAC on 4.9 for further management of respiratory failure, acute and chronic kidney failure. There was no cause of death noted on recent notes. Pt. passed away on 5.9.2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1992707

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 68,0
Geschlecht: M
Eingang: 30.12.2021
Impfdatum: 18.02.2021
Beginn: 14.12.2021
Tage bis Beginn: 299,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Death Pulmonary embolism

Symptomtext

Hospitalized with COVID 12/14/2021 and deceased 12/29/2021 multiple subsegmental pulmonary embolism.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 15,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1992401

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 85,0
Geschlecht: M
Eingang: 30.12.2021
Impfdatum: 20.08.2021
Beginn: 06.12.2021
Tage bis Beginn: 108,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had breakthrough infection and passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 1,0
Labordaten: Positive COVID test on 12/01/2021 and 12/05/2021.
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Atrail fibrillation COPD DM Hypertension Atrial Flutter Necrotizing pancreatitis Osteoarthritis Rheumatoid arthritis Temporal arteritis
Andere Medikamente: -
Allergien: Morphine
Vorherige Impfungen: -

VAERS 2521605

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 29.12.2021
Impfdatum: 17.02.2021
Beginn: 17.02.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Accident Death Injury

Symptomtext

A 65yo male with PMH of CAD, Viral Hepatitis, HTN, DM, Tobacco user, Nicotine Dependence, Opioid Dependence, Neuropathic Diabetic Ulcer, peripheral Venous Insufficiency, Dysphagia oral Phase, End Stage Renal Disease, Osteomyelitis, Therapy Opioid Induced Constipation and Severe COPD He received Pfizer Covid - 19 vaccine per policy and protocol on February 17, 2021 without complication No ADE was reported March 16, 2021 Telephone note documents "Phone call was received from relative listed as next to kin, stating the patient expired early that morning at the local Hospital Center Burn unit, d/t Injuries sustained in house fire on February 21, 2021"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1988940

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 29.12.2021
Impfdatum: 01.03.2021
Beginn: 20.10.2021
Tage bis Beginn: 233,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Acute respiratory failure Atrial fibrillation COVID-19 Chronic obstructive pulmonary disease Condition aggravated Death Mydriasis Positive airway pressure therapy Pulmonary embolism Septic shock Unresponsive to stimuli

Symptomtext

pt presented to ED with AHRF requiring BiPAP; two weeks prior pt was hospitalized for COVID; PE, A Fib, COPD, AKI; given solumedrol and antibiotics; eventually went into septic shock and treated with vasopressors; DNI/DNR; pt found unresponsive with dilated left pupil; comfort measures; pt died in the hosp

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: A FIB, COPD
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1985282

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: PA
Alter: 78,0
Geschlecht: F
Eingang: 28.12.2021
Impfdatum: 20.10.2021
Beginn: 21.10.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram Chills Computerised tomogram Cough Death Dyspnoea Heart rate decreased Laboratory test Pain in extremity Pneumonia Pyrexia Skin discolouration Stent placement Thrombectomy Thrombosis

Symptomtext

Oct. 21, started out with chills and fever that went up to 102.7. Fever lasted 5 days. Monday, Oct. 25. we called PCP, He said it was a side affect of booster, it should pass. Monday night Mom started to have a cough and hard time breathing. she could not catch her breath after coughing. she was getting worse. Oct. 26, her left hand and fingers started to turn black and very painful, while getting worse with the breathing and coughing. Took her to ER. she had multifocal pneumonia and very low pulse in left arm and wrist. So then she was transfered to Medical Center OCt. 27, had angiogram done then Life flighted Oct. 28. then died Nov. 2, 2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: ct. scans, labs were done daily, angiogram was done. Surgery to try and remove clots from arm and collarbone area. Stint was placed in Collarbone area. Clot was to big to remove.
Aktuelle Erkrankungen: -
Vorgeschichte: high blood pressure, fibromalgia , degeberatuve disc disease
Andere Medikamente: Losarten/hctz 100-25MG, Laryca 100mg 3x day. Hydrcodone 7.5mg
Allergien: morphine and novicane
Vorherige Impfungen: -

VAERS 1982028

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TN
Alter: 79,0
Geschlecht: M
Eingang: 27.12.2021
Impfdatum: 26.02.2021
Beginn: 01.09.2021
Tage bis Beginn: 187,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 COVID-19 pneumonia Death Dementia Prostate cancer metastatic

Symptomtext

medical records mention COVID infection in 09/2021; per death certificate, pt died in a hospice facility of Recent COVID pneumonia, prostate CA with metastases and dementia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1963630

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 86,0
Geschlecht: F
Eingang: 20.12.2021
Impfdatum: 21.02.2021
Beginn: 10.11.2021
Tage bis Beginn: 262,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 pneumonia Communication disorder Death Dyspnoea Speech disorder

Symptomtext

pt in hospice facility with diagnosis of COVID pna; dyspnea; non-verbal; poorly responsive; unable to make needs known; on supplemental O2 via NC (prongs set in mouth since she's a mouth breather); pt found to be deceased by the nurse while making rounds

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1959096

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WI
Alter: 90,0
Geschlecht: M
Eingang: 17.12.2021
Impfdatum: 10.03.2021
Beginn: 15.12.2021
Tage bis Beginn: 280,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

fully vaccinated-covid related death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Complications of CVA,dementia; HTN; HLD; prostate cancer
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1955186

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MT
Alter: 88,0
Geschlecht: M
Eingang: 16.12.2021
Impfdatum: 26.02.2021
Beginn: 13.11.2021
Tage bis Beginn: 260,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

Patient diagnosed, hospitalized and expired with COVID while fully vaccinated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1955125

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MT
Alter: 75,0
Geschlecht: M
Eingang: 16.12.2021
Impfdatum: 26.02.2021
Beginn: 01.11.2021
Tage bis Beginn: 248,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

Patient was diagnosed, hospitalized and expired with COVID while fully vaccinated

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 20,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1952045

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 72,0
Geschlecht: F
Eingang: 15.12.2021
Impfdatum: 27.02.2021
Beginn: 06.12.2021
Tage bis Beginn: 282,0
Dosis: 2
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cardiac failure congestive Death SARS-CoV-2 test positive

Symptomtext

Tested positive for Covid on 12/6/21 and expired on 12/11/21. Patient was admitted to hospice for end stage CHF on 11/24/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: 12/6/21- Binax Now Covid 19 Ag Card- Positive result
Aktuelle Erkrankungen: -
Vorgeschichte: CHF, A-Fib, Dementia, Pulmonary Edema, CVA
Andere Medikamente: -
Allergien: Cortisone, Ativan, Sulfa antibiotics
Vorherige Impfungen: -

VAERS 1950749

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MO
Alter: 85,0
Geschlecht: F
Eingang: 15.12.2021
Impfdatum: 26.02.2021
Beginn: 12.05.2021
Tage bis Beginn: 75,0
Dosis: 2
Route/Site: - / LA

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Atrial fibrillation Cardiac failure Myocardial infarction

Symptomtext

Heart Failure; AFIB; Death by probable Myocardial Infarction; This is a spontaneous report received from a contactable Consumer. An 85 year-old female patient (not pregnant) received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), administered in arm left, administration date 26Feb2021 13:00 (Lot number: EN6201) at the age of 85 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Fibromyalgia" (unspecified if ongoing); "Hypertension" (unspecified if ongoing). There were no known allergies. The patient took unspecified concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Lot No: EL9262, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 20Jan2021, when the patient was 85 years old, for Covid-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The following information was reported: MYOCARDIAL INFARCTION (death) with onset 22Sep2021, outcome "fatal", described as "Death by probable Myocardial Infarction"; ATRIAL FIBRILLATION (hospitalization, life threatening) with onset 12May2021, outcome "unknown", described as "AFIB"; CARDIAC FAILURE (hospitalization, life threatening) with onset 01Jul2021, outcome "unknown", described as "Heart Failure". The patient was hospitalized for atrial fibrillation, cardiac failure (start date: 2021, discharge date: 2021, hospitalization duration: 5 days). The events "death by probable myocardial infarction", "afib" and "heart failure" were evaluated at the physician office visit and emergency room visit. A pacemaker placed on 02Jul2021 upon heart failure. Therapeutic measures were taken as a result of atrial fibrillation, cardiac failure. The patient date of death was 22Sep2021. The reported cause of death was myocardial infarction. No autopsy was performed. Follow-up attempts are completed. No further information is expected.; Reported Cause(s) of Death: Probable Myocardial Infarction

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Fibromyalgia; Hypertension
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1944880

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TN
Alter: 89,0
Geschlecht: M
Eingang: 13.12.2021
Impfdatum: 30.01.2021
Beginn: 16.11.2021
Tage bis Beginn: 290,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient admitted for COVID-19 and expired

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Positive COVID-19 test
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Afib COPD Hypertension Hyperlipidemia
Andere Medikamente: Albuterol Umeclindinium Rivaroxaban Atorvastatin Diltiazem Calcium Carb Potassium Advair Xalatan Docusate Magnesium Oxide Omeprazole Hydrocortisone
Allergien: None
Vorherige Impfungen: -

VAERS 1933023

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: SD
Alter: 73,0
Geschlecht: M
Eingang: 08.12.2021
Impfdatum: 27.02.2021
Beginn: 22.04.2021
Tage bis Beginn: 54,0
Dosis: 2
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 Death Inappropriate schedule of product administration SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease, after which death occurred. The individual was a resident of a long-term care facility. The individual was vaccinated with the Pfizer product on 01/21/2021 and 02/27/2021 at two different facilities. The individual tested positive for COVID-19 via a PCR test on 04/22/2021. The individual was seen in a clinic on 04/23/2021 and was released from isolation on 05/03/2021. There was no hospitalization associated with this illness reported, but the individual died on 05/14/2021. Death certificate details are as follows: Part I Cause of Death A: Acute Pulmonary Failure B: COVID 19 Part II Other Significant Conditions: COPD, CHF, Chronic Kidney Disease, Obstructive Sleep Apnea

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: COVID-19 PCR positive despite being fully vaccinated
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, Congestive Heart Failure, Chronic Kidney Disease, Obstructive Sleep Apnea, Gout, Orthostatic Hypotension, Obesity. This individual was oxygen-dependent. This individual was a resident in a long-term care facility and was on hospice at the time of the adverse event.
Andere Medikamente: Dexamethasone, guaifenesin
Allergien: Simvastatin, Sulfasalazine
Vorherige Impfungen: -

VAERS 1916888

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MT
Alter: 87,0
Geschlecht: M
Eingang: 02.12.2021
Impfdatum: 25.02.2021
Beginn: 15.10.2021
Tage bis Beginn: 232,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Angiogram pulmonary abnormal Aspergillus test negative Blood beta-D-glucan negative COVID-19 Chest X-ray abnormal Emphysema Fungal test Influenza virus test negative Lung consolidation Lung opacity SARS-CoV-2 test positive Sputum culture positive Staphylococcal sepsis Urine analysis normal

Symptomtext

Case was hospitalized for Covid after completion of Covid vaccine series. * Acute hypoxemic respiratory failure due to COVID-19 (HCC) Assessment & Plan Developed symptoms approximately October 3, tested positive for Covid on October 7. He was treated with remdesivir. He had his initial dexamethasone start date 10/15 - this was stopped on 10/27. Baricitinib started 10/16 for increased oxygen needs - this was eventually stopped on 10/31. CT angiogram of chest October 23:, no pulmonary embolism, extensive bilateral ill-defined groundglass opacities. ID was consulted on 10/24 due to persistent high oxygen requirements but he gradually improved. He was off steroids for a few days and had acute worsening, sepsis on 10/30 evening. Full workup initiated - UA neg, CXR concerning for cavitary lung lesion. Sputum cultures with 4+ staph (MSSA). Flu swabs negative. Ceftriaxone started and later switched to cefepime per ID, now on Ancef given the MSSA on sputum cx. CT 10/31 showed extensive bilateral lung consolidation R>L, no cavitation or mass, mild emphysema. He has clinically improved with addition of abx - O2 needs have gradually declined. Now on 3L. Plan for 14 days of abx per ID (to finish 11/12). Fungal workup: beta d glucan negative, aspergillus ag negative, - fungal culture pending Palliative care consulted

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 27,0
Labordaten: Ordered Test: SARS-CoV-2 RNA Resp Ql NAA+probe Ordered Test Codes: 94500-6 (LN LOINC)/ Status: Final Accession Number: Specimen Source: SOFT TISSUE SAMPLE Specimen Site: ENTIRE NASOPHARYNX Specimen Collection Date/Time: 2021-10-15 13:47:00.0 REsuults: * Resulted Test: SARS-CoV-2 RNA Resp Ql NAA+probe Coded Result: DETECTED Numeric Result: Units: Text Result: Reference Range From: Not Detected Reference Range To: Performing Facility Details: Date/Time: 2021-10-15 14:54:20.0 Performing Facility: (Privacy) Facility ID: (Privacy) Interpretation: Very abnormal Result Method: LAB DEVICE: CEPHEID GENEXPERT DX SYSTEM Status: Final Test Code: 94500-6 (LN LOINC)/ Result Code:
Aktuelle Erkrankungen: ? Anemia 2011 Trauscht - full evaluation, unclear reason. Chronic ? Aortic regurgitation 10/30/2012 Mild to Moderate ? Ascending aortic aneurysm (HCC) CT 5/2012 5.2 cm ascending aorta Echo 6/2012 trileaflet aortic valve with moderate insufficiency CT 10/26/2012 4.9 cm on enhanced imaging, stable Echo 10/26/2012 mild to moderate aortic and mitral regurgitation ? Atrial fibrillation (HCC) 9/28/2015 ? Basal cell carcinoma of skin of upper limb, including shoulder ? Benign Prostate Hypertrophy 3/1/2007 ? Bilateral leg edema 11/1/2018 11/18 - mild ? Esophageal dysphagia 5/8/2020 5/20 - most days, schedule EGD ? Esophagitis Nos 3/2/2007 ? GERD (gastroesophageal reflux disease) ? HTN (hypertension) ? Hx-Malig Skin Melanoma 11/10/2010 ? Macular degeneration of left eye ? Mass of colon worked up by (Privacy) & neg for Ca., Likely infection, ischemia. ? Osteoarthritis 4/24/2013 ? Osteoporosis, unspecified 4/24/2013 4/13 alendronate 6 years to this point, DEXA ? Thoracogenic scoliosis of thoracolumbar region 7/6/2020
Vorgeschichte: ? Anemia 2011 Trauscht - full evaluation, unclear reason. Chronic ? Aortic regurgitation 10/30/2012 Mild to Moderate ? Ascending aortic aneurysm (HCC) CT 5/2012 5.2 cm ascending aorta Echo 6/2012 trileaflet aortic valve with moderate insufficiency CT 10/26/2012 4.9 cm on enhanced imaging, stable Echo 10/26/2012 mild to moderate aortic and mitral regurgitation ? Atrial fibrillation (HCC) 9/28/2015 ? Basal cell carcinoma of skin of upper limb, including shoulder ? Benign Prostate Hypertrophy 3/1/2007 ? Bilateral leg edema 11/1/2018 11/18 - mild ? Esophageal dysphagia 5/8/2020 5/20 - most days, schedule EGD ? Esophagitis Nos 3/2/2007 ? GERD (gastroesophageal reflux disease) ? HTN (hypertension) ? Hx-Malig Skin Melanoma 11/10/2010 ? Macular degeneration of left eye ? Mass of colon worked up by (Privacy) & neg for Ca., Likely infection, ischemia. ? Osteoarthritis 4/24/2013 ? Osteoporosis, unspecified 4/24/2013 4/13 alendronate 6 years to this point, DEXA ? Thoracogenic scoliosis of thoracolumbar region 7/6/2020
Andere Medikamente: Ascorbic Acid (VITAMIN C) 1000 MG tablet Take 1,000 mg by mouth Daily. cholecalciferol (VITAMIN D-3) 1,000 units tablet Take 2,000 Units by mouth Daily. gabapentin (NEURONTIN) 300 mg capsule Take 900 mg by mouth nightly take 300mg
Allergien: NKA
Vorherige Impfungen: -

VAERS 1943186

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 78,0
Geschlecht: M
Eingang: 30.11.2021
Impfdatum: 10.02.2021
Beginn: 10.10.2021
Tage bis Beginn: 242,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angiogram pulmonary abnormal Atelectasis Blood fibrinogen normal COVID-19 Chest X-ray normal Dizziness Fall Fibrin D dimer Lung opacity Pulmonary embolism Red blood cell sedimentation rate increased SARS-CoV-2 test positive

Symptomtext

Narrative: COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 10/10 pt admit to medicine cc: fall dx: Diziness, COVID + LOS: 3 days 10/10 pt cc: exposure: unknown 10/10 COVID swab, result: detected 10/10 CXR Impression: Clear lungs without acute findings 10/11 CTA PE Impression: 1. No large pulmonary embolism identified. Small area of subtle low attenuation area within a subsegmental pulmonary artery to the left lower lobe, favored to reflect artifact from patient respiratory motion given associated findings. Small pulmonary embolism is difficult to entirely exclude in the setting of high clinical suspicion. 2. Two new small ground glass opacities in the left upper lobe and a new focal ground glass opacity in the left lower lobe, which may reflect an infectious/inflammatory process. Focal opacity in the inferior left upper lobe reflects atelectasis. Attention on follow-up imaging to confirm resolution. 10/11 FIBRINOGEN: 264 10/11 DDIMER: 0.99 10/11 ESR: 300 10/12 DDIMMER: 1.01 10/12 ESR: 5 10/13 FIBRINOGEN: 281 10/13 DDIMER: 0.98 10/13 ESR: 11

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: 10/10 COVID swab, result: detected 10/10 CXR Impression: Clear lungs without acute findings 10/11 CTA PE Impression: 1. No large pulmonary embolism identified. Small area of subtle low attenuation area within a subsegmental pulmonary artery to the left lower lobe, favored to reflect artifact from patient respiratory motion given associated findings. Small pulmonary embolism is difficult to entirely exclude in the setting of high clinical suspicion. 2. Two new small ground glass opacities in the left upper lobe and a new focal ground glass opacity in the left lower lobe, which may reflect an infectious/inflammatory process. Focal opacity in the inferior left upper lobe reflects atelectasis. Attention on follow-up imaging to confirm resolution. 10/11 FIBRINOGEN: 264 10/11 DDIMER: 0.99 10/11 ESR: 300 10/12 DDIMMER: 1.01 10/12 ESR: 5 10/13 FIBRINOGEN: 281 10/13 DDIMER: 0.98 10/13 ESR: 11
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1909762

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 61,0
Geschlecht: F
Eingang: 30.11.2021
Impfdatum: 18.02.2021
Beginn: 24.11.2021
Tage bis Beginn: 279,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Malaise SARS-CoV-2 test positive

Symptomtext

evaluation and management of symptomatic COVID-19 infection with acute hypoxic respiratory failure. Symptom onset occurred on 11/24/21 with positive SARS-CoV-2 testing on 11/24/21. He had not been in contact with known COVID-19 positive individual(s) prior to being hospitalized.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1905509

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 75,0
Geschlecht: M
Eingang: 29.11.2021
Impfdatum: 20.02.2021
Beginn: 28.11.2021
Tage bis Beginn: 281,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 Dyspnoea Lactic acidosis Troponin increased

Symptomtext

Acute hypoxemic respiratory failure due to COVID-19; shortness of breath; elevated troponin; lactic acidosis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1893746

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 83,0
Geschlecht: F
Eingang: 23.11.2021
Impfdatum: 16.10.2021
Beginn: 22.11.2021
Tage bis Beginn: 37,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory failure Brain natriuretic peptide increased COVID-19 Chronic kidney disease Dyspnoea

Symptomtext

Shortness of breath; Acute hypoxemic respiratory failure due to COVID-19; Elevated brain natriuretic peptide (BNP) level; AKI; CKD, stage III;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1893708

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 79,0
Geschlecht: F
Eingang: 23.11.2021
Impfdatum: 04.03.2021
Beginn: 21.10.2021
Tage bis Beginn: 231,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Pt deceased. Unsure of reason for death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiovascular and Mediastinum Atrial fibrillation with RVR Atrial fibrillation, permanent Exhausted vascular access Respiratory Pneumonia Digestive GERD (gastroesophageal reflux disease) Chronic diarrhea Gastric outlet obstruction GI bleed Endocrine Proteinuria due to type 2 diabetes mellitus Type 2 diabetes mellitus with hemoglobin A1c goal of less than 7.5% Type 2 diabetes mellitus with diabetic neuropathy, with long-term current use of insulin Moderate nonproliferative diabetic retinopathy of both eyes without macular edema associated with type 2 diabetes mellitus Diabetic ketoacidosis without coma associated with type 2 diabetes mellitus Musculoskeletal and Integument DDD (degenerative disc disease), cervical Onychomycosis Genitourinary Acute kidney injury superimposed on CKD CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min Pyelonephritis Other Gout, unspecified Low magnesium levels Monitoring for long-term anticoagulant use Leukocytosis Mixed hyperlipidemia Severe sepsis Chronic anticoagulation Bacteremia due to Klebsiella pneumoniae
Andere Medikamente: allopurinol (ZYLOPRIM) 100 MG tablet apixaban (ELIQUIS) 5 MG tablet atorvastatin (LIPITOR) 40 MG tablet (Expired) Blood Glucose Monitoring Suppl (ACCU-CHEK GUIDE ME) w/Device KIT calcium carbonate (TUMS) 500 MG chewable tablet Continuo
Allergien: MetforminDiarrhea Sulfa AntibioticsDiarrhea Covid-19 Mrna Vaccine (Pfizer) [Covid-19 Mrna Vacc (Moderna)]Swelling Ace Inhibitors Aricept [Donepezil]Diarrhea
Vorherige Impfungen: Swelling after pfizer vaccine

VAERS 1846258

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WI
Alter: 70,0
Geschlecht: F
Eingang: 23.11.2021
Impfdatum: 11.03.2021
Beginn: 26.10.2021
Tage bis Beginn: 229,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute myocardial infarction COVID-19 Cardiac failure congestive Chest X-ray abnormal Condition aggravated Malaise SARS-CoV-2 test positive

Symptomtext

The client was diagnosed with COVID-19 on October 26, 2021. She was fully-vaccinated at the time. Other health conditions (subacute NSTEMI) prompted her to seek emergent care. The client was hospitalized locally then transferred to Hospital. Once stable, she returned to the local hospital and was subsequently discharged to a skilled nursing facility (on or around November 14, 2021).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1885536

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 81,0
Geschlecht: M
Eingang: 19.11.2021
Impfdatum: 18.02.2021
Beginn: 01.11.2021
Tage bis Beginn: 256,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Nothing listed

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Not listed
Aktuelle Erkrankungen: not listed
Vorgeschichte: Squamous cell carcinoma of skin of scalp and neck, Diagnosed 4/26/2021
Andere Medikamente: not listed
Allergien: Oxycodone-aspirin
Vorherige Impfungen: -

VAERS 1885363

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 69,0
Geschlecht: F
Eingang: 19.11.2021
Impfdatum: 19.10.2021
Beginn: 25.10.2021
Tage bis Beginn: 6,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Death Disseminated intravascular coagulation

Symptomtext

death- Disseminated intravascular coagulation (defibrination syndrome)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1881335

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 71,0
Geschlecht: F
Eingang: 18.11.2021
Impfdatum: 03.03.2021
Beginn: 10.10.2021
Tage bis Beginn: 221,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient death 10/10/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 9,0
Labordaten: Positive COVID test 10/2/2021
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1880376

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 71,0
Geschlecht: F
Eingang: 18.11.2021
Impfdatum: 01.03.2021
Beginn: 17.11.2021
Tage bis Beginn: 261,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 pneumonia

Symptomtext

Acute hypoxemic respiratory failure secondary to COVID 19 pneumonia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1876660

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 87,0
Geschlecht: F
Eingang: 17.11.2021
Impfdatum: 17.03.2021
Beginn: 21.09.2021
Tage bis Beginn: 188,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Craniocerebral injury Death

Symptomtext

Pt deceased r/t closed head injury

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: Cardiovascular and Mediastinum Hypertension Hypertension, benign essential, goal below 140/90 Other Hyperlipidemia Glaucoma Hyperglycemia
Andere Medikamente: latanoprost (XALATAN) 0.005 % ophthalmic solution simvastatin (ZOCOR) 10 MG tablet triamcinolone (KENALOG) 0.1 % cream Vitamin D, Cholecalciferol, 400 units CAPS
Allergien: NKA
Vorherige Impfungen: -

VAERS 1876584

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

kritisch

Staat: -
Alter: 89,0
Geschlecht: M
Eingang: 17.11.2021
Impfdatum: 17.02.2021
Beginn: 02.08.2021
Tage bis Beginn: 166,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

limited medical records received on this pt; pt presents to hospital being positive for COVID; HX of A Fib, CAD, CKD stage III, HTN; pt actively dying in the hospital; comfort care measures; family agrees to reduce O2 by mask; pt died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1873358

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 83,0
Geschlecht: F
Eingang: 16.11.2021
Impfdatum: 25.02.2021
Beginn: 12.07.2021
Tage bis Beginn: 137,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury COVID-19 pneumonia Cardiac arrest Confusional state Cough Death Endotracheal intubation Intensive care Mechanical ventilation Nausea Respiratory failure Respiratory tract congestion Sepsis Thrombocytopenia Vomiting

Symptomtext

pt seen in ED and dx with AHRF, sepsis due to COVID pneumonia, AKI, thrombocytopenia; started on decadron, pepcid, zofran, IV fluids; admitted to hospital; pt has had cough, congestion, confusion, N/V; pt's condition worsened in the hospital requiring intubation with mechanical ventilation; transferred to ICU; pt experienced cardiac arrest and died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1873209

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 79,0
Geschlecht: M
Eingang: 16.11.2021
Impfdatum: 24.02.2021
Beginn: 10.08.2021
Tage bis Beginn: 167,0
Dosis: 2
Route/Site: IM / OT

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia COVID-19 COVID-19 pneumonia Cough Death Dyspnoea Endotracheal intubation

Symptomtext

Presented with SOB/weakness/non-productive cough; fully vaccinated; dx Covid PNA; treated with steroids, antibiotics, remdesivir, zinc, veletri infusion; intubated; initial covid dx 8/8; hospital admit 8/10; intubated 8/22; comfort care 8/24; died 8/24

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 15,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1869414

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

kritisch

Staat: -
Alter: 79,0
Geschlecht: M
Eingang: 15.11.2021
Impfdatum: 23.02.2021
Beginn: 29.08.2021
Tage bis Beginn: 187,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Asthenia COVID-19 Chest pain Death Dyspnoea General physical health deterioration Hypoxia

Symptomtext

dx'd with COVID 8/29/21, admitted to hospital, dc'd to home on 8/31/21; sent per Home Health nurse to ED on 9/13/21 for chest pain, dyspnea, increased weakness past 2-3 dys; pt found to be hypoxic; placed on O2 OptiFlow 50/70; given diuretics, antibiotics, steroids; DNI/DNR; condition worsened and pt placed on OptiFlow 100%; inpatient hospice; comfort care measures; pt died in the hosp after condition continued to deteriorate

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1860978

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 73,0
Geschlecht: F
Eingang: 11.11.2021
Impfdatum: -
Beginn: 30.01.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Pulmonary embolism

Symptomtext

hospitalized c/b bilateral PEs

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Lupus, CKD
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1850882

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 87,0
Geschlecht: M
Eingang: 10.11.2021
Impfdatum: 21.02.2021
Beginn: 10.11.2021
Tage bis Beginn: 262,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Cardiac failure acute Cough Diarrhoea Dyspnoea Fatigue Fluid intake reduced Hypophagia Myalgia Inappropriate schedule of product administration Nausea Oxygen saturation decreased Productive cough Pyrexia SARS-CoV-2 test positive

Symptomtext

hospitalization (non-ICU)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1854296

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 69,0
Geschlecht: F
Eingang: 09.11.2021
Impfdatum: 17.02.2021
Beginn: 14.10.2021
Tage bis Beginn: 239,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain COVID-19 Chest X-ray abnormal Cough Death Endotracheal intubation Lung infiltration Malaise Positive airway pressure therapy Pyrexia SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/20/2021 and 2/17/2021. Patient presented to ED on 10/14 with c/o general malaise, abdominal pain with a cough and fever that had been ongoing for 4 days. CXR revealed diffuse bilateral lung infiltrates concerning for PNA. Upon arrival to the ED, pt tested positive for COVID-19. Patient started on BiPAP and subsequently intubated on 10/18. CRRT started on 10/20 and requiring vasopressor support. Patient treated with Remdesivir, methylpred, and tocilizumab. Patient family requested palliative care and transitioned to comfort care on 11/3. Patient expired 11/3.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 20,0
Labordaten: COVID-19 Positive on 10/14/21 using the Luminex Aries platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology
Aktuelle Erkrankungen: -
Vorgeschichte: Allergic rhinitis, Anemia, Autoimmune disease, Carpal Tunnel syndrome, Cataracts, Chronic Kidney Disease, Chronic
Andere Medikamente: Albuterol MDU 2 puff BID, Amlodipine 2.5 mg QD, Apixaban 5 mg
Allergien: Pregabablin (Altered Mental Status), Gabapentin (Hives)
Vorherige Impfungen: -

VAERS 2577828

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 68,0
Geschlecht: M
Eingang: 05.11.2021
Impfdatum: 16.02.2021
Beginn: 02.08.2021
Tage bis Beginn: 167,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Cough Deep vein thrombosis Dyspnoea Endotracheal intubation Intensive care Malaise Productive cough Pulmonary embolism Pyrexia SARS-CoV-2 test positive Septic shock Sputum discoloured Superinfection

Symptomtext

Narrative: Presented to the ER on 8/2. Completed full COVID vaccine series in March 2021. PMH significant for CAD, HFpEF, HLD, atrial fibrillation (on rivaroxaban), DM2, Crohn's disease, bipolar disorder, and obesity. He started feeling ill 6 days prior to ER visit and presented with worsening symptoms of cough with greenish sputum, SOB, and fever. Diagnosed with COVID pneumonia and hypoxic respiratory failure and admitted. Treated with dexamethasone, remdesivir, supplemental oxygen, and supportive care. Discharged on 8/9 with dexamethasone course. Presented to the ED again on 8/13 due to worsening SOB, persistent non-productive cough, and O2 sat 86%. Admitted to ICU with acute hypoxic respiratory failure secondary to new submassive bilateral PEs and bilateral DVTs (suspected to be provoked coagulopathy s/p COVID infection). Progressive respiratory failure requiring intubation 8/19 (13 day duration) for superimposed pneumonia with septic shock. Discharged on 9/14 to skilled nursing facility for rehab while still on oxygen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: 8/2 COVID PCR - POS, Delta variant 8/13 COVID PCR and Biofire nasal swab - NEG
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1846699

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 92,0
Geschlecht: M
Eingang: 05.11.2021
Impfdatum: 22.03.2021
Beginn: 21.09.2021
Tage bis Beginn: 183,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Bacterial infection COVID-19 Chills Death Decreased appetite Delirium Dyspnoea Metabolic acidosis Productive cough Respiratory failure SARS-CoV-2 test positive Sepsis Superinfection

Symptomtext

pt admitted to hosp on 9/21/21 with positive COVID test; dc'd on 9/22/21; presents back to ED with increasing SOB, productive cough, chills, poor appetite; Respiratory failure probable superimposed bacterial infection; antibiotics given; worsening sepsis and metabolic acidosis; given dexamethasone; worsening delirium; placed on comfort measures only and pt expired in the hosp

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1846211

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 79,0
Geschlecht: F
Eingang: 05.11.2021
Impfdatum: 26.02.2021
Beginn: 30.08.2021
Tage bis Beginn: 185,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Asthenia COVID-19 Death Dyspnoea General physical health deterioration Peripheral swelling Positive airway pressure therapy Productive cough SARS-CoV-2 test positive

Symptomtext

diagnosed positive for COVID on 8/31/21; presents to ED on 9/8/21 with c/o SOB, productive cough, weakness and leg swelling; Hx of CKD III-IV, CAD, lupus, HTN, Gout; states has not taken any polyclonal antibodies; started on dexamethasone and remdisivir; on O2 4-6L and High Flow; DNR/DNI; placed on BiPAP for short period of time but unable to tolerate; pt's condition declined and she was placed on comfort care; she died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1846194

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 77,0
Geschlecht: M
Eingang: 05.11.2021
Impfdatum: 23.02.2021
Beginn: 24.08.2021
Tage bis Beginn: 182,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Asthenia COVID-19 Cough Death Dyspnoea Haemodialysis SARS-CoV-2 test positive

Symptomtext

pt diagnosed positive for COVID on 8/24/21; received monoclonal antibody infusion 8/31/21; presented to ED(9/1/21) via EMS for increasing SOB, cough, weakness; O2 sats 75% on RA; Hx of CKD, DM; suffered AKI requiring hemodialysis during his stay; pt's condition worsened; he was made comfort care; died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 26,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1840564

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MT
Alter: 86,0
Geschlecht: M
Eingang: 03.11.2021
Impfdatum: 02.03.2021
Beginn: 23.10.2021
Tage bis Beginn: 235,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Case completed his Covid vaccine series in March 2021, then was hospitalized and died in October 2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: Ordered Test: SARS-CoV-2 RNA Resp Ql NAA+probe (COVID-19 Screen(Abbott),Reg) Ordered Test Codes: 94500-6 (LN LOINC)/7140746979 (L LOCAL) Status: Final Accession Number: 2021291006693001 Specimen Source: Nasal Specimen Site: Specimen Collection Date/Time: 2021-10-18 23:54:00.0 Result: Resulted Test: SARS-CoV-2 RdRp Resp Ql NAA+probe (SARS CoV-2 Rapid (COVID-19)) Coded Result: Positive (LOCAL) Numeric Result: Units: Text Result: Reference Range From: Presumptive negative Reference Range To: Performing Facility Details: Date/Time: 2021-10-19 00:20:47.0 Performing Facility:Community Med Cntr Facility ID:27D0666145 (FI) Interpretation: Abnormal Result Method: (ID NOW COVID-19_Abbo) Status: Final Test Code: 94534-5 (LN LOINC)/7137798081 (L LOCAL) Result Code: 10828004 (SCT/Positive (L LOCAL) Result Comments: corrected and called result 10/19/2021 00:20:03 MDT
Aktuelle Erkrankungen: Anemia, Arthritis, CHF, Depression, chronic renal insufficiency, Diabetes mellitus, DJD, GERD, Hyperlipidemia, HTN, Hypothyroidism, OSA on CPAP, Osteoarthritis, peripheral neuropathy, Restless leg syndrome
Vorgeschichte: Anemia, Arthritis, CHF, Depression, chronic renal insufficiency, Diabetes mellitus, DJD, GERD, Hyperlipidemia, HTN, Hypothyroidism, OSA on CPAP, Osteoarthritis, peripheral neuropathy, Restless leg syndrome
Andere Medikamente: Accu-ccchek Aviva Aspirin Celexa Cholecaalciferol Docusate sodium Ferrous sulfate gabapentin Flucosamine Chondroitin Levoxyl Metamucil Prilosec probiotic Requip Vitimin B complex
Allergien: -
Vorherige Impfungen: -

VAERS 1840279

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 03.11.2021
Impfdatum: 22.02.2021
Beginn: 22.09.2021
Tage bis Beginn: 212,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Death Dyspnoea Endotracheal intubation Haematoma muscle Intensive care SARS-CoV-2 test positive

Symptomtext

pt to ED with hx of COPD; presents with increasing SOB x 4-5 days; positive test for COVID; placed on supplemental O2, given remdisivir and steroids; pt's condition worsened and he was admitted to ICU; intubates; developed left intramuscular neck hematoma; condition declined; placed on comfort care and extubated; pt died in the ICU

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 13,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1840063

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 97,0
Geschlecht: F
Eingang: 03.11.2021
Impfdatum: 04.03.2021
Beginn: 03.09.2021
Tage bis Beginn: 183,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Asthenia Atrial fibrillation COVID-19 Confusional state Cough Death Decreased appetite Dyspnoea Fall Metabolic encephalopathy Pneumonia Respiratory failure SARS-CoV-2 test positive Tachycardia Urinary tract infection

Symptomtext

pt was seen in ED yesterday with Left lower lobe pneumonia and UTI; presented back to ED today after being so weak she fell and EMS was called; pt is confused and has tachycardia; c/o SOB and cough today, appetite decreased; dx with A Fib with RVR; positive for COVID; respiratory failure requiring aggressive O2 therapy; acute metabolic encephalopathy; comfort care measures instituted; pt died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2602986

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 82,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 16.02.2021
Beginn: 27.08.2021
Tage bis Beginn: 192,0
Dosis: UNK
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 pneumonia Death Dyspnoea Intensive care Positive airway pressure therapy

Symptomtext

Narrative: 81 yo M with PMH significant for CKD 3a, RCC s/p L nephrectomy (2016) with hepatic dome mass, psoas mass, and mesenteric nodule, COPD, OSA, and hypothyroidism who was admitted for COVID PNA s/p Pfizer (02/21), initially on 4L NC but with worsening dyspnea and increased spO2 requirements was transferred to ICU 8/11 for higher level of care. Patient was initially placed on HFNC for oxygenation support, but decompensated despite steroid, dexamethasone. Patient eventually was fully BIPAP bound starting 8/22. On 8/27, patient was no longer able to maintain oxygenation >85% despite maximal BIPAP support. We discussed with the family that intubation at this point would just result in further suffering, and that patient is very unlikely to recover from overwhelming COVID PNA. Family decided to withdraw care and patient was placed on comfort care. He passed on 11:02 PM 8/27.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2602711

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 09.02.2021
Beginn: 04.09.2021
Tage bis Beginn: 207,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Acute respiratory failure Angiogram pulmonary abnormal Blood glucose normal Bronchial secretion retention COVID-19 Chronic obstructive pulmonary disease Condition aggravated Cough Culture urine positive Diarrhoea Escherichia test positive Lung infiltration Pain Productive cough Pseudomonas infection Pseudomonas test positive Pulmonary mass

Symptomtext

Narrative: ADMISSION DATE: 09/04/2021 DISCHARGE DATE: 09/14/2021 DISCHARGE TYPE: Regular PRINCIPAL DIAGNOSIS (Reason for admission after study): Acute Hypoxic Respiratory Failure: Improving course. Acute Exacerbation of COPD: secondary to mucous plugging Covid 19 infection: + 9/4/21 Multiple Pulmonary nodules - multiple pulmonary nodules since 2017 with currently enlarging LLL nodule Acute UTI d/t Pseudomonas aeruginosa: ADDITIONAL DIAGNOSES: ASCAD Depression/ anxiety: DM Type II: HLD: HISTORY OF PRESENT ILLNESS: Patient is a 72 year old with a PMH notable for CAD COPD PROSTATECTOMEY 8/23/21 admitted via ED for Covid with severe diarrhea and multiple comorbidities. Patient who just had a radical suprapubic prostatectomy on 8/23/2021 for which she was discharged on Aug 30 presents with a 3-day history of severe diarrhea, some abdominal cramping and generalized body aches. Patient apparently spent some time in the ICU postoperatively due to a combination of volume overload combined with COPD. He reports having a chronic cough productive of sputum but no respiratory distress. He does have chronic COPD he feels is mostly at his baseline. Patient does have a CT scan scheduled for tomorrow (Sunday) at 10 AM due to some change in the size of some nodules noted on imaging. HOSPITAL COURSE: Acute Hypoxic Respiratory Failure: Improving course. - Likely multifactorial from COPD exacerbation, mucous plugging, COVID 19. - Anticipate d/c home. No home O2 is needed. Acute Exacerbation of COPD: secondary to mucous plugging - cont pulmonary toilet - home bronchodilators continued, scheduled nebs - cont Dexamethasone for 10 total days Covid 19 infection: +9/4/21 - evidence of early infiltrate on CTA last pm, no PE identified. - cont Remdesivir started 9/9/21, Last treatment dose 9/13 - D/C Dexamethoasone - trend inflammatory markers Multiple Pulmonary nodules - multiple pulmonary nodules since 2017 with currently enlarging LLL nodule - see pulmonary e consult 9/7/21 for recommendations - will need outpt PET scan once Covid 19 infection cleared F/u as per Pulm. UTU d/t pseudomonas aeruginosa: - admitted with urinary retention S/P recent prostatectomy 08/2021 - secondary to Pseudomonas and E coli on urine cx 9/4/21 - Cont Cefepime for complicated UTI completed 7 days today ASCAD - Cont Carvedilol, Isosorbide mononitrate, and Atorvastatin. Plavix continued. Depression/ anxiety: - cont Sertraline - Taper off Celexa with mild prolonged QTc DM Type II: blood sugars okay - Continue correction insulin with metformin held HLD: - Cont Crestor PROCEDURES/OPEATIONS: None PERTINENT ROS: diarrhea, abdominal pain, body aches PERTINENT PAST MEDICAL HISTORY: Patient is a 72 year old with a PMH notable for CAD COPD PROSTATECTOMEY 8/23/21 admitted via ED for Covid with severe diarrhea and multiple comorbidities. Patient who just had a radical suprapubic prostatectomy on 8/23/2021 for which she was discharged on Aug 30 presents with a 3-day history of severe diarrhea, some abdominal cramping and generalized body aches. Patient apparently spent some time in the ICU postoperatively due to a combination of volume overload combined with COPD. He reports having a chronic cough productive of sputum but no respiratory distress. He does have chronic COPD he feels is mostly at his baseline. Patient does have a CT scan scheduled for tomorrow (Sunday) at 10 AM due to some change in the size of some nodules noted on imaging.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2602051

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 94,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 05.03.2021
Beginn: 12.07.2021
Tage bis Beginn: 129,0
Dosis: UNK
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute coronary syndrome Acute myocardial infarction Arthralgia COVID-19 Femur fracture Haemoglobin decreased Hip arthroplasty Hip fracture Mental status changes Post procedural hypotension Pulmonary embolism Red blood cell transfusion SARS-CoV-2 test positive Shock haemorrhagic Unresponsive to stimuli Urinary tract infection

Symptomtext

Narrative: 93 year old patient was found to have covid19 after full vaccination (Pfizer 2/12, 3/5/2021). Pt tested positive on 7/12/2021 while he was inpatient. Pt was admitted for left hip pain (left femoral hip fracture) on 7/11/2021. On 7/13, he under went left partial hip arthroplasty from the fracture and developed hypotension and AMS, he was also found to have hbg of 7.6 (drop from 7.6). Pt required 3 units of pRBCs, his course was also complicated with UTI and type 2 NSTEMI from hemorrhagic shock. Hospice care discussed with family. Pt was found to be unresponsive on 7/14/2021. Medical cause of death listed as: *Hemorrhagic shock and acute coronary syndrome or pulmonary emboli

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2602050

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: -
Beginn: 31.08.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Acute respiratory failure COVID-19 pneumonia Death Malnutrition Sepsis

Symptomtext

Narrative: 65 yo patient with PMH: CAD, COPD, low back pain, OA, squamous cell carcinoma of lung, HLD, Schatzki's ring, SCC of tongue who was admitted on 8/31/2021 or acute hypoxic respiratory failure secondary to covid19 pneumonia, severe sepsis, AKI and malnutrition. Patient has full vaccination status (PFizer, 2/4/2021, 2/25/2021) Pt's prognosis was guarded (per note) due to poor pulmonary reserve and chemo-induced immunosuppression. Patient had worsening clinical status after a couple of days. Family opted for comfort measure on 9/3/2021 and patient passed away on 9/4/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2602019

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 88,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 17.02.2021
Beginn: 11.08.2021
Tage bis Beginn: 175,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Sepsis

Symptomtext

Narrative: Pneumonia due to coronavirus disease 2019 J12.82(ICD-10-CM) Other specified sepsis A41.89(ICD-10-CM) Acute respiratory failure with hypoxia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2596637

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 96,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 09.02.2021
Beginn: 26.08.2021
Tage bis Beginn: 198,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Atelectasis COVID-19 COVID-19 pneumonia Chest X-ray abnormal Death Fatigue Lung opacity Nausea SARS-CoV-2 test positive Ventilation/perfusion scan Vomiting

Symptomtext

Narrative: COVID infection following COVID vaccine series 01/20, Pfizer, dose #1 02/09, Pfizer, dose #2 08/27 COVID swab, result: detected 08/27 CXR impression: Probable atelectatic changes in the left base. Otherwise no acute process is seen. 08/26 pt cc: Nausea, vomiting, fatigue exposure: unknown 08/28 pulm v/q impression: No definite perfusion abnormality to suggest significant pulmonary embolus. Small pulmonary emboli cannot be completely excluded. 09/01 CXR impression: New and large-volume parenchymal opacities within both lungs, RIGHT much worse than LEFT, since 5 days ago, most in keeping with ongoing COVID pneumonitis. No large pleural effusion. 09/04 pt deceased

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: COVID infection following COVID vaccine series 01/20, Pfizer, dose #1 02/09, Pfizer, dose #2 08/27 COVID swab, result: detected 08/27 CXR impression: Probable atelectatic changes in the left base. Otherwise no acute process is seen. 08/03 pt cc: exposure: unknown 08/28 pulm v/q impression: No definite perfusion abnormality to suggest significant pulmonary embolus. Small pulmonary emboli cannot be completely excluded. 09/01 CXR impression: New and large-volume parenchymal opacities within both lungs, RIGHT much worse than LEFT, since 5 days ago, most in keeping with ongoing COVID pneumonitis. No large pleural effusion. 09/04 pt deceased
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2595849

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 79,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 05.02.2021
Beginn: 13.07.2021
Tage bis Beginn: 158,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Death Vaccine breakthrough infection

Symptomtext

Narrative: Breakthrough COVID infection resulting in patient death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1836809

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 82,0
Geschlecht: F
Eingang: 02.11.2021
Impfdatum: 04.03.2021
Beginn: 22.10.2021
Tage bis Beginn: 232,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 Condition aggravated Death Pneumonia Respiratory distress SARS-CoV-2 test positive

Symptomtext

Patient presented to emergency department on 10/27/21 with resp distress. patient was admitted for further management of pneumonia. patient was found to be covid-19 positive on 10/22/2021. patient did requirement treatment for symptoms associated with covid-19 infection. Treatment included aggressive respiratory care, oxygen therapy, breathing treatments and other supportive measures. patient given dexamethasone, remdesivir. patient expired 10/31/2021 due to respiratory distress, acute hypoxemic respiratory failure secondary to covid 19

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: patient reported positive covid-19 test on 10/22/21
Aktuelle Erkrankungen: none known
Vorgeschichte: GERD (gastroesophageal reflux disease) Rheumatoid arthritis CVA (cerebral infarction) TIA (transient ischemic attack) HTN (hypertension) Hyperglycemia Hyperlipidemia CAD (coronary artery disease) Hypercalcemia Increased PTH level Spinal stenosis of lumbar region Gout LBP radiating to right leg Right leg numbness CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min Secondary hyperparathyroidism Colon polyp Degenerative disc disease, lumbar LBP radiating to left leg Vitamin D deficiency Back pain Chronic pain of right knee Coronary artery disease involving native coronary artery of native heart without angina pectoris Primary hyperparathyroidism Irritable bowel syndrome with diarrhea Renal cyst Hemorrhoid Hematochezia Spinal stenosis, lumbar region, with neurogenic claudication Other form of scoliosis of lumbar spine Chest pain Pneumonia due to COVID-19 virus Acute respiratory distress Hypoxemia requiring supplemental oxygen Secondary bacterial pneumonia
Andere Medikamente: acetaminophen (TYLENOL EXTRA STRENGTH) 500 MG tablet allopurinol (ZYLOPRIM) 100 MG tablet amLODIPine (NORVASC) 10 MG tablet aspirin (HALFPRIN) 81 MG tablet benzonatate (TESSALON) 100 MG capsule calcium carbonate (TUMS) 500 MG chew tablet Ch
Allergien: amoxicillin, brilinta
Vorherige Impfungen: -

VAERS 1836703

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 56,0
Geschlecht: F
Eingang: 02.11.2021
Impfdatum: 17.02.2021
Beginn: 21.10.2021
Tage bis Beginn: 246,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Angiogram pulmonary normal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chest discomfort Diarrhoea Dyspnoea Dyspnoea exertional Endotracheal intubation Fraction of inspired oxygen Hypoxia Intensive care Lung disorder Lung infiltration Mechanical ventilation Oxygen saturation decreased Prone position

Symptomtext

Hospitalized 10/24/2021; COVID-19 positive 10/21/2021; fully vaccinated Assessment/Plan COVID-19 pneumonia Acute hypoxic respiratory failure - Admit to hospital as inpatient, anticipate >2 midnight hospital stay. - Symptom onset 10/18, PCR+ on 10/21 and again on 10/24. - Desat to 86% on baseline RA, now on 2L via NC. - CXR with extensive bilateral patchy airspace disease. - Continue Decadron started in ER - plan for 10-day course. - Start remdesivir - plan for 5-day course. - Check CTA thorax. - Supportive care, symptom control, proning PRN, encourage IS. - CPO monitoring, wean supplemental oxygen as able. HISTORY OF PRESENT ILLNESS: Patient is a 57 y.o. female with h/o HTN, HLD, GERD, anxiety/depression and obesity, who presented to the ER on 10/24 with 6-day h/o progressive dyspnea, chest tightness, fevers and loose stools. She was diagnosed with COVID-19 on Thursday and has since been monitoring her SpO2 via home pulse oximeter. She has been mostly saturating normally at rest, but with any exertion will drop into the 80's. 10/26/2021 note: CHIEF COMPLAINT: Pneumonia due to COVID-19 virus ASSESSMENT / PLAN: Principal Problem: Pneumonia due to COVID-19 virus COVID-19 pneumonia Acute hypoxic respiratory failure - Vaccinated - 2nd dose pfizer 2/17/21. Hadn't qualified for booster yet unfortunately. - Symptom onset 10/18, PCR+ on 10/21 and again on 10/24. - Increased oxygen requirements now up to 75% FiO2 HFNC - CXR with extensive bilateral patchy airspace disease. - Continue Decadron started in ER - plan for 10-day course. - continue remdesevir - CTA negative for PE - Supportive care, symptom control, proning PRN, encourage IS. - CPO monitoring, wean supplemental oxygen as able. SUBJECTIVE: Patient overnight had increasing oxygen requirements. Initially required increased regular nasal cannula followed by NRB then was transitioned to HFNC which she is tolerating well. Feeling like air is being pushed in a bit more than usual with the HFNC but overall doing okay with it. She is very grateful for the care she is receiving here. She is proning as often as she can, using the acapella. 10/27/2021 note: CHIEF COMPLAINT: Pneumonia due to COVID-19 virus Assessment/Plan Pneumonia due to COVID-19 virus COVID-19 pneumonia Acute hypoxic respiratory failure - worsening. - Vaccinated - 2nd dose pfizer 2/17/21. Hadn't gotten booster yet unfortunately. - Symptom onset 10/18, PCR+ on 10/21 and again on 10/24. - Increased oxygen requirements now 100% HFNC with NRB - CXR with extensive bilateral patchy airspace disease. - Continue Decadron started in ER - plan for 10-day course. - continue remdesevir - CTA negative for PE - Supportive care, symptom control, proning PRN, encourage IS. - CPO monitoring, wean supplemental oxygen as able. - will trial push of lasix 40 given coarse breath sounds - consult pulmonology given maxing out on HFNC with NRB overtop periodically ?higher steroids

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: 10/28/2021 note: Patient on 100% FiO2. High-flow Despite this, saturating mid to lower 80s Placed in prone position, improved somewhat to higher 80s and low 90s Unfortunately this was short lived, patient returned back to mid 80s Discussed with intensive care unit, recommending transfer, plans for possible intubation. Significant events in the last 24 hours: See initial consult by Dr on 10.28.21 for HX and ROS. Progressive hypoxemia requiring 100% high-flow and non-rebreather. Oxygen saturations dropping into the 70s. Patient transferred to the intensive care unit and emergently intubated. 10/31/2021 note: ASSESSMENT / PLAN: 57 y.o. vaccinated, with HTN, obesity, admitted 10/24/2021 with respiratory failure due to COVID-19 pneumonia. Intubated 10/28. Acute hypoxemic respiratory failure due to COVID-19 Overview Required 3L on admission 10/24, in context of bilateral pulmonary infiltrates due to COVID pneumonia CTA chest without PE on 10/25 Escalating O2 requirements daily, on 100% HFNC by 10/26 PM Intubated 10/28 due to progressive hypoxemia Plan: Doing very well supine today Try to reduce PEEP to 12 and stay supine 11/2/2021 note: Plan: Okay to transition to pressure support ventilation to allow for weaning sedation Goal SpO2 88-92%, PaO2 55-65 Monitor PF ratio goal greater than 150 Wean sedation for RASS goal -3 SUBJECTIVE: Significant events in the last 24 hours: Paralytic stopped today. Patient is not interactive at this time. Weaning sedation. Tolerated paralytic holiday very well without any dyssynchrony, while able to transition to pressure support ventilation
Aktuelle Erkrankungen: -
Vorgeschichte: Pneumonia due to COVID-19 virus Acute hypoxemic respiratory failure due to COVID-19 Reactive airway disease with acute exacerbation Class 1 obesity in adult Essential hypertension Steroid-induced hyperglycemia Hypertension, benign Polyp of nasal cavity
Andere Medikamente: acetaminophen (TYLENOL) 325 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ALPRAZolam (XANAX) 0.5 MG tablet B Complex Vitamins (VITAMIN B COMPLEX PO) budesonide (PULMICORT) 90 MCG/ACT inhaler
Allergien: NKA
Vorherige Impfungen: -

VAERS 1963029

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6201

kritisch

Staat: NY
Alter: 71,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 09.02.2021
Beginn: 11.03.2021
Tage bis Beginn: 30,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Cardiac stress test Chest X-ray Computerised tomogram thorax abnormal Dyspnoea Electrocardiogram Full blood count Haemoglobin Prothrombin time Pulmonary embolism Pulmonary function test

Symptomtext

Shortness of breath less than two weeks after second shot, continuing until present day (11.01.2021). I cannot walk more than 250 ft. without pausing to catch my breath.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Multiple EKGS, Lung X-rays, Blood tests, External Pulmonary Function test, Stress test, CT scan Chest/Heart Pharmacologic, CT Scan ChestPulmonary Artery Embolus, CBC, Protime, Hemoglobin A1C (performed some at Hospital)
Aktuelle Erkrankungen: None
Vorgeschichte: Atrial fibrillation, Diabetes, Obesity, High cholesterol, Sleep apnea, Upper GI bleed
Andere Medikamente: Digoxin, Warfarin, Torsemide, Potassium Chloride, Rosuvastatin, Ramipril, Carvedilol, Metformin, Novalin N, Januvia, Jardiance, Methocarbamol, Tramadol, Gabapentin, Diltiazem ER
Allergien: Penicillin, Cefzil, Quinidine, Clindamycin
Vorherige Impfungen: -

VAERS 2638797

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 70,0
Geschlecht: M
Eingang: 31.10.2021
Impfdatum: 09.09.2021
Beginn: 10.10.2021
Tage bis Beginn: 31,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Adenovirus test Angiogram pulmonary abnormal Asthenia Blood lactic acid Bordetella test negative COVID-19 COVID-19 pneumonia Cardiac arrest Chest X-ray abnormal Chlamydia test negative Computerised tomogram thorax normal Coronavirus test negative Death Dyspnoea Endotracheal intubation Enterovirus test negative Fibrin D dimer

Symptomtext

Narrative: 70-year-old male patient with past medical history most significant for hypertension, hyperlipidemia, diabetes, sleep apnea, anemia, CLL (treated with Ibrutinib), thrombocytopenia, and recent diagnosis of COVID-19 who presented to the Emergency Department complaining of generalized weakness and shortness of breath. Patient was walking from the bathroom back to his chair when he felt so weak that he could not make it all way to his chair. He denied any injuries, head or neck pain, back pain, hip or pelvis pain, extremity pain. EMS was called. He stated he had been short of breath. EMS checked room air saturation several times and stated it was roughly 55%. He was placed on nonrebreather with oxygen saturations in the 70s, then additional 6 L via nasal cannula was added at which point he was satting 88 to 94%. Patient stated that he was feeling well once he was on oxygen. In the ED he was receiving 15 L via nonrebreather satting 89%, placed on HFNC @ 40L & 60% FiO2. He had persistent general malaise/weakness but no focal symptoms. He denied chest pain, palpitations, lightheadedness. He had had no recent fever or chills. He stated he has had recent diffuse mild dull myalgias after his flu shot on 9/23/2021. Otherwise afebrile, BP 144/113, HR 115, RR 20. Labs significant for leukocytosis to 15.5 with left shift, Hgb 9.3, procal 1.57, lactic acid 1.75, d-dimer >20. U/A with 20 ketones. He was admitted on 10/10/2021. On 10/17, the patient had an acute decompensation. He had been weaned to nasal cannula (6L) but had a rapidly increasing oxygen requirement. Subsequent ABG 7.47/34/39, patient in severe respiratory distress. He was intubated and was hypoxic in the 70s despite 100% FIO2. Inhaled NO was started with improvement in hypoxemia. CTPE negative for PE. Source of presume sepsis is due to a superimposed bacterial pneumonia and wide spectrum antibiotics were prescribed. The goal was to wean the patient eventually from the ventilator but on 10/21/2021, the patient had PEA arrest and passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: Specimen Collection Date: Sep 30, 2021 COVID-19 PCR (FLUVID CEPH) DETECTED H* Specimen Collection Date: Oct 10, 2021 @08:30 Test name Result units Ref. range Site Code COVID-19 (BIOFIRE) DETECTED ADENOVIRUS (BIOFIRE) Not Detected CORONAVIRUS 229E (BIOFIRE) Not Detected CORONAVIUS HKU1 (BIOFIRE) Not Detected CORONAVIRUS NL63 (BIOFIRE) Not Detected CORONAVIRUS OC43 (BIOFIRE) Not Detected HUMAN METAPNEUMO Not Detected HUMAN RHINO/ENTERP Not Detected FLU A (BIOFIRE) Not Detected INFLUENZA B (BIOFIRE) Not Detected PARA 1 Not Detected PARA 2 Not Detected PARA 3 Not Detected PARA 4 Not Detected RSV BIOFIRE Not Detected B PARAPERTUSSIS Not Detected B PERTUSSIS Not Detected CHLAM PNEUMO Not Detected MYCO PNEUMO Not Detected Specimen Collection Date: Oct 20, 2021@14:00 COVID-19 SCR POSITIVE H* COVID CT VALUE (ALINITY M) 20.89 Exam Date/Time 10/10/2021 04:54 Procedure Name CHEST-1 VIEW (AP/PA) Reason for Study COVID+; hypoxic Impression Findings that can be seen with atypical pneumonia given the history. Report Technique: Single frontal portable chest radiograph Comparison: September 13, 2021 and July 28, 2021 chest radiographs Findings: Groundglass opacities overlie the right mid and lower lung zones and the left lower lung zone. There are superimposed small interstitial opacities in in the right mid-lower lung zones and patchy airspace disease. The cardiomediastinal silhouette is within normal limits. There is no large pleural effusion or pneumothorax. Exam Date/Time 10/10/2021 10:07 Procedure Name CTA PULMONARY ANGIOGRAPHY NONCORONARY Reason for Study Eval for PE Impression 1. No visualized pulmonary embolism, although evaluation is limited by poor contrast bolus timing and motion artifact. 2. Diffuse bilateral subpleural predominant groundglass and consolidative opacities, most noted in the bilateral lower lobes. Consistent with COVID pneumonia. 3. Mediastinal and hilar lymphadenopathy. Favor reactive.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1821624

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 27.10.2021
Impfdatum: 21.02.2021
Beginn: 03.09.2021
Tage bis Beginn: 194,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 COVID-19 pneumonia Death Dyspnoea Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

presented to ED with SOB; tested positive for COVID; dx with COVID pneumonia; given monoclonal antibody; continued to require high amounts of O2; given high doses of steroids; respiratory support with NIPPV; DNI; removed NIPPV and pt expired in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 18,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1808091

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IN
Alter: 66,0
Geschlecht: F
Eingang: 22.10.2021
Impfdatum: 23.02.2021
Beginn: 04.08.2021
Tage bis Beginn: 162,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Asthenia Blood pressure abnormal Cardiac failure acute Chest discomfort Dyspnoea Echocardiogram normal Electrocardiogram abnormal Intensive care Myocardial infarction Stress cardiomyopathy

Symptomtext

On August 4, 2021, after going to the store with my husband and two of our grandchildren, I noticed I had trouble walking up the hills and had to stop and catch my breath because I had no energy. I had my husband bring the vehicle to where I was sitting when we left to go home, rather than walk to our vehicle. At home that evening, I couldn't wait to get out of the shower to sit or lie down as my chest felt very weak. I went to the ER the next day and was diagnosed with acute heart failure and later diagnosed with Takosubo, broken heart syndrome, where the upper part of my heart was not pumping blood. I was put in ICU the Medical Center for two days, where they worked on getting my blood pressure back to normal. They changed my blood pressure medications (dropped furosemide to 5mg before bedtime if systolic number above 100; added Metropolol [Toprol]and added Spironolactone. An Echocardiogram showed normal function of my heart on August 30, 2021. I read where this syndrome corrects itself after a month or two with medical assistance. I still have pinching in my heart occasionally. I am afraid to get a COVID booster vaccine, which I am due for. What is your advice????

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 3,0
Labordaten: August 4, 2021 -- ER trip indicated a heart attack on EKG, but no blockages; Takosubo Syndrome indicated August 18, 2021 -- Second trip to ER showed improvement on EKG August 30, 2021 -- ECHO showed normal function of heart
Aktuelle Erkrankungen: None
Vorgeschichte: Anxiety, depression, high blood pressure,
Andere Medikamente: Lisinopril, Furosemide, Protonix, Amitriptylene, Paxil, Shaklee multiple vitamin (Vita Lea Gold)
Allergien: Sulfa and Penicillin
Vorherige Impfungen: -

VAERS 1807988

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 22.10.2021
Impfdatum: 07.02.2021
Beginn: 27.08.2021
Tage bis Beginn: 201,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury COVID-19 COVID-19 pneumonia Cough Death Dyspnoea General physical health deterioration Positive airway pressure therapy Pyrexia SARS-CoV-2 test positive

Symptomtext

pt presented with worsening SOB, cough, fever since 8/27; tested positive for COVID on 8/30; supplemental O2 started via NC and proceeded to BiPAP; diagnosed with AKI and COVID pneumonia; pt's condition worsened and he expired in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1806170

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 67,0
Geschlecht: M
Eingang: 21.10.2021
Impfdatum: 13.02.2021
Beginn: 13.10.2021
Tage bis Beginn: 242,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Atrial fibrillation COVID-19 COVID-19 pneumonia Chills Chronic obstructive pulmonary disease Condition aggravated Fatigue Gastrooesophageal reflux disease Hypertension Hypoxia Myalgia Productive cough Pyrexia SARS-CoV-2 test positive Tachycardia X-ray normal

Symptomtext

Hospitalized (10.13.21); COVID-19 positive (10.13.21); fully vaccinated Admission Date: 10/13/2021 Discharge Date: Oct 15, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 68-year-old male without medical history of chronic obstructive pulmonary disease on chronic 2 L oxygen, paroxysmal atrial fibrillation, hypertension, mi BPH, GERD he presented to the hospital with acute on chronic hypoxic respiratory failure and at generalized complaints of fatigue. He patient was admitted to the hospital for an acute exacerbation of chronic obstructive pulmonary disease. He was also found to be COVID positive patient was vaccinated with Pfizer vaccine in February of 2021. Patient did have an x-ray performed in the hospital which did not reveal evidence of infiltrate. Patient was admitted to the hospital treated with dexamethasone, remdesivir. He did well with treatment. His oxygen requirement decreased back to his baseline and he was no longer having any symptoms of fevers or chills. He was feeling well enough to be discharged home. Patient was treated for elevated hypertension in the hospital he was started on Norvasc which she is to continue outpatient and follow-up with his primary care physician Discharge diagnosis: 1. Acute on chronic hypoxic respiratory failure- secondary to his underlying COPD with now acute excerebration with superimposed covid 19 infection. 2. -COVID-19 3. Hypertension accelerated 4. Paroxysmal atrial fibrillation 5. GERD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: Reported to PCP on 10.13.21 before ED: The patient has been struggling for last 3 to 4 days. Today he has 104 temperatures with myalgias and chills. Cough is significant with minimal sputum. No nausea vomiting or diarrhea. Tachycardia is present.
Vorgeschichte: Mucopurulent chronic bronchitis Panlobular emphysema Hypoxemia COPD exacerbation GERD Hypertension Osteoporosis Paroxysmal A-Fib
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler alendronate (FOSAMAX) 70 MG tablet amLODIPine (NORVASC) 5 MG tablet ascorbic acid (VITAMIN C) 500 MG tablet aspirin 81 MG enteric coated tablet buPROPion
Allergien: doxycycline
Vorherige Impfungen: -

VAERS 1804819

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 88,0
Geschlecht: M
Eingang: 21.10.2021
Impfdatum: 23.02.2021
Beginn: 16.08.2021
Tage bis Beginn: 174,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Abdominal pain COVID-19 Death Dementia Failure to thrive General physical health deterioration SARS-CoV-2 test positive

Symptomtext

pt admitted to hospital with c/o abdominal pain; pt has dementia and failure to thrive due to inadequate home care; COVID positive; pt's condition worsened and he was placed on comfort care; pt expired in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 14,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1801645

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 74,0
Geschlecht: M
Eingang: 20.10.2021
Impfdatum: 26.01.2021
Beginn: 02.10.2021
Tage bis Beginn: 249,0
Dosis: 2
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Death Laboratory test Vaccine breakthrough infection

Symptomtext

Patient had breakthrough infection and expired while infected

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 11,0
Labordaten: Clinic, laboratory test: 9/14/2021
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, hypertension, diabetes, BPH, and arthritis.
Andere Medikamente: None
Allergien: N/A
Vorherige Impfungen: -

VAERS 1801611

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 72,0
Geschlecht: F
Eingang: 20.10.2021
Impfdatum: 21.02.2021
Beginn: 06.10.2021
Tage bis Beginn: 227,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cardiac arrest Death Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and expired while infected with virus.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: Clinic Laboratory Report: 9/16/2021
Aktuelle Erkrankungen: N/A
Vorgeschichte: According to death note, patient went into cardiac arrest at home.
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1798190

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 19.10.2021
Impfdatum: 04.03.2021
Beginn: 21.08.2021
Tage bis Beginn: 170,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure Ageusia COVID-19 COVID-19 pneumonia Confusional state Cough Death Dyspnoea Metabolic encephalopathy Oxygen saturation decreased SARS-CoV-2 test positive

Symptomtext

pt diagnosed COVID positive in ED on 8/21, cough and no taste, dc'd to home; next day received monoclonal antibodies; on 8/24 pt was confused and had more SOB, O2 saturations low, placed on O2 via nasal cannula; started on full treatment for COVID; pt's condition worsened where he died in the hospital; acute respiratory failure, COVID pneumonia, metabolic encephalopathy

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1797300

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WI
Alter: 58,0
Geschlecht: M
Eingang: 19.10.2021
Impfdatum: 12.02.2021
Beginn: 26.02.2021
Tage bis Beginn: 14,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Myocardial infarction SARS-CoV-2 test

Symptomtext

Heart Attack; This is a spontaneous report from a contactable consumer reported for himself. This 59-year-old male patient received the 2nd dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6201) via an unspecified route of administration in the left arm on 12Feb2021 at age of 58 years old as single dose for COVID-19 immunization. Medical history included having risk factors for heart disease, Covid prior vaccination, known allergies: penicillin. Concomitant medications included other medications in two weeks. The patient had no other vaccine in four weeks. The patient previously received the 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249) via an unspecified route of administration in the left arm on 22Jan2021 at age of 58 years old for COVID-19 immunization. The patient suffered from a heart attack on 26Feb2021 at 02:30 AM. AE resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization for 2 days. AE treatment was received including cardiac catherization. The patient had Covid test post vaccination with negative result via nasal swab. Outcome of the event was recovered with sequel. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 2,0
Labordaten: Test Name: Nasal swab; Test Result: Negative ; Comments: Nasal swab
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19; Heart disease, unspecified; Penicillin allergy.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1795480

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 77,0
Geschlecht: M
Eingang: 18.10.2021
Impfdatum: 13.02.2021
Beginn: 25.08.2021
Tage bis Beginn: 193,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Cough Death Diarrhoea Dyspnoea Endotracheal intubation Extubation Nausea Shock Vomiting

Symptomtext

pt presented to ED with SOB, cough, N/V/D x 3 days; PMH: dementia, OSA on CPAP, chronic hypercapnic respiratory failure; intubated on 8/31; developed AKI and shock; transitioned to comfort care; extubation on 9/4; pt died shortly after extubation

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1795216

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 73,0
Geschlecht: M
Eingang: 18.10.2021
Impfdatum: 19.02.2021
Beginn: 11.10.2021
Tage bis Beginn: 234,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 COVID-19 pneumonia Condition aggravated Culture urine Diarrhoea Dyspnoea Fatigue Glycosylated haemoglobin Haematuria Headache Hyperglycaemia Renal disorder Renal hypertrophy SARS-CoV-2 test positive Sepsis Urinary tract infection

Symptomtext

Hospitalized; COVID-19 vaccine positive; fully vaccinated; Admission Date: 10/11/2021 Discharge Date: 10/13/2021; PRESENTING PROBLEM:Urinary tract infection with hematuria, site unspecified [N39.0, R31.9]Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (HCC) [A41.9]Acute hypoxemic respiratory failure due to COVID-19 [U07.1, J96.01]Pneumonia due to COVID-19 virus [U07.1, J12.82]HOSPITAL COURSE: 73 y.o. male who presented with fatigue and found to have Sepsis secondary to UTI with COVID-19 viral pneumonia with 5 days of symptoms prior to admission. The patient has a pmh copd, htn, osa, htn , obesity. He is fully vaccinated with x2 moderna dosing. The patient was treated with remdesivir x 2 days and decadron while hospitalized. Will discharge home on decadron to complete the 10 day steroid coarse. The patient was also given a prescription for mucinex and metformin due to steroid induced hyperglycemia. An A1C is pending. Recommend outpatient follow-up with PCP for BG monitoring. Acute hypoxic respiratory failure resolved, he had a home oxygen evaluation completed and no oxygen is required. The patient is eager to return home. The patient received 2 days of ceftriaxone and will be transitioned home on keflex to complete the antibiotic course. The urine culture is pending upon discharge. Recommend post-hospitalization follow-up with PCP in 1-week. CT abdomen pelvis recommend outpatient follow-up with dedicated kidney imaging with IV contrast is suggested to exclude presence of mass. Due to finding suggestive of bilateral multilobulated kidneys with presence of cortical thickening overlying the left kidney superior pole and the right kidney middle pole probably representing hypertrophied column.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: 10.11.21: Office Visit - Fatigue, breathing problems; diarrhea; headache
Vorgeschichte: HTN (hypertension), benign GERD (gastroesophageal reflux disease) Hyperlipidemia with target LDL less than 100 Primary hypertension Tobacco abuse COPD, severe (HCC) Obesity (BMI 30-39.9) Metabolic syndrome Hypolipoproteinemia BPH (benign prostatic hypertrophy) Family history of colon cancer GI AVM (gastrointestinal arteriovenous vascular malformation) Family history of stroke GERD (gastroesophageal reflux disease) Diverticulosis large intestine w/o perforation or abscess w/o bleeding Stuttering Penile wart Bilateral pneumonia Hypoalbuminemia Stress hyperglycemia Bilateral edema of lower extremity Prediabetes Snoring Leucocytosis Normochromic normocytic anemia Left carotid artery stenosis History of right-sided carotid endarterectomy History of adenomatous polyp of colon OSA (obstructive sleep apnea) Posterior vitreous detachment, bilateral Myopia of both eyes Stenosis of right carotid artery Presbyopia of both eyes Dry eyes, bilateral Pneumonia due to COVID-19 virus UTI (urinary tract infection)
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol (PROAIR HFA) 108 (90 BASE) MCG/ACT inhaler amlodipine (NORVASC) 10 MG tablet ascorbic acid 500 MG tablet aspirin 325 MG tablet atorvastatin (LIPITOR) 40 MG tablet buPROPion (WELLBUTRIN XL) 150
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1786661

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: PA
Alter: 78,0
Geschlecht: M
Eingang: 14.10.2021
Impfdatum: 15.03.2021
Beginn: 27.09.2021
Tage bis Beginn: 196,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Ageusia Anosmia Antiplatelet therapy Aspartate aminotransferase increased Atrial fibrillation Blood albumin decreased Brain natriuretic peptide normal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chills Condition aggravated Cough Dehydration Diarrhoea Dyslipidaemia Dyspnoea

Symptomtext

09/30/2021 Chief Complaint Patient presents with ? Nasal Congestion sx started Monday ? Sinus Problem ? Vomiting ? Diarrhea ? Chills ? Cough 79 year old patient presents with 3 days of N/V/D, cough, nasal congestion, wheezing, rhinorhea, and chills. Has been vaccinated in 4/2021 with Pfizer. Went camping over the weekend and found out that 43 of his friends tested (+) for COVID 19 who he was camping with. Taking:Albuterol inhaler. Tylenol BID. FLonase daily Outpatient COVID-19 Testing Provider Testing Criteria Decision Support Symptoms: (X ) Fever (X ) Shortness of breath (X ) Cough (X ) Sore throat (X ) Diarrhea ( ) Loss of taste/smell ( X) Other N/V, rhinorrhea, HA, wheezing ( ) None When did symptoms start? 3 days ED to Hosp-Admission Discharged 10/4/2021 - 10/9/2021 (5 days) Acute hypoxemic respiratory failure due to COVID-19 (CMS/HCC) Principal problem Hospital Problems POA * (Principal) Acute hypoxemic respiratory failure due to COVID-19 (CMS/HCC) Yes Plan Chief Complaint Patient presents with ? Shortness of Breath 1. Acute hypoxemic respiratory failure secondary to COVID-19 pneumonitis. Admit to general medical floor. Start patient on IV remdesivir, Decadron therapy. Check procalcitonin, inflammatory markers. Wean supplemental oxygen as tolerated to keep SaO2 greater than 90. Encourage proning. 2. Hyponatremia. Given concurrent hypochloremia, likely represents dehydration. Gentle IV hydration x24 hours. Monitor BMP. 3. Hypertension. Blood pressures appear well controlled, continue home regimen. 4. Atrial fibrillation. On Eliquis for anticoagulation, continue beta-blocker. Monitor on telemetry. 5. Dyslipidemia. Continue statin therapy. 6. Type 2 diabetes. Continue long-acting insulin per home regimen. Hold oral hypoglycemics. Will place on insulin sliding scale and Accu-Cheks per protocol. History of Present Illness Patient is an 79 y.o. male. With past medical history significant for A. fib on Eliquis, hypertension, dyslipidemia, diabetes presented to the emergency room for evaluation of hypoxia. Home health nurse found the patient to be hypoxic, oxygen saturation in the 80s on room air today. Patient was diagnosed with Covid about 13 days ago, does not use any oxygen at baseline. Denies any associated fevers, nausea or vomiting. Does endorse chest tightness, abdominal discomfort, particularly with coughing. Cough is productive of gray sputum. Initial work-up in the emergency room includes CBC within normal limits, BMP with evidence of hyponatremia, hypochloremia. Troponin negative x1 set, LFTs show mildly abnormal AST 55, albumin 3.2. BNP normal. Respiratory viral panel confirms SARS-CoV-2 infection. A 1 view chest x-ray shows bilateral infiltrates, consistent with COVID-19 infection. Patient has been administered 6 mg IV Decadron in the ER, and endorsed for hospitalization for further management of acute hypoxic respiratory failure from Covid 19 infection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: Collected Procedure 10/04/2021 1152 Respiratory virus detection panel Collected: 10/04/21 1152 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result Detected Critical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Syncytial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected Procedure Component Value Ref Range Date/Time X-ray chest 1 view - Portable Resulted: 10/04/21 2245 Order Status: Completed Updated: 10/04/21 2245 Narrative: XR CHEST 1 VW PORT IMPRESSION: Patchy bilateral opacities. Compatible with COVID pneumonia, in correlation with the history. END OF IMPRESSION: INDICATION: shortness of breath. COVID positive. TECHNIQUE: Portable AP projection of the chest was acquired. COMPARISON: PA chest 12/15/2005. FINDINGS: Sternotomy wires and CABG clips are new since 2005. The heart size is normal. The vascular distribution is normal. The hilar and mediastinal silhouettes appear unremarkable. Patchy mixed bilateral interstitial and airspace opacities project over the mid to lower lung bilaterally. These are newly seen. No pleural effusion is identified. There is no evidence of pneumothorax. There are no significant bony findings.
Aktuelle Erkrankungen: -
Vorgeschichte: Respiratory Acute hypoxemic respiratory failure due to COVID-19 (CMS/HCC) Digestive Unspecified protein-calorie malnutrition (CMS/HCC)
Andere Medikamente: acetaminophen (TYLENOL) 500 mg tablet albuterol HFA (PROVENTIL;VENTOLIN) 90 mcg/actuation inhaler amLODIPine (NORVASC) 5 mg tablet atorvastatin (LIPITOR) 40 mg tablet BD ULTRA-FINE NANO PEN NEEDLE 32 gauge x 5/32" needle chlorhexidine
Allergien: NKA
Vorherige Impfungen: -

VAERS 1776409

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 89,0
Geschlecht: F
Eingang: 11.10.2021
Impfdatum: 13.02.2021
Beginn: 10.10.2021
Tage bis Beginn: 239,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19

Symptomtext

Hospitalization - acute respiratory failure with hypoxia; COVID-19 virus infection

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1190942

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 39,0
Geschlecht: F
Eingang: 09.10.2021
Impfdatum: 01.03.2021
Beginn: 02.03.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Aspiration pleural cavity Bone pain Brain cancer metastatic Cerebrovascular accident Chest X-ray Computerised tomogram Cough Dyspnoea Feeling abnormal Lung cancer metastatic Lymphadenopathy Magnetic resonance imaging head abnormal Musculoskeletal chest pain Magnetic resonance imaging head Myalgia Neoplasm progression Pain

Symptomtext

Pleural effusion; Possible progression of her lung cancer/ new brain cancer; Stroke; Anxiety; Stress urinary incontinence; Enlarged lymph node; She had a little cough, it started to get a little worse; Could not take a deep breath and could not expand ribcage because there was immense pain; Pain in the right side under the ribcage muscle in the serratus anterior muscleshe thought she cracked her ribs; This is a spontaneous report from a contactable physician (patient). A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in right deltoid (arm) on 01Mar2021 (at the age of 39-year-old) (Lot Number: EN6201) as dose 2, single for COVID-19 immunization. Medical history included dyslipidemia due to taking LORBRENA, hypertension from 2007, lung cancer from 03Jul2017 and metastatic disease from lung cancer from Dec2018, all ongoing. Concomitant medication(s) included losartan taken for hypertension from an unspecified start date and ongoing; atorvastatin taken for blood cholesterol from an unspecified start date and ongoing; lorlatinib (LORBRENA) taken for lung neoplasm malignant from 26Jun2019 and ongoing; vitamin D 3 taken for an unspecified indication from an unspecified start date and ongoing; ubidecarenone, vitamin e nos (COQ10 COMPLEX) taken for an unspecified indication from an unspecified start date and ongoing. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left deltoid (arm) on 08Feb2021 14:25 (at the age of 39-year-old) (Lot Number: EN6201) as dose 1, single for COVID-19 immunization and experienced bone pain and muscle pain. The patient did not receive any other vaccine within 4 weeks prior to COVID vaccine. The patient reported possible progression of her lung cancer. The patient stated that stated that there was severe pain after the second dose which started with a little cough, which progressively got worse. The patient had pain so bad that she thought she cracked her ribs. On 02Mar2021, patient had pain in the right side under the ribcage muscle in the serratus anterior muscle. On 06Mar2021, the patient could not take a deep breath and could not expand ribcage because there was immense pain. Patient stated she took some CBD and went to sleep and this lasted about 2 days and after that it got a little better. Patient stated it was improved but had slight lasting effects. The patient reported the whole next week the cough got worse, stated it was so bad and it was productive. She stated that by Thursday 11Mar2021, she started to have massive pain that started in the serratus anterior muscle, under her arm pit and around the rib cage. Patient stated that then over the weekend it precipitated towards extreme bone and muscle pain spanning over left upper torso and pain got so bad she thought she cracked her ribs and this lasted for 3 weeks. The patient's cough got worse and it was productive, had stress urinary incontinence. On 13Mar2021, patient had enlarged lymph node. On 18Mar2021, patient had a chest x-ray and it showed pleural effusion and fluid in her pleural space around her lungs. The patient had a thoracentesis 19Mar2021 to drain the fluid and they tested it and it was confirmed as cancer. The patient stated that it seemed to her there was a correlation with getting the COVID vaccine. The patient said that she knows that the immune system has to work very hard to combat COVID and she was wondering if it made her immune system fail and go haywire and wondering if it perpetrated, and stated if the immune system could have dealt with both. On 22Mar2021, the patient got CT scans which showed progression in her body and stated the pleural effusion had been drained and was less, but was still present. The patient reported thoracentesis caused her anxiety. On 23Mar2021, patient stated she felt weird and had neurological symptoms and thought she had a stroke or something because she has had that in the past. The patient was discharged on night of 24Mar2021. The patient received treatment with oral steroids. The outcome of the events was unknown. The patient said that it was all related to her lung cancer. On the same day, patient got hospitalized for getting more imaging. It was reported that new brain cancer was found and patient stated that all this was new worsening disease. The patient further stated that it her a little nervous all the side effects after she got it. The patient reported that she did not believe urinary incontinence was caused by the COVID 19 vaccine, she has had it for years. The patient stated that bone pain, not being able to take a deep breath, muscle pain, lymph node were in conjunction with the timing of the vaccine. The patient stated that anxiety was only in relation to psychological symptoms due to the stroke situation. No follow-up attempts are needed. No further information is expected.; Sender's Comments: Based on the information in the case report, a possible causal relationship between reported events Pleural effusion, Lung cancer metastatic, Cerebrovascular accident and suspect drug BNT162B2 cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 1,0
Labordaten: Test Date: 20210319; Test Name: Thoracentesis; Result Unstructured Data: Test Result:see additional context; Test Date: 20210318; Test Name: Chest X-ray; Result Unstructured Data: Test Result:pleural effusion; Test Date: 20210322; Test Name: CT scans; Result Unstructured Data: Test Result:see additional context; Test Date: 20210323; Test Name: Brain MRI; Result Unstructured Data: Test Result:see additional context
Aktuelle Erkrankungen: Hypertension (Verbatim: Hypertension); Lung cancer (Verbatim: Lung cancer); Metastatic disease (Verbatim: metastatic disease from lung cancer)
Vorgeschichte: -
Andere Medikamente: LOSARTAN; ATORVASTATIN; LORBRENA; VITAMIN D3; COQ10 COMPLEX
Allergien: -
Vorherige Impfungen: -

VAERS 1190942

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 39,0
Geschlecht: F
Eingang: 09.10.2021
Impfdatum: 01.03.2021
Beginn: 02.03.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Aspiration pleural cavity Bone pain Brain cancer metastatic Cerebrovascular accident Chest X-ray Computerised tomogram Cough Dyspnoea Feeling abnormal Lung cancer metastatic Lymphadenopathy Magnetic resonance imaging head abnormal Musculoskeletal chest pain Magnetic resonance imaging head Myalgia Neoplasm progression Pain

Symptomtext

Pleural effusion; Possible progression of her lung cancer/ new brain cancer; Stroke; Anxiety; Stress urinary incontinence; Enlarged lymph node; She had a little cough, it started to get a little worse; Could not take a deep breath and could not expand ribcage because there was immense pain; Pain in the right side under the ribcage muscle in the serratus anterior muscleshe thought she cracked her ribs; This is a spontaneous report from a contactable physician (patient). A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in right deltoid (arm) on 01Mar2021 (at the age of 39-year-old) (Lot Number: EN6201) as dose 2, single for COVID-19 immunization. Medical history included dyslipidemia due to taking LORBRENA, hypertension from 2007, lung cancer from 03Jul2017 and metastatic disease from lung cancer from Dec2018, all ongoing. Concomitant medication(s) included losartan taken for hypertension from an unspecified start date and ongoing; atorvastatin taken for blood cholesterol from an unspecified start date and ongoing; lorlatinib (LORBRENA) taken for lung neoplasm malignant from 26Jun2019 and ongoing; vitamin D 3 taken for an unspecified indication from an unspecified start date and ongoing; ubidecarenone, vitamin e nos (COQ10 COMPLEX) taken for an unspecified indication from an unspecified start date and ongoing. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left deltoid (arm) on 08Feb2021 14:25 (at the age of 39-year-old) (Lot Number: EN6201) as dose 1, single for COVID-19 immunization and experienced bone pain and muscle pain. The patient did not receive any other vaccine within 4 weeks prior to COVID vaccine. The patient reported possible progression of her lung cancer. The patient stated that stated that there was severe pain after the second dose which started with a little cough, which progressively got worse. The patient had pain so bad that she thought she cracked her ribs. On 02Mar2021, patient had pain in the right side under the ribcage muscle in the serratus anterior muscle. On 06Mar2021, the patient could not take a deep breath and could not expand ribcage because there was immense pain. Patient stated she took some CBD and went to sleep and this lasted about 2 days and after that it got a little better. Patient stated it was improved but had slight lasting effects. The patient reported the whole next week the cough got worse, stated it was so bad and it was productive. She stated that by Thursday 11Mar2021, she started to have massive pain that started in the serratus anterior muscle, under her arm pit and around the rib cage. Patient stated that then over the weekend it precipitated towards extreme bone and muscle pain spanning over left upper torso and pain got so bad she thought she cracked her ribs and this lasted for 3 weeks. The patient's cough got worse and it was productive, had stress urinary incontinence. On 13Mar2021, patient had enlarged lymph node. On 18Mar2021, patient had a chest x-ray and it showed pleural effusion and fluid in her pleural space around her lungs. The patient had a thoracentesis 19Mar2021 to drain the fluid and they tested it and it was confirmed as cancer. The patient stated that it seemed to her there was a correlation with getting the COVID vaccine. The patient said that she knows that the immune system has to work very hard to combat COVID and she was wondering if it made her immune system fail and go haywire and wondering if it perpetrated, and stated if the immune system could have dealt with both. On 22Mar2021, the patient got CT scans which showed progression in her body and stated the pleural effusion had been drained and was less, but was still present. The patient reported thoracentesis caused her anxiety. On 23Mar2021, patient stated she felt weird and had neurological symptoms and thought she had a stroke or something because she has had that in the past. The patient was discharged on night of 24Mar2021. The patient received treatment with oral steroids. The outcome of the events was unknown. The patient said that it was all related to her lung cancer. On the same day, patient got hospitalized for getting more imaging. It was reported that new brain cancer was found and patient stated that all this was new worsening disease. The patient further stated that it her a little nervous all the side effects after she got it. The patient reported that she did not believe urinary incontinence was caused by the COVID 19 vaccine, she has had it for years. The patient stated that bone pain, not being able to take a deep breath, muscle pain, lymph node were in conjunction with the timing of the vaccine. The patient stated that anxiety was only in relation to psychological symptoms due to the stroke situation. No follow-up attempts are needed. No further information is expected.; Sender's Comments: Based on the information in the case report, a possible causal relationship between reported events Pleural effusion, Lung cancer metastatic, Cerebrovascular accident and suspect drug BNT162B2 cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 1,0
Labordaten: Test Date: 20210319; Test Name: Thoracentesis; Result Unstructured Data: Test Result:see additional context; Test Date: 20210318; Test Name: Chest X-ray; Result Unstructured Data: Test Result:pleural effusion; Test Date: 20210322; Test Name: CT scans; Result Unstructured Data: Test Result:see additional context; Test Date: 20210323; Test Name: Brain MRI; Result Unstructured Data: Test Result:see additional context
Aktuelle Erkrankungen: Hypertension (Verbatim: Hypertension); Lung cancer (Verbatim: Lung cancer); Metastatic disease (Verbatim: metastatic disease from lung cancer)
Vorgeschichte: -
Andere Medikamente: LOSARTAN; ATORVASTATIN; LORBRENA; VITAMIN D3; COQ10 COMPLEX
Allergien: -
Vorherige Impfungen: -

VAERS 1768588

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 07.10.2021
Impfdatum: 10.03.2021
Beginn: 01.10.2021
Tage bis Beginn: 205,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Acute respiratory failure Death

Symptomtext

death N17.9 - AKI (acute kidney injury) (CMS/HCC) J96.01 - Acute respiratory failure with hypoxia (CMS/HCC)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1767140

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: GA
Alter: 65,0
Geschlecht: M
Eingang: 07.10.2021
Impfdatum: 12.02.2021
Beginn: 14.08.2021
Tage bis Beginn: 183,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

Patient fully vaccinated and hospitalized. Died about 20 days later due to Covid related causes

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1764852

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 89,0
Geschlecht: F
Eingang: 06.10.2021
Impfdatum: 26.01.2021
Beginn: 04.09.2021
Tage bis Beginn: 221,0
Dosis: 2
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia COVID-19 Cough Death Exposure to SARS-CoV-2 Feeling abnormal Nausea SARS-CoV-2 test positive

Symptomtext

9/4 Pt had various symptoms last week prior to ED visit, Nausea, no vomiting, cough for last 4-5 days, generally felt poorly and weak for the last two to three weeks. Pt had exposure to family member who was COVID positive about 3 days prior . She was fully COVID vaccinated. Denies SOB and was not hypoxic.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: COVID-19 test positive - fully vaccinated/breakthrough case. NOTE: Patient has since died, unknown cause of death by this reporter; patient had other co-morbidities.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1764714

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 72,0
Geschlecht: M
Eingang: 06.10.2021
Impfdatum: 20.03.2021
Beginn: 05.10.2021
Tage bis Beginn: 199,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 pneumonia

Symptomtext

Pneumonia due to COVID-19 virus; acute respiratory failure due to hypoxia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1759518

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: PA
Alter: 85,0
Geschlecht: M
Eingang: 04.10.2021
Impfdatum: 16.03.2021
Beginn: 15.09.2021
Tage bis Beginn: 183,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Acute pulmonary oedema Adenovirus test Anticoagulant therapy Aortic arteriosclerosis Blood creatinine increased Blood urea increased Bordetella test negative COVID-19 COVID-19 pneumonia Cardiac failure congestive Cellulitis Central venous catheterisation Chest X-ray abnormal Chills Chlamydia test negative Computerised tomogram head normal Computerised tomogram thorax abnormal

Symptomtext

ED to Hosp-Admission Discharged 9/15/2021 - 9/19/2021 (4 days) Last attending ? Treatment team Septic shock Principal problem Final Summary for Deceased Patient BRIEF OVERVIEW Admission Date: 9/15/2021 Discharge Date: 9/20/2021 Final Diagnosis Principal Problem: Septic shock Active Problems: Chronic lymphocytic leukemia Pneumonia of right lower lobe due to infectious organism Infected laceration COVID-19 virus infection Suspected urinary tract infection Elevated troponin Acute respiratory failure with hypoxia Immunocompromised state Cellulitis DETAILS OF HOSPITAL STAY Presenting Problem/History of Present Illness/Reason for Admission Acute pulmonary edema [J81.0] SIRS (systemic inflammatory response syndrome) [R65.10] Septic shock [A41.9, R65.21] Urinary tract infection without hematuria, site unspecified [N39.0] Congestive heart failure, unspecified HF chronicity, unspecified heart failure type [I50.9] COVID-19 [U07.1] Sepsis [A41.9] Pneumonia due to COVID-19 virus [U07.1, J12.82] Hospital Course: Please send details from H&P intensive care critical care note cardiology was done for neurologist as well as palliative care note In briefly 85-year-old male history of multiple comorbid condition including CLL with history colon cancer with hemicolectomy admitted with fever chills confusion found to have a right lower lobe pneumonia UTI sepsis septic shock left arm cellulitis. Complicated with septic shock secondary from pneumonia UTI with immunosuppressive state COVID-19 pneumonia patient progressively going downhill even with dopamine drip and continue having persistent hypotension including respiratory failure. Patient also found to have a right lower extremity DVT patient was initially started Lovenox changed to therapeutic since patient was continued required dopamine unable to discontinue dopamine because of persistent low blood pressure Case discussed with patient family palliative care was consulted and in spite of of all the antibiotic Maxipime and Zithromax and dexamethasone for COVID-19 patient progressively getting downhill palliative care was consulted patient family was involved with the case and since patient prognosis going downhill initially there may DO NOT RESUSCITATE and do not intubation and finally his 2 sons who is the power of attorney decided to comfort care only. Patient was discontinued dopamine as per policy and was only on oxygen comfort medication was started patient expired approximately September 19 approximately 1830. Because of that respiratory failure secondary from septic shock secondary from multifactorial including pneumonia UTI cellulitis COVID-19 and persistent hypotension in the setting of immunosuppressive patient with CLL colon cancer and lung mass. Operative Procedures Performed Treatments: As per hospital policy Procedures: ICU care including dopamine infusion Consults: Intensivist palliative care Pertinent Test Results: CT right lower lobe pneumonia right middle and lower lobe pneumonia POA * (Principal) Septic shock Yes Chronic lymphocytic leukemia Yes Acute nontraumatic kidney injury Yes Pneumonia of right lower lobe due to infectious organism Yes Infected laceration Yes Overview Signed 9/16/2021 7:31 AM Infected laceration left wrist with surrounding cellulitis COVID-19 virus infection Yes Suspected urinary tract infection Yes Elevated troponin Yes Overview Signed 9/16/2021 1:19 AM Probably due to demand Acute respiratory failure with hypoxia Yes Immunocompromised state Yes Overview Signed 9/16/2021 1:23 AM Due to Medical Problems Plan: 1. Sepsis with shock probably due to multifactorial, including right lower lobe pneumonia, infected laceration left wrist with cellulitis, suspected UTI. The patient will be started on vancomycin, cefepime, and Zithromax. Patient will be continued on Levophed which has been started in the emergency room. Respiratory treatment. Oxygen support. Continue with BiPAP. 2. Elevated troponin probably due to demand. Serial cardiac enzymes. If the troponi increase, we will get get an echocardiogram as well as start the patient on IV heparin drip. 3. Acute respiratory failure with hypoxia. The family does not want the patient to be intubated. The agreeable to using BiPAP. And they also agreeable to admitting the patient to the ICU and use ICU level medications to maintain the blood pressure. We will continue aggressive management with BiPAP. Respiratory treatment. 4. Acute kidney injury. Gentle IV hydration. If kidney function continues to discharge in the morning, consider nephrology consultation. VTE Prophylaxis: SCD Lovenox 40mg subcu daily DNR (Do Not Resuscitate) History of Present Illness Chief Complaint Patient presents with ? Fever ? Altered Mental Status Patient is an 85 y.o. male. Patient was brought to the emergency room and altered mental status and unable to give any history. According to the emergency room doctor, the patient was found in respiratory distress with O2 sat of 90% on room air but the patient was very tachypneic. Patient was also noted to be hypotensive with a blood pressure of 78/68. Temperature was 101.5. Patient has history of CLL. The white count in the emergency room was 94.6. Hemoglobin was 7.8. BUN was 41 with a serum creatinine of 2.53. Chest x-ray revealed bibasilar interstitial prominence. However, CT scan of the chest shows right lower lobe pneumonia. Assessment Review of Systems Unable to perform ROS: Mental status change

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 4,0
Labordaten: 09/16/21 0022 Respiratory virus detection panel Collected: 09/15/21 2308 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result Detected Critical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Syncytial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected Procedure Component Value Ref Range Date/Time Ultrasound lower extremity venous right [3303463186] (Abnormal) Resulted: 09/17/21 0638 Order Status: Completed Updated: 09/17/21 0638 Narrative: PROCEDURE INFORMATION: Exam: US Duplex Right Lower Extremity Veins, Limited Exam date and time: 9/17/2021 4:56 AM Age: 85 years old Clinical indication: Swelling (edema) of limb; Lower extremity, right; Additional info: Eval for dvt TECHNIQUE: Imaging protocol: Real-time Duplex ultrasound of the Right Lower Extremity with 2-D gray scale, color Doppler flow and spectral waveform analysis with image documentation. Limited exam was focused on the right lower extremity veins. COMPARISON: CT ABD PEL W 4/5/2018 9:13 AM FINDINGS: Right deep veins: DVT involving the right posterior tibialis vein. The common femoral, femoral, proximal profunda femoral and popliteal veins are patent without thrombus. Normal Doppler waveforms. Normal compressibility and/or augmentation response. Right superficial veins: Unremarkable. Saphenofemoral junction is patent without thrombus. Soft tissues: Partially visualized enlarged right inguinal lymph node. IMPRESSION: DVT involving the right posterior tibialis vein. No other area of deep venous thrombosis. X-ray chest 1 view, Portable [3303267489] Resulted: 09/16/21 0730 Order Status: Completed Updated: 09/16/21 0730 Narrative: XR CHEST 1 VW PORT IMPRESSION: Mild interstitial pulmonary edema. END OF IMPRESSION: INDICATION: Suspected sepsis Suspected sepsis. TECHNIQUE: AP view of the chest. COMPARISON: None. FINDINGS: Pulmonary vascular congestion and basilar interstitial prominence. Median sternotomy wires and mediastinal clips are redemonstrated. Cervical posterior fusion hardware partially imaged. The heart is not enlarged. Costophrenic angles are clear. No pleural effusion or pneumothorax. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT chest without contrast [3303272248] (Abnormal) Resulted: 09/16/21 0304 Order Status: Completed Updated: 09/16/21 0304 Narrative: PROCEDURE INFORMATION: Exam: CT Chest Without Contrast; Diagnostic Exam date and time: 9/16/2021 2:03 AM Age: 85 years old Clinical indication: Shortness of breath; Patient HX: Covid; Additional info: SOB TECHNIQUE: Imaging protocol: Diagnostic computed tomography of the chest without contrast. Radiation optimization: All CT scans at this facility use at least one of these dose optimization techniques: automated exposure control; mA and/or kV adjustment per patient size (includes targeted exams where dose is matched to clinical indication); or iterative reconstruction. COMPARISON: DX XR CHEST 1 VW 9/16/2021 1:46 AM FINDINGS: Lungs: Unremarkable. No consolidation. No masses. Pleural spaces: Unremarkable. No pneumothorax. No pleural effusion. Heart: Stable CABG procedure. Aorta: Unremarkable. No aortic aneurysm. Great vessels off aortic arch: Calcification of the thoracic aorta and/or great vessels consistent with atherosclerotic vessel disease. Lymph nodes: Calcified left hilar nodes and/or mediastinal nodes and/or lung granulomas consistent with old granulomatous disease. Calcified left hilar nodes and/or mediastinal nodes and/or lung granulomas consistent with old granulomatous disease. Moderate right lower lobe pneumonia with possible mild right hilar adenopathy. Spleen: 20 cm large splenomegaly. Bones/joints: Unremarkable. No acute fracture. Soft tissues: Unremarkable. Other findings: Examination is limited by artifact from one or both arms by the patient's side. IMPRESSION: 1. Stable CABG procedure. 2. Moderate right lower lobe pneumonia with possible mild right hilar adenopathy. 3. 20 cm large splenomegaly. THIS DOCUMENT HAS BEEN ELECTRONICALLY SIGNED X-ray chest 1 view, Portable [3303286895] (Abnormal) Resulted: 09/16/21 0258 Order Status: Completed Updated: 09/16/21 0258 Narrative: PROCEDURE INFORMATION: Exam: XR Chest Exam date and time: 9/16/2021 1:41 AM Age: 85 years old Clinical indication: Other vascular access device placement or adjustment; Other: Central line; Prior surgery; Surgery date: Post-operative (0-2 days); Additional info: Post central line TECHNIQUE: Imaging protocol: XR of the chest. Views: 1 view. COMPARISON: DX XR CHEST 1 VW 9/15/2021 10:48 PM FINDINGS: Tubes, catheters and devices: Right IJ line placement with tip over the region of the azygos vein. Lungs: Stable mild nonspecific bilateral pulmonary opacities. Pleural spaces: Unremarkable. No pleural effusion. No pneumothorax. Heart/Mediastinum: Unremarkable. No cardiomegaly. Vasculature: Calcification of the thoracic aorta and/or great vessels consistent with atherosclerotic vessel disease. Bones/joints: Stable postoperative metallic fixation of the cervical spine with or without metallic artifact. Stable sternotomy. IMPRESSION: Right IJ line placement with tip over the region of the azygos vein. THIS DOCUMENT HAS BEEN ELECTRONICALLY SIGNED CT head without contrast [3303286897] (Abnormal) Resulted: 09/16/21 0247 Order Status: Completed Updated: 09/16/21 0247 Narrative: PROCEDURE INFORMATION: Exam: CT Head Without Contrast Exam date and time: 9/16/2021 2:03 AM Age: 85 years old Clinical indication: Injury or trauma; Fall; Concussion/head injury; Without loss of consciousness; Injury date: Today TECHNIQUE: Imaging protocol: Computed tomography of the head without contrast. Radiation optimization: All CT scans at this facility use at least one of these dose optimization techniques: automated exposure control; mA and/or kV adjustment per patient size (includes targeted exams where dose is matched to clinical indication); or iterative reconstruction. COMPARISON: No relevant prior studies available. FINDINGS: Brain: No acute intracranial hemorrhage, mass effect or midline shift. Nonspecific white matter hypodensities without mass effect suggesting chronic ischemic changes. No evidence of obvious acute large vessel territorial infarct. Cerebral ventricles: Moderate to marked diffuse ventricular and sulcal prominence. Paranasal sinuses: Moderate bilateral paranasal sinus thickening/opacification. Mastoid air cells: No mastoid effusion. Vasculature: Intracranial atherosclerosis. Bones/joints: No acute fracture. Soft tissues: Unremarkable. IMPRESSION: 1. No acute intracranial hemorrhage or obvious acute large vessel territorial infarct 2. If there is concern for acute CVA, follow-up/further evaluation with MRI may provide additional information.
Aktuelle Erkrankungen: -
Vorgeschichte: Respiratory Chronic obstructive lung disease Pneumonia of right lower lobe due to infectious organism Malignant neoplasm of bronchus, unspecified laterality Acute respiratory failure with hypoxia Circulatory Arteriosclerosis of autologous vein coronary artery bypass graft Chronic ischemic heart disease Essential hypertension Digestive Viral gastritis Genitourinary Benign prostatic hyperplasia with urinary obstruction Musculoskeletal Generalized osteoarthritis Infected laceration Cellulitis of left upper extremity Endocrine/Metabolic Mixed hyperlipidemia Hematologic Chronic lymphocytic leukemia Platelets decreased Infectious/Inflammatory Septic shock COVID-19 virus infection Cellulitis Other Inguinal hernia without obstruction or gangrene Suspected urinary tract infection Elevated troponin Immunocompromised state
Andere Medikamente: acalabrutinib 100 mg capsule aspirin 81 mg tablet cholestyramine (QUESTRAN) 4 gram packet gabapentin (NEURONTIN) 300 mg capsule rOPINIRole (REQUIP) 0.5 mg tablet tamsulosin (FLOMAX) 0.4 mg capsule
Allergien: NKA
Vorherige Impfungen: -

VAERS 1759477

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 77,0
Geschlecht: M
Eingang: 04.10.2021
Impfdatum: 26.02.2021
Beginn: 25.09.2021
Tage bis Beginn: 211,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Alanine aminotransferase increased Anion gap Antibody test negative Aspartate aminotransferase increased Basophil percentage decreased Bilirubin conjugated increased Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin increased Blood chloride decreased Blood creatine phosphokinase increased Blood creatinine normal Blood culture Blood fibrinogen increased Blood glucose normal Blood group A Blood lactate dehydrogenase increased

Symptomtext

78 Y male with hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21) who developed cough, fever, bodyaches ~ 9/14. COVID-19 positive on 9/15 came back positive, yesterday O2 sat was 89% on room air with activity so came to ED COVID Pneumonia, Acute hypoxemic Respiratory failure - symptom onset on 9/14. COVID positive on 9/15. Last fever on 9/25. CXR showed bilateral opacities.Treated with decadron 6mg x 3 days. He was not a candidate for remdesivir due to elevated transaminases. Supplemental O2 at 2 lpm was successfully weaned to room air and he was discharged to home. Elevated LFT's - abdominal US was unremarkable. Likely due to acute covid disease. Can repeat once acute illness resolves. Primary Procedures: None Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis): covid pneumonia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: Results for patient as of 10/4/2021 12:58 9/25/2021 12:00 NA: 131 (L) K: 4.2 CL: 94 (L) CO2: 27 BUN: 14 CREAT: 0.85 ANION GAP4 SERPL: 10 GLUC: 116 TROPONIN I: 0.02 CK: 209 (H) LDH: 454 (H) BNP: 85 ALT: 334 (H) AST: 219 (H) ALKP: 186 (H) LIPASE: 23 TBILI: 1.5 (H) BILID: 0.5 (H) GFR-AFRAM: >60 GFR NONAFR AMER: >60 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE ALB: 3.3 (L) CRP, SER QL: 15.0 (H) FERRITIN: 3,638 (H) LACTATE: 2.9 (AA) TP: 5.6 (L) WBC: 6.6 RBC'S: 3.91 (L) HGB: 12.9 (L) HCT: 36.6 (L) MCV: 94 RDW, RBC: 12.6 PLT: 230 IMMAT GRANULO % AUTO: 1 NRBC: 0 NEUTROPHILS % AUTO: 78 (H) ANC: 5.2 LYMPHS % AUTO: 7 (L) MONOS % AUTO: 10 EOS % AUTO: 4 BASO'S % AUTO: 0 PT: 15.3 (H) INR: 1.3 D-DIMER: 2.55 (H) FIBRINOGEN: 1,074 (H) AB SCR BLD: Negative ABO+ RH GRP: A POS BLD CULT RSLT: Final Report... 9/25/2021 12:00 BLD CULT RSLT: Final Report... 9/25/2021 12:32 XR CHEST: Rpt (A) 9/25/2021 14:13 LACTATE: 1.4 9/25/2021 17:30 HIV 1+2 AB/AG: NON REAC HEP B COREAB: NEGATIVE HEP B S AB: NEGATIVE HEP B S AG: NEGATIVE HEP C AB: NEGATIVE 9/26/2021 06:38 NA: 134 (L) K: 4.7 CL: 99 (L) CO2: 28 BUN: 18 CREAT: 0.78 ANION GAP4 SERPL: 7 CA: 8.4 (L) MG: 2.1 PHOS: 3.7 GLUC: 144 LDH: 336 (H) ALT: 247 (H) AST: 124 (H) ALKP: 148 (H) TBILI: 1.1 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE ALB: 2.9 (L) CRP, SER QL: 14.2 (H) FERRITIN: 2,745 (H) WBC: 6.2 RBC'S: 3.68 (L) HGB: 12.3 (L) HCT: 34.6 (L) MCV: 94 RDW, RBC: 12.5 PLT: 252 IMMAT GRANULO % AUTO: 1 NRBC: 0 NEUTROPHILS % AUTO: 86 (H) ANC: 5.4 LYMPHS % AUTO: 7 (L) MONOS % AUTO: 6 EOS % AUTO: 0 BASO'S % AUTO: 0 PT: 15.2 (H) INR: 1.2 D-DIMER: 1.28 (H) FIBRINOGEN: 1,022 (H) 9/26/2021 10:03 US ABDOMEN: Rpt 9/27/2021 06:36 NA: 136 K: 5.2 CL: 100 CO2: 28 BUN: 21 CREAT: 0.79 ANION GAP4 SERPL: 8 GLUC: 128 ALT: 287 (H) AST: 149 (H) ALKP: 163 (H) TBILI: 1.2 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE CRP, SER QL: 9.3 (H) D-DIMER: 1.09 (H) 9/28/2021 06:12 NA: 134 (L) K: 5.0 CL: 100 CO2: 25 BUN: 25 CREAT: 0.77 ANION GAP4 SERPL: 9 GLUC: 113 ALT: 318 (H) AST: 162 (H) ALKP: 155 (H) TBILI: 1.2 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE CRP, SER QL: 5.2 (H) WBC: 8.5 RBC'S: 3.73 (L) HGB: 12.6 (L) HCT: 35.6 (L) MCV: 95 RDW, RBC: 12.6 PLT: 402 (H) NRBC: 0 D-DIMER: 1.17 (H)
Aktuelle Erkrankungen: None
Vorgeschichte: hypertension, gilbert syndrome, prediabetes, diverticulosis of colon, gout, vaccinated w 2 doses of PFIZER for COVID-19 (2/5/21 & 2/26/21)
Andere Medikamente: Outpatient Medications: confirmed with Patient Prior to Admission Medications Outpatient Home Medications Taking? Allopurinol (ZYLOPRIM) 300 mg Oral Tab Takes Regularly Sig: Take 1 tablet by mouth daily after a meal Calcium Carbonate-Vit D3
Allergien: Amoxicillin - Body rash
Vorherige Impfungen: -

VAERS 1759163

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 81,0
Geschlecht: F
Eingang: 04.10.2021
Impfdatum: 15.02.2021
Beginn: 01.10.2021
Tage bis Beginn: 228,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 pneumonia Chest pain Hypoxia Troponin increased

Symptomtext

Acute on chronic respiratory failure with hypoxia; pneumonia due to COVID-19; chest pain; elevated troponin

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1754255

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 72,0
Geschlecht: M
Eingang: 01.10.2021
Impfdatum: 05.03.2021
Beginn: 25.07.2021
Tage bis Beginn: 142,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Abdominal pain upper Bowel movement irregularity COVID-19 Chronic obstructive pulmonary disease Dyspnoea Feeling abnormal Hypersomnia Myocardial infarction Nasopharyngitis SARS-CoV-2 test positive Sinus congestion

Symptomtext

Breakthrough case: My symptoms included a bad head cold, sinuses were packed up, stomach pain, odd bowel movements, and I slept for a couple of days. I felt lousy. A week later, I went to the ER since I couldn't breathe. They called it Covid exasperated COPD. A week after that, I was in the hospital for a mild heart attack.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: I tested positive for Covid-19 around July 30, 2021.
Aktuelle Erkrankungen: None
Vorgeschichte: Heart failure; COPD
Andere Medikamente: Allopurinol; atorvastatin; carvedilol; aspirin; isosorbide mononitrate; LASIX; hydralazine
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1741027

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 60,0
Geschlecht: M
Eingang: 28.09.2021
Impfdatum: 16.02.2021
Beginn: 23.09.2021
Tage bis Beginn: 219,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram pulmonary Computerised tomogram thorax Pulmonary embolism

Symptomtext

pulmonary embolism

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 1,0
Labordaten: Ct chest pulmonary angiogram 9/24/2021
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1737285

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 79,0
Geschlecht: M
Eingang: 27.09.2021
Impfdatum: 09.03.2021
Beginn: 21.08.2021
Tage bis Beginn: 165,0
Dosis: UNK
Route/Site: - / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

PATIENT DEVELOPED COVID19 INFECTION FOLLOWED BY SUBSEQUENT HOSPITALIZATION AND DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, HTN, CVA
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1734999

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 76,0
Geschlecht: M
Eingang: 25.09.2021
Impfdatum: 12.02.2021
Beginn: 30.07.2021
Tage bis Beginn: 168,0
Dosis: 2
Route/Site: IM / OT

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Chest X-ray abnormal Fall Hip fracture SARS-CoV-2 test positive

Symptomtext

Admit for fall, hip fx. No other COVID related complaints aside from recent weakness. Hx of CKD, s/p kidney transplant on immunosuppression, CAD, HTN. COVID+, CXR shows COVID PNA. On RA, supportive care with abx. Acute resp fx resolved at time of DC. DC to SNF.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1734654

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 59,0
Geschlecht: M
Eingang: 25.09.2021
Impfdatum: 10.02.2021
Beginn: 22.08.2021
Tage bis Beginn: 193,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Angiogram pulmonary abnormal Chest discomfort Chest pain Cough Fibrin D dimer increased Peripheral swelling Pulmonary embolism Ultrasound Doppler normal

Symptomtext

Began having vague chest pain/pressure symptoms in April, come and go. Around August 16 began having cough, worsening chest pressure . On August 22 noticed swelling in left calf. Went to the ER and diagnosed with pulmonary emboli in my right lung

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 1,0
Labordaten: CTA chest confirmed pulmonary emboli in right lung Doppler of lower extremities was negative for DVT D-Dimer was elevated
Aktuelle Erkrankungen: -
Vorgeschichte: Sleep Apnea Depression
Andere Medikamente: Lexapro
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1734172

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NC
Alter: 74,0
Geschlecht: F
Eingang: 25.09.2021
Impfdatum: 18.02.2021
Beginn: 01.04.2021
Tage bis Beginn: 42,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation Cardiac disorder Cerebrovascular accident Investigation

Symptomtext

Stroke; AFib; a lot of heart things; This is a spontaneous report from a contactable consumer (patient) received from a Pfizer sponsored program via Regulatory Authority Support. A 74-years-old female patient received the second dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine administered at Movie theater, via an unspecified route in left arm on 18Feb2021, at 74 years of age, (Batch/Lot Number: EN6201) as single dose for COVID-19 immunization. Historical vaccine included the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine administered via an unspecified route in left arm on 28Jan2021, (Batch/Lot Number: EL9262) as single dose for COVID-19 immunization. The patient didn't receive any other vaccine within the 4 weeks previous to vaccination. Medical history included an unspecified neoplasm malignant and lymphoedema from cancer in her right arm, both from an unknown date and that's the reason why she can't receive shots in her right arm. The patient's concomitant medication included blood thinner. In Apr2021 the patient experienced stroke for which she was hospitalized from Apr2021 to an unknown date and it was determined she had atrial fibrillation (onset date unknown), assessed as medically significant and "a whole bunch of other things as well. She states she had just "a lot of heart things". The patient stated she was just trying to find out where she can get the third dose, as per her doctor's recommendation. She states she didn't have any problems with the first two shots, she is just concerned that she didn't get her third one. The patient stated she had tests done (unspecified). The events outcome was unknown at the time of the report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Test Name: Test; Result Unstructured Data: Test Result: Unknown result.
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Cancer; Lymphedema (she has lymphedema from cancer in her right arm).
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1708597

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WI
Alter: 86,0
Geschlecht: F
Eingang: 24.09.2021
Impfdatum: 12.02.2021
Beginn: 06.09.2021
Tage bis Beginn: 206,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure COVID-19 Chest X-ray abnormal Confusional state Lung opacity Neurological symptom Pneumonia SARS-CoV-2 test positive

Symptomtext

Pt received both doses of the Pfizer COVID-19 vaccine, on 1/22/2021 and 2/12/2021 respectively. Pt tested positive for COVID on 9/6/2021, presented to ED same day and was admitted for stroke-like symptoms. Over the course of her hospitalization, she developed symptoms of severe COVID, with pneumonia and acute hypoxic respiratory failure. She was discharged back to her ALF on 9/15/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: bronchiectasis, chronic idiopathic thrombocytopenia, chronic rhinitis, CREST syndrome, decubital ulcer, depression, GERD, hyperlipidemia, hypertension, interstitial lung disease, left shoulder pain, asthma, osteoarthrosis, osteoporosis, parotid mass, stroke, vitamin D deficiency.
Andere Medikamente: acetaminophen, combivent respimat, alendronate, aspirin, atorvastatin, budesonide inhaler, cholecalciferol, diltiazem, fluticasone nasal spray, breo ellipta inhaler, furosemide, ipratropium-albuterol (neb), melatonin, montelukast, nystatin
Allergien: environmental (mold, dust), sertraline, onion.
Vorherige Impfungen: -

VAERS 1708597

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WI
Alter: 86,0
Geschlecht: F
Eingang: 24.09.2021
Impfdatum: 12.02.2021
Beginn: 06.09.2021
Tage bis Beginn: 206,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure COVID-19 Chest X-ray abnormal Confusional state Lung opacity Neurological symptom Pneumonia SARS-CoV-2 test positive

Symptomtext

Pt received both doses of the Pfizer COVID-19 vaccine, on 1/22/2021 and 2/12/2021 respectively. Pt tested positive for COVID on 9/6/2021, presented to ED same day and was admitted for stroke-like symptoms. Over the course of her hospitalization, she developed symptoms of severe COVID, with pneumonia and acute hypoxic respiratory failure. She was discharged back to her ALF on 9/15/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: bronchiectasis, chronic idiopathic thrombocytopenia, chronic rhinitis, CREST syndrome, decubital ulcer, depression, GERD, hyperlipidemia, hypertension, interstitial lung disease, left shoulder pain, asthma, osteoarthrosis, osteoporosis, parotid mass, stroke, vitamin D deficiency.
Andere Medikamente: acetaminophen, combivent respimat, alendronate, aspirin, atorvastatin, budesonide inhaler, cholecalciferol, diltiazem, fluticasone nasal spray, breo ellipta inhaler, furosemide, ipratropium-albuterol (neb), melatonin, montelukast, nystatin
Allergien: environmental (mold, dust), sertraline, onion.
Vorherige Impfungen: -

VAERS 1719006

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 89,0
Geschlecht: F
Eingang: 21.09.2021
Impfdatum: 17.02.2021
Beginn: 12.09.2021
Tage bis Beginn: 207,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient passed away on 09/12/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Roxanol, Senna, Dulcolax, Insulin glargine, Miralax, Cardizem, Nystatin
Allergien: Lipitor
Vorherige Impfungen: -

VAERS 1716355

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IL
Alter: 73,0
Geschlecht: F
Eingang: 20.09.2021
Impfdatum: 25.02.2021
Beginn: 18.09.2021
Tage bis Beginn: 205,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Asthenia Blood glucose increased Blood lactic acid COVID-19 COVID-19 treatment Cerebrovascular accident Chest X-ray normal Cold sweat Computerised tomogram head abnormal Condition aggravated Cough Culture urine Fall Fatigue Lacunar infarction Pollakiuria Procalcitonin SARS-CoV-2 test positive

Symptomtext

Patient's husband is acting as primary historian. He reports that his wife tried to get up around midnight to use the bathroom and she fell on the side of their bed. He states that around 4:00 a.m. she had another fall. She has had increased urinary frequency thinking that she had a urinary tract infection over the past 2 weeks. He states this morning when she had her 2nd fall she did feel quite clammy. He denies any seizure activity, facial droop or slurred speech. He states it was difficult to get her off the ground because she was so weak. He reports that yesterday she complained of being fatigued. She is recovering from a stroke but did not have any residuals from this. She has been actively participating in physical therapy. He notes that she has some tremors that may be associated with a Parkinson's diagnoses. They arrived in the emergency room for evaluation. Patient tested positive for COVID. Her husband states that they both has had a cough for the past couple of days. He associated this with allergies. They both have received the COVID vaccine. Her procalcitonin was 0.12, lactic acid of 2.05. Glucose level 164. No leukocytosis appreciated. She had an abnormal urinalysis. She is pending a urine culture. The remainder of her labs were unremarkable. Patient's vitals are stable in the emergency room. She had a negative chest x-ray. Her CT of her head just showed bilateral old lacunar infarcts otherwise her CT of her head was negative for any acute abnormalities. Interventions in the emergency room include COVID protocol being initiated. Patient is not requiring any supplemental oxygenation. She received Rocephin IV and Lovenox 40 mg subcutaneous. Admitted on 9/18/2021. CEftriaxone continued inpatient x 2 days. Discharged on 9/20/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: 9/18/21 Chest xray: The lungs are clear bilaterally. The pulmonary vasculature is unremarkable. There is no pleural effusion or pneumothorax. Bones and soft tissues are negative.
Aktuelle Erkrankungen: -
Vorgeschichte: diabetes type 2 non insulin dependent, history of tremor, history of stroke with no residual affects status post tPA, osteoarthritis, and hypertension, parkinsons disease, TMJ
Andere Medikamente: Aspirin, calcium carbonate with vitamin D3, melatonin, metformin, multivitamin, rosuvastatin, trandolapril
Allergien: Pollen
Vorherige Impfungen: -

VAERS 1714925

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: OH
Alter: 79,0
Geschlecht: M
Eingang: 20.09.2021
Impfdatum: 25.02.2021
Beginn: 13.09.2021
Tage bis Beginn: 200,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 COVID-19 pneumonia Death SARS-CoV-2 test positive

Symptomtext

Hospitalized for COVID and died as a result of COVID pneumonia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 4,0
Labordaten: RNA positive COVID 19
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1701099

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IL
Alter: 77,0
Geschlecht: M
Eingang: 15.09.2021
Impfdatum: 05.02.2021
Beginn: 13.08.2021
Tage bis Beginn: 189,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Anticoagulant therapy Atypical pneumonia Blood pH normal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram thorax abnormal Dyspnoea PCO2 decreased PO2 decreased Pyrexia SARS-CoV-2 test positive Viral infection

Symptomtext

He tested positive for COVID 8/12/21 after he developed shortness of breath. He was found to be afebrile in the emergency room at 101.5. He was placed on nasal cannula. He is satting at 95% on 4 L. He is in no obvious distress. Chest x-ray does show atypical pneumonia consistent with viral infection. He does take Xarelto for history of pulmonary emboli. He has been compliant. He is agreeable to admission at this time for acute hypoxic respiratory failure secondary to COVID pneumonia. ABG did show a PO2 of 75, pH of 7.45, pCO2 of 31. He was picked up by EMS and by report his oxygen saturation was in the 70s. Patient was treated with supportive care, supplemental oxygen, remdesivir, Decadron. During the course of hospitalization patient started to feel better and was not requiring oxygen at rest or with 6 minute ambulation test. Discharged on 8/18/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: 8/12/21 COVID19: positive 8/15/21 chest xray: Multifocal atypical pneumonia concordant with history of COVID-19. 8/15/21 ct chest: Multifocal atypical pneumonia concordant with history of COVID-19.
Aktuelle Erkrankungen: -
Vorgeschichte: past medical history of Arthritis, CAD in native artery (10/16/2017), Cataract, H/O hypercoagulable state (1/30/2018), High cholesterol, History of prostate cancer (2017), radiation therapy (2018), Hx of visual disturbance (floaters) (10/12/2017), pulmonary embolism (2017), Hypertension, Kidney stone (07/2019), Morbid obesity (10/12/2017), On anticoagulant therapy, Prostate nodule, S/P PTCA/Stent Prox Lad 11/2017 (1/30/2018), Sleep apnea, and Thyroid disease.
Andere Medikamente: Carvedilol, cinnamon, clonidine, clopidogrel, fish oil, hydralazine, hydrochlorothiazide, levothyroxine, losartran, multiple vitamin, nifedipine, prednisone, simvastatin, stool softner, tadalafil, tamsulosin, vitamin b-12
Allergien: None
Vorherige Impfungen: -

VAERS 1696643

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WI
Alter: 73,0
Geschlecht: M
Eingang: 14.09.2021
Impfdatum: 17.08.2021
Beginn: 06.09.2021
Tage bis Beginn: 20,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia SARS-CoV-2 test positive

Symptomtext

Patient admitted as inpatient on 9/6 due to acute respiratory failure with hypoxia 2/2 COVID pneumonia. Patient was tested for COVID-19 and was positive on 8/29.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: allopurinoL, amLODIPine,atorvastatin, calcitRIOL, carvediloL, cholecalciferol, VITAMIN D3,cyanocobalamin, Ferrous Sulfate,mycophenolate mofetil,mycophenolate mofetil , torsemide
Allergien: -
Vorherige Impfungen: -

VAERS 1689587

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: FL
Alter: 70,0
Geschlecht: M
Eingang: 10.09.2021
Impfdatum: 06.03.2021
Beginn: 24.08.2021
Tage bis Beginn: 171,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Cough Decreased appetite Diarrhoea Dyspnoea Myalgia Oxygen saturation decreased Pyrexia SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID-19 Breakthrough case. on 8/24/21: Patient arrived to ER due to generalized weakness. Per EMS, patient tested positive for COVID on 8/19/2021. EMS reports the pt has been experiencing decreased appetite and weakness over the past 5 days. EMS states the patient received Regeneron treatment today at 0930. He is on 4 liters of O2 at baseline and his O2 saturation was 77% when found by EMS. EMS states the pt's O2 saturation was 100% on 15 liters NC. He reports fever, cough, SOB, myalgias, and diarrhea. Admitted 8/24/21. Diagnosed and treated for covid-19 pneumonia and acute hypoxic respiratory failure. Condition did not improve. Moved to hospice on 8/27/21. Patient received first dose Pfizer vaccine on 2/13/2021 Lot # EN6201 and the second dose on 03/06/2021 Lot # EM9810

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Pulmonary fibrosis, end-stage pulmonary disease
Andere Medikamente: Crestor 10 mg PO qDay azaTHIOprine 150 mg PO qDay, predniSONE 15 mg PO qDay hydroCHLOROthiazide 12.5 mg PO qDay losartan 100 mg PO qDay Fish Oil oral capsule 1,000 mg PO qDay Vitamin B-12 500 mcg PO qDay Vitamin C 1,000
Allergien: penicillin
Vorherige Impfungen: -

VAERS 1686223

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6201

kritisch

Staat: CA
Alter: 70,0
Geschlecht: F
Eingang: 09.09.2021
Impfdatum: 13.02.2021
Beginn: 17.02.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Cerebrovascular accident Confusional state Dizziness Gait disturbance Laboratory test Magnetic resonance imaging

Symptomtext

3 days after injection I experienced confusion, lightheadedness and difficulty walking (it felt like there were weights on my feet). The next day I was advised to go to the ER and after being admitted to the hospital, where many tests were performed , I was diagnosed with having had a stroke. Fortunately it was a light stroke & I was sent home after 24 Hrs with a prescription for Plavix & a follow up with neurologist.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 1,0
Labordaten: MRI (2/18/21)
Aktuelle Erkrankungen: None
Vorgeschichte: Osteoporosis, Luekocytoclastic Vasculitus , Hypertension
Andere Medikamente: Lisinopril 10 mg. Hydrochlorothiazide; Rosuvastatin 20 mg. Calcium, Strontium, Vit. D
Allergien: Penicillin, shellfish, gluten, milk products
Vorherige Impfungen: -

VAERS 1683127

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: GA
Alter: 79,0
Geschlecht: M
Eingang: 08.09.2021
Impfdatum: 12.02.2021
Beginn: 09.08.2021
Tage bis Beginn: 178,0
Dosis: 2
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Admitted in the hospital on 08/09/2021. Date of death 09/02/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1683086

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WA
Alter: 75,0
Geschlecht: F
Eingang: 08.09.2021
Impfdatum: 04.03.2021
Beginn: 28.03.2021
Tage bis Beginn: 24,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Abdominal pain Anticoagulant therapy Back pain Chest pain Computerised tomogram thorax abnormal Fibrin D dimer normal Gait inability Pulmonary embolism

Symptomtext

About 2 weeks afterwards I started having abdominal and chest pain. It got to where I couldn't walk, so I went to the doctor. I was diagnosed on March 30th with a pulmonary embolism. I was given blood thinners. I have been on blood thinners since then. I will know after 6 months if I need to continue taking them. They checked my back to make sure there weren't any back problems because of my back pain but they didn't find anything.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: CT scan- pulmonary embolism D-dimer- negative
Aktuelle Erkrankungen: no
Vorgeschichte: hypothyroidism, high blood pressure, high cholesterol, GERD, arthritis, depression, back problems, artificial knees, gout
Andere Medikamente: thyroid supplement, Prevacid, Nabumetone, Venlafaxine, Singulair, Amitriptyline, multivitamin, vitamin c, cherry extract, Lisinopril
Allergien: sulfa, allopulonol, grass
Vorherige Impfungen: -

VAERS 1675092

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: FL
Alter: 75,0
Geschlecht: M
Eingang: 05.09.2021
Impfdatum: 19.02.2021
Beginn: 13.08.2021
Tage bis Beginn: 175,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory failure Atrial fibrillation Breath sounds absent Bronchoscopy normal COVID-19 Chronic kidney disease Culture negative Death Dyspnoea Endotracheal intubation Haematemesis Haemoglobin decreased Hypoglycaemia Intensive care Lethargy Leukocytosis Mental status changes

Symptomtext

Patient required hospitalization due to breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 02/19/21. Patient was hospitalized from 08/13/21 - 08/31/21. Below is copied from patients discharge (death) summary: Hospital Course: Patient is a vaccinated 75 y.o. male with a pmhx of HTN, DM, CAD s/p PCI (10 yrs ago), CKD3 and breast cancer s/p lumpectomy and CT who presented to ED on 8/13/21 c/o SOB in setting of known COVID-19 infection. Patient recieved both doses of his vaccine (2nd dose 2/2021). Patient was admitted to hospitalist service for acute hypoxic respiratory failure in setting of COVID-19. Throughout course of stay, had increasing oxygenation requirements (requiring FFCPAP after found to have removed mask from face) with pulse ox O2 sats reportedly in 20's, lethargy, and new onset tremor. On pulmonology's evaluation at bedside, patient was A&Ox2 (person/place, thinks year is 2001). Not hypoglycemic on accucheck. Difficult to obtain hx as patient with AMS however shakes head yes when asked if he feels SOB. Admitted to ICU on 18Aug, now intubated and sedated. Bronchoscopy performed at bedside, which was unrevealing. Did not show any mucous plugging. Received solumedrol and lipitor. Toci not given due to depleted supplies. Episodes of hypoglycemia, NPH 35u TID d/c. S/p D5W drip. Continue with SSI. Oligouric AKI on CKD, requiring CRRT. Nephrology on board. New onset A-fib with RVR, now rate controlled. S/p amiodarone drip & metoprolol. Increasing leukocytosis. Continue Vanc/Aztreonam/Flagyl and empiric Caspo, follow cultures. Episodes of coffee ground emesis. Hgb downtrended. Recevied 1 unit of pRBC. Hgb stable. On Levophed. Continue proning protocol. CRRT better when placed in left position. Keep net even. Wean off Levo as tolerated, start midodrine 10mg tid. DC empiric Abx given negative cultures. Palliative care for goals of care. Shock state of unclear etiology at this time. EV1000 hemodynamics to help guide management. Currently on 40 of levophed and vasopressin. Poor oxygenation. Prone ventilation discontinued. DC'd empiric Abx given negative cultures. Spoke to patient's wife and she wants patient to be DNR with no escalation of care given his overall poor prognosis. Plan to compassionately wean. Confirmed DNR. No further escalation of care. Death Note I was called to the room of patient to pronounce that patient had died. Patient was laying motionless and unresponsive to verbal/tactile stimuli. Pupils where fixed and dilated. There were no spontaneous breath sounds. Peripheral pulses were absent. No heartbeat was heard during auscultation. Family was made aware. Condolences offered. Chaplain and postmortem services offered. Pt was DNR code. Time of death was 1724, confirmed and witnessed by Nurse

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 18,0
Labordaten: SARS-COV-2, NAA, Detected: 08/13/21.
Aktuelle Erkrankungen: -
Vorgeschichte: Allergy to environmental factors ? Anemia ? Arthritis ? Blind left eye 2012 ? CAD (coronary artery disease) 2 stents per patient ? Cancer ( 12) basal cell carcinoma ? Cancer ( 12) skin cancer - excisions on left hand and right arm ? Cerebral artery occlusion with cerebral infarction (100) stroke 2 years ago- blind left eye ? Cerebral artery occlusion with cerebral infarction (100) "stroke in left eye about 5 years ago" per patient ? Chronic kidney disease ? CKD (chronic kidney disease), stage III per patient ? Coronary artery disease ? Diabetes ? Diabetes mellitus ? Dysphagia ? Fall ? GERD (gastroesophageal reflux disease) ? History of chemotherapy ? Hyperlipidemia ? Hypertension ? Malignant neoplasm of breast ? Thyroid disease
Andere Medikamente: albuterol 108 (90 Base) MCG/ACT Inhalation Aerosol Solution Inhale 2 puffs every 6 hours as needed for wheezing. 8/11/21 PA-C amLODIPine (NORVASC) 5 MG PO Tablet Take 5 mg by mouth daily. 12/12/18 Information, Historical atorvastati
Allergien: Penicillin, Sulfa Antibiotics
Vorherige Impfungen: -

VAERS 1666135

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 55,0
Geschlecht: F
Eingang: 02.09.2021
Impfdatum: 12.03.2021
Beginn: 25.08.2021
Tage bis Beginn: 166,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Atelectasis Blood gases normal Blood lactate dehydrogenase C-reactive protein normal Cough Decreased appetite Diarrhoea Dyspnoea Fatigue COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chest discomfort Chills Fibrin D dimer normal Headache Infection

Symptomtext

History of present illness (8/25/21): This is a 55 year old female with known COVID-19 infection (symptom onset 08/21/21 and positive test 08/23/21) and PMHx including DMII, OSA, HTN, and obesity who presents to ED for progressively worsening shortness of air. Pt. reports initial symptoms included headache, body aches, and nausea/vomiting/diarrhea. She notes a productive cough with green sputum, and has developed left-sided rib pain with coughing. Pt. completed 2 series Pfizer covid vaccination on 03/12/2021. Review of Systems (8/25/21): Constitutional: Positive for activity change, appetite change, chills, fatigue and fever. Respiratory: Positive for cough, chest tightness and shortness of breath. Negative for wheezing. Gastrointestinal: Positive for diarrhea, nausea and vomiting. Negative for abdominal distention, abdominal pain and constipation. Musculoskeletal: Positive for myalgias. Negative for back pain, gait problem and joint swelling. #Acute hypoxic respiratory failure 2/2 SARS CoV2 bilateral pneumonia (8/25/21) - Pt. O2 sat 91% on RA at rest. VBG 7.35/55/23/31. - CXR showing mild basilar opacities (L>R) representing atelectasis vs early infection - Afebrile with WBC (8), procal minimally elevated. CRP (127) LDH () d-dimer (0.43) - 08/25 ? starting Remdesivir and dexamethasone 6 mg PO daily with GI ppx #Acute hypoxic respiratory failure 2/2 COVID-19 PNA (8/28/21) - Initially required O2 via NC - CXR showing mild basilar opacities (L>R) - Continue remdesivir for 5 day course-- > end date 8/29 - Continue dexamethasone for 10 day course-- > end date 9/3 - Trend CRP and CMP while on remdesivir - Mucinex, dextromethorphan, albuterol MDI PRN - Supplemental O2 for sats >92% Discharged home 8/29/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: 8/23/21: SARS CoV-2/COVID-19 RNA PCR Detected 8/25/21: - O2 sat 91% on RA at rest. VBG 7.35/55/23/31. - CXR showing mild basilar opacities (L>R) representing atelectasis vs early infection - Afebrile with WBC (8), procal minimally elevated (0.18). CRP (127) d-dimer (0.43) - lymphocytes 7.0% 8/28/21: - lymphocytes 30.0%
Aktuelle Erkrankungen: -
Vorgeschichte: Type II diabetes mellitus, obstructive sleep apnea, hypertension, hyperlipidemia, thyroid nodule, restless leg syndrome, diabetic polyneuropathy, gastroesophageal reflux disease, obesity
Andere Medikamente: Amitriptyline, amlodipine, atorvastatin, baclofen, cetirizine, clindamycin 1% external solution, cyclobenzaprine, estradiol (Vivelle-Dot) patch, fexofenadine, fluticasone nasal spray, hydrochlorothiazide, linaclotide, lisinopril, metformin,
Allergien: Shellfish (anaphylaxis), morphine (nausea)
Vorherige Impfungen: -

VAERS 1662260

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: PA
Alter: 75,0
Geschlecht: F
Eingang: 01.09.2021
Impfdatum: 19.03.2021
Beginn: 22.08.2021
Tage bis Beginn: 156,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Abdominal pain Acute respiratory failure Appetite disorder Aspartate aminotransferase increased Asthenia Bacteriuria Blood magnesium normal Brain natriuretic peptide increased COVID-19 Chest X-ray normal Cough Diarrhoea Dizziness Dyspnoea Dyspnoea exertional Exercise tolerance decreased Fatigue Haematology test normal

Symptomtext

Bronchopneumonia, Cough. SOB, FEVER, ABD PAIN, NAUSEA, VOMITING AND DIARRHEA ED to Hosp-Admission Current 8/27/2021 - present (5 days) Hospital Acute respiratory failure with hypoxia (HCC Patient presents with ? Shortness of Breath is an 75 y.o. female. HPI: Patient is a 75-year-old female with a history of morbid obesity/hypertension/OSA who presents to the ER with complaints of worsening shortness of breath. History goes that patient was well until approximately 6 days ago when she began feeling ill. At the time she was experiencing cough, shortness of breath, as well as dyspnea on exertion with reduced exercise tolerance. She was evaluated at the urgent care on 8/25 where plain chest x-ray was performed which showed no evidence of infiltrate. She was started on azithromycin and COVID-19 test was ordered. Recommendations was made for her to get OTC medications for symptom relief. She was called on 8/27 and informed that she had COVID-19. During all this her symptoms did not get any better with progressively worsening symptoms with body aches and pains, progressively worsening shortness of breath, cough, and fatigue. Due to worsening symptoms 911 call was made prior to arrival to the ER. EMTs found patient to to be dyspneic with pulse ox reading of 80% on room air requiring supportive oxygen of up to 6 L/min prior to transport. She was transported to the ER where she was started on noninvasive mechanical ventilation. Upon arrival she was tachypneic, with visible work of breathing. She was afebrile. Her labs were nonacute on hematology, chemistries showed magnesium of 1.6, BNP of 101, with elevated AST of 69. Her UA showed hazy urine, positive for leukocyte esterase and nitrites, she also has proteinuria with hematuria pyuria and bacteriuria. Plain chest imaging showed chronic lung changes. Patient is being admitted for further management. Of note patient lives with her son who was recently hospitalized with COVID-19 pneumonia. Review of Systems Constitutional: Positive for activity change, appetite change and fatigue. HENT: Positive for congestion, postnasal drip and rhinorrhea. Eyes: Negative. Respiratory: Positive for cough and shortness of breath. Cardiovascular: Negative. Gastrointestinal: Positive for diarrhea and nausea. Endocrine: Negative. Genitourinary: Negative. Musculoskeletal: Negative. Skin: Negative. Allergic/Immunologic: Negative. Neurological: Positive for dizziness, weakness, light-headedness and headaches. Hematological: Negative. Psychiatric/Behavioral: Negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: 08/26/21 1334 COVID-19 (SARS CoV-2,RNA Molecular Amplification) Collected: 08/25/21 0832 | Final result | Specimen: Swab from Nasopharynx COVID-19 SARS-CoV-2 Overall Result DetectedCritical Narrative: XR CHEST 2 VW IMPRESSION: No acute cardiac pulmonary process. END OF IMPRESSION: INDICATION: Cough. TECHNIQUE: Two views of the chest were performed. COMPARISON: Chest x-ray 4/16/2012 FINDINGS: There is no acute pulmonary, parenchymal, or vascular process suspected. The cardiac size and configuration are unremarkable. No hilar or mediastinal abnormality is suspected. No active pleural process is identified . Osseous structures demonstrate bilateral shoulder prostheses. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient.
Aktuelle Erkrankungen: -
Vorgeschichte: Allergic rhinitis Disability of walking Generalized anxiety disorder Generalized osteoarthritis Depressive disorder Disorder of lung Impaired fasting glucose
Andere Medikamente: allopurinoL (ZYLOPRIM) 300 mg tablet azithromycin (ZITHROMAX) 250 mg tablet b complex vitamins capsule celecoxib (CeleBREX) 200 mg capsule cholecalciferol, vitamin D3, 25 mcg (1,000 unit) capsule dilTIAZem CD (CARDIZEM CD) 240 mg 24 hr
Allergien: OxytocinHives / Urticaria, Welts TramadolOther (document details in comments) CodeineOther (document details in comments) Naproxen SodiumOther (document details in comments)
Vorherige Impfungen: -

VAERS 1658899

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 84,0
Geschlecht: M
Eingang: 31.08.2021
Impfdatum: 17.02.2021
Beginn: 20.08.2021
Tage bis Beginn: 184,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient passed away on 08/20/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Tylenol, Milk of Mag, Maalox, Dulcolax, Roxanol, Lorazepam, Synthroid, Proscar
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1655726

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 94,0
Geschlecht: M
Eingang: 30.08.2021
Impfdatum: 17.02.2021
Beginn: 09.08.2021
Tage bis Beginn: 173,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute myocardial infarction Acute respiratory failure Anticoagulant therapy Aortic arteriosclerosis Aortic disorder Aspiration Asthenia Atrial fibrillation Blood glucose Blood lactate dehydrogenase increased Blood magnesium Brain natriuretic peptide increased C-reactive protein increased COVID-19 COVID-19 pneumonia Cardiac telemetry Cardiomyopathy Chest X-ray abnormal

Symptomtext

Patient vaccinated 2/17/2021 (first dose 1/28/2021), admitted 8/9/2021, tested positive for COVID 8/9/2021. Infection prevention has determined COVID resolved due to >20 days. Patient is awaiting discharge to facility Patient admitted and tested positive for COVID on 8/9/21 Date of Clinic Visit or Hospitalization: 8/9/2021 Reason for clinic visit or hospitalization: SOA in setting of COVID infection COVID-19 positive test result: Yes; if Yes, date 8/9/2021 Plans to monitor (include medications if prescribed):dexamethasone 10d course CC: dyspnea, fatigue, weakness, hospitalized for Acute hypoxis resp failure History Of Present Illness Patient is a 95 y.o. male with a PMH of Afib on Coumadin, recently diagnosed with Covid-19 on 8/4/21 who presents to the ED with worsening SOA, fatigue and weakness. The patient started having symptoms roughly one week ago on Saturday. That day, according to his son, he was confused upon waking, thinking it was Sunday, and then went back to bed and slept for the next 24 hours. The next day his son states he was very weak and had no energy to eat and just wanted to go back to bed. They called his PCP who is also a close friend who advised them to monitor his oxygen. A few days later the patient reported not feeling good and the family checked his oxygen which was <90%. He was taken to Hospital that day and admitted from 8/4/21-8/6/21 and subsequently diagnosed with Covid. He was discharged due to lack of oxygen requirement inpatient. His son states at the time he was too weak to walk from the building to the car and could hardly sit up for any period of time. He had also developed a productive cough with dark brown sputum. He was seen by his PCP two days ago who prescribed azithromycin (he had two tablets yesterday and one today). Then this morning he complained of chest pain and dyspnea. His son checked his oxygen and it was 89% so they called 911 again. The patient states hat he is only comfortable when laying flat on his back which his son also endorses but overall he has difficulty communicating about his symptoms. The patient states his chest pain is located to the left lower ribs and questionably reproducible. Symptoms overall improved by laying flat, at one point saying it is because he can roll over on different sides, but otherwise no clear aggravating or relieving factors. Currently he rates his pain as a 2-3/10 and states it is improved compared to this morning. Of note, he was previously vaccinated in February 2021. Review of Systems Constitutional: Positive for unexpected weight change. Negative for chills and fever. HENT: Positive for congestion. Negative for ear pain and sore throat. +hard of hearing (has hearing aids) Eyes: Positive for discharge and itching. Negative for pain and visual disturbance. Respiratory: Positive for cough (productive). Cardiovascular: Positive for chest pain. Negative for leg swelling. Gastrointestinal: Negative for abdominal pain, constipation, diarrhea, nausea and vomiting. Genitourinary: Negative for dysuria. Musculoskeletal: Negative for arthralgias. Skin: Negative for rash and wound. Neurological: Positive for dizziness. Negative for light-headedness and headaches. Numbness: mornings. Hematological: Bruises/bleeds easily. Psychiatric/Behavioral: Negative for confusion. Patient is a 95 y.o. male On presentation to the ED he was tachycardic with HR of 112, reportedly hypoxic to 80-85% on RA this morning, now stable with oxygen at 96% on 4L NC. He is afebrile and hemodynamically stable. Initial lab-work notable for leukocytosis (wbc 12.45), elevated D-dimer, CRP, LDH and ferritin and appropriate INR of 3.1. BNP elevated at 5,570. He was given IV Decadron and started on IVF due to recent PO intake. A bedside swallow study was completed which patient did not pass. EKG obtained showing Afib. CXR performed and images personally reviewed - hyperinflation noted as per report with no obvious focal consolidation. Principal Problem: Acute respiratory failure with hypoxia Acute hypoxic respiratory failure with recently diagnosed Covid-19 infection - leukocytosis (wbc 12.45), elevated D-dimer (1.47), CRP (125), LDH (285) and ferritin (appropriate INR of 3.1. - patient meeting sepsis criteria based on HR>90, RR>20, WBC >12 - mildly elevated procalcitonin (0.4), afebrile - CXR performed and images personally reviewed - hyperinflation noted as per report with no obvious focal consolidation - Covid and viral panel pending, UA ordered and pending - s/p 1 dose decadron, 1L IVF in the ED Plan: -continue decadron 6mg daily; hold remdesivir at this time given age and decreased likelihood of benefit given duration of time since dx and symptom onset -start broad spectrum abx with cefepime, vancomycin and flagyl (given possible aspiration) due to sepsis criteria, elevated procalcitonin and productive cough -continue oxygen supplementation to maintain saturation >92% -delsum and mucinex prn for cough Atypical chest pain with elevated BNP and D-dimer -labs notable for elevated BNP and D-dimer as above. EKG obtained showing Afib. CXR as above -pain possibly musculoskeletal in nature, son mentioned a strap of some kind located in the area previously. Ddx for pain and elevated BNP also includes cardiomyopathy due to covid-19, cardiac injury/NSTEMI, Afib, pulmonary HTN, PE. No evidence of renal failure based on labs and no hx of CHF or clinical evidence of volume overload on exam or cxr that would explain BNP elevation. Plan: -troponin ordered and pending -obtain CTPE to further assess for evidence of PE or pneumonia -if negative CT or evidence of PE consider echo for evaluation of CMP or right heart strain -tylenol prn for pain -telemetry monitoring Dysphagia in setting of known esophageal diverticulum - patient failed bedside swallow by RN, has reportedly had swallow study 6 months ago, son is not aware of results, no findings on imaging concerning for aspiration pneumonia at this time Plan: - NPO for now - start D5 @50ml/hr, fingerstick glucose q6hr - speech consult placed - nutrition consulted Afib on Coumadin -HR ranging 100s-120s in the room, but generally around 110s. EKG obtained showing Afib -INR 3.1 on admission -normally on metoprolol 12.5mg daily at night, warfarin 2.5mg nightly; last doses yesterday evening Plan: -continue coumadin, pharmacy to dose -initiate IV medications as needed for rate control -daily INR Generalized weakness and poor PO intake -patient's overall health status has been poor since Covid diagnosis with decreased PO intake and weakness -s/p 1L IVF in the ED Plan: -nutrition consulted as above -PT/OT consult when clinically improved Hypomagnesemia - Mg 1.8 on admission, replaced in ED - continue to monitor and replace as needed 8/25/2021 No acute complaints overnight, COVID precautions have been lifted as it has been 20 days since his first positive test. Patient and family request that he been discharged to recieve hospice care along with some rehabilitation so that he might be able to return home with hospice with better quality of life. Review of Systems: Review of Systems Constitutional: Negative for activity change, fatigue and fever. Respiratory: Negative for cough, chest tightness and shortness of breath. Assessment and Plan: patient is a 95 y.o. male who presented with dyspnea and chest pain found to have likely aspiration pneumonia, now receiving comfort measures only and awaiting transfer to hospice when possible. Acute hypoxic respiratory failure requiring supplemental oxygen secondary to COVID 19 and aspiration Aspiration pneumonia/ leucocytosis | aspiration - Had worsening leukocytosis with elevation in CRP. Chest radiograph showed evidence of possible aspiration in the left lower lung fields on 8/13 with worsening on 8/15. Initially started on empiric antibiotics, however now discontinued as patient is comfort care only. PLAN: -supplemental oxygen as needed for comfort, Albuterol HFA inhaler Q4h PRN -morphine 2-4mg IVP q3H prn pain or dyspnea -glycopyrrolate, dextromethorphan, guanfacine PRN -ordered diet for comfort. Acute Encephalopathy on Chronic Encephalopathy; Resolved Chronic Sensorineural Hearing Loss - Likely secondary to acute illness and hospitalization and hearing loss. PLAN: - Maintain sleep/wake cycle with nightly trazodone - orienting to day/night, family calls twice daily - has hearing aids in room Viral pneumonia secondary to SARS/CoVID-19 pneumonia - Diagnosed 8/4 at Hospital; received 5 days dexamethasone, remdesivir not started given late presentation. Now comfort care only PLAN: - patient no longer requires COVID isolation precautions as it has been 20 days since his first positive test, he is no longer considered to be infectious - Acetaminophen 650mg PO Q6h PRN for fever Atrial Fibrillation | CHADSVasc 2 Home regimen: metoprolol 12.5mg daily at night, warfarin 2.5mg daily; comfort care only at this time PLAN: - discontinued home medications Esophageal diverticulum - Failed bedside swallow by RN. Seen by speech and later cleared to eat on 8/11. Now eating ad lib for comfort Debility secondary to prolonged hospital stay - Patient will be discharged to hospice, however would like to eventually return home with hospice care if possible. He requests PT/OT evaluation and discharge to appropriate facility PLAN: - PT/OT consulted, awaiting recommendations for rehab CHRONIC | STABLE | RESOLVED Proteus UTI- Received 5 days of appropriate antimicrobial therapy Hypomagnesemia, hypophosphatemia- monitored and replaced, now comfort care only. Normocytic anemia- hgb 12.1 on admission with MCV of 91 Fluids: PO Nutrition: Regular diet DVT prophylaxis -none, comfort care only Dispo: Hospice once cleared from COVID isolation 8/29/2021 Subjective: No acute events overnight. Reports feeling comfortable. Asks what he has to do to be able to leave the hospital. I had another long conversation with patient's son this morning about his fathers wishes to be able to return home. Son, tells me that the only way he could come home is if he can eat by himself, sit up and walk. Son tells me that he 'gave his dad these goals.' I told him that his dad is very unlikely to achieve this and that he could be at home with hospice care. Son tells me that home is not an option and he doesn't have the means to help him if he started to pass. I told him that the goal of hospice is to allow a person to pass comfortably at home, he expressed understanding and tells me that even if he did come home, son and his wife are going on vacation from September 12th to Early October and there are no other family members in area able to care for his father. Son requested that we continue to search for a 'facility.' Assessment and Plan: Patient is a 95 year old male with history of atrial fibrillation and recent COVID admitted for dyspnea and chest pain, now with continued aspiration and decision to be comfort care only. He is comfortable on current level of supplemental oxygen and is awaiting transfer home or to a facility for hospice care. Viral pneumonia secondary to SARS/CoVID-19 pneumonia: Diagnosed 8/4 at Hospital; Now comfort care only. No longer requires COVID isolation precautions as it has been 20 days since his first positive test

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 22,0
Labordaten: XR Chest 1 View Result Date: 8/9/2021 Narrative: Exam/Procedure: XR CHEST 1 VIEW ordered by Physician CLINICAL INDICATION: Short of air, Covid positive TECHNIQUE: XR CHEST 1 VIEW COMPARISON: Chest radiograph from August 14, 2017 FINDINGS: The lungs are hyperinflated similar to the previous exam. There is no lung opacification. The heart size is normal. There is tortuosity of the aorta and there is calcified atherosclerotic disease. No pneumothorax. No pleural effusion. No acute osseous abnormality. Severe degenerative change of both shoulders.. IMPRESSION: Hyperinflated lungs without evidence of acute pulmonary disease.
Aktuelle Erkrankungen: -
Vorgeschichte: Afib, Basal cell carcinoma, prostate cancer resolved S/P surgery, former smoker (smoked 7 years)
Andere Medikamente: azithromycin, Refresh celluvisc, fluticasone, metoprolol succinate XL, aquaphor, senna, warfarin, artificial tears
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1653985

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: FL
Alter: 74,0
Geschlecht: M
Eingang: 29.08.2021
Impfdatum: 19.03.2021
Beginn: 25.08.2021
Tage bis Beginn: 159,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Anticoagulant therapy Blood electrolytes COVID-19 COVID-19 pneumonia Cardiac telemetry abnormal Computerised tomogram thorax abnormal Condition aggravated Coronary artery disease Deep vein thrombosis Hyperlipidaemia Hypertension Hypokalaemia Insomnia Liver function test increased Myocardial ischaemia Pulmonary mass

Symptomtext

Patient required hospitalization due to breakthrough infection. He received Pfizer vaccine (2nd dose in series) on 03/19/21. Patient was hospitalized from 08/25/21 - 08/28/21. Below is copied from discharge summary: Acute respiratory failure with hypoxia 2/2 COVID 19 PNA: - uptititrate O2 as needed to keep O2 sat>92 - continue Decadron IV - continue IV Remdesevir, monitor LFT's - symptom management with prn meds - Isolation Hyperlipidemia - lipitor 80 mg daily Hypokalemia, resolved -Monitor Elevated LFTs monitor AKI/Urine retention, improved - Flomax 0.4 mg daily Vit D deficiency: -Vit D 1.25 mg weekly Elevated troponin, likely from demand ischemia -Telemetry Left lung mass: - 1.5 cm - F/U OPD with CT chest as recommended by Radiology HTN, fairly well controlled - Stable - Resume losartan, hold HCTZ - continue amlodipine Insomnia: Continue trazodone CAD s/p DES: - Stable ASA+statin Morbid Obesity, BMI of>40: - would benefit from lifestyle modifications regarding low fat diet, weight loss and daily excercise - F/U OPD with PCP Vitals and labs personally reviewed. PT/OT: DVT PPx. Lovenox His electrolytes, pain and vitals were monitored and optimized during the course of hospitalization. Patient's symptoms improved and he remained hemodynamically stable. Patient wanted to go home and self isolate at home. 6 MIN WALK TEST WAS DONE, PT SENT HOME ON HOME O2 POOR ADHERENCE AND POOR INSIGHT, HIGH RISK OF RE-ADMISISON Discharge Diagnoses: Acute respiratory failure with hypoxia 2/2 COVID 19 PNA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: SARS-COV-2, NAA, Detected 08/25/21.
Aktuelle Erkrankungen: -
Vorgeschichte: ? CAD (coronary artery disease) ? Hypertension
Andere Medikamente: amLODIPine (NORVASC) 2.5 MG Oral Tablet TAKE 1 TABLET DAILY 7/27/21 aspirin 81 MG Oral Tablet Take 81 mg by mouth daily. Information, Historical atorvastatin (LIPITOR) 80 MG Oral Tablet TAKE 1 TABLET NIGHTLY AT BEDTIME 1/19/21
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1651415

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6201

kritisch

Staat: OR
Alter: 47,0
Geschlecht: F
Eingang: 28.08.2021
Impfdatum: 29.03.2021
Beginn: 06.04.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autopsy Death Dizziness Fatigue Malaise Mitral valve prolapse Sudden cardiac death

Symptomtext

Patient felt unwell - dizzy and tired on the evening of April 5, 2021. She went to bed and died in her sleep, likely early in the morning April 6, 2021. Medical Examiner recorded her cause of death "Sudden Cardiac Death associated with Mitral Valve Prolapse

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Autopsy and associated testing
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1641551

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: FL
Alter: 74,0
Geschlecht: M
Eingang: 27.08.2021
Impfdatum: 08.03.2021
Beginn: 13.08.2021
Tage bis Beginn: 158,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Confusional state Death Fall Hypoxia Mental status changes SARS-CoV-2 test positive

Symptomtext

7/30/21: admitted for multiple falls 8/5/21: Transitioned to Inpatient Rehab. 8/13/21: He became altered and hypoxic, prompting testing for COVID-19. Resulted positive COVID PCR on 8/13/21; breathing comfortably on 2L nasal cannula 8/17/21: completed remdesivir course, worsening confusion and altered mentation; using heated-high flow at 35L, non-rebreather 8/19/21: patient discharged to hospice. 8/22/21: patient passed. Time of death 0508.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: SARS CoV2 PCR detected on 8/13/21
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes, hypertension, COPD CAD, afib, MI, former smoker
Andere Medikamente: Glimepiride, metformin, Flonase, omeprazole, Synthroid, Zyrtec
Allergien: Carvedilol, Olmesartan, Penicillin
Vorherige Impfungen: -

VAERS 1632569

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WI
Alter: 74,0
Geschlecht: M
Eingang: 25.08.2021
Impfdatum: 18.02.2021
Beginn: 23.08.2021
Tage bis Beginn: 186,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Chest X-ray abnormal Condition aggravated Cough Dyspnoea Respiratory failure SARS-CoV-2 test positive Wheezing

Symptomtext

"Pt received his second dose of Pfizer COVID-19 on 2/18/21. Pt was admitted to reporting hospital on 8/23/21 with an admitting diagnosis of COVID-19 Pneumonia and acute on chronic hypoxic respiratory failure. Pt was reported in ER to have worsening shortness of breath, wheezing and cough on 6L of oxygen. Patient's wife is also positive for COVID. Admission test for COVID was positive per PCR NP swab on 8/23/21. Pt is currently admitted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: COVID PCR 8/23/21 Positive Chest XRay 8/23/21- Lower lobe predominant multifocal airspace disease. Correlate with COVID status.
Aktuelle Erkrankungen: Thrombophletitis
Vorgeschichte: 1. GI Blood loss from AVM 2. COPD exacerbation 3. Acute or chronic hypoxic respiratory failure 4. Chronic heart failure with preserved ejection fraction 5. Paroxysmal atrial fibrillation
Andere Medikamente: Lasix, Proscar 5mg, Azithromycin, Zyrtec, Lioresal, Aspirin 81mg, Ferrous sulfate 325, Bumex
Allergien: Levaquin, Loratadine-pseudoephedrine
Vorherige Impfungen: -

VAERS 1628520

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WI
Alter: 75,0
Geschlecht: M
Eingang: 24.08.2021
Impfdatum: 15.02.2021
Beginn: 11.08.2021
Tage bis Beginn: 177,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Asthenia COVID-19 Chest X-ray abnormal Condition aggravated Device occlusion Fatigue Haemoptysis Infection Oxygen saturation decreased Pneumonia SARS-CoV-2 test positive

Symptomtext

Pt received both doses of the COVID 19 Pfizer vaccine (on 1/25/2021 and 2/15/2021). Pt presented to the ED on 8/11/2021 and tested positive for COVID-19. At first, he had only generalized non specific symptoms relating to COVID (weakness, fatigue), and treatment was focused on blocked nephrostomy tubes with infection. Starting on 8/14/2021, provider was notified that patient was having O2 desaturation to 83% and transient increases in O2 requirement (up to 10 L and then weaned to 6L). Diagnosed with acute hypoxic respiratory failure, experienced episodes of hemoptysis. Chest xray on 8/17 showed right upper lobe pneumonia. Pt started on dexamethasone remdesivir on 8/14/2021. Appears that COVID extended hospitalization but unsure by how many days. Discharged from hospital on 8/23/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hx PE, bell's palsy, calculus of ureter, cataract, cellulitis, CKD stage 3, Chronic respiratory failure with hypoxia, COPD,CAD, cystitis, DM, Emphysema, GERD, Hyperlipidemia, HTN, HX MDRO, multiple pulmonary nodules, nephrolithiasis, obesity hypoventilation syndrome, OSA, hx malignant neoplasm of prostate, hx SOB, urethral stricture, unstable angina, vertigo, nephrostomies.
Andere Medikamente: apixaban, ascorbic acid, aspirin, atorvastatin, benazepril, famotidine, fluticasone-salmeterol, furosemide, isosorbide mononitrate, metformin, metoprolol, niacin, pantoprazole, potassium citrate
Allergien: Nitroglycerin
Vorherige Impfungen: -

VAERS 1592122

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CO
Alter: 46,0
Geschlecht: M
Eingang: 20.08.2021
Impfdatum: 10.03.2021
Beginn: 14.08.2021
Tage bis Beginn: 157,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 SARS-CoV-2 test positive

Symptomtext

Pt admitted to hospital 8/18/21 due to acute hypoxic respiratory failure. Per H&P, tested positive at drive-up testing site on 8/14/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: Positive COVID-19 test 8/14/21 - completed Pfizer series on 3/10/21
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1583196

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: AR
Alter: 72,0
Geschlecht: F
Eingang: 18.08.2021
Impfdatum: 12.02.2021
Beginn: 11.08.2021
Tage bis Beginn: 180,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Pt was hospitalized with covid and died

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: Covid positive 8/9
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Diabetes, arthritis, HTN, hypothyroidism, sleep apnea
Andere Medikamente: Unknown
Allergien: Aspirin, Codeine, compazine, NSAIDs
Vorherige Impfungen: -

VAERS 1583081

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TN
Alter: 78,0
Geschlecht: M
Eingang: 18.08.2021
Impfdatum: 23.02.2021
Beginn: 15.08.2021
Tage bis Beginn: 173,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

COVID19 death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Parkinson's, Dementia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1582948

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: FL
Alter: 65,0
Geschlecht: F
Eingang: 18.08.2021
Impfdatum: 10.02.2021
Beginn: 15.08.2021
Tage bis Beginn: 186,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Dehydration Dyspnoea Fatigue Oxygen saturation abnormal SARS-CoV-2 test positive

Symptomtext

he patient presents with SOB x a few days ago with associated fatigue. Pt was COVID-19 positive 1.5 weeks ago and had the Pfizer COVID-19 vaccine in March 2021. Pt was placed on 2L nasal cannula upon arrival to the ED and notes that her oxygen saturation was 84% on room air while at home. Diagnostic Impression: Acute hypoxic respiratory failure due to COVID-19 pneumonia Bilateral viral COVID-19 pneumonia Mild dehydration History of hypertension History of fatal arrhythmia status post AICD placement COVID-19 vaccinated, March 2021, Pfizer

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: SARS COV2 COVID 19 PCR 08/15/2021
Aktuelle Erkrankungen: unknown
Vorgeschichte: HTN, Cardiac arrhythmia s/p defibrillator, MI, Colon Surgery
Andere Medikamente: Metoprolol, Losartan, Rosuvastatin
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1578413

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 86,0
Geschlecht: M
Eingang: 17.08.2021
Impfdatum: 24.02.2021
Beginn: 24.07.2021
Tage bis Beginn: 150,0
Dosis: 2
Route/Site: IM / OT

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 pneumonia Fall

Symptomtext

past medical history of Parkinson's disease, hypertension, BPH, who presents from home after having down 3 times over the past 72 hours. The following problems were addressed: Acute hypoxic respiratory failure secondary to COVID-19 pneumonia. Patient has been vaccinated previously. On dexamethasoneto complete 10 days,has completed 5 days of Remdesivir.Currently satting well on room air. Frequent falls, suspect related to above. Continue PT/OTAdmit for COVID pneumonia. Vaccinated completely "3 months ago". Steroids, remdesivir, O2, zinc. discharged today to skilled nursing unit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1574576

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WA
Alter: 71,0
Geschlecht: F
Eingang: 16.08.2021
Impfdatum: 03.03.2021
Beginn: 20.05.2021
Tage bis Beginn: 78,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 pneumonia Death Dyspnoea SARS-CoV-2 test positive

Symptomtext

5/20/2021 experiencing symptoms: dyspnea 5/24/2021 Admitted to hosp. and treated for COVID-19/ pneumonia 5/30/2021: died

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: 5/23/2021 COVID-19 PCR positive
Aktuelle Erkrankungen: UNK
Vorgeschichte: Chronic heart disease, Diabetes Mellitus, Severe obesity
Andere Medikamente: UNK
Allergien: UNK
Vorherige Impfungen: -

VAERS 1569053

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: FL
Alter: 84,0
Geschlecht: M
Eingang: 15.08.2021
Impfdatum: 03.03.2021
Beginn: 10.08.2021
Tage bis Beginn: 160,0
Dosis: 2
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Agitation Asthenia Atrial fibrillation Back pain Blood magnesium decreased Blood phosphorus decreased Blood potassium decreased COVID-19 COVID-19 pneumonia Cardiac arrest Condition aggravated Culture urine positive Death Dyspnoea Echocardiogram abnormal Ejection fraction decreased Fall

Symptomtext

Patient required hospitalization due to breakthrough infection. He received the Pfizer vaccine (2nd dose in series) on 03/03/21. Hospitalized from 08/10/21 - 08/14/21 (death). Below is copied from patients discharge (death) summary: Hospital Course: Patient is an 84 year old man with a past medical history of Afib (on eliquis, metoprolol), HTN, HLD, MI admitted to the ICU for acute hypoxemic respiratory failure secondary to Covid-19 pneumonia. He presented to the ED after EMS was called for fall out of bed with generalized weakness, he denies hitting his head or LOC. He was satting 78% on EMS arrival and tachypneic, he had minimal improvement with NRB. In the ED he was found to be in Afib RVR to the 160s with hypotension, levophed was begun, he was cardioverted, and was begun on amiodarone infusion. The patient reports a 1 week history of generalized fatigue and shortness of breath without leg swelling or orthopnea. He was vaccinated in March with the Pfizer vaccine. He reports his cardiologist is at another facility and doesn't remember his medications offhand but knows he takes Eliquis BID. 8/11: TTE ordered, not yet performed. K+, Mg, phos low and repleted. On HFNC + NRB 60L/92% satting high 80s/low 90s. Currently on amio drip. No other acute events. 8/12 Patient elected to be DNR/DNI yesterday. Urine culture growing >100K Staph, started on Vanc/Cefepime while waiting sensitivity. Amio gtt changed to metoprolol. Patient endorsing soreness/back pain and states he uses Percocet and fentanyl patch outpatient. On HFNC + NRB 60L/95%, satting high 80s/low 90s past 24 hours. Echo performed shows EF 50-55%, impaired relaxation, moderately enlarged RV, moderately dilated LA, PASP 45 mm Hg. 8/13: Patient elected to rescind DNR/DNI 1 day ago. Became acutely agitated throughout the night and was removing HFNC stating that he "did not want to do this anymore". Started on precedex gtt and haldol prn for agitation. Pt w/ improved compliance w/ HFNC and able to maintain O2 saturation between 87-89%. 8/14: Patient now DNR/DNI, daughter at bedside while patient's wife was again admitted to the hospital. Decision made to pursue compassionate wean. Started on Morphine infusion for comfort and to prevent air hunger. O2 saturation continually downtrending. Asystole at 1803, confirmed in 2 leads. No signs of life. Pronounced expired at 1803. Dr notified at 1806.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: SARS-COV-2, NAA, Detected on 08/10/21.
Aktuelle Erkrankungen: -
Vorgeschichte: Abdominal hernia Chronic constipation Colon polyp GERD (gastroesophageal reflux disease) Heart attack Hyperlipidemia Hypertension
Andere Medikamente: apixaban (ELIQUIS) 5 MG aspirin 81 MG Tablet l atorvastatin (LIPITOR) 80 MG Tablet fentaNYL (DURAGESIC) 100 MCG/HR fluticasone (FLONASE) 50 MCG/ACT Suspension losartan-hydroCHLOROthiazide (HYZAAR) 100-12.5 MG Ta
Allergien: Penicillins
Vorherige Impfungen: -

VAERS 1525789

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 81,0
Geschlecht: F
Eingang: 04.08.2021
Impfdatum: 17.02.2021
Beginn: 02.07.2021
Tage bis Beginn: 135,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Death

Symptomtext

death N17.9 - Acute renal failure, unspecified acute renal failure type

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1320232

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NC
Alter: 67,0
Geschlecht: F
Eingang: 02.08.2021
Impfdatum: 15.02.2021
Beginn: 19.02.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Blood test Cerebrovascular accident Computerised tomogram Dizziness Echocardiogram Ischaemic stroke Magnetic resonance imaging Ultrasound scan Electrocardiogram Facial paralysis

Symptomtext

Four days after the second dose of the vaccine I suffered a stroke. I got very dizzy all of a sudden. My family noticed my face had drooped on the left-hand side. I went to the emergency room and they confirmed that I had had a stroke. I still have lack of energy and I have seen a neurologist. I am scheduled to see my doctor again and I am unsure if I have recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: CT Scans; EKG; Blood Work.
Aktuelle Erkrankungen: -
Vorgeschichte: Hypothyroidism.
Andere Medikamente: Levothyroxine; Multivitamin; Vitamin D; Magnesium; Niacin; Calcium.
Allergien: Bee Stings; Morphine Intolerance.
Vorherige Impfungen: -

VAERS 1320232

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NC
Alter: 67,0
Geschlecht: F
Eingang: 02.08.2021
Impfdatum: 15.02.2021
Beginn: 19.02.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Blood test Cerebrovascular accident Computerised tomogram Dizziness Echocardiogram Ischaemic stroke Magnetic resonance imaging Ultrasound scan Electrocardiogram Facial paralysis

Symptomtext

Four days after the second dose of the vaccine I suffered a stroke. I got very dizzy all of a sudden. My family noticed my face had drooped on the left-hand side. I went to the emergency room and they confirmed that I had had a stroke. I still have lack of energy and I have seen a neurologist. I am scheduled to see my doctor again and I am unsure if I have recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: CT Scans; EKG; Blood Work.
Aktuelle Erkrankungen: -
Vorgeschichte: Hypothyroidism.
Andere Medikamente: Levothyroxine; Multivitamin; Vitamin D; Magnesium; Niacin; Calcium.
Allergien: Bee Stings; Morphine Intolerance.
Vorherige Impfungen: -

VAERS 1515178

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WI
Alter: 80,0
Geschlecht: M
Eingang: 30.07.2021
Impfdatum: 26.02.2021
Beginn: 29.07.2021
Tage bis Beginn: 153,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anticoagulant therapy Asthenia Atelectasis Blood lactic acid increased COVID-19 pneumonia Cardio-respiratory arrest Chest X-ray abnormal Cough Deep vein thrombosis Exposure to SARS-CoV-2 Fluid overload Hyperlipidaemia Hypertension Incontinence Lung consolidation Lung opacity Nasopharyngitis Nausea

Symptomtext

Date of Hospitalization: 7/29/2021 2:41 PM CC: Cough and more weak The below information was obtained directly from the patient and the below portions of the epic record was reviewed and confirmed with the patient. Patient is an 80-year-old male, who states that the reason for coming into the ER cough was increased weakness. Had a cold-like symptoms more weakness. Patient has been trying to stay out of the public not doing much but on Sunday he went to his mother's birthday and lots of family members were present. From that party two other people have turned positive for Covid. + nausea -patient did have an episode of vomiting today yellow emesis did have 2 episodes of incontinence. This is unlikely the patient's baseline. ASSESSMENT/PLAN: SARS-CoV-2 viral pneumonia/COVID-19: POA Dexamethasone 6 mg daily for total of 10 days No need for repeat Covid test -to confirm negative. Appropriate PPE was used to see the patient daily (N95, gown, gloves) Elevated lactic acid - POA - IV hydration and follow Diabetes mellitus type 2 POA -start on insulin per protocol Hyperlipidemia POA Hypertension POA Obesity BMI 39 POA Acute on Chronic DVT POA - started on Xarelto on 7/23 DVT prophalaxsis - Xarelto We will hospitalized this patient to the Hospitalist's service, with the diagnosis of SARS Covid viral pneumonia and fully vaccinated patient. The patients current condition is serious. The patient requires Hospitalization because of treatment of SARS Covid. The patient is a FULL CODE. The anticipated duration of length of stay will be 3-5 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: 2,0
Labordaten: PROCEDURE: XR CHEST PORTABLE VIEW(S): AP DATE: 7/29/2021 4:42 PM COMPARISONS: Priors, most recently 02/13/2016 CLINICAL INDICATION: 80 years Male cough, fever FINDINGS: The cardiac silhouette is enlarged and the pulmonary vascular appears congested. No apparent pleural effusion or pneumothorax. Low lung volumes resulting in crowding of bronchovascular structures.. Scattered ill-defined bilateral airspace opacities and retrocardiac consolidation. IMPRESSION: 1. Findings suggesting fluid overload/heart rate with mild edema. 2. Bilateral airspace opacities, which could relate to atelectasis, edema or an infectious process/pneumonia given clinical history. Contains critical data ED RAPID CORONAVIRUS (COVID-19) SOFIA ANTIGEN TEST W/ REFLEX Order: 273048746 Status: Final result Specimen Information: NASAL 0 Result Notes Ref Range & Units 7/29/21 1728 CORONAVIRUS ANTIGEN IA NEGATIVE POSITIVEPanic Comment: NO CONFIRMATION TESTING REQUIRED Contains critical data ED RAPID CORONAVIRUS (COVID-19) SOFIA ANTIGEN TEST W/ REFLEX Order: 273048746 Status: Final result Specimen Information: NASAL 0 Result Notes Ref Range & Units 7/29/21 1728 CORONAVIRUS ANTIGEN IA NEGATIVE POSITIVEPanic Comment: NO CONFIRMATION TESTING REQUIRED
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1509224

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 71,0
Geschlecht: F
Eingang: 28.07.2021
Impfdatum: 05.03.2021
Beginn: 09.07.2021
Tage bis Beginn: 126,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebral infarction Death

Symptomtext

death I63.9 - Cerebral infarction, unspecified

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1502233

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 84,0
Geschlecht: F
Eingang: 26.07.2021
Impfdatum: 16.03.2021
Beginn: 25.07.2021
Tage bis Beginn: 131,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 COVID-19 pneumonia Cough Death Dysgeusia Endotracheal intubation Fatigue Intensive care SARS-CoV-2 test positive

Symptomtext

Received Pfizer vaccines on 2/19/21, 3/16/21. Tested positive for COVID-19 on 7/10/21. Symptoms began on 7/6/21 w/ cough, dysgeusia, fatigue. Hospitalized on 7/13/21; transferred to ICU on 7/22/21. Patient expired on 7/25/21 due to pneumonia d/t COVID-19. Patient was intubated; given dexamethasone 6 mg x9 d, 5 day course of remdesivir, one dose of tocilizumab for COVID pneumonia. PMH significant for past medical history significant for pulmonary sarcoidosis, on prednisone 5 mg daily; immune thrombocytopenic purpura, on rituximab.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Past medical history significant for pulmonary sarcoidosis, on prednisone 5 mg daily; immune thrombocytopenic purpura, on rituximab.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1502067

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 80,0
Geschlecht: M
Eingang: 26.07.2021
Impfdatum: 18.02.2021
Beginn: 04.07.2021
Tage bis Beginn: 136,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Death Pneumonia

Symptomtext

death J18.9 - Pneumonia, unspecified organism N17.9 - Acute kidney failure, unspecified

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1494303

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WA
Alter: 77,0
Geschlecht: F
Eingang: 22.07.2021
Impfdatum: 12.02.2021
Beginn: 20.02.2021
Tage bis Beginn: 8,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction Angiogram pulmonary normal Atrial fibrillation Brain natriuretic peptide increased Chest discomfort Chest pain Condition aggravated Cough Electrocardiogram ST segment elevation Electrocardiogram change Fibrin D dimer increased Hypopnoea Neck pain Pain Painful respiration Pericarditis Pleural effusion Pleuritic pain

Symptomtext

Pericarditis S/S: actue chest pain or pressure, Chest pain made worse bu lying down, deep inspiration or cough, Pain Hx from 3 providers Patient presents for CP that started on Sunday night. Worse with inspiration states she feels like she has to breath shallow. Reports at 3:30 this morning pain was worse. Developed this retrosternal pleuritic chest pain late Sunday that has worsened over the course of the day yesterday and early this morning. She describes it as radiating up into her neck at times. No shortness of breath or cough. The pain encompasses a large area of her central chest which can radiate up the center of her neck. It is worse with deep breaths but not worse with walking. Initial Admit for Chest pain, developed A Fib during ED admission. Seen by Cardiology. Admitted 2/16-2/18. Neg CT pulm angiogram. Disch Diag including Cardiology 1. Pleuritic chest pain, 02/17/2021 2. Atrial fibrillation, 02/18/2021 3. NSTEMI (non-ST elevated myocardial infarction), 02/17/2021 4. Pleural effusion, bilateral, 02/18/2021 Pt readmitted 2/19/21. Troponin neg at that admit. D Dimer, Quantitative: 2.62 mcg/mL FEU Troponin I: <0.030 ng/mL BNP: 227 pg/mL Cardiology consult 2/20/21 called it pericarditis On 3/10/21 admitted for salicylate toxicity (on ASA for AFib) and ED provider stated that 2/16/21 admit for chest pain states that cardiology note at 3/10/21 stated the prior admit included diagnosis of pericarditis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 3,0
Labordaten: Vitals: Temp: 39.9 C Resp: 16 HR: 98 BP: 105/55 O2: 98 EKG: Abnormal-Sinus rhythm, minimal ST elevation, inferior leads Significant rhythm and ECG contour changes Tropinin: abnormal: 0.094 ng/ml reference range:<0.030 ng/mL Date of highest Troponin level: 02/16/2021 COVID-19: Negative
Aktuelle Erkrankungen: NA
Vorgeschichte: History of chronic metabolic disease
Andere Medikamente: NA
Allergien: NA
Vorherige Impfungen: -

VAERS 1487270

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 75,0
Geschlecht: M
Eingang: 20.07.2021
Impfdatum: 17.02.2021
Beginn: 09.07.2021
Tage bis Beginn: 142,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient passed away on 07/09/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: albuterol, dulcolax, senna, tylenol, roxanol, haldol, ativan, atropine sulfate, diphenhist, benadryl
Allergien: Brazil nuts
Vorherige Impfungen: -

VAERS 1487226

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 93,0
Geschlecht: F
Eingang: 20.07.2021
Impfdatum: 11.02.2021
Beginn: 02.07.2021
Tage bis Beginn: 141,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient passed away on 07/02/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: methadone, tramadol, furosemide, depakote, metformin, klor-con, prilosec, coreg, iron, colestid, lanoxin, cymbalta, namenda, lisinopril, norvasc, xalatan, cosopt, prednisolone, simethicone, aspirin, narcan, tylenol, vit b6, vit d3, melatoni
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1486808

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 82,0
Geschlecht: M
Eingang: 20.07.2021
Impfdatum: 17.02.2021
Beginn: 07.07.2021
Tage bis Beginn: 140,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Death

Symptomtext

death N17.9 - Acute renal failure, unspecified acute renal failure

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1133727

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 82,0
Geschlecht: F
Eingang: 18.07.2021
Impfdatum: 20.02.2021
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Altered state of consciousness Amnesia Blindness Chills Computerised tomogram normal Cerebrovascular accident Hypoacusis Loss of consciousness Computerised tomogram Feeling abnormal Headache Magnetic resonance imaging Presyncope Confusional state Electroencephalogram normal Fall Fear Feeling cold

Symptomtext

weird feeling in her head; headache; she thought she would pass out; This is a spontaneous report from a contactable consumer or other non hcp (patient). An 83 year old elderly female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6201, expiration date unspecified), via an unspecified route of administration on 20Feb2021 as DOSE 2, SINGLE for covid-19 immunization (82 year when vaccinated). Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EL9263, expiration date unspecified), via an unspecified route of administration on 29Jan2021 as DOSE 1, SINGLE for covid-19 immunization. Medical history included patient catheterized reason unspecified. The patient's concomitant medications were not reported. On an unknown date, the patient came home and experienced weird feeling in her head with headache and she thought she would pass out. Patient stated that she had a minimal reaction to the second dose. She had no problems the day she got it other than a weird feeling in her head later that day. It was a strange, weird feeling with a headache. She says for about 5 minutes, she thought she would pass out. She laid back in her chair and then she felt better. She said what else was she going to do, she would probably die if she didn't get the vaccine. The patient also had 2 CT scans and 2 MRI but the results are unknown at the time of report. The outcome of the events was reported as unknown at the time of report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Test Name: cat scans; Result Unstructured Data: Test Result:unknowresults; Test Name: cat scans; Result Unstructured Data: Test Result:unknowresults; Test Name: MRIs; Result Unstructured Data: Test Result:unknowresults; Test Name: MRIs; Result Unstructured Data: Test Result:unknowresults
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Catheter placement (unspecified)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1465138

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WI
Alter: 27,0
Geschlecht: F
Eingang: 12.07.2021
Impfdatum: 26.02.2021
Beginn: 26.04.2021
Tage bis Beginn: 59,0
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Exposure during pregnancy Foetal death Stillbirth

Symptomtext

Adverse Event: Stillbirth at 36 weeks gestation First pregnancy, normal previously Due date: 5/26/21 Delivery Date: 4/28/21 Fetal Demise determined on 4/26/21 Birth Weight: 6lbs, 2oz

Weitere VAERSDATA-Felder

Praegender Schweregrund: Foetal death
Hospital-Tage: 2,0
Labordaten: Autopsy completed on 4/30/21
Aktuelle Erkrankungen: n/a
Vorgeschichte: Rheumatoid Arthritis, Migraines
Andere Medikamente: Cimzia, Propranolol, Hydroxychloroquine, Vitamin B6, Unisom, Tylenol
Allergien: Diclofenac
Vorherige Impfungen: -

VAERS 1463450

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CT
Alter: 63,0
Geschlecht: M
Eingang: 11.07.2021
Impfdatum: 19.01.2021
Beginn: 01.02.2021
Tage bis Beginn: 13,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Pulmonary embolism

Symptomtext

13 days after receiving first dose I had a Pulmonary Emoblism in my left lung

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: Pulmonary Embolism
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension
Andere Medikamente: Allopurinol 300 mg - 1 daily Anastrozole 1 mg - 1 daily Atorvastatin 20 mg - 1 daily Finasteride 5 mg - 1 daily Olmesartan Medoxomil 20 mg - 1 daily Potassium Citrate 1620 mg (15 MEQ) - 1 daily Tamsulosin 0.4 mg - 2 daily Testosterone CYP 2
Allergien: Altace
Vorherige Impfungen: -

VAERS 1457374

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 61,0
Geschlecht: F
Eingang: 08.07.2021
Impfdatum: 19.02.2021
Beginn: 11.06.2021
Tage bis Beginn: 112,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Cerebrovascular accident

Symptomtext

I63.9 - Cerebrovascular accident (CVA), unspecified mechanism (CMS/HCC)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1453655

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CO
Alter: 68,0
Geschlecht: F
Eingang: 07.07.2021
Impfdatum: 13.02.2021
Beginn: 14.02.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Axillary pain Feeling abnormal Muscle injury Myocardial infarction Pain Pain assessment Peripheral swelling X-ray

Symptomtext

Her arm feels swollen at times and that it hurts so bad it feels strangled; soreness and pain all on the left side, muscle problems, joint pain in the elbow, wrist, 2-3 fingers usually the outside fingers hurt, painful ache in left shoulder, and sever arm pain.; Muscle problems; painful ache left shoulder; Underneath left armpit , zings when pressed in; started experiencing some difficulty; having a heart attack and was hurting everywhere especially the left arm; This is a spontaneous report from a contactable consumer or other non-health care professional. A 68-year-old female patient received dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EN6201) via an unspecified route of administration and administered in left arm on 13Feb2021 08:00 (age at vaccination was 68 years) as dose 1, single for COVID-19 immunization. The patient didnt had any vaccinations prior four weeks. No additional vaccines administered on same date of covid vaccine administration. The patient medical history include High Blood Pressure around the late 1990s, 2000s, diabetes mellitus from 2015. Patients concomitant drugs include hydrochlorothiazide taken for high Blood Pressure 25 mg once a day, losartan taken for High Blood Pressure 100mg orally once a day, metformin taken for blood glucose abnormal from 2016 1000mg twice daily. Patient first shot on 13Feb2021 around 8 PM that night, Saturday 14Feb2021 started experiencing some difficulty, by Sunday 15Feb2021 caller reports soreness and pain all on the left side, muscle problems, joint pain in the elbow, wrist, 2-3 fingers usually the outside fingers hurt, painful ache in left shoulder, and sever arm pain. She reports that she has been to the doctor and no one knows if it is from the Covid shot or not, she has had different test taken and no one can pinpoint what is going on. she thought she was having a heart attack and was hurting everywhere especially the left arm. She stated the pain ballooned and that is when she went to the doctor. having pain that runs from left shoulder down arm and around underneath the arm pit that zings when you put pressure on it, it causes pain. She said it hurt where her lymph nodes are. And she said the pain goes down to the fingertips. Patient said as far as the shoulder pain she is unsure if it is muscle pain or joint pain. But it is painful, and it aches. a scale of 1-10 she told the doctor it was a 10. Patient said she dont have fever. Her arm feels swollen at times and that it hurts so bad it feels strangled. Its like stopping dead in the water; she has not been good for the last 2 weeks and severe pain going down her arm. she has High Blood pressure and diabetes. she states this is part of the reason she got the vaccine as she is in the high-risk category. Events doesnt leads to hospitalization but require physician visit and emergency room. Therapeutic measures were taken as a result of events with steroid was Methylpred 4mg dose pack started 24Feb2021 and completed 01Mar2021. This was prescribed because doctor thought the steroids would help get everything under control of the pain. She also clarified that the muscle relaxer was Cyclobenzaprine which she spelled cylobenzap. She states the dose was 10mg orally and was prescribed to help the other medication work with to knock some of the soreness out. Medication was started 23Feb2021 and completed 01Mar2021. She does not have a lot or expiration for the Methylpred or the Cyclobenzaprine, states it was not on either bottle. She mentioned that these medications did not do very good. Declines to provide HCP information at this time but states she has been to see the doctor 16Feb2021. Lisinopril was changed to losartan because they had to try and get the right blood pressure medication for her and was changed in the late 1990s. She was on Lisinopril for 2-3 years. She has no lot number, expiration, or NDC to provide. Her appointment time was 7 pm but she received the vaccine somewhere between 7:30 an 8pm. she wanted to start life over again and do the things she did before. The patient underwent lab tests and procedures which included pain assessment: 10 on Caller says on a scale of 1-10 she told the doctor it was a 10, x-ray: unknown result on unknown date (she seen the doctor and got x-rays and all kinds of stuff). Second Covid vaccine is scheduled for this Friday. She stated she does not know what else to do, she is supposed to see the doctor this afternoon and is trying to gather information from Pfizer that can help them in any way. Caller reporting on COVID Vaccine. Caller mentioned she was taking Methylpred and Cyclobenzaprine and they did not help. Caller clarified the steroid was Methylpred 4mg dose pack started 24Feb2021 and completed 01Mar2021. This was prescribed because doctor thought the steroids would help get everything under control of the pain. She also clarified that the muscle relaxer was Cyclobenzaprine which she spelled cylobenzap. She states the dose was 10mg orally and was prescribed to help the other medication work with to knock some of the soreness out. Medication was started 23Feb2021 and completed 01Mar2021. She does not have a lot or expiration for the Methylpred or the Cyclobenzaprine, states it was not on either bottle. She mentioned that these medications did not do very good. Caller also mentioned detail about a historical medication which was Lisinopril. Lisinopril was changed to Losartan because they had to try and get the right blood pressure medication for her and was changed in the late 1990s. She was on Lisinopril for 2-3 years. She has no lot number, expiration, or NDC to provide for the Lisinopril. The outcome of events Muscle problems, Joint problems in elbow, wrist, and 2 outside fingers/soreness and pain all on the left side, muscle problems, joint pain in the elbow, wrist, 2-3 fingers usually the outside fingers hurt, painful ache in left shoulder, and sever arm pain, painful ache left shoulder, Underneath left armpit , zings when pressed in was not recovered and outcome of events started experiencing some difficulty, Her arm feels swollen at times and that it hurts so bad it feels strangled and having a heart attack and was hurting everywhere especially the left arm was unknown. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: Test Name: scale of 1-10/muscle pain or joint pain; Result Unstructured Data: Test Result:10; Comments: Caller says on a scale of 1-10 she told the doctor it was a 10.; Test Name: x-ray; Result Unstructured Data: Test Result:Unknown Result
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood pressure high (around the late 1990's , 2000's); Diabetes
Andere Medikamente: HYDROCHLOROTHIAZIDE; LOSARTAN; METFORMIN
Allergien: -
Vorherige Impfungen: -

VAERS 1450697

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 06.07.2021
Impfdatum: 17.02.2021
Beginn: 20.06.2021
Tage bis Beginn: 123,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebral infarction Cerebrovascular accident

Symptomtext

I63.9 - Acute CVA (cerebrovascular accident) (CMS/HCC) I63.9 - Acute cerebral infarction (CMS/HCC)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1450643

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 87,0
Geschlecht: U
Eingang: 06.07.2021
Impfdatum: 18.02.2021
Beginn: 29.04.2021
Tage bis Beginn: 70,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Death

Symptomtext

death N17.9 - Acute kidney failure, unspecified

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1450510

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 06.07.2021
Impfdatum: 06.03.2021
Beginn: 06.03.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Death Pneumonia

Symptomtext

death J18.9 - Pneumonia, unspecified organism abdominal pain

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1440579

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 01.07.2021
Impfdatum: 18.02.2021
Beginn: 24.06.2021
Tage bis Beginn: 126,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cerebrovascular accident

Symptomtext

I63.9 - Cerebrovascular accident (CVA), unspecified mechanism

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1440449

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 84,0
Geschlecht: F
Eingang: 01.07.2021
Impfdatum: 18.02.2021
Beginn: 24.06.2021
Tage bis Beginn: 126,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebral haemorrhage Death

Symptomtext

death I61.9 - Intraparenchymal hemorrhage of brain (CMS/HCC)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1437373

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IN
Alter: 88,0
Geschlecht: M
Eingang: 30.06.2021
Impfdatum: 24.02.2021
Beginn: 13.05.2021
Tage bis Beginn: 78,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation COVID-19 Chronic kidney disease Condition aggravated Death Hypertension SARS-CoV-2 test

Symptomtext

Death 05/24/2021 Causes of death listed on death certificate: 1) COVID 2) ATRIAL FIB 3) CKD 3 4) Hypertension

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: RT-PCR or other test
Aktuelle Erkrankungen: COVID
Vorgeschichte: ATRIAL FIB CKD 3 Hypertension
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1434068

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WA
Alter: 88,0
Geschlecht: U
Eingang: 29.06.2021
Impfdatum: 13.05.1932
Beginn: 23.04.2021
Tage bis Beginn: 32.487,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Died of COVID-19 illness on 04/23/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 13,0
Labordaten: Positive COVID-19 PCR test on 4/19/2021
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Diabetes mellitus Chronic heart disease Chronic lung disease hyperlipidemia
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1433813

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IN
Alter: 83,0
Geschlecht: F
Eingang: 29.06.2021
Impfdatum: 28.02.2021
Beginn: 11.05.2021
Tage bis Beginn: 72,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction Acute respiratory failure COVID-19 Condition aggravated Coronary artery thrombosis Death

Symptomtext

Death 5/12/2021 Causes of death listed on death certificate: 1) Acute Myocardial Infarction 2) Acute Coronary Artery Thrombosis 3) COVID-19 Other: Acute Respiratory Failure

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: COVID-19
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1433789

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 82,0
Geschlecht: F
Eingang: 29.06.2021
Impfdatum: 16.02.2021
Beginn: 04.05.2021
Tage bis Beginn: 77,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac arrest Death Resuscitation

Symptomtext

Patient went into cardiac arrest on 05/04/2021 when she was getting into a vehicle. CPR was initiated from EMS in the ambulance to the hospital. CPR was done for approx. 30 minutes when family asked them to stop. Patient passed away on 05/04/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CKD Stage 5, A fib
Andere Medikamente: Pepcid, Zyloprim, Zofran, Eliquis, diltiazem, dialyvite, furosemide, magnesium, ferrous gluconate, metoprolol tartrate, albuterol, simvastatin, zoloft, cholecalciferol, cyancobalamin
Allergien: Shellfish, sulfa drugs
Vorherige Impfungen: -

VAERS 1433722

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 93,0
Geschlecht: M
Eingang: 29.06.2021
Impfdatum: 17.02.2021
Beginn: 30.04.2021
Tage bis Beginn: 72,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient passed away on 04/30/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, CAD, hypertension, GERD
Andere Medikamente: Albuterol, Ellipta, Aricept, Gavilax
Allergien: Celebrex
Vorherige Impfungen: -

VAERS 1433513

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TN
Alter: 81,0
Geschlecht: M
Eingang: 29.06.2021
Impfdatum: 12.02.2021
Beginn: 27.04.2021
Tage bis Beginn: 74,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

DOD 4/27/21 AT HOSPICE. SPOKE WITH PATIENT 4/13 AND REPORTS HOSPITALIZATION NOT DUE TO COVID

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: REFUSED BY PATIENT
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1433471

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WA
Alter: 83,0
Geschlecht: M
Eingang: 29.06.2021
Impfdatum: 04.02.2021
Beginn: 08.05.2021
Tage bis Beginn: 93,0
Dosis: 2
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Died of COVID-19 illness on 05/08/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: Positive COVID-19 PCR test on 04/30/2021
Aktuelle Erkrankungen: Chronic Lymphocetic Leukemia - had blood infusions last summer, last one was on July 7
Vorgeschichte: Chronic heart disease Chronic kidney disease High blood pressure quadruple heart bypass in 2004
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1433241

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 29.06.2021
Impfdatum: 10.03.2021
Beginn: 11.03.2021
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction

Symptomtext

NSTEMI (non-ST elevated myocardial infarction)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1433235

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 68,0
Geschlecht: M
Eingang: 29.06.2021
Impfdatum: 09.03.2021
Beginn: 20.05.2021
Tage bis Beginn: 72,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction

Symptomtext

I21.4 - NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1432917

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 73,0
Geschlecht: F
Eingang: 29.06.2021
Impfdatum: 12.03.2021
Beginn: 17.05.2021
Tage bis Beginn: 66,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction

Symptomtext

NSTEMI (non-ST elevated myocardial infarction)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1431227

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 68,0
Geschlecht: F
Eingang: 28.06.2021
Impfdatum: 08.03.2021
Beginn: 24.06.2021
Tage bis Beginn: 108,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Death Pneumonia

Symptomtext

Death N17.9 - Acute kidney injury (CMS/HCC) J18.9 - Bilateral pneumonia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1426471

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IN
Alter: 73,0
Geschlecht: M
Eingang: 25.06.2021
Impfdatum: 04.03.2021
Beginn: 28.04.2021
Tage bis Beginn: 55,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Death Nucleic acid test Polymerase chain reaction Small intestinal obstruction Small intestine carcinoma

Symptomtext

Death 5/2/2021 Causes of death listed on death certificate: 1) Small-bowel obstruction 2) Carcinoma of small-bowel

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: RT-PCR or other NAAT test
Aktuelle Erkrankungen: -
Vorgeschichte: Small-bowel obstruction Carcinoma of small-bowel
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1426143

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IN
Alter: 84,0
Geschlecht: M
Eingang: 25.06.2021
Impfdatum: 15.02.2021
Beginn: 18.04.2021
Tage bis Beginn: 62,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 pneumonia Condition aggravated Death Diabetes mellitus Emphysema Nucleic acid test Polymerase chain reaction Respiratory failure

Symptomtext

Death: 4/22/2021 Causes of death listed on death certificate: 1) Respiratory failure 2) Emphysema Other: Covid-19 pneumonia, diabetes

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: RT-PCR or other NAAT test
Aktuelle Erkrankungen: Covid-19 pneumonia
Vorgeschichte: Emphysema diabetes
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1426105

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IN
Alter: 82,0
Geschlecht: M
Eingang: 25.06.2021
Impfdatum: 03.03.2021
Beginn: 16.04.2021
Tage bis Beginn: 44,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 pneumonia Cardiac failure acute Cardiac failure congestive Death Nucleic acid test Polymerase chain reaction

Symptomtext

Death 4/21/2021 Causes of death listed on death certificate: 1) Acute respiratory failure (onset interval 1 week) 2) COVID Pneumonia (onset interval 1 week) Other: acute on chronic congestive heart failure

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: RT-PCR or other NAAT test
Aktuelle Erkrankungen: COVID Pneumonia (onset interval 1 week) acute on chronic congestive heart failure
Vorgeschichte: Acute respiratory failure (onset interval 1 week) Other: acute on chronic congestive heart failure
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1425844

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IN
Alter: 84,0
Geschlecht: M
Eingang: 25.06.2021
Impfdatum: 19.02.2021
Beginn: 13.04.2021
Tage bis Beginn: 53,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 pneumonia Death Nucleic acid test Respiratory failure SARS-CoV-2 test positive

Symptomtext

Death 4/21/2021 Causes of death listed on death certificate: 1) respiratory failure 2) covid 19 pneumonia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: RT-PCR or other NAAT test
Aktuelle Erkrankungen: covid 19 pneumonia
Vorgeschichte: respiratory failure
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1360758

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 72,0
Geschlecht: M
Eingang: 22.06.2021
Impfdatum: 11.02.2021
Beginn: 13.02.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Intensive care Pulmonary embolism SARS-CoV-2 test

Symptomtext

Pulmonary Embolism; This is a spontaneous report from a contactable consumer. A 72-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6201, Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 11Feb2021 12:00(Age at vaccination 72 years) as 2nd dose, single for covid-19 immunisation. Medical history included, psoriatic Arthritis, RA(Rheumatoid arthritis) .The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9262, Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 21Jan2021 02:00 as 1st dose, single for covid-19 immunisation. On 13Feb2021 12:00 the patient experienced pulmonary embolism leads to hospitalization, life threatening . The patient was hospitalized for pulmonary embolism for 2 days. The patient underwent lab tests and procedures which included sars-cov-2 test was negative on 13Feb2021. Patient received treatment of clot buster blood thinners. The outcome of event was recovering. Information on Lot/Batch number was available. Additional information has been requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: Test Date: 20210213; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Psoriatic arthritis; RA
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1410894

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MT
Alter: 75,0
Geschlecht: M
Eingang: 18.06.2021
Impfdatum: 18.02.2021
Beginn: 11.03.2021
Tage bis Beginn: 21,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient was hospitalized due to COVID-19 from May 19, 2021 to May 22, 2021. Patient was then placed on hospice on 6/5/2021 and expired on 6/7/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: Positive SARS-CoV-2 PCR test collected on 5/19/2021 and resulted out on 5/19/2021.
Aktuelle Erkrankungen: diffuse large B cell lymphoma, cardiovascular disease, diabetes mellitus type 2, hypertension.
Vorgeschichte: diffuse large B cell lymphoma, cardiovascular disease, diabetes mellitus type 2, hypertension.
Andere Medikamente: allopurinol 300 mg PO DAILY amoxicillin 500 mg PO 2 caps prior to dental appt then 2 caps BID the following day. ; apixaban (Eliquis) 5 mg PO BID aspirin 81 mg PO QHS cholecalciferol (vitamin D3) 2,000 units PO DAILY coenzyme Q10 30 mg PO
Allergien: streptomycin
Vorherige Impfungen: -

VAERS 1407099

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 72,0
Geschlecht: F
Eingang: 17.06.2021
Impfdatum: 18.02.2021
Beginn: 22.02.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Cerebrovascular accident Computerised tomogram head normal Hemiparesis Hypoaesthesia Magnetic resonance imaging head normal Muscular weakness

Symptomtext

4 days later patient developed left sided weakness, findings consistent with stroke.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 1,0
Labordaten: CT and MRI of head were negative for bleed or ischemia, but symptoms consistent with stroke due to left facial numbness and left leg weakness.
Aktuelle Erkrankungen: None
Vorgeschichte: History of stroke (hemorrhagic)
Andere Medikamente: Red yeast, Tylenol, gabapentin, arnica, estradiol
Allergien: Codeine, amoxicillin, bactrim
Vorherige Impfungen: -

VAERS 1398538

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: VA
Alter: 56,0
Geschlecht: F
Eingang: 15.06.2021
Impfdatum: 24.02.2021
Beginn: 22.05.2021
Tage bis Beginn: 87,0
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident SARS-CoV-2 test

Symptomtext

Stroke like symptoms 5 months after shot; This is a spontaneous report from a contactable nurse (consumer). A non-pregnant 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 24Feb2021 01:00 PM (at 56-year-old) (Lot Number: EN5318) at 2nd dose, single in arm right for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received via an unspecified route of administration on 27Jan2021 08:15 AM (at 56-year-old) (lot number: EN5318) at 1st dose, single in arm right for COVID-19 immunisation. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient wasn't diagnosed with COVID-19. The patient experienced stroke like symptoms 5 months after shot on 22May2021 08:00. The patient was hospitalized for stroke like symptoms 5 months after shot (cerebrovascular accident) for 3 days. Event resulted in emergency room/department or urgent care, and treatment was received. The patient underwent lab tests and procedures which included SARS-COV-2 test (Nasal Swab): negative on 22May2021. The outcome of the event was not resolved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: Test Date: 20210522; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1389554

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 89,0
Geschlecht: F
Eingang: 10.06.2021
Impfdatum: 02.02.2021
Beginn: 22.02.2021
Tage bis Beginn: 20,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Death Disturbance in attention Feeling abnormal Hypersomnia Hyporesponsive to stimuli

Symptomtext

Message received from the daughter of the patient, daughter states that the 3-4 days after the administration of the vaccine that she reported to feel unfocused and "out of it", falling asleep more, and was seen by physician who advised to keep an eye on her, then was later found slightly unresponsive, transported to hospital and found to be suffering from stroke. Patient later discharged from hospital to nursing home and stayed there until 3/28/2021, where she was later transferred to the care of the family and passed away on 4/6/2021. Daughter of patient

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Only information received was that patient had stroke.
Aktuelle Erkrankungen: None noted per daughter of patient, just usual issues with hypertension and diabetes
Vorgeschichte: Hypertension, Diabetes, Thyroid issues
Andere Medikamente: None noted per daughter of patient, daughter of patient
Allergien: None noted per daughter of patient, daughter of patient
Vorherige Impfungen: -

VAERS 1388002

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 77,0
Geschlecht: F
Eingang: 10.06.2021
Impfdatum: 08.03.2021
Beginn: 25.05.2021
Tage bis Beginn: 78,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebral haemorrhage

Symptomtext

Nontraumatic intracerebral hemorrhage, unspecified

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1377896

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IL
Alter: 69,0
Geschlecht: F
Eingang: 07.06.2021
Impfdatum: 27.03.2021
Beginn: 02.06.2021
Tage bis Beginn: 67,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Alanine aminotransferase increased Amylase Aspartate aminotransferase increased Blood albumin increased Blood alkaline phosphatase increased Blood calcium normal Blood chloride normal Blood creatinine normal Blood glucose normal Blood potassium normal Blood sodium normal Blood urea normal Blood urine absent Brain natriuretic peptide Carbon dioxide normal Cerebrovascular accident Chest X-ray normal Computerised tomogram head abnormal

Symptomtext

69 y.o. female that presented to my office with a 5 day history of weakness on her right side. In particular, she states her right arm, right face, and right torso was numb when she woke up on Saturday morning, May 29th. She initially thought she just had some radicular symptoms going down her right arm as she has had before. However, she does admit that the facial numbness did concern her. She had a headache that morning, but no headache after that. She states that some of the sensation has come back a little bit in the right arm and hand. However, she still can not hold anything without up falling out of her hand because she can not feel it. She denies any weakness in the right side of her body. She denies any facial droop. She does think her vision may have gotten a little bit worse, but this is difficult to tell because she does usually have poor vision. Because of her symptoms in the office, I thought it was best that I admit her for observation in order to rule out acute stroke. I sent her for a stat head CT which did come back showing a subacute left-sided CVA. Further workup is underway. Active Hospital Problems Diagnosis Date Noted ? Right sided numbness 06/02/2021 ? Acute cerebrovascular accident (CVA) (HCC) 06/02/2021 ? Essential hypertension 01/27/2021 ? Dyslipidemia 05/22/2017

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: CBC Recent Labs Lab 06/02/21 1601 03/01/21 0800 WBC 10.3 4.7 HGB 16.4* 15.3* HCT 49.2* 45.3* PLT 222 193 MCV 93.5 92.4 RBC 5.26* 4.90 CHEMISTRY Recent Labs Lab 06/02/21 1601 04/26/21 0917 03/01/21 0800 03/01/21 0800 GLU 165* -- -- 113* BUN 16 -- -- 14 CREATININE 0.6 -- -- 0.7 NA 141 -- -- 138 K 4.2 -- -- 3.6 CL 105 -- -- 103 CO2 25 -- -- 30 CALCIUM 9.8 -- -- 9.1 LABALBU 4.4 -- -- 3.6 ALT 33 31 < > 27 AST 17 17 < > 15 ALKPHOS 121* -- -- 113 LABBILI 0.3 -- -- 0.4 < > = values in this interval not displayed. GI No results for input(s): AMYLASE, LIPASE in the last 70080 hours. COAGS Recent Labs Lab 06/02/21 1601 10/21/19 0914 PROTIME 11.5 12.6 INR 0.9 1.0 CARDIAC No results for input(s): TROPONINI, TROPONIN2, TROPONIN3, TROPONIN4, BNP in the last 70080 hours. URINE Recent Labs Lab 06/02/21 1601 LEUKOCYTESUR NEGATIVE NITRITE NEGATIVE BLOODU NEGATIVE WBCU 0 to 5 SPECGRAV 1.015 KETONESU NEGATIVE PROTEINUA NEGATIVE PHUR 5.5 Imaging Review EKG Result Date: 6/2/2021 EKG Report Date: 6/2/2021 Time: 15:00:05 Previous EKG available for comparison: No The EKG showed a normal sinus rhythm with a ventricular rate of 84 bpm. PR interval normal at 140 ms. QRS duration normal at 94 ms. QT and QTC intervals are within normal range. R axis is normal at 77 degrees. There is no evidence of acute ST or T-wave changes. There is no voltage criteria for left ventricular hypertrophy. MD 6/2/2021 5:22 PM XR CHEST PA AND LATERAL 2 VIEW Result Date: 6/2/2021 EXAM DESCRIPTION: XR CHEST PA AND LATERAL 2 VIEW CLINICAL HISTORY: 69 years Female, right sided numbness COMPARISON: 10/22/2018 TECHNIQUE: PA and lateral views FINDINGS: There is no focal consolidation, pleural effusion or pneumothorax. The cardiac silhouette and pulmonary vascularity are within normal limits. Degenerative changes are seen in the thoracic spine. IMPRESSION: No acute cardiopulmonary pathology. Electronically signed by: MD 6/2/2021 4:09 PM. US CAROTID DUPLEX DOPPLER Result Date: 6/2/2021 EXAM DESCRIPTION: US CAROTID DUPLEX DOPPLER CLINICAL HISTORY: 69 years Female, right sided numbness COMPARISON: 2/1/2021 TECHNIQUE: Carotid duplex scan was performed using gray scale imaging and Doppler interrogation.NASCET criteria was utilized. FINDINGS: The peak systolic velocities in bilateral common carotid, internal and external carotid arteries are within normal limits. Peak systolic velocity for the ICA is 99.3cm/s on the right and 83.5cm/s on the left. Mild arthrosclerotic plaques are seen at the carotid bifurcations bilaterally. The vertebral arteries are patent with antegrade flow bilaterally. There has not been significant interval change. IMPRESSION: No hemodynamically significant stenosis. Electronically signed by: MD 6/2/2021 4:15 PM CT HEAD WO CONTRAST Addendum Date: 6/2/2021 ADDENDUM #1 Findings were discussed with Dr. (Name) on 6/2/2021 3:50 PM Electronically signed by: MD 6/2/2021 3:54 PM Result Date: 6/2/2021 EXAMINATION: UNENHANCED CT OF THE HEAD CLINICAL HISTORY: 69 years Female,stroke like symptoms, right sided numbness COMPARISON: There is no prior similar study available for correlation. TECHNIQUE: Axial imaging and 2-D reformatting performed without IV contrast. This exam was performed according to our departmental dose-optimization program, which includes automated exposure control, adjustment of the mA and/or kV according to patient size and/or use of iterative reconstruction technique. TOTAL DLP: 1150.84 mGy-cm FINDINGS: The mastoid air cells, middle ears and paranasal sinuses are clear. There is a 2 cm focal area of low-attenuation in the left centrum semiovale secondary to subacute infarct, mass. There is no acute hemorrhage, ventriculomegaly, midline shift. There is no tonsillar ectopia. IMPRESSION: 2 cm focal area of low-attenuation in the left centrum semiovale secondary to subacute infarct or mass. Correlate with clinical findings. MRI recommended for further evaluation. Electronically signed by: MD 6/2/2021 3:24 PM
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: nka
Vorherige Impfungen: -

VAERS 1355806

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: FL
Alter: 73,0
Geschlecht: M
Eingang: 04.06.2021
Impfdatum: 13.02.2021
Beginn: 17.04.2021
Tage bis Beginn: 63,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood culture Blood lactate dehydrogenase Blood lactic acid Blood magnesium Blood phosphorus C-reactive protein COVID-19 pneumonia Cough Culture urine Death SARS-CoV-2 test Vaccination failure Diarrhoea Differential white blood cell count Dyspnoea Endotracheal intubation Fibrin D dimer Full blood count

Symptomtext

COVID PNA/COVID 19 PNA/Covid test result=Positive; COVID PNA/COVID 19 PNA/Covid test result=Positive; This is a spontaneous report from a contactable consumer ((patient Daughter). A 73-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on 13Feb2021 (Batch/Lot Number: EN6201) as single dose, and dose 1 via an unspecified route of administration on 23Jan2021 (Batch/Lot Number: E18982) as single dose for covid-19 immunisation. Medical history included hypertension, hyperlipidaemia , type 2 diabetes mellitus , coronary artery disease , coronary artery bypass, chronic kidney disease, post-traumatic stress disorder, depression. Concomitant medications included amlodipine (AMLODIPINE) taken for an unspecified indication, start and stop date were not reported; hydralazine hydrochloride (APRESOLINE) taken for an unspecified indication, start and stop date were not reported; acetylsalicylic acid (ASPRIN) taken for an unspecified indication, start and stop date were not reported; atorvastatin (ATORVASTATIN) taken for an unspecified indication, start and stop date were not reported; clopidogrel (CLOPIDOGREL) taken for an unspecified indication, start and stop date were not reported; furosemide (FUROSEMIDE) taken for an unspecified indication, start and stop date were not reported; gabapentin (GABAPENTIN) taken for an unspecified indication, start and stop date were not reported; gramicidin, neomycin sulfate, nystatin, triamcinolone acetonide (KENALOG COMP. MED MYCOSTATIN) taken for an unspecified indication, start and stop date were not reported; ketoconazole (KETOCONAZOLE) taken for an unspecified indication, start and stop date were not reported; lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported; melatonin (MELATONIN) taken for an unspecified indication, start and stop date were not reported; metoprolol tartrate (METOPROLOL TARTRAS) taken for an unspecified indication, start and stop date were not reported; pantoprazole (PANTOPRAZOLE) taken for an unspecified indication, start and stop date were not reported; insulin human, insulin human injection, isophane (NOVOLIN 70/30) taken for an unspecified indication, start and stop date were not reported; sertraline (SERTRALINE) taken for an unspecified indication, start and stop date were not reported; vitamin C (ASCORBIC ACID) taken for an unspecified indication, start and stop date were not reported; vitamin E nos (VITAMIN E) taken for an unspecified indication, start and stop date were not reported. The patient previously took morphine and experienced drug hypersensitivity, doxycycline and experienced drug hypersensitivity. The patient experienced covid pna//covid test result=positive on 17Apr2021 , causing patient's death on 07May2021. The patient was hospitalized for covid 19 pna/covid test result=positive for 20 days. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 17Apr2021 , sars-cov-2 test: positive on 04May2021. The patient died on 07May2021. An autopsy was not performed. Course of the event. The week prior to 17Apr2021 the patient started with diarrhea and cough. During the week it progressed to Vomiting, diarrhea and cough. He was unable to hold down any food or fluids. His diarrhea was uncontrollable with many accidents. On 17Apr21 he became SOB, cough, weak. He was taken to hospital ER where he was diagnosed with COVID PNA. He was admitted into the hospital for 20 days and passed away 07May2021 from COVID 19 PNA, acute hypoxc respiratory failure, SARS. The patient was treated with the following drugs: remdesivir, decadron, zithromax, cefepime, rocephin, BIPAP, intubation, dexamethasone, insulin, vanc. Follow up information has been requested. Lot numbers already provided.; Reported Cause(s) of Death: SARS; COVID-19 pneumonia; Hypoxia; Acute respiratory failure

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Date: 20210417; Test Name: Nasal Swab; Test Result: Positive ; Test Date: 20210504; Test Name: Nasal Swab; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: CABG; Chronic kidney disease; Coronary artery disease; Depression; Hyperlipidemia; Hypertension; Post-traumatic stress disorder; Stent placement; Type 2 diabetes mellitus
Andere Medikamente: AMLODIPINE; APRESOLINE; ASPRIN; ATORVASTATIN; CLOPIDOGREL; FUROSEMIDE; GABAPENTIN; KENALOG COMP. MED MYCOSTATIN; KETOCONAZOLE; LISINOPRIL; MELATONIN; METOPROLOL TARTRAS; PANTOPRAZOLE; NOVOLIN 70/30; SERTRALINE; VITAMIN C [ASCORBIC ACID]; VI
Allergien: -
Vorherige Impfungen: -

VAERS 1355806

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: FL
Alter: 73,0
Geschlecht: M
Eingang: 04.06.2021
Impfdatum: 13.02.2021
Beginn: 17.04.2021
Tage bis Beginn: 63,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood culture Blood lactate dehydrogenase Blood lactic acid Blood magnesium Blood phosphorus C-reactive protein COVID-19 pneumonia Cough Culture urine Death SARS-CoV-2 test Vaccination failure Diarrhoea Differential white blood cell count Dyspnoea Endotracheal intubation Fibrin D dimer Full blood count

Symptomtext

COVID PNA/COVID 19 PNA/Covid test result=Positive; COVID PNA/COVID 19 PNA/Covid test result=Positive; This is a spontaneous report from a contactable consumer ((patient Daughter). A 73-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on 13Feb2021 (Batch/Lot Number: EN6201) as single dose, and dose 1 via an unspecified route of administration on 23Jan2021 (Batch/Lot Number: E18982) as single dose for covid-19 immunisation. Medical history included hypertension, hyperlipidaemia , type 2 diabetes mellitus , coronary artery disease , coronary artery bypass, chronic kidney disease, post-traumatic stress disorder, depression. Concomitant medications included amlodipine (AMLODIPINE) taken for an unspecified indication, start and stop date were not reported; hydralazine hydrochloride (APRESOLINE) taken for an unspecified indication, start and stop date were not reported; acetylsalicylic acid (ASPRIN) taken for an unspecified indication, start and stop date were not reported; atorvastatin (ATORVASTATIN) taken for an unspecified indication, start and stop date were not reported; clopidogrel (CLOPIDOGREL) taken for an unspecified indication, start and stop date were not reported; furosemide (FUROSEMIDE) taken for an unspecified indication, start and stop date were not reported; gabapentin (GABAPENTIN) taken for an unspecified indication, start and stop date were not reported; gramicidin, neomycin sulfate, nystatin, triamcinolone acetonide (KENALOG COMP. MED MYCOSTATIN) taken for an unspecified indication, start and stop date were not reported; ketoconazole (KETOCONAZOLE) taken for an unspecified indication, start and stop date were not reported; lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported; melatonin (MELATONIN) taken for an unspecified indication, start and stop date were not reported; metoprolol tartrate (METOPROLOL TARTRAS) taken for an unspecified indication, start and stop date were not reported; pantoprazole (PANTOPRAZOLE) taken for an unspecified indication, start and stop date were not reported; insulin human, insulin human injection, isophane (NOVOLIN 70/30) taken for an unspecified indication, start and stop date were not reported; sertraline (SERTRALINE) taken for an unspecified indication, start and stop date were not reported; vitamin C (ASCORBIC ACID) taken for an unspecified indication, start and stop date were not reported; vitamin E nos (VITAMIN E) taken for an unspecified indication, start and stop date were not reported. The patient previously took morphine and experienced drug hypersensitivity, doxycycline and experienced drug hypersensitivity. The patient experienced covid pna//covid test result=positive on 17Apr2021 , causing patient's death on 07May2021. The patient was hospitalized for covid 19 pna/covid test result=positive for 20 days. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 17Apr2021 , sars-cov-2 test: positive on 04May2021. The patient died on 07May2021. An autopsy was not performed. Course of the event. The week prior to 17Apr2021 the patient started with diarrhea and cough. During the week it progressed to Vomiting, diarrhea and cough. He was unable to hold down any food or fluids. His diarrhea was uncontrollable with many accidents. On 17Apr21 he became SOB, cough, weak. He was taken to hospital ER where he was diagnosed with COVID PNA. He was admitted into the hospital for 20 days and passed away 07May2021 from COVID 19 PNA, acute hypoxc respiratory failure, SARS. The patient was treated with the following drugs: remdesivir, decadron, zithromax, cefepime, rocephin, BIPAP, intubation, dexamethasone, insulin, vanc. Follow up information has been requested. Lot numbers already provided.; Reported Cause(s) of Death: SARS; COVID-19 pneumonia; Hypoxia; Acute respiratory failure

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Date: 20210417; Test Name: Nasal Swab; Test Result: Positive ; Test Date: 20210504; Test Name: Nasal Swab; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: CABG; Chronic kidney disease; Coronary artery disease; Depression; Hyperlipidemia; Hypertension; Post-traumatic stress disorder; Stent placement; Type 2 diabetes mellitus
Andere Medikamente: AMLODIPINE; APRESOLINE; ASPRIN; ATORVASTATIN; CLOPIDOGREL; FUROSEMIDE; GABAPENTIN; KENALOG COMP. MED MYCOSTATIN; KETOCONAZOLE; LISINOPRIL; MELATONIN; METOPROLOL TARTRAS; PANTOPRAZOLE; NOVOLIN 70/30; SERTRALINE; VITAMIN C [ASCORBIC ACID]; VI
Allergien: -
Vorherige Impfungen: -

VAERS 1367900

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 02.06.2021
Impfdatum: 16.02.2021
Beginn: 18.05.2021
Tage bis Beginn: 91,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebral infarction Cerebrovascular accident

Symptomtext

I63.9 - Stroke (cerebrum) I63.9 - Cerebral infarction, unspecified

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1320378

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: FL
Alter: 78,0
Geschlecht: M
Eingang: 26.05.2021
Impfdatum: 27.02.2021
Beginn: 12.03.2021
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Death Deep vein thrombosis Laboratory test Pulmonary embolism

Symptomtext

Pulmonary embolism; DVT; This is a spontaneous report from a contactable nurse (patient's wife). A 78-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201; Expiration Date: 30Jun2021), via an unspecified route of administration on 27Feb2021 (at the age of 78-year-old) as single dose for COVID-19 immunization. Medical history included diabetes mellitus, Liver cirrhosis, thrombocytopenia, kidney stone, sarcoidosis, blood pressure (unspecified condition) and high cholesterol and a pacemaker (cardiac pacemaker insertion). Concomitant medications included insulin (manufacturer unknown), simvastatin (manufacturer unknown), hydrochlorothiazide (manufacturer unknown), carvedilol (COREG) taken for blood pressure, and omeprazole (PROTONIX). On 12Mar2021, the patient developed pulmonary embolism and DVT (deep vein thrombosis) that requiring a hospitalization on 12Mar2021. The nurse reported, "He went into the hospital 12Mar2021 that's when they find out he had pulmonary embolism and DVT. They putted the IVC filter for blood clot." On 12Mar2021, the patient was hospitalized for pulmonary embolism and DVT. Therapeutic measures were taken as a result of pulmonary embolism and DVT. The clinical outcome of the events pulmonary embolism and DVT was unknown. Additional information has been requested and will be provided as it becomes available.; Sender's Comments: Based on available information and known drug profile it is unlikely that the reported pulmonary embolism and DVT (deep vein thrombosis) were causally related to BNT162b2 . These are intercurrent medical conditions. Case will be reassessed if additional information is received. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021528357 same patient/reporter, different vaccine dose with different events separated by time gap.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood pressure; Cardiac pacemaker insertion; Diabetes; High cholesterol; Kidney stone; Liver cirrhosis; Sarcoidosis; Thrombocytopenia
Andere Medikamente: INSULIN; SIMVASTATIN; HYDROCHLOROTHIAZIDE; COREG; PROTONIX [OMEPRAZOLE]
Allergien: -
Vorherige Impfungen: -

VAERS 1320378

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: FL
Alter: 78,0
Geschlecht: M
Eingang: 26.05.2021
Impfdatum: 27.02.2021
Beginn: 12.03.2021
Tage bis Beginn: 13,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Death Deep vein thrombosis Laboratory test Pulmonary embolism

Symptomtext

Pulmonary embolism; DVT; This is a spontaneous report from a contactable nurse (patient's wife). A 78-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201; Expiration Date: 30Jun2021), via an unspecified route of administration on 27Feb2021 (at the age of 78-year-old) as single dose for COVID-19 immunization. Medical history included diabetes mellitus, Liver cirrhosis, thrombocytopenia, kidney stone, sarcoidosis, blood pressure (unspecified condition) and high cholesterol and a pacemaker (cardiac pacemaker insertion). Concomitant medications included insulin (manufacturer unknown), simvastatin (manufacturer unknown), hydrochlorothiazide (manufacturer unknown), carvedilol (COREG) taken for blood pressure, and omeprazole (PROTONIX). On 12Mar2021, the patient developed pulmonary embolism and DVT (deep vein thrombosis) that requiring a hospitalization on 12Mar2021. The nurse reported, "He went into the hospital 12Mar2021 that's when they find out he had pulmonary embolism and DVT. They putted the IVC filter for blood clot." On 12Mar2021, the patient was hospitalized for pulmonary embolism and DVT. Therapeutic measures were taken as a result of pulmonary embolism and DVT. The clinical outcome of the events pulmonary embolism and DVT was unknown. Additional information has been requested and will be provided as it becomes available.; Sender's Comments: Based on available information and known drug profile it is unlikely that the reported pulmonary embolism and DVT (deep vein thrombosis) were causally related to BNT162b2 . These are intercurrent medical conditions. Case will be reassessed if additional information is received. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021528357 same patient/reporter, different vaccine dose with different events separated by time gap.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood pressure; Cardiac pacemaker insertion; Diabetes; High cholesterol; Kidney stone; Liver cirrhosis; Sarcoidosis; Thrombocytopenia
Andere Medikamente: INSULIN; SIMVASTATIN; HYDROCHLOROTHIAZIDE; COREG; PROTONIX [OMEPRAZOLE]
Allergien: -
Vorherige Impfungen: -

VAERS 1340939

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

kritisch

Staat: AZ
Alter: 91,0
Geschlecht: U
Eingang: 22.05.2021
Impfdatum: 21.01.2021
Beginn: 23.01.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: SYR / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Chills Death Dysstasia Fatigue Gait disturbance Visual impairment

Symptomtext

Approximately two days after first shot, he was unable to stand in the Am. He had to crawl to the bathroom. The following day he expressed vision problems. He also experienced fatigue. He was very active for his age, but his loss of energy kept him in his room most of the time (very unlike him.) After the second shot, he expressed chill in his body and stated he was unable to feel warm. The fatigue and chills continued. At approximately four weeks after the second shot, he felt it necessary to try to go outside and do some mild yardwork. His symptoms continued, so he returned to his room. On April the 3rd he passed away in the AM after I had a brief conversation with him on the phone.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: neuropathy/legs
Vorgeschichte: none
Andere Medikamente: Blood pressure, heart medication
Allergien: none
Vorherige Impfungen: -

VAERS 1337098

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CO
Alter: 69,0
Geschlecht: M
Eingang: 21.05.2021
Impfdatum: 06.03.2021
Beginn: 27.04.2021
Tage bis Beginn: 52,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Activated partial thromboplastin time shortened Anti-thrombin antibody Antiphospholipid antibodies negative Blood homocysteine normal Brain natriuretic peptide increased Cardiolipin antibody Chest X-ray normal Computerised tomogram thorax abnormal Dyspnoea Fibrin D dimer Full blood count normal Parietal cell antibody normal Protein C Protein S Pulmonary embolism SARS-CoV-2 test negative Ultrasound scan abnormal

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine : Pfizer-BioNTech COVID-19 Vaccine : patient presented to clinic with shortness of breath on exertion for one week. Obtained labs and imaging: found to have bilateral pulmonary embolism and left lower extremity DVT and sent immediately to emergency department where vitals were within normal ranges and the patient was not in respiratory distress. Long car ride 26 days prior to arrival. Patient received heparin, admitted to the hospital, transitioned to a direct-acting oral anticoagulant, and discharged to home medically stable. On follow-up after discharge patient is doing well and compliant with anticoagulation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: CBC: within normal ranges Electrolytes: within normal ranges except sodium 130 mmol/L and chloride 96 mmol/L D-dimer 3580 FEU BNP 254 pg/mL Baseline PTT 29.3 seconds SARS-CoV-2 RNA negative Cardiolipin, APC, protein C and S, lupus anticoagulant, homocysteine, antithrombin activity: all normal Chest x-ray: no findings of acute cardiopulmonary process CTA chest: Large burden of pulmonary embolism, involving both right and left main pulmonary arteries and extending into all five lobes. Lower extremity ultrasound: Acute DVT of the left proximal femoral vein through the calf veins. No DVT of the right lower extremity.
Aktuelle Erkrankungen: none reported
Vorgeschichte: BPH, basal cell carcinoma, GERD, glaucoma, hyperlipidemia, orthostatic syncope, umbilical hernia
Andere Medikamente: vitamin C, calcium carbonate, vitamin D3, coenzyme Q-10, vitamin B12, COSOPT ophthalmic, latanoprost, naproxen, omega-3 fatty acids, rosuvastatin
Allergien: None reported
Vorherige Impfungen: -

VAERS 1330767

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TN
Alter: 78,0
Geschlecht: M
Eingang: 19.05.2021
Impfdatum: 28.01.2021
Beginn: 27.03.2021
Tage bis Beginn: 58,0
Dosis: 2
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute left ventricular failure Back pain Chronic kidney disease Chronic left ventricular failure Condition aggravated Cough Death Dyspnoea Oedema peripheral Pyrexia Renal impairment

Symptomtext

Patient presented to the ER on 3/28/2021 with shortness of breath and lower extremity edema and complaining of lower back pain. O2 sat high 80s on room air. Worsening renal failure since last discharge from hospital on 3/23/2021. Patient was readmitted to hospital from skilled care facility after being discharged 5 days prior with acute on chronic stage IV kidney disease as well as acute on chronic diastolic heart failure and had slowly worsening with renal dysfunction and growing concern for dialysis. Patient had developed a cough, a fever up to 101, and 1 questionable sewed of either hemoptysis or hematemesis since being discharged to skilled nursing facility on 3/23/2021. Patient was transitioned to the hospice team and expired on 4/2/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Chronic kidney disease stage IV, chronic Afib, and dementia
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1323117

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 72,0
Geschlecht: F
Eingang: 17.05.2021
Impfdatum: 09.03.2021
Beginn: 26.03.2021
Tage bis Beginn: 17,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Abdominal pain Back pain Death Hydronephrosis Hyponatraemia Metastatic neoplasm Nephrolithiasis Obstructive nephropathy Pleural effusion Pneumonia Ureterolithiasis

Symptomtext

Death ABDOMINAL PAIN BACK PAIN J18.9, J91.8 - Pleural effusion associated with pulmonary infection E87.1 - Hyponatremia N13.2 - Hydronephrosis with renal and ureteral calculous obstruction C79.9 - Metastatic disease (CMS/HCC)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1323109

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 69,0
Geschlecht: M
Eingang: 17.05.2021
Impfdatum: 15.02.2021
Beginn: 08.03.2021
Tage bis Beginn: 21,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Bacterial sepsis Cholecystitis acute Death Dehydration Device malfunction Hypercapnia Hypomagnesaemia Leukocytosis Respiratory acidosis Urinary tract infection

Symptomtext

Death A41.50 - Gram-negative sepsis, unspecified K81.0 - Acute cholecystitis E86.0 - Dehydration E83.42 - Hypomagnesemia N39.0 - Urinary tract infection E87.2 - Respiratory acidosis R06.89 - Hypercarbia T85.518A - Cholecystostomy tube dysfunction, initial encounter D72.829 - Leukocytosis, unspecified type

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1317736

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 69,0
Geschlecht: F
Eingang: 14.05.2021
Impfdatum: 12.03.2021
Beginn: 03.05.2021
Tage bis Beginn: 52,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction

Symptomtext

I21.4 - NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1317359

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 94,0
Geschlecht: M
Eingang: 14.05.2021
Impfdatum: 16.02.2021
Beginn: 12.05.2021
Tage bis Beginn: 85,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1312036

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 68,0
Geschlecht: M
Eingang: 12.05.2021
Impfdatum: 10.03.2021
Beginn: 08.05.2021
Tage bis Beginn: 59,0
Dosis: 1
Route/Site: SYR / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Afib
Vorgeschichte: -
Andere Medikamente: Tricor, xarelto, toprol
Allergien: -
Vorherige Impfungen: -

VAERS 1311404

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 71,0
Geschlecht: F
Eingang: 12.05.2021
Impfdatum: 17.02.2021
Beginn: 23.03.2021
Tage bis Beginn: 34,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Pulmonary embolism

Symptomtext

Other pulmonary embolism without acute cor pulmonale

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1310742

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 75,0
Geschlecht: F
Eingang: 12.05.2021
Impfdatum: 17.02.2021
Beginn: 04.05.2021
Tage bis Beginn: 76,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Asthma COVID-19 pneumonia Condition aggravated Cough Dyspnoea Pyrexia SARS-CoV-2 test positive

Symptomtext

past medical history significant for asthma, pulmonary sarcoidosis, hypertension presents to the hospital with fever, cough and worsening dyspnea. Patient had struggles with asthma exacerbation in February 2021 and since then has never felt back to her baseline in spite of 3 separate prednisone courses. Most recently she finished a prednisone course just prior to this hospitalization. It is unclear when her symptoms that are specific to COVID-19 started. Nonetheless she was tested negative for COVID-19 prior to most recent prednisone start but did test positive at this ER visit. Patient admitted for COVID-19 pneumonia associated with acute hypoxic respiratory failure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: None Known
Vorgeschichte: Asthma HTN
Andere Medikamente: Albuterol Singulair Estrace
Allergien: Codiene
Vorherige Impfungen: -

VAERS 1308208

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WA
Alter: 58,0
Geschlecht: M
Eingang: 11.05.2021
Impfdatum: 21.04.2021
Beginn: 05.05.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Overdose

Symptomtext

Patient died from methamphetamine/opiate overdose

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetic Neuropathy Diabetes Osteoarthritis of the knee ADHD Depression GERD Anemia Hyperlipidemia Hypertension
Andere Medikamente: Metformin 500mg 1 tab BIDPO Acetaminophen PRN Iron Tablets 1 tab POQD Protonix 40mg 1 tab POQD Cyclobenzaprine 5mg POTID Lisniporil 40mg 1 tab POQD
Allergien: Iodine Shellfish
Vorherige Impfungen: -

VAERS 1307713

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 11.05.2021
Impfdatum: 28.01.2021
Beginn: 15.02.2021
Tage bis Beginn: 18,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Pulmonary embolism

Symptomtext

Pulmonary embolism

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1307350

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: F
Eingang: 11.05.2021
Impfdatum: 16.02.2021
Beginn: 03.05.2021
Tage bis Beginn: 76,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction

Symptomtext

I21.4 - NSTEMI (non-ST elevated myocardial infarction)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1304105

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 75,0
Geschlecht: F
Eingang: 10.05.2021
Impfdatum: 10.03.2021
Beginn: 18.04.2021
Tage bis Beginn: 39,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cerebrovascular accident Facial paresis

Symptomtext

CEREBROVASCULAR ACCIDENT R29.810 - Facial weakness

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1303254

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 80,0
Geschlecht: F
Eingang: 10.05.2021
Impfdatum: 10.03.2021
Beginn: 15.03.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Pneumonia Pulmonary embolism

Symptomtext

This 80 year old white female received the Covid shot on 3/10/21 and went to the ED and was admitted on 3/15/21 with the following diagnoses listed below. Pneumonia Pulmonary embolism

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1303190

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 10.05.2021
Impfdatum: 12.03.2021
Beginn: 11.04.2021
Tage bis Beginn: 30,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Abdominal pain Death Vomiting

Symptomtext

This 74 year old female received the Covid shot on 3/12/21 and went to the ED on 4/11/21 with the diagnoses listed below and died on 5/3/21. ABDOMINAL PAIN VOMITING

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1302689

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 87,0
Geschlecht: M
Eingang: 10.05.2021
Impfdatum: 16.02.2021
Beginn: 04.05.2021
Tage bis Beginn: 77,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

This 87 year old male hospice received the Covid shot on 2/16/21 and died on 5/4/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1302224

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NY
Alter: 59,0
Geschlecht: F
Eingang: 10.05.2021
Impfdatum: 15.03.2021
Beginn: 26.03.2021
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Computerised tomogram thorax abnormal Condition aggravated Dyspnoea Fibrin D dimer increased Heart rate increased Oxygen saturation decreased Pain in extremity Pulmonary embolism SARS-CoV-2 test Scan with contrast abnormal Ultrasound Doppler normal

Symptomtext

I was hospitalized for bilateral pulmonary embolism 4/18/2021 at hospital. I think I had symptoms for over 3 weeks prior to hospitalization. I was rapid COVID tested on 3/26/2021 the nurse at CVS asked why my blood oxygen was low. I did not know but had me pant and move my fingers and it went up to 96. I also remember severe leg pain on a drive 3/25/21. I noticed shortness of breath 4/5/21 and fast pulse but didnot go to hospital until 4/18/21. I previously had a PE 7/2009 and also had it for ~2 weeks before going to hospital. I was not on blood thinner since 2015. The doctors at the hospital and primary care doctor did not seem to think the PE was vaccine related but they also do not believe I had symptoms for over 3 weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: blood test showed elevated dimer, CT scan with contrast showed bilateral pulmonary embolism, leg ultra sound scan did not show blood clots in legs.
Aktuelle Erkrankungen: none
Vorgeschichte: high blood pressure, obesity
Andere Medikamente: 25 mg Atenolo, 50 mg HCT, 300 mg Allopurinol, multi-vitamin, folgard equivalent
Allergien: none
Vorherige Impfungen: -

VAERS 1302209

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

kritisch

Staat: AR
Alter: 82,0
Geschlecht: M
Eingang: 10.05.2021
Impfdatum: 12.02.2021
Beginn: 01.05.2021
Tage bis Beginn: 78,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cardiac failure acute Condition aggravated Death Dyspnoea Endotracheal intubation Hypoxia Intensive care Intensive care unit acquired weakness Respiratory failure SARS-CoV-2 test positive

Symptomtext

death from covid 3 months after completing series

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 41,0
Labordaten: covid biofire pcr test
Aktuelle Erkrankungen: -
Vorgeschichte: pt is 82 yo wm with acute on chronic CHF, CAD, CKD, DM2, and AF. Presented to hospital with acute SOB/hypoxia. Was intubated and sent to another hospital and admitted to ICU. Gradually improved and was transferred to Rehab Hospital due to ICU myopathy. Acutely decompensated with respiratory failure on 5/1. transferred back to ICU in LR and tested positive for COVID via biofire pcr . of note his first pfizer dose was on 1/21 and the lot was EL3302. Patient died on 5/5/21
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1300454

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 65,0
Geschlecht: F
Eingang: 08.05.2021
Impfdatum: 10.03.2021
Beginn: 03.05.2021
Tage bis Beginn: 54,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cerebrovascular accident Facial paralysis

Symptomtext

This 65 year old female received the Pfizer Covid shot on 3/10/21 and went to the ED on 5/3/21 and was admitted on 5/3/21 with the following diagnoses listed below. I63.9 - Acute CVA (cerebrovascular accident) (CMS/HCC) FACIAL DROOP

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1300353

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: F
Eingang: 08.05.2021
Impfdatum: 26.01.2021
Beginn: 31.01.2021
Tage bis Beginn: 5,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cerebrovascular accident Facial paresis

Symptomtext

This 85 year old white female received the Pfizer Covid shot on 1/26 /21 and went to the ED on 1/31/21 and was admitted on 1/31/21 with the following diagnoses listed below. I63.9 - CVA (cerebral vascular accident) (CMS/HCC) I63.9 - Stroke determined by clinical assessment (CMS/HCC) R29.810 - Facial weakness

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1293523

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 79,0
Geschlecht: F
Eingang: 06.05.2021
Impfdatum: 18.02.2021
Beginn: 26.02.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Abdominal pain Acute kidney injury Chest pain Death Hyperkalaemia

Symptomtext

This 79 year old female received the Covid shot on 2/18 and went to the ED on 2/26 and was admitted on 2/26 with chest pain and abdominal pain and again to the ED on 3/14 and admitted on 3/14 with hyperkalemia, acute renal injury, chest pain and died on 05/04/21 . Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1289681

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 92,0
Geschlecht: M
Eingang: 05.05.2021
Impfdatum: 17.02.2021
Beginn: 03.05.2021
Tage bis Beginn: 75,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cerebrovascular accident Hemiparesis

Symptomtext

I63.9 - Stroke (CMS/HCC) R53.1 - Acute left-sided weakness

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1285763

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MO
Alter: 82,0
Geschlecht: M
Eingang: 04.05.2021
Impfdatum: 19.01.2021
Beginn: 09.02.2021
Tage bis Beginn: 21,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Balance disorder Cerebrovascular accident Computerised tomogram Facial paralysis Magnetic resonance imaging Malaise Memory impairment

Symptomtext

On April 24, patient started not feeling well while away from home in the early afternoon. Later noticed some balance issues and some memory problems. The next day, balance issues continued and had noticeable mouth drooping on left side first noticed by daughter who was visiting and son-in-law. Was taken to the hospital and diagnosed with a stroke.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: CT scan 4/25/2021, MRI 4/26/2021, 4/30/2021 and 5/3/2021
Aktuelle Erkrankungen: -
Vorgeschichte: CABG, DM II, hx of atrial fibrillation, last known episode greater than 10 years ago
Andere Medikamente: Glimeperide, Protonix (generic), Lipitor (generic), Amiodarone, Metformin, Coreg (generic), Plavix (generic), ASA, Vitamin D, super acidopholous.
Allergien: Versed Morphine
Vorherige Impfungen: -

VAERS 1027051

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 78,0
Geschlecht: F
Eingang: 03.05.2021
Impfdatum: 12.02.2021
Beginn: 12.02.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood glucose increased Dizziness Resuscitation Syncope Tryptase increased Cardio-respiratory arrest Cardioversion Death Eye movement disorder Presyncope Vaccination complication Intraosseous access placement Loss of consciousness Ventricular fibrillation

Symptomtext

Death of patient Cause of death :VasoVagl reaction to Covid Vaccination

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Diabetes, Heart condition, Cataracts
Vorgeschichte: Diabetes, Heart condition, high blood pressure, Breast cancer 2014
Andere Medikamente: Furosmide/20mg, Humulin 70/30 10ml, Womans one a day, Iron, B12, 81mg aspirin, Calcium 600mg, Hydralazine100mg,Plaviix/Cloppidogrel 75mg, IsosorbideMnER60mg, Metopolo25mg, Astrovastatin/80mg, Lisinopril/20mg
Allergien: High dose age morphine.
Vorherige Impfungen: -

VAERS 1027051

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 78,0
Geschlecht: F
Eingang: 03.05.2021
Impfdatum: 12.02.2021
Beginn: 12.02.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood glucose increased Dizziness Resuscitation Syncope Tryptase increased Cardio-respiratory arrest Cardioversion Death Eye movement disorder Presyncope Vaccination complication Intraosseous access placement Loss of consciousness Ventricular fibrillation

Symptomtext

Death of patient Cause of death :VasoVagl reaction to Covid Vaccination

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Diabetes, Heart condition, Cataracts
Vorgeschichte: Diabetes, Heart condition, high blood pressure, Breast cancer 2014
Andere Medikamente: Furosmide/20mg, Humulin 70/30 10ml, Womans one a day, Iron, B12, 81mg aspirin, Calcium 600mg, Hydralazine100mg,Plaviix/Cloppidogrel 75mg, IsosorbideMnER60mg, Metopolo25mg, Astrovastatin/80mg, Lisinopril/20mg
Allergien: High dose age morphine.
Vorherige Impfungen: -

VAERS 1255478

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 62,0
Geschlecht: F
Eingang: 01.05.2021
Impfdatum: 05.03.2021
Beginn: 05.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Chills Dehydration Dizziness Eating disorder Feeling of body temperature change Gingival bleeding Hyperhidrosis Nausea Near death experience Oral herpes Pain Retching Vomiting Weight Pain in extremity

Symptomtext

arm hurt after first dose; This is a spontaneous report from a contactable consumer (reporting for herself). A 62-years-old female patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 05Mar2021 (Batch/Lot Number: EN6201) as SINGLE DOSE, 2 via an unspecified route of administration in Arm Left on 07Apr2021 (Batch/Lot number: FR8737) as SINGLE DOSE for covid-19 immunisation (62-year age at Vaccination). The patient medical history was not reported. Concomitant medications included paracetamol (TYLENOL), Ondansetron hydrochloride (ZOFRAN [ONDANSETRON HYDROCHLORIDE]) for an unspecified indication. It was reported that patient received first dose of Pfizer covid vaccine on 05Mar2021 and experienced arm hurt after the first dose. Patient second dose was scheduled on 27Mar2021, but she did not get it till 07Apr2021. It was reported that on 08Apr2021, patient had such an awful reaction to the second dose of the vaccine. She started to get dizzy and weak, chills, everything was a blur, sweating, could not drink threw up if she tried dry heave went back to sleep and slept for 48 hours had just chills the whole time. She was in bed sleeping trying to drink, getting up to go to the bathroom and feeling like she was going to die for the next three days. She was nauseated and is still nauseated and could not drive. She took Tylenol an antiemetic at urgent care that stopped. She took Zofran with the saline solution infusion and she went home and slept. She was dehydrated and had soreness all over. On 09Apr2021, she could not roll over and had a sore on her left butt cheek that was still there cold sores on lips. She thought the sore on her left butt cheek came from laying in bed so much, and it was not in any other space but that one spot almost like she would have gotten the shot there, but she didn't. On 10Apr2021, patient felt like she was going to die and went to urgent care and asked if they could give her fluids. They gave her fluids and Zofran and that helped a lot. This one shocked the hell out her, she thinks it was her gums that started to bleed on 11Apr2021. She had the best oral hygiene and went to the dentist all the time. She was flosses like crazy. She started to drink a ton of water and has not seen it since. She cannot guess what the reason was. On 11Apr2021, she could function a little and had chills again last night and sweating. She did not have a fever. She started to feel better, but not 100% better not even 90%, not even 80%, but was heading towards the right direction. Patient also hasn't eaten for 5 days after second dose. She experienced cold and hot. She was not complaining at all and she has been sick for days and cannot eat and will throw up but will gain it right back. The dizziness and weakness were subsided. She feels like she is getting beat up but is recovering. Patient thought that vaccine pulled out with a syringe and that's the problem everyone gets the same dose. Patient's weight was 136 or 138 lbs. Outcome of the event was recovered on 09Mar2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Near death experience
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: TYLENOL; ZOFRAN [ONDANSETRON HYDROCHLORIDE]
Allergien: -
Vorherige Impfungen: -

VAERS 1270105

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 29.04.2021
Impfdatum: 17.02.2021
Beginn: 20.04.2021
Tage bis Beginn: 62,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Death Hypercalcaemia Laboratory test abnormal Mental status changes

Symptomtext

This 86 year old male received the Covid shot on 2/17/21 and went to the ED on 4/20 with abnormal lab of hypercalcemia and again on 4/25 with altered mental status and was admitted on 4/25 and died on 4/25/21. Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1269851

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 90,0
Geschlecht: M
Eingang: 29.04.2021
Impfdatum: 16.02.2021
Beginn: 16.04.2021
Tage bis Beginn: 59,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Atrial fibrillation COVID-19 Cardiac failure Condition aggravated Death Hypotension SARS-CoV-2 test positive Tachycardia

Symptomtext

Death Narrative: Patient was previously tested COVID-19 positive on 3/2/2021, but did not have any other predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was admitted with afib with RVR on 2/17/21 and was having a HFrEF exacerbation. HR was controlled during admission and he was discharged on 2/19/21. Patient was hospitalized 4 more times over the next two months for cardiac symptoms with last hospitalization occurring 4/12/21 for hypotension/tachycardia and decompensated heart failure. Patient never recovered and transitioned to hospice before passing on 4/16/21. Patient had a PMH significant for afib s/p DCCV on eliquis, CKD, HFpEF on home O2 2L, PMR on prednisone, known R pleural effusion, Covid PNA in 11/2020 and chronic foley

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1203475

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 83,0
Geschlecht: F
Eingang: 23.04.2021
Impfdatum: 17.02.2021
Beginn: 25.03.2021
Tage bis Beginn: 36,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction Death

Symptomtext

Patient had ED visit / hospitalization within 6 weeks of receiving COVID vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1203475

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 83,0
Geschlecht: F
Eingang: 23.04.2021
Impfdatum: 17.02.2021
Beginn: 25.03.2021
Tage bis Beginn: 36,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction Death

Symptomtext

Patient had ED visit / hospitalization within 6 weeks of receiving COVID vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1245051

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MA
Alter: 62,0
Geschlecht: F
Eingang: 22.04.2021
Impfdatum: 22.02.2021
Beginn: 09.03.2021
Tage bis Beginn: 15,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Aphasia Blood test normal Cardiac monitoring normal Cerebrovascular accident Computerised tomogram normal Confusional state Dysarthria Headache Magnetic resonance imaging normal Memory impairment Muscular weakness SARS-CoV-2 test negative Transient ischaemic attack Ultrasound scan normal Urine analysis normal

Symptomtext

TIA - mini stroke/transient ischemic attack. Started with loss of ability to speak/understand, weakness of left arm and leg, headache, slurring of words - 3 days in Hospital - resulted in damage to memory, confusion, weakness in left arm+leg, severe headaches - ongoing, but slightly improved after 3 weeks. Also diagnosed with acute cerebrovascular accident.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: 3/9 - blood tests, MRI, CT, COVID, urine - normal 3/10 - MRI, blood (hypercoagulation panel), ultrasound - normal, hole in heart 3/12 - 1 month monitoring by wearable heart monitor - no abnormalities found 4/21 - MRI - findings not yet known
Aktuelle Erkrankungen: -
Vorgeschichte: Kidney Disease, immunocompromised
Andere Medikamente: DULCOLAX, vitamin D2, IRON, TOPAMAX, TOFRANIL, DESYREL, IMITREMINE, LEVOTHROID, CYTOMEL,
Allergien: Shellfish, nuts, celcept, advil, imiaun
Vorherige Impfungen: -

VAERS 1238268

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 91,0
Geschlecht: M
Eingang: 21.04.2021
Impfdatum: 19.02.2021
Beginn: 21.03.2021
Tage bis Beginn: 30,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

This 91 year old white male received the Covid shot on 2/19/21 and subsequently died on 3/21/21. Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation..

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1237923

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 21.04.2021
Impfdatum: 19.02.2021
Beginn: 05.04.2021
Tage bis Beginn: 45,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Asthenia Blood bilirubin increased Death Decreased appetite Haematuria Hyponatraemia Ketonuria Leukocytosis Pyrexia Renal failure Troponin increased

Symptomtext

This 85 year old white male received the vaccine on 2/19/21 and went to the ED on 4/05 and was admitted with generalized weakness, hyponatremia, fever and elevated bilirubin. On 04/16/21, he went to the ED and was admitted to the hospital on 4/17 with poor appetite and hospital admission dx of ketonuria, leukocytosis, renal insufficiency, elevated troponin, hematuria, generalized weakness and died on 4/19/2021. Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1237672

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CT
Alter: 84,0
Geschlecht: M
Eingang: 21.04.2021
Impfdatum: 10.02.2021
Beginn: 13.04.2021
Tage bis Beginn: 62,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute coronary syndrome Anticoagulant therapy Blood bicarbonate abnormal Blood creatinine abnormal Blood potassium abnormal Bradycardia COVID-19 Cardiac arrest Catheterisation cardiac abnormal Coronary artery disease Dyspnoea Electrocardiogram ST segment elevation Fibrin D dimer Hypoaesthesia Hypotension Hypoxia Intensive care Oxygen saturation decreased

Symptomtext

Presents with dyspnea for a few days. Pt was tested positive for COVID 19 one wk ago (outside health system). Pt also c/o L arm numbness. Pt denied f/c, CP, n/v/d, abd pain, HA, syncope. In ED, Pt was found to have hypoxic O2 sat at 89% and was put 2L NC. Pt got loading dose of ASA and dexamethasone (7 day course), completed 5 day course of remdesivir and received tocilizumab due to increased oxygen requirements. Pt also has mildly elevated troponin and cardiology was consulted in ED. St elevation noted 4/20 AM, heparin bolus given for acute coronary syndrome and ticagrelor LD. Left heart cath on 4/20/21 showed 3 vessel disease but due to difficulty revascularizing LAD in setting of worsening K+, Bicarb, S no further revasc attempts were made. Upon return to MICU, pt found to be hypotensive and bradycardic. PEA arrest. Family contacted during code and in agreement to transition to comfort measures.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: 4/13/2021 SARS CoV-2 (Covid19) RNA - Positive, d-dimer
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension, GERD, diffuse large b cell lymphoma (s/p chemo/radiation), COPD
Andere Medikamente: Symbicort, omeprazole
Allergien: NKA
Vorherige Impfungen: -

VAERS 1236114

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: GA
Alter: 67,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 20.02.2021
Beginn: 20.02.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic reaction Anaphylactic shock Blood thyroid stimulating hormone Chest X-ray Chest scan Differential white blood cell count Electrocardiogram Fibrin D dimer Full blood count Laboratory test Metabolic function test Red blood cell morphology SARS-CoV-2 test Troponin I Ultrasound Doppler

Symptomtext

Anaphylaxis or anaphylactic shock Treatment: Epinephrine, Benadryl and steroids

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic shock
Hospital-Tage: -
Labordaten: 2/20/21 lab tests: basic metabolic panel, CBC, Comprehensive metabolic panel, D-dimer, Red blood cell morphology, SARS-COV-2 Molecular assay, NAA/PCR, Thyroid-stimulating hormone, Troponin 1, White blood cell differential, Chest x-ray, CT Scan Thorax, EKG 12 or more leads w int & rpt, Ultrasound doppler study
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: B12, D3, Cod liver Oil
Allergien: Contrast Dye, penicillin, ampicillin
Vorherige Impfungen: -

VAERS 1236411

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 91,0
Geschlecht: M
Eingang: 20.04.2021
Impfdatum: 17.02.2021
Beginn: 25.02.2021
Tage bis Beginn: 8,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac arrest Death

Symptomtext

Death Narrative: Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 90 and suffered cardiac arrest at home on 2/25/21. Patient had afib w/ a pacemaker, cardiomyopathy, CKD4, and PVD.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1229733

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: AL
Alter: 68,0
Geschlecht: M
Eingang: 19.04.2021
Impfdatum: 09.03.2021
Beginn: 10.03.2021
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

PATIENT DIED THE DAY AFTER GETTING VACCINE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CORONARY ATHEREOSCLEROISIS, HYPERTENSION, HYPERLIPEDIMA
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1223834

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: OH
Alter: 62,0
Geschlecht: M
Eingang: 17.04.2021
Impfdatum: 13.03.2021
Beginn: 05.04.2021
Tage bis Beginn: 23,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident Facial paralysis Hypoaesthesia Loss of control of legs Mobility decreased

Symptomtext

Stroke symptoms (numbness on left hand, then developed into loss of control of left hand and left leg, and also drooping of left side of face) showed up about three weeks after 1st dose of Pfizer COVID19 vaccine, and stroke occurred on 04/12/21 which is two days after the 2nd dose of Pfizer COVID19 vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 8,0
Labordaten: Patient was admitted into emergency room on 04/12/21 and then ICU, and still in hospital as of now.
Aktuelle Erkrankungen: no
Vorgeschichte: high blood pressure
Andere Medikamente: medication for high blood pressure
Allergien: no
Vorherige Impfungen: -

VAERS 1220208

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MA
Alter: 48,0
Geschlecht: M
Eingang: 16.04.2021
Impfdatum: 11.02.2021
Beginn: 12.02.2021
Tage bis Beginn: 1,0
Dosis: N/A
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time Anticoagulant therapy Antiphospholipid antibodies negative Antithrombin III Blood cholesterol increased Blood immunoglobulin G normal Blood immunoglobulin M Blood magnesium normal Brain natriuretic peptide normal Cardiolipin antibody negative Chest X-ray abnormal Chest discomfort Computerised tomogram thorax abnormal Culture urine negative Differential white blood cell count normal Echocardiogram Electrocardiogram normal Factor V Leiden mutation

Symptomtext

The night after my first shot, I felt pressure on my lungs, It felt as if I had the onset of Pleurisy as I have had that issue in the past. I figure I would wait to get it treated as it is not always picked up in the x-ray in its infant stages (based on past experience). On March 2, the pain became unbearable and I went into a urgent care center to get an x-ray and something to help with my issue. The urgent care did not take my x-ray they immediately sent me to the hospital strongly intimating that the problem was probably more serious than I thought. I was in the emergency room, they ran tests and made me comfortable enough as they also gave me a ct-scan which is when they found the bi-lateral pulmonary embolisms. I have since gone to my primary care physician and he directed me to a hematologist/oncologist. The event was found to be unprovoked. I am on blood thinners for 6 months.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 1,0
Labordaten: Mar 24, 2021 SERUM PROTEIN EP CBC and differential Prothrombin gene mutation (G20210A) Protein S antigen, free Antithrombin III Lupus anticoagulant panel Anti-cardiolipin antibodies IMMUNOFIXATION WITH IGA IGG IGM Protein C antigen Protein C SPECIAL COAGULATION Mar 8, 2021 Lipid panel Hemoglobin A1c test Comprehensive metabolic panel CBC and differential Factor V leiden mutation PCR HIV-1/2 antigen/antibody Hepatitis C antibody, qualitative Direct LDL Mar 3, 2021 TRANSTHORACIC ECHO (TTE) COMPLETE TROPONIN I COMPREHENSIVE METABOLIC PANEL MAGNESIUM CBC WITH AUTO DIFFERENTIAL CBC W/AUTO DIFF Mar 2, 2021 TROPONIN I B-TYPE NATRIURETIC PEPTIDE Mar 2, 2021 URINE CULTURE URINALYSIS AUTO ONLY COVID-19 (EC DISCHARGE, INPATIENT, PREPROCEDURE) CT CHEST PULMONARY EMBOLISM W IV CONTRAST XR CHEST 1 VIEW PORTABLE EKG 12-Lead BASIC METABOLIC PANEL TROPONIN I D-DIMER,QUANTITATIVE CBC WITH AUTO DIFFERENTIAL CBC W/AUTO DIFF APTT PROTIME-INR I have high cholesterol, all other tests are negative.
Aktuelle Erkrankungen: No illnesses, Bulging disc in my neck
Vorgeschichte: Pleurisy - off and on for over 20 years Lower back pain ( bulging disc) Neck pain (bulging disc)
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1219386

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: PA
Alter: 76,0
Geschlecht: F
Eingang: 16.04.2021
Impfdatum: 17.02.2021
Beginn: 26.02.2021
Tage bis Beginn: 9,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Blood test abnormal Chest X-ray abnormal Computerised tomogram thorax abnormal Deep vein thrombosis Electrocardiogram Pulmonary embolism Ultrasound Doppler abnormal

Symptomtext

On 02/26/2021, 10 days after given the vaccine I was admitted to the hospital with a blood clot in my left leg and in both lungs. I was given Heparin, admitted, started on Xarelto, released on 02/28/2021. I will be on blood thinners for a at least 90 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: Blood test and CT scan confirmed the blood clots. I had an EKG, chest x-ray, continued blood work, ultra sound of legs and arms.
Aktuelle Erkrankungen: Reflux
Vorgeschichte: COPD
Andere Medikamente: Flovent, Carvedilol Levothyroxine, Vitamin D, Calcium, Travoprost ,
Allergien: None
Vorherige Impfungen: -

VAERS 1342730

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NH
Alter: 73,0
Geschlecht: F
Eingang: 15.04.2021
Impfdatum: 01.03.2021
Beginn: 25.03.2021
Tage bis Beginn: 24,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Computerised tomogram thorax abnormal Flank pain Pulmonary embolism Pyrexia Sleep disorder

Symptomtext

Found to have a Pulmonary Embolism woke up at night with R side Flank pain. went toER Fever of 100 The day before.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: CT
Aktuelle Erkrankungen: -
Vorgeschichte: HTN osteoporosis
Andere Medikamente: Lisinopril, Zoloft, mag oxide, glucosamine calcium/Vit D, Flonase
Allergien: NKA
Vorherige Impfungen: -

VAERS 1213302

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IL
Alter: 65,0
Geschlecht: M
Eingang: 15.04.2021
Impfdatum: 02.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Angiogram pulmonary abnormal Chest X-ray abnormal Death Decreased insulin requirement Dyspnoea Fall Hypoglycaemia Lung opacity Mobility decreased Neutropenia Pleural effusion Pneumonia Pulmonary mass Sepsis

Symptomtext

He received his first COVID19 shot (Pfizer) reportedly on 3/2/21, then began a new chemotherapy regimen on 3/10/21. On 3/18, he fell to the floor and could not get up. He was admitted to the hospital for sepsis, pneumonia, and chemotherapy-induced neutropenia, treated on IV antibiotics and discharged on PO antibiotics. His home insulin was also decreased but continued to have hypoglycemic to hyperglycemic events. Insulin was decreased in clinic afterward and was compliant on antibiotics. Returned to hospital again a few days later for sepsis and pneumonia/effusion. He later went to a nursing facility / on hospice. He ultimately required supplemental oxygen and breathing increasingly became labored. Patient ultimately died on 4/9/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: CXR 3/18: patchy airspace disease CXR 3/25: multifocal pneumonia CT angio of chest 3/29: multifocal pneumonia, pleural effusions, 3rd spacing CXR 4/3: diffuse bilateral lung opacities with disseminated nodular morphology, possible superimposed pneumonia
Aktuelle Erkrankungen: worsening hypoglycemic to hyperglycemic swings/events, bruising, insomnia
Vorgeschichte: type 2 diabetes on insulin, peripheral arterial disease, hyperparathyroidism, esophageal cancer, hx of pancreatic tumor, insomnia
Andere Medikamente: aspirin, carboplatin, gabapentin, ibuprofen, insulin glargine, insulin regular human, lidocaine-prilocaine cream, lorazepam, magnesium, paclitaxel, pancrelipase, simvastatin, trazodone
Allergien: no known drug allergies
Vorherige Impfungen: -

VAERS 1209081

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 14.04.2021
Impfdatum: 18.02.2021
Beginn: 27.02.2021
Tage bis Beginn: 9,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cardiac arrest Death Staphylococcal sepsis

Symptomtext

Cardiac Arrest Death Sepsis due to methicillin susceptible Staphylococcus aureus

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1112373

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 58,0
Geschlecht: F
Eingang: 14.04.2021
Impfdatum: 05.03.2021
Beginn: 09.03.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Antiphospholipid antibodies negative Antithrombin III Antithrombin III deficiency Blood immunoglobulin M Cardiolipin antibody Chest pain Computerised tomogram thorax abnormal Dyspnoea Dyspnoea exertional Palpitations Computerised tomogram thorax Pulmonary embolism Paroxysmal nocturnal haemoglobinuria Pleuritic pain Protein S normal Prothrombin index Prothrombin level normal

Symptomtext

shortness of breath, right sided pleuritic chest pain started 4 days after 2nd dose. Patient whom is a MD, initially thought asthma exacerbation possibly from the vaccine, took inhaler and steroids. Symptoms worsened and then diagnosed with bilateral pulmonary embolism (see below).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: 3/18/2021 presents to emergency department for pleuritic chest pain to the right side with radiation to right arm. Of note, she received her second dose of Pfizer COVID-19 vaccine on 3/5/2021. 4 days after that, she noted right-sided pleuritic chest pain and dyspnea. It improved with a course of steroids and bronchodilators. After stopping her steroids, the symptoms recurred. 3/18/2021 CTA chest at hospital: Bilateral segmental and subsegmental pulmonary emboli. No CT evidence of right heart strain or pulmonary infarct. She was started on Rivaroxaban (=Xarelto) and discharged home. Labs drawn on same day included laboratory hypercoagulable work-up. Antithrombin antigen mildly low 60% with normal Antithrombin III activity, protein C and protein S normal, factor V Leiden gene mutation negative, prothrombin gene mutation negative, MTHFR heterozygous for C677T with normal homocysteine, PNH 0.001%, PNH monocytes 0.009%, phospholipid antibody panel remarkable for cardiolipin IgM 21, phosphatidylserine IgM 46; dRVVT was prolonged but lupus anticoagulant was not detected. Psoriatic arthritis takes infliximab (=Remicade) and methotrexate PO weekly. Symptoms uncontrolled. She was taking Estrace for menopausal symptoms. She stopped this at timing of PE. Still with residual DOE with activity and trouble taking a deep inspiration. Palpitations with PVCs/bigeminy.
Aktuelle Erkrankungen: psoriatic arthritis
Vorgeschichte: psoriatic arthritis
Andere Medikamente: Estradiol, Remicade, methotrexate, gabapentin, pantoprazole, valacyclovir, symbicort
Allergien: none
Vorherige Impfungen: -

VAERS 1205959

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NY
Alter: 78,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Cardiac monitoring Cerebrovascular accident Computerised tomogram normal Dizziness Eating disorder Facial paralysis Gait disturbance Magnetic resonance imaging abnormal Speech disorder Ultrasound Doppler

Symptomtext

3/17: dizzyness attributed to hunger, ate, went to bed. 3/18: unsteadiness walking, difficulty eating and speaking. Did not call 911/alert family. 3/19: symptoms continued. Daughter observed symptoms, including facial droop, and transported to local hospital ED. 3/20: discharged without seeing neurologist. CT scan and other tests failed to show stroke. However, MRI not performed. 3/22: outpatient visit to neurologist who, based on symptoms, concluded stroke had occured on left side of brain due to COVID 19 vaccine. 3/24: MRI performed and shows stroke. 3/30: MD orders additional tests. 4/1: admitted to Rehab. Hospital for 9 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: MRI: basal ganglia ischemic stroke left side. Other tests normal: CT scan, heart monitor, ultrasounds neck and brain. Pre-existing carotid artery blockage on right side not a factor
Aktuelle Erkrankungen: none
Vorgeschichte: 50-70% blocked carotid artery right side, history of anemia and osteoporosis
Andere Medikamente: atorvastatin, 81 mg asprin, vitamins C, D, B12, Iron
Allergien: none
Vorherige Impfungen: -

VAERS 1205121

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NJ
Alter: 73,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 10.03.2021
Beginn: 10.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal discomfort Blood glucose increased Confusional state Disorientation Respiratory arrest

Symptomtext

twelve hours after getting the shot my wife woke up with an upset stomach; her blood sugar was also slightly elevated; within ~the next two hours she became disoriented and confused; I called 911 and within a couple of minutes of the first 911 call she stopped breathing and could not be revived.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Heart Disease and Diabetes
Andere Medikamente: atorvastatin 10 mg (lipitor) clopidogrel 75mg (plavix) ecotrin 81 mg esomeprazole 40mg nebivolol 5mg (bystolic) ranolazine 1000mg (ranexa) rivaroxaban 2.5mg (xarelto) scubitril-valsartan 24-26mg (entresto) Torsemide repatha sureclick 140mg
Allergien: sulfa drugs
Vorherige Impfungen: -

VAERS 1202561

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 18.02.2021
Beginn: 11.04.2021
Tage bis Beginn: 52,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Asthenia Cerebrovascular accident Clostridium difficile colitis Hemiparesis

Symptomtext

CVA with residual hemiparesis - C-Diff, diarrhea, weakness. AKI

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1201277

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 79,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 16.02.2021
Beginn: 12.04.2021
Tage bis Beginn: 55,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1200719

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NY
Alter: 86,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 21.02.2021
Beginn: 21.02.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Blood test Cerebrovascular accident Computerised tomogram Magnetic resonance imaging Muscular weakness Thrombosis

Symptomtext

She had a stroke caused by blood clot in brain. Suffered a second stroke 4 weeks later. Has weakness left leg. Is now in Rehab Center

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 4,0
Labordaten: MRI, Cat Scans 2/21/21 and blood tests
Aktuelle Erkrankungen: -
Vorgeschichte: Kidney disease, Multiple meyeloma, high blood pressure, high cholesterol
Andere Medikamente: Zoloft 50mg 2 x a day Nortripptyline 25 mg 2 x day Xanax .5 mg 2 x day Atorvastin 20 mg Amlodipine Besylae 5 mg Folic acid 1 mg Calcitriol .25mg Sodium Bicarb 10 mg 2 x day Pomalyst 4 mg 1 a day for 21 days 1 week off Dexamethasone 4 mg 5 t
Allergien: -
Vorherige Impfungen: -

VAERS 1185441

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 79,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 20.02.2021
Beginn: 05.03.2021
Tage bis Beginn: 13,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Dyspnoea Magnetic resonance imaging abnormal Pulmonary embolism Thrombosis

Symptomtext

13 days after receiving the second dose I was walking my trash can to the street and I could not breath very well. I went to the Urgent Care and was told I had blood clots in my lungs. I was hospitalized and given treatment for the blood clots.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 8,0
Labordaten: MRI- showed the blood clots
Aktuelle Erkrankungen: No
Vorgeschichte: High Blood Pressure, Diabetic
Andere Medikamente: esomeprazole
Allergien: Penicillin
Vorherige Impfungen: 1960's penicillin

VAERS 1177384

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 70,0
Geschlecht: F
Eingang: 07.04.2021
Impfdatum: 12.02.2021
Beginn: 12.02.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Breath sounds abnormal Cerebral haemorrhage Chills Death Facial paralysis Haemorrhagic stroke Headache Joint contracture Loss of consciousness Nausea Pain Pain in extremity Vomiting

Symptomtext

4:30pm slight nausea; arm pain; mild headache 5:00 pm headache more severe; up the back of head, described as unusual pain; thought a migraine was coming on. 5-7:00pm headache continues to worsen; chills; research on line side effects of Pfizer vaccine and they coincide with symptoms; 7:05 gets up to urinate (no assistance needed); screams out in pain 3 times while on toilet; starts to vomit; right side of face (eye and cheek and mouth droop like a stroke; left hand starts to curl. Loses consciousness immediately thereafter. 911 call; paramedics on the way; airway was swept and clear; gurgled breathing. Rushed to Hospital and assessed as having massive brain bleed. Pronounced dead at 10:22pm. Acute Hemorrhagic Stroke on Death Certificate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1171303

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IL
Alter: 72,0
Geschlecht: F
Eingang: 06.04.2021
Impfdatum: 07.03.2021
Beginn: 11.03.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Arthralgia Back pain Blood test abnormal Cerebrovascular accident Computerised tomogram head abnormal Echocardiogram abnormal Gait disturbance Magnetic resonance imaging head abnormal

Symptomtext

Severe pain started in my back and knee on 3/11/21 and I was unable to walk properly. On 3/30/21, I had a stroke. Treatment is ongoing. Outcome is TBD.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: CT Scan 3/30/21 MRI 3/30/21 Echo 3/30/21 Blood Work 3/30/21 All results indicated I had a stroke.
Aktuelle Erkrankungen: NONE
Vorgeschichte: HIGH CHOLESTEROL
Andere Medikamente: LEVOTHROXINE 88 MG PAROXATINE 20 MG AMEPREZOLE 40 MG CRANBERRY 500 MG PROBIOTICS VITAMIN C 500MG MULTI VITAMIN COQ10 100 MG CALCIUM MAGNESIUM ZINC TUMERIC PROVISTATIN 40 MG
Allergien: SULPHUR
Vorherige Impfungen: -

VAERS 1168794

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 68,0
Geschlecht: M
Eingang: 05.04.2021
Impfdatum: 03.02.2021
Beginn: 21.03.2021
Tage bis Beginn: 46,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Mental status changes

Symptomtext

Death Narrative: Death on 03/21/2021. 2nd dose administered 46 days before serious event. Patient had been admitted to the hospital for AMS of unknown etiology concerning for sepsis with multiple sources and was on comfort care measures only. There are no indications that death was related to the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1165965

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: OH
Alter: 81,0
Geschlecht: F
Eingang: 04.04.2021
Impfdatum: 24.02.2021
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

she was hospitalized due to a stroke; This is a spontaneous report from a contactable nurse (patient herself). An 81-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose 1 via an unspecified route of administration, administered in arm at age 81 years on 24Feb2021 (Batch/Lot Number: EN6201) as single dose for COVID-19 vaccination. Medical history was reported as none. Patient had not had any other recent vaccinations. The concomitant medication includes an unspecified medication since she started a new cancer drug that starts with a L.Registered nurse calling as patient says she was supposed to have her second Pfizer COVID-19 shot 17Mar2021, but she was in the hospital. She says she is trying to reschedule her second shot. She says the first dose was given at (Hospital Name), and it says BNOI on her vaccine card. Patient was admitted to the hospital this past Monday evening (15Mar2021) and it was (Hospital name). She says her admitting diagnosis was unknown. She says she was discharged from the hospital Thursday 18Mar2021. Hospitalization seriousness patient says it was not serious. Patient missed the 2nd dose (17Mar2021) because she was hospitalized due to a stroke on an unspecified date. The outcome of the event was unknown.; Sender's Comments: Based on the information provided by the reporter, it appears unlikely that subject vaccine contributed to the event of stroke. The reported event likely represent intercurrent medical condition in this elderly patient. There is limited information provided in this report. This case will be reassessed upon receipt of follow-up information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1160062

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 82,0
Geschlecht: F
Eingang: 02.04.2021
Impfdatum: 19.02.2021
Beginn: 16.03.2021
Tage bis Beginn: 25,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: ja

Cerebrovascular accident Computerised tomogram head Echocardiogram Lethargy Magnetic resonance imaging head

Symptomtext

lethargy post vaccinations 3 weeks (march 16) after 2nd vaccination admitted to hospital for stroke

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: ct scan brain (march 16) mri scan brain (march 17) echocardiogram (march 17)
Aktuelle Erkrankungen: Wegner's granulomatosis hypothyroid
Vorgeschichte: Wegner's granulomatosis hypotbyroid meinere's
Andere Medikamente: vitamin b complex multivitamin vitamin D2 calcium
Allergien: NA
Vorherige Impfungen: -

VAERS 1134454

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 69,0
Geschlecht: M
Eingang: 02.04.2021
Impfdatum: 15.02.2021
Beginn: 13.03.2021
Tage bis Beginn: 26,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death Unevaluable event

Symptomtext

Death within 60 days of vaccine, irrespective of reason.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1134454

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MN
Alter: 69,0
Geschlecht: M
Eingang: 02.04.2021
Impfdatum: 15.02.2021
Beginn: 13.03.2021
Tage bis Beginn: 26,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death Unevaluable event

Symptomtext

Death within 60 days of vaccine, irrespective of reason.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1154141

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 67,0
Geschlecht: M
Eingang: 31.03.2021
Impfdatum: 09.02.2021
Beginn: 02.03.2021
Tage bis Beginn: 21,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Acute kidney injury Asymptomatic bacteriuria Azotaemia Body temperature increased Change of bowel habit Computerised tomogram abdomen abnormal Computerised tomogram liver Computerised tomogram normal Computerised tomogram pancreas normal Death Decreased appetite Depressed level of consciousness Dyspnoea Endotracheal intubation Gastrointestinal carcinoma Hydronephrosis Hypotension

Symptomtext

loss of appetite, abdominal pain, weight loss, death Narrative: 02/12/21: GI VISIT-ASSESSMENT: 1-R/O Gastric or Cecal Cancer with Peritoneal Carcinomatosis is most the cause of his weight loss and early satiety. Liver and Pancreas on CT Scan unremarkable. 2- Weight loss and early satiety may be due to Gastric Mass with metastasis or Colon Mass. 02/17/21: ED VISIT AND ADMISSION w/ CC 4 weeks of poor appetite and 2 weeks of inability to hold down food and abdominal pain, decreased BM and decreased urination Assessment on admission: acute kidney insufficiency, Possible partial Gastric outlet obstruction 2/2 malignancy, GI malignancy with peritoneal carcinomatosis as per CT scan 2/11, asymptomatic bacteruria hyperkalemia and AKI during admission 02/21/21: pt signed out of hospital AMA due to 'personal problems' 02/22/21: pt returned to hospital for continuation of care and was readmitted with same c/o 02/24/21: pt tachycardic and hypotensive w/ altered mental status; rapid response team called, transferred to icu; impression: acute severe sepsis with uremia; during procedure to place nephrostomy tubes, pt goes into wide complex vtach then vfib and ACLS done w/ compressions, ROSC @ 2255 w/ BP 70-41, Norepi started; pt intubated 02/25/21: pt extubated 02/25/21@2106: pt with inferior lateral stemi 03/01/21: pt w/ sudden deterioration with decreased LOC and increased WOB., intubated, found to be profoundly hypoxemic, developed severe metabolic acidosis and hyperkalemia, severe refractory hypotension 03/02/21: pt unresponsive without pulse or respirations, NOK declined autopsy no prior covid infection noted, no immediate reaction after covid vaccine, pt was hospitalized leading up to death with unrelenting abdominal pain, AKI, metabolic abnormalities. It is unlikely that vaccine led to patient's death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: 02/17/2021 13:52 Temp F (C) 99.9 (37.7) " " Pulse 89 " " Respir 15 " " BP 138/84 " " Ht in (cm) 71 (180.34) " " Wt lbs (kg)[BMI] 142 (64.41)[20] " " Pain 8 " " POx (L/Min)(%) 99 US on 2/18/211 Impression: Persistent pelvocaliectasis; hydronephrosis can't be conclusively excluded. If clinical suspicion of hydronephrosis remains sufficiently high technetium 99 MAG3 renal scan with Lasix washout should be considered. New echogenic 7 mm mass in the left kidney; this does not correspond to a stone on the recent CT it might represent some hemorrhagic products.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1153547

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WA
Alter: 77,0
Geschlecht: M
Eingang: 31.03.2021
Impfdatum: 12.02.2021
Beginn: 18.02.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal discomfort Abdominal pain lower Abdominal tenderness Biopsy lymph gland abnormal Cough Computerised tomogram Infection Leukaemia Lymphoma SARS-CoV-2 test Death Diarrhoea Diffuse large B-cell lymphoma Faeces discoloured Fluorescent in situ hybridisation negative Immunohistochemistry Nausea Weight decreased

Symptomtext

Diffuse large B cell lymphoma. Died 03/25/2021. See item 11 for additional details. We became aware of the situation via a post on our social media page placed by the patient's daughter-in-law on or about 03/22/2021. I reached the patient's son on 03/25/2021, and then we pursued information from the hospital. The initial social media post suggested that the onset of cervical lymphadenopathy followed dose 1, but the hospitalist's history suggests it predated that ("8-10 weeks" prior to 03/18/2021 admission).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: See item 11. Cervical LN bx 03/22/2021: Diffuse large B-cell lymphoma, activated B-cell phenotype (Hans Classification). Positive for double expression (BCL-2 80-90%, c-MYC 50-60%) by immunohistochemistry. EBV-EBER is negative by in situ hybridization.
Aktuelle Erkrankungen: Upon admission to hospital on 03/18/2021, he reported, "...for the last month or so he has had 'really bad cough,' nausea and abdominal pain but no vomiting. Abdominal pain is in lower abdomen, pressure-like, non-radiating, hurts more when moves onto left side and better laying down and on right side. Has watery diarrhea, non-bloody, 'yellow water' having several episodes per day over this time as well. Has lost nearly 30 pounds with weight down to 260 from 288 pounds over this period of time. Has noticed lymph node swelling in neck 8 to 10 weeks ago, generally nonpainful unless lays on eat wrong way. Has been evaluated as an outpatient with reported multiple negative COVID-19 tests. Had recent labs with elevated WBC and liver function tests with CT neck,chest/abdomen/pelvis recently showing diffuse adenopathy concerning for lymphoma for which he underwentFNA the other day which was non-diagnostic. He was scheduled for lymph node biopsy today but when he woke up felt poorly and had wife call 911." Left cervical lymph node biopsy of 03/22/2021 revealed a diffuse large B-cell lymphoma, activated B-cell phenotype.
Vorgeschichte: Aortic regurgitation, diabetes mellitus type 2, hypertension, hyperlipidemia, obesity
Andere Medikamente: Pfizer dose 1: 02/12/2021 (left deltoid) Pfizer dose 2: 03/09/2021 (left deltoid) No other known medications.
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1152267

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: VT
Alter: 94,0
Geschlecht: M
Eingang: 31.03.2021
Impfdatum: 26.02.2021
Beginn: 14.03.2021
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

The patient was a Hospice patient that passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: Hospice patient
Vorgeschichte: Hypertensive heart disease with heart failure
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1149925

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 70,0
Geschlecht: F
Eingang: 31.03.2021
Impfdatum: 13.02.2021
Beginn: 16.03.2021
Tage bis Beginn: 31,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Pulmonary embolism SARS-CoV-2 test

Symptomtext

Three weeks after my vaccine shot I was dx with bilateral pulmonary embolism; This is a spontaneous report from a contactable consumer (patient). A 70-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 13Feb2021 (Batch/Lot Number: EN6201) as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. None Known allergies. Patient was not pregnant. No other vaccine in four weeks. Historical vaccine included BNT162B2 (product=COVID 19, brand=Pfizer, lot number=EL9261) first dose administered in Left arm on 23Jan2021 01:15 PM. The patient experienced three weeks after her vaccine shot she was dx with bilateral pulmonary embolism on 16Mar2021 06:00 AM with outcome of not recovered. The event resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). The patient was hospitalized for the event for 4 days. The patient's hospitalization was prolonged as a result of this event. The patient underwent lab tests which included Nasal Swab (sars-cov-2 test): negative on 17Mar2021. No covid prior vaccination. The treatment received included anti-coagulative therapy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: Test Date: 20210317; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1144826

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 39,0
Geschlecht: M
Eingang: 29.03.2021
Impfdatum: 17.02.2021
Beginn: 05.03.2021
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

received word that the patient passed away on 3/5/2021. Do not know the cause of death, nor where he passed away. He does not have any significant medical history at Health Care Corporation, but did get his first vaccination here on 2/17/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: unknown
Vorgeschichte: none listed in our medical record
Andere Medikamente: unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 1143277

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 84,0
Geschlecht: F
Eingang: 29.03.2021
Impfdatum: 10.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cerebral haemorrhage Haemorrhage intracranial Hypertension Mental status changes

Symptomtext

Altered mental status Intracranial hemorrhage (CMS/HCC) Hypertension Cerebral brain hemorrhage (CMS/HCC

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1142957

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 29.03.2021
Impfdatum: 16.02.2021
Beginn: 22.03.2021
Tage bis Beginn: 34,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Chronic kidney disease Death Dyspnoea Pleural effusion

Symptomtext

SHORTNESS OF BREATH Pleural effusion Acute renal failure superimposed on chronic kidney disease, unspecified CKD stage, unspecified acute renal failure type (CMS/HCC) DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1140670

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NY
Alter: 69,0
Geschlecht: M
Eingang: 28.03.2021
Impfdatum: 18.02.2021
Beginn: 19.02.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Fatigue Feeding disorder Haemorrhage urinary tract Hyperactive pharyngeal reflex Myocardial infarction Nausea Somnolence Vaccination site bruising

Symptomtext

heart attack; pass blood clots in his urine; nauseous; really tired; knocked him on his butt/did not get out of bed, did not do anything for 2 weeks; couldn't stay awake/ slept for two weeks; couldn't eat anything; the sight or smell of food made him gag; bruise on his arm about the size of a half dollar where he got the shot; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered on the right arm at the age of 69 years, on 18Feb2021 16:00 at a single dose for COVID-19 immunisation. Medical history included known for a history of heart disease, stage 4 kidney failure and polycystic disease. He had been bleeding from the kidneys for a week prior to receiving the vaccine, heart attack and cholesterol. He stated he needs some reassurance and added he has Stage 4 kidney failure with polycystic disease. He already consulted with his heart doctor and kidney doctor and they say get the vaccine. He mentioned that every now and then he gets blood from a cyst rupture. On the day of the first shot he was having a little bit of bleeding in his urine. Concomitant medications included acetylsalicylic acid, ascorbic acid (ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID]) taken for cardiac disorder; atorvastatin (ATORVASTATIN) taken for blood cholesterol abnormal; amlodipine (AMLODIPINE) taken for blood pressure abnormal and multivitamins. The first shot knocked him on his butt. He slept for two weeks then he started to pass blood clots in his urine. He read that the vaccine can cause clotting and he doesn't know if that might have caused the clots right after the shot. He just needs someone to hold his hand about getting the second shot. He has to leave in a couple of hours to get it. He was asking do we see a pattern where people have had a bad first reaction with the first shot and they don't have a bad a reaction the second time around. He clarified he received the first dose of the Pfizer COVID 19 vaccine on 18Feb2021 at 1600 in the right arm. He was fine until Saturday (20Feb2021) when he woke up nauseous; really tired; could not get out of bed; and then really didn't do anything for two weeks. He added he couldn't stay awake even sitting up in his chair. He couldn't eat anything because the sight or smell of food made him gag, even in the grocery store. He added he also noticed he started to get the blood clots in his urine the second day after the shot (20Feb2021). On 19Feb2021, he mentioned he had a bruise on his arm about the size of a half dollar where he got the shot and he usually does not bruise. He stated he felt like he had all the symptoms of COVID. All of these symptoms lasted two weeks. When he finally felt better the only thing he wanted to eat was a burger and fries. He is still bleeding but it is not clotting anymore. The clots only lasted about a week. He also thought he was having a heart attack, but was too tired to go to the hospital. After speaking to his physician/specialist, they encouraged him to go ahead and get the 2nd dose. The patient would like to know whether the benefits outweigh the risks for him to receive the 2nd dose of the Pfizer covid vaccine based on his medical history. The patient would like to know whether one dose of the Pfizer covid vaccine provides some protection. The patient was asking whether he might die from receiving the 2nd dose of the Pfizer covid vaccine. The outcome of the events heart attack was unknown; events bruise on his arm about the size of a half dollar where he got the shot and blood clot in urine was recovered on 27Feb2021 while other events were recovered on 06Mar2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood cholesterol abnormal; Blood in urine; Blood pressure abnormal; Cyst rupture; Heart disorder (history of heart disease); Kidney failure (stage 4 kidney failure); Polycystic kidney (polycystic disease, Polycystic kidney); Renal haemorrhage
Andere Medikamente: ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID]; ATORVASTATIN; AMLODIPINE
Allergien: -
Vorherige Impfungen: -

VAERS 1134002

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge EN6201

kritisch

Staat: OR
Alter: 69,0
Geschlecht: M
Eingang: 25.03.2021
Impfdatum: 24.02.2021
Beginn: 28.02.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Death 4 days after vaccination

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: poor appetite
Vorgeschichte: Palliative care Dementia Ejection fraction of 25%, history of AFIB, CAD, Obsructive sleep apnea, Shortness of breath on exertion, Alcoholic dementia, Chronic Hep C, emphysema, chronic renal failure stage 4,
Andere Medikamente: Zofran , Morphine, Potassium, Lasix,Risperdal, Senna, Rivastigmine, Prozosin,Memantine, Haldol,Tylenol
Allergien: NO known allergies
Vorherige Impfungen: -

VAERS 1109729

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6201

kritisch

Staat: ME
Alter: 62,0
Geschlecht: M
Eingang: 25.03.2021
Impfdatum: 27.02.2021
Beginn: 07.03.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Angiogram pulmonary abnormal Blood test Brain natriuretic peptide increased Chest X-ray abnormal Condition aggravated Cough Dyspnoea exertional Echocardiogram Electrocardiogram Fibrin D dimer increased Nucleic acid test Pulmonary embolism SARS-CoV-2 test

Symptomtext

Pulmonary emboli Symptoms (dyspnea on exertion) began about 07Mar2021; Pulmonary emboli Symptoms (dyspnea on exertion) began about 07Mar2021; This is a spontaneous report from a contactable consumer. This 62-year-old male consumer (patient) reported that he received the first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 27Feb2021 16:45 (Batch/Lot Number: EN6201) as single dose for covid-19 immunization. Medical history included melanoma removed in 1991. The patient's concomitant medication was none. No other vaccine in four weeks. No other medications in two weeks. The patient experienced pulmonary emboli symptoms (dyspnea on exertion) began about 07Mar2021 (hospitalization in Mar2021 for 2 days, disability, life threatening) with outcome of not recovered. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests included Hologic nucleic acid amplification (Nasal Swab): negative on 10Mar2021, cobas RT-PCR (Nasal Swab): negative on 15Mar2021 (testing to identify diagnosis began about 10Mar2021, diagnosed 15Mar2021). Treatment for events included Heparin IV drip; discharged on apixaban (ELIQUIS). No COVID prior vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: Test Date: 20210310; Test Name: Hologic nucleic acid amplification; Test Result: Negative ; Test Date: 20210315; Test Name: cobas RT-PCR; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Melanoma (melanoma removed in 1991)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1109729

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: ME
Alter: 62,0
Geschlecht: M
Eingang: 25.03.2021
Impfdatum: 27.02.2021
Beginn: 07.03.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Angiogram pulmonary abnormal Blood test Brain natriuretic peptide increased Chest X-ray abnormal Condition aggravated Cough Dyspnoea exertional Echocardiogram Electrocardiogram Fibrin D dimer increased Nucleic acid test Pulmonary embolism SARS-CoV-2 test

Symptomtext

Pulmonary emboli Symptoms (dyspnea on exertion) began about 07Mar2021; Pulmonary emboli Symptoms (dyspnea on exertion) began about 07Mar2021; This is a spontaneous report from a contactable consumer. This 62-year-old male consumer (patient) reported that he received the first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 27Feb2021 16:45 (Batch/Lot Number: EN6201) as single dose for covid-19 immunization. Medical history included melanoma removed in 1991. The patient's concomitant medication was none. No other vaccine in four weeks. No other medications in two weeks. The patient experienced pulmonary emboli symptoms (dyspnea on exertion) began about 07Mar2021 (hospitalization in Mar2021 for 2 days, disability, life threatening) with outcome of not recovered. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests included Hologic nucleic acid amplification (Nasal Swab): negative on 10Mar2021, cobas RT-PCR (Nasal Swab): negative on 15Mar2021 (testing to identify diagnosis began about 10Mar2021, diagnosed 15Mar2021). Treatment for events included Heparin IV drip; discharged on apixaban (ELIQUIS). No COVID prior vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: Test Date: 20210310; Test Name: Hologic nucleic acid amplification; Test Result: Negative ; Test Date: 20210315; Test Name: cobas RT-PCR; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Melanoma (melanoma removed in 1991)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1129450

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NE
Alter: 85,0
Geschlecht: F
Eingang: 24.03.2021
Impfdatum: 18.02.2021
Beginn: 18.02.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Acute respiratory failure Dyspnoea Endotracheal intubation Fall Gait disturbance Pain in extremity Pulmonary alveolar haemorrhage Pulmonary oedema Rash Tendon rupture Vasculitis

Symptomtext

1st vaccine on 2/18. Developed rash bilateral lower extremities. Underwent work-up for suspected vasculitis. Had lower extremity pain limiting ambulation and contributing to fall. Required hospital admission on 3/1 for ongoing work-up and treatment of vasculitis. Also found to have right Achilles tendon rupture. Discharged to skilled nursing facility on 3/6. 2nd vaccine on 3/11. Presented to ER on 3/13 with dyspnea and acute hypoxic respiratory failure due to diffuse alveolar hemorrhage/pulmonary edema requiring intubation on 3/17. Extubated 3/21 and transitioned to hospice care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 13,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: anemia of chronic disease, aortic stenosis, left bundle branch block, chronic atrial fibrillation, end-stage renal disease on dialysis GERD, hyperlipidemia, hypertension, rheumatoid arthritis
Andere Medikamente: UNKNOWN
Allergien: NKA
Vorherige Impfungen: -

VAERS 1129260

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NY
Alter: 79,0
Geschlecht: F
Eingang: 24.03.2021
Impfdatum: 18.02.2021
Beginn: 01.03.2021
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Diarrhoea Fall Magnetic resonance imaging Muscle spasms Muscle spasticity Myalgia Myocardial infarction Pain in extremity Rhinorrhoea

Symptomtext

Stood up to go to the bathroom and could not put her right leg down; thought she was having a heart attack or a stroke or something; Fell on her right side; Cerebrovascular accident; Diarrhea; Nose running; Her calves were so sore, like having charley horse where her calf muscles were so tight it hurt; like having charley horse where her calf muscles were so tight it hurther calf muscles were so tight it hurt; her calf muscles were so tight it hurt; This is a spontaneous report from a contactable consumer. A 79-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in right arm on 18Feb2021 (Batch/Lot Number: EN6201) as single dose for COVID-19 immunisation. Medical history included family history of glaucoma from 2019 (Her mother has Glaucoma); memory ain't that good (she puts everything on her calendar because her memory ain't that good); ongoing irregular heart beat since 2006 (periodically when she goes to the doctor they have her walk the treadmill and stuff like that); ongoing diabetes since 2011; and was allergic to Penicillin (as a kid she was bitten by a dog, she must have been about 12 years old, went to hospital they gave her a shot of penicillin, her head blew up, she looked like a monster, she went back they gave her Streptomycin). Concomitant medication(s) included brimonidine taken for glaucoma from 21Feb2021 to 01Mar2021; latanoprost taken for glaucoma; apixaban (ELIQUIS) taken for arrhythmia, and dyspnoea from 2019 and ongoing; and metoprolol taken for arrhythmia. The patient was administered with her first dose of COVID-19 vaccine on 18Feb2021. It went beautiful, she did not have any aftereffects or anything initially. On 01Mar2021, while in her own apartment she stood up to go to the bathroom and could not put her right leg down; she thought she was having a heart attack or a stroke or something and she fell on her right side. She went to the hospital where she was hospitalized overnight for observation and testing. MRI performed during that hospitalization had result of Cerebrovascular Accident-CVA. She also reported onset of diarrhea and nose running around 01Mar2021. When she went to the hospital on 01Mar2021 she was laying down, and when the doctor moved the blanket to test her legs her calves were so sore, like having charley horse where her calf muscles were so tight it hurt. The events were reported to have required a visit to the emergency room. They did not find anything else during hospitalization with testing. The only thing she can think of related to these events was the COVID-19 vaccine. She called to ask if she should or should not get the second dose of the COVID-19 vaccine as scheduled for 11Mar2021 relative to these events. She was scheduled for second dose on 11Mar2021, but she is scared because of events that occurred 01Mar2021. The outcome of the events diarrhea, "Nose running", "Her calves were so sore, like having charley horse where her calf muscles were so tight it hurt", "her calf muscles were so tight it hurt" was recovering, and for other events was unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 1,0
Labordaten: Test Date: 20210301; Test Name: MRI; Result Unstructured Data: Test Result:Cerebrovascular accident-CVA
Aktuelle Erkrankungen: Diabetes; Heartbeats irregular
Vorgeschichte: Medical History/Concurrent Conditions: Glaucoma (Her mother has Glaucoma.); Memory impairment; Penicillin allergy
Andere Medikamente: BRIMONIDINE; LATANOPROST; ELIQUIS; METOPROLOL
Allergien: -
Vorherige Impfungen: -

VAERS 1127716

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IL
Alter: 51,0
Geschlecht: F
Eingang: 23.03.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram pulmonary abnormal Chest discomfort Dizziness Dyspnoea Fibrin D dimer Pulmonary embolism

Symptomtext

Shortness of breath, chest heaviness onset 1 week. 1st vaccine injection 2/17/21, 2nd vaccine 3/17/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: D dimer 1.24 HIGH EXAM: CT ANGIOGRAPHY, CHEST CLINICAL INDICATION: Dizziness, shortness of breath, chest pressure TECHNIQUE: Following IV administration of 80 cc iodinated contrast, CT scan of the pulmonary arteries with multiplanar reformatted images including MIPs generated from the data set. Dose reduction techniques were utilized. COMPARISON: 6/11/2020 FINDINGS: Pulmonary arteries: The evaluation is degraded by respiratory motion artifact, there appears to be a small acute pulmonary embolism at the branch point of the right middle lobe lobar pulmonary artery extending into the medial and lateral segmental pulmonary arteries. Cardiomediastinum: No pathologically enlarged lymph nodes. Normal heart size. There is no flattening of the interventricular septum to suggest right heart strain. Soft tissues: Peripheral soft tissues are unremarkable. Upper abdomen: No gross abnormality of the included upper abdominal structures. Lungs: Patent central airways. No focal consolidation, pulmonary edema, pleural effusion, or pneumothorax. 3 mm right upper lobe pulmonary nodule is unchanged (series 3 image 54), likely benign. No pulmonary infarction. Bones: No destructive osseous lesion. Impression IMPRESSION: Small acute right middle lobe pulmonary embolism as described. Important findings were communicated by Dr. at 3/23/2021 5:28 PM.
Aktuelle Erkrankungen: Asthma, new diagnosis celiac disease
Vorgeschichte: -
Andere Medikamente: ATROVENT HFA 17 MCG/ACT Inhalation diphenoxylate-atropine 2.5-0.025 MG Oral Tab Sig: Take 1 tablet by mouth 2 (two) times daily as needed
Allergien: Albuterol Augmentin [amoxicillin-pot Clavulanate] Levaquin [levofloxacin] Omeprazole Seasonal
Vorherige Impfungen: -

VAERS 1123066

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WA
Alter: 80,0
Geschlecht: M
Eingang: 22.03.2021
Impfdatum: 20.02.2021
Beginn: 05.03.2021
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: Atrial fibrillation, spinal stenosis, abnormal liver enzymes, BPH, genital herpes, heart murmur, , hyperlipidemia, hypertension, peripheral vascular disease
Andere Medikamente: Eliquis, Lipitor, Cartia XT, Vitamin D3, Finasteride, Latanoprost opth, Toprolol- XL, Flomax, Dyazide, Ambien
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1119002

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: IN
Alter: 81,0
Geschlecht: M
Eingang: 20.03.2021
Impfdatum: 11.02.2021
Beginn: 12.02.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Confusional state Death Dysphagia Fatigue Hypoxia Incontinence Pneumonia

Symptomtext

Day 1-Confusion and weakness Day2-Increase in weakness, inability to swallow, confusion, fatigue Day 3-Weakness, confusion, incontinence, hospitalized for hypoxia, pneumonia Day 20- Deceased

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 20,0
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: CVA, hypertension, hyperlipidemia, atrial fibrillation, AAA, Pulmonary Embolism, OSA, hypothyroidism, dysphagia
Andere Medikamente: eliquis 5mg bid, lasix 20 mg bid, cardizem 30mg q8hrs, asprin 81 mg daily, KCl 20 meq every other day, prevastatin 40mg, famotadine 20mg bid, prozac 40 mg daily, levoythyroxine 50mcg daily, glycopyrrolate 1mg bid
Allergien: doxycycline
Vorherige Impfungen: -

VAERS 1115451

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 67,0
Geschlecht: M
Eingang: 19.03.2021
Impfdatum: 24.02.2021
Beginn: 03.03.2021
Tage bis Beginn: 7,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

Home care treatment History of COPD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1110673

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 18.03.2021
Impfdatum: 28.01.2021
Beginn: 11.02.2021
Tage bis Beginn: 14,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death Limb injury

Symptomtext

shoulder injury death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1076972

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MA
Alter: 78,0
Geschlecht: M
Eingang: 18.03.2021
Impfdatum: 28.02.2021
Beginn: 01.03.2021
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Balance disorder Cerebrovascular accident Dysarthria Facial paralysis Fall Blood test Computerised tomogram Echocardiogram Lack of spontaneous speech Gait disturbance Hypoaesthesia Magnetic resonance imaging Posture abnormal Gait inability Head injury Hemiplegia Physical examination SARS-CoV-2 test

Symptomtext

stroke; fell; body was pulling to one side, he fell and hit his head on the couch; body was pulling to one side, he fell and hit his head on the couch; slurred speech; numbness in arm/left arm was numb; not able to walk/he could not really walk on his own.; facial drooping on the left side and his whole left side is not working; facial drooping on the left side and his whole left side is not working; This is a spontaneous report from a contactable consumer. A 78-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration (left arm), on 28Feb2021, 12:00 at single dose for COVID-19 immunisation. Medical history included High blood pressure and High cholesterol. The patient had no known allergies. Ongoing concomitant medications included atorvastatin for high cholesterol and atenolol for blood pressure. It was reported that the patient received the 1st vaccine on Sunday afternoon, then Monday morning, 01Mar2021, 08:30, he collapsed and had a stroke and they had to call an ambulance. The reporter stated that his body was pulling to one side, he fell and hit his head on the couch, and his speech was slurred, and his left arm was numb. When they tried to get him up, he could not really walk on his own. She said that he developed facial drooping on the left side and his whole left side was not working. He had his physical last week, on an unspecified date and everything was good at that time. The events resulted in emergency room/department or urgent care, hospitalization, disability or permanent damage. The patient was hospitalized on an unspecified date for 3 days due to the events. Patient was currently in the hospital. The patient received unspecified treatment for the events. The patient had no Covid prior vaccination and was not Covid tested post vaccination. Outcome of events was not recovered. Information on the lot/batch number has been requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: Test Name: physical; Result Unstructured Data: Test Result:everything was good; Comments: physical last week and everything was good at that time
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood pressure high; High cholesterol
Andere Medikamente: ATORVASTATIN; ATENOLOL
Allergien: -
Vorherige Impfungen: -

VAERS 1104175

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MD
Alter: 35,0
Geschlecht: F
Eingang: 16.03.2021
Impfdatum: 09.03.2021
Beginn: 11.03.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: - / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Death Decreased appetite Headache Unresponsive to stimuli

Symptomtext

She received the 2nd Dose on 3/9/2021. On 3/10/2021 She complained of a headache. On the morning of 3/11/2021 she complained of abdominal pain and had no appetite. We then found her unresponsive, called 911 and the medics pronounced her at around 1300.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None
Vorgeschichte: Myotonic Dystrophy DM 1 - Congenital : characterized by progressive muscle wasting and weakness. Physical and Intellectual Disability
Andere Medikamente: Norethindrone .35MG Daily - Birth Control 10 MG Zyrtec Allergy Daily - Allergies 5000 mcg Biotin Gummy Daily - Hari, Skin & Nails Vitamin 50 mcg D3 Gummy Daily - Bone & Immune System Vitamin 45 mg Iron plus Vitamin C Soft Chew Daily - Vitam
Allergien: None to Date
Vorherige Impfungen: -

VAERS 1103837

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 16.03.2021
Impfdatum: 19.02.2021
Beginn: 23.02.2021
Tage bis Beginn: 4,0
Dosis: UNK
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death Dizziness Dyspnoea

Symptomtext

shortness of breath, dizziness death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1103750

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6201

kritisch

Staat: HI
Alter: 92,0
Geschlecht: F
Eingang: 16.03.2021
Impfdatum: 12.02.2021
Beginn: 13.02.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bone pain Death

Symptomtext

DAY AFTER, PT COMPLAINED OF PAIN IN LEFT COLLAR BONE. PATIENT DECLINED IN FUNCTION OVER NEXT 11 DAYS. HOSPICE WAS CONSULTED AND PT PASSED ON 2/23/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: HTN ECZEMA HYPOTHYROIDISM DIABETIC NEUROPATHY RESTLESS LEG SYNDROME
Vorgeschichte: -
Andere Medikamente: UNKNOWN
Allergien: PENICILLIN
Vorherige Impfungen: -

VAERS 1099264

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 71,0
Geschlecht: M
Eingang: 16.03.2021
Impfdatum: 06.03.2021
Beginn: 07.03.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Myocardial infarction

Symptomtext

Patient found dead in bed at home 3/7/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: no autopsy
Aktuelle Erkrankungen: None
Vorgeschichte: COPD,CKD 3,HTN, high lipids
Andere Medikamente: Nifedipine, hydrochlorothiazide, lisinopril, gabapentine, spirva
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1099438

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: OR
Alter: 89,0
Geschlecht: M
Eingang: 14.03.2021
Impfdatum: 19.02.2021
Beginn: 03.03.2021
Tage bis Beginn: 12,0
Dosis: UNK
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time Bell's palsy Cerebrovascular accident Computerised tomogram head Computerised tomogram neck Differential white blood cell count Electrocardiogram Full blood count International normalised ratio Metabolic function test Troponin I Urine analysis

Symptomtext

Client was taken to the Emergency Room. He was diagnosed with Bell's Palsy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: CBC with Differential Comprehensive Metabolic Panel PTT Protime INR Troponin I Urinalysis with Microscopic with Culture if indicated CT Head we Contrast Acute Stroke CTA Head Neck Acute Stroke ECG 12 Lead
Aktuelle Erkrankungen: none
Vorgeschichte: A fib COPD
Andere Medikamente: Tamsulosin 0.4 mg Xarelto 20 mg Metoprolol 50 mg Simvastatin 20 mg
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 1095642

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 94,0
Geschlecht: M
Eingang: 12.03.2021
Impfdatum: 25.01.2021
Beginn: 15.02.2021
Tage bis Beginn: 21,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1095636

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 89,0
Geschlecht: F
Eingang: 12.03.2021
Impfdatum: 29.01.2021
Beginn: 19.02.2021
Tage bis Beginn: 21,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1095634

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 18,0
Geschlecht: F
Eingang: 12.03.2021
Impfdatum: 12.03.2021
Beginn: 12.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood test Death Magnetic resonance imaging

Symptomtext

2nd injection given on 2/19/2021 death 2/27/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: MRI and blood
Aktuelle Erkrankungen: none
Vorgeschichte: no
Andere Medikamente: unknown
Allergien: none
Vorherige Impfungen: -

VAERS 1095360

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 84,0
Geschlecht: F
Eingang: 12.03.2021
Impfdatum: 28.01.2021
Beginn: 22.02.2021
Tage bis Beginn: 25,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Bradycardia Cardiomyopathy Death Dyspnoea Hypothermia Troponin increased

Symptomtext

SHORTNESS OF BREATH Bradycardia Hypothermia Cardiomyopathy Elevated troponin Acute renal failure (ARF) Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1095183

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 83,0
Geschlecht: F
Eingang: 12.03.2021
Impfdatum: 15.02.2021
Beginn: 01.03.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1094993

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 12.03.2021
Impfdatum: 26.01.2021
Beginn: 03.03.2021
Tage bis Beginn: 36,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cardiac arrest Death Rectal haemorrhage

Symptomtext

2nd vaccine dose given on 02/16/2021, admitted to hospital on 02/24/2021 CARDIAC ARREST RECTAL BLEEDING died on 03/03/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1094719

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MI
Alter: 71,0
Geschlecht: F
Eingang: 12.03.2021
Impfdatum: 19.02.2021
Beginn: 22.02.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient reported as deceased 3 days after vaccination by son.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1093857

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MS
Alter: 74,0
Geschlecht: M
Eingang: 12.03.2021
Impfdatum: 10.02.2021
Beginn: 12.02.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Hyperhidrosis Influenza like illness Seizure Thirst

Symptomtext

According to the patient's wife, the patient had flu like symptoms 2/11/2021. Complaints: Thirsty, sweaty and seizure with no prior history. Died at home. Not sent to hospital. Pronounced by coroner

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: HTN; Stroke
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1093762

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NH
Alter: 101,0
Geschlecht: F
Eingang: 12.03.2021
Impfdatum: 18.02.2021
Beginn: 12.03.2021
Tage bis Beginn: 22,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death SARS-CoV-2 test negative

Symptomtext

3/12/2021-EXPIRED AT FACILITY ON HOSPICE SERVICES

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: MULTIPLE COVID-19 SCREENING TESTS-ALL NEGATIVE
Aktuelle Erkrankungen: NO ACUTE MEDICAL ISSUES. RESIDENT ON HOSPICE SERVICES FOR END STAGE ALZHEIMER'S DEMENTIA SINCE 6/11/2020 WITH OVERALL POOR ORAL INTAKE, WEIGHT LOSS AND DECLINE. COVID NEGATIVE AND NO HX OF COVID-19. RECEIVING REGULAR HOSPICE SERVICES FOR CARE, COMFORT AND PAIN MANAGEMENT. COMPASSIONATE VISITS WITH DAUGHTER. IMPULSIVE WITH POOR SAFETY AWARENESS AND MULTIPLE FALLS.
Vorgeschichte: ALZHEIMER'S DISEASE, UNSPECIFIED DYSPHAGIA, UNSPECIFIED ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE POLYMYALGIA RHEUMATICA ESSENTIAL (PRIMARY) HYPERTENSION HYPOTHYROIDISM, UNSPECIFIED OTHER CHRONIC PAIN UNSPECIFIED MOOD [AFFECTIVE] DISORDER ABDOMINAL AORTIC ANEURYSM, WITHOUT RUPTURE NEOPLASM OF UNCERTAIN BEHAVIOR OF CONNCTV/SOFT TISS ENCOUNTER FOR PALLIATIVE CARE OTHER INTERVERTEBRAL DISC DEGENERATION, LUMBAR REGION CERVICAL DISC DISORDER, UNSP, UNSPECIFIED CERVICAL REGION ACTINIC KERATOSIS DEMENTIA IN OTH DISEASES CLASSD ELSWHR W/O BEHAVRL DISTURB MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED HYPERLIPIDEMIA, UNSPECIFIED SECONDARY MALIGNANT NEOPLASM OF SKIN
Andere Medikamente: Acetaminophen Tablet 500 MG QHS; Aspirin Tablet 81 MG QD; CeleXA Tablet 20 MG QD; GlycoLax Powder (Polyethylene Glycol 3350) Give 17 gram QD; PredniSONE Tablet 2.5 MG(JUST COMPLETED 3 WEEK LOW DOSE TAPER ON 2/15);Remeron Tablet (Mirtazapin
Allergien: CODEINE, OXYCODONE
Vorherige Impfungen: -

VAERS 1092883

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: ME
Alter: 72,0
Geschlecht: M
Eingang: 11.03.2021
Impfdatum: 09.03.2021
Beginn: 10.03.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Death. Patient lived alone, was found dead at 11:04 the morning following his second dose of vaccine. Actual time of death is unknown. Time of vaccine administration the previous day is estimated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: Vertigo
Vorgeschichte: Coronary artery disease, hypertension, hyperlipidemia
Andere Medikamente: Aspirin, telmisartan, valacyclovir, brinzolamide/brimonidine, fluoromethalone, lumigan, timolol
Allergien: Lyrica, Prinivil, Lipitor, Penicillin
Vorherige Impfungen: -

VAERS 1090322

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 71,0
Geschlecht: F
Eingang: 11.03.2021
Impfdatum: 13.02.2021
Beginn: 17.02.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

MY WIFE DIED UNEXPECTEDLY 4 DAYS AFTER HER SECOND DOSAGE SHOT, ON FEBRUARY 17, 2021. SHE HAD BEEN HEALTHY AND HAD A RECENT CHECKUP AT WHICH THE DOCTOR GAVE HER A CLEAN BILL OF HEALTH. SHE WAS ALERT AND IN GOOD SPIRITS JUST THE NIGHT BEFORE WHEN WE WATCHED A MOVIE TOGETHER. I SAW NO INDICATION THAT SHE WAS FEELING POORLY OR OTHERWISE. I FOUND HER IN BED, DECEASED, UPON COMING HOME FROM WORK THE NEXT DAY.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: I'M TOLD SHE WAS SCHEDULED FOR A TOXICOLOGY TEST BY THE MEDICAL EXAMINER. WE HAVE NOT RECEIVED THOSE RESULTS AS YET.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Supplements: Krill Oil, turmeric Curcumin, Lecithin, Multivitamin; Alergy (antihistamine)
Allergien: None
Vorherige Impfungen: -

VAERS 1087735

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NH
Alter: 68,0
Geschlecht: M
Eingang: 10.03.2021
Impfdatum: 18.02.2021
Beginn: 05.03.2021
Tage bis Beginn: 15,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Respiratory tract congestion Weight increased

Symptomtext

On 3/5/21 at approximately 0200 became congested suddenly. Doctor was notified with N.O. Torsemide 20 mg tab via PEG-tube NOW, IM Rocephin 1 mg QD x7 days for possible aspiration, Chest X Ray, CBC/BMP in morning, and may suction resident if tolerated PRN. Received both Torsemide and the Rocephin and then deceased at 0350.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Labs and CXR unable to be completed on day of event due to patient expired prior.
Aktuelle Erkrankungen: 12/7/20 BMP with elevated kidney function, some diuretics on hold 12/10/20 BMP with continued elevated kidney function, diuretic decreased 12/14/20 C/O body aches, rapid covid test negative, potassium adjusted based on labs 12/15/21 BMP drawn, increased weight gain. N.O. increase torsemide to 100mg PO QD, QD weights, and weekly BMP Q Monday. 12/28/20 Vomited small amount, rapid covid negative, continued with weight gain and diuretics increased. 1/7/21 Difficulties swallowing, picked up by ST and fluids change to nectar thick consistency. 1/11/21 Drowsy and weak with low CBGs. Dieuretic put on hold 1/12/21 Low temperature and low CBG 1/13/21 All diuretics put on hold. N.O. nephrology consult for advancing CKD & explore if dialysis is an appropriate options. Diet downgraded to all ground. 1/15/21 Had modified barium swallow and per report recommends NPO r/t aspiration. Diet changed to puree, thin liquids. 1/18/21 UA sent for C&S if indicated for / blood clots in urine. Then had congested cough. Had CXR and results showed bilateral lower lobe infiltrates and bilateral effusions. 1/19/21 Sent to ER for eval of lethargy, not eating, and acute on chronic kidney injury. Admitted to CMC. 1/31/21 Returned form hospital NPO with PEG tube, all diuretics D/C. 2/1/21 Oral thrush tx 10 cc Nystatin swish and spit TID for 10 days 2/8/21 CBC/BMP with no significant acute findings 3/4/21 Increased weight and started back on diuretic torsemide 20mg. Approximately 0200 on 3/5/21 became congested. Doctor was notified with N.O. Torsemide 20 mg tab via PEG-tube NOW, IM Rocephin 1 mg QD x7 days for possible aspiration, Chest X Ray, CBC/BMP in morning, and may suction resident if tolerated PRN. 3/5/2021-0350 deceased.
Vorgeschichte: Pneumonitis due to inhalation of food and vomit, acute kidney failure, anemia, dysphagia, malaise, weakness, cognitive communication deficient, abnormal posture, personal history of COVID19, gastrostomy statsu, vitamin D deficiency, essential tremor, chronic diastolic heart failure, muscle spasm, benign prostatic hyperplasia without lower urinary tract symptoms, gout, sleep apnea. Anxiety disoreder, atrial fibrillation, dementia with behavioral disturbance, lymphedema, epiliepsy, schizophrenia, major depressive disorder, hyperlipidemia, hypothyroidism, Essential hypertenision, drug induced subacute dyskinesia
Andere Medikamente: Medications received day of dose 2 (2/18/21)vaccination: abilify 20mg, benztropine mesylate 2mg, celexa 40mg, clonazepam 2mg, Aricept 10mg, lactulose 30ml, synthroid 75mcg, Pepcid 20mg, Risperdal 1mg in am and 2mg at HS, senna-s 2 tablets,
Allergien: Codeine, Buspar, Clozaril, Geodon, Mellaril, Seroquel, Thorazine, Pineapple, Plum, Prune, Dust, Tetanus Toxin
Vorherige Impfungen: -

VAERS 1081416

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: OK
Alter: 74,0
Geschlecht: F
Eingang: 08.03.2021
Impfdatum: 22.02.2021
Beginn: 25.02.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Brain herniation Cerebral haemorrhage Cerebral mass effect Coma Death Endotracheal intubation Hypertension Respiratory failure Subarachnoid haemorrhage Subdural haematoma

Symptomtext

Pt. presented to ED via EMS for emergent coma. EMS intubated patient in field due to respiratory failure. Pt. was severely hypertensive with nearly total loss of brainstem reflexes. Patient had known L MCA cerebral aneurysm with appointment to undergo intervention to address in the near future. NCCT reported massive multifocal brain hemorrhage, SAH, SDH, and parenchymal hemmorhage with midline shift and subfalcine herniation. Due to dismal/poor prognosis, family requested withdrawal of support approximately 4 hours after presentation and patient expired shortly thereafter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 1,0
Labordaten: INR-0.9 - 2/25/2021
Aktuelle Erkrankungen: None
Vorgeschichte: Known L MCA cerebral aneurysm HTN Hypothyroidism
Andere Medikamente: Albuterol 90 mcg inhaler 2 puffs q6h prn SOB ASA 81 mg PO daily Excedrin Extra Strength 1 tab PO PRN Atenolol 100 mg PO daily Caltrate 600+D 1 tab PO daily Cetirizine 10 mg PO daily Cholecalciferol 2000 unit PO daily Dicyclomine 20 mg PO da
Allergien: Benzocaine Codeine Penicillins Sulfa
Vorherige Impfungen: -

VAERS 1063457

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 64,0
Geschlecht: M
Eingang: 07.03.2021
Impfdatum: 27.02.2021
Beginn: 03.03.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: - / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Autopsy Death Diarrhoea Fatigue Unresponsive to stimuli

Symptomtext

Death Narrative: On 3/3/21 an MSA from the Decedent Affairs Office received a call from the Office of the Chief Medical Examiner. The ME office informed the MSA that an autopsy was conducted on 3/2/21 and is pending results. No further information was given. A clinical review was conducted by the PCP but no conclusions could be made until autopsy results are received. The Office of Decedent Affairs will be reaching out periodically to the ME's office to retrieve these results. This Issue Brief will be updated by 3/17/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Cause of death is unknown at this time
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1075971

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: VA
Alter: 72,0
Geschlecht: F
Eingang: 05.03.2021
Impfdatum: 17.02.2021
Beginn: 19.02.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Husband put her to bed on 2/19/2021 and she was fine. Found her later that evening on the floor of the bathroom deceased.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Parkinsons - limited mobility with swallowing issues
Andere Medikamente: Levodopa
Allergien: Morphine, arm swelling and pain with pneumovax
Vorherige Impfungen: -

VAERS 1074549

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CT
Alter: 77,0
Geschlecht: M
Eingang: 05.03.2021
Impfdatum: 21.02.2021
Beginn: 23.02.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram Angiogram pulmonary abnormal Brain natriuretic peptide increased Dyspnoea Echocardiogram Echocardiogram abnormal Pulmonary embolism Thrombectomy Troponin increased

Symptomtext

Two days after receiving the vaccine the patient began experiencing shortness of breath. One week after onset of symptoms he presented to the hospital and was diagnosed with submassive pulmonary embolism. He underwent IR suction thrombectomy which removed 30% of the PE burden and spent two days in the ICU. He has now been transferred to the floor.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: Labs: BNP 812, troponin .43 CTA chest: positive for pulmonary embolism with thrombi in the right and left main pulmonary arteries and filling defects involving all 5 lobes. TTE: positive for McConnell's sign
Aktuelle Erkrankungen: -
Vorgeschichte: benign prostatic hypertrophy, hyperlipidemia, hypertension
Andere Medikamente: Amlodipine, benazepril, rosuvastatin, tamsulosin, famotidine, Ventolin inhaler, cholecalciferol/Vitamin D3, Vitamin B12, latanoprost ophthalmic solution, turmeric oil
Allergien: Corn, peanut, shellfish
Vorherige Impfungen: -

VAERS 1073167

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: TX
Alter: 54,0
Geschlecht: F
Eingang: 04.03.2021
Impfdatum: 11.02.2021
Beginn: 24.02.2021
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: SYR / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

She passed away 2/24/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: No
Aktuelle Erkrankungen: No
Vorgeschichte: Hypertrophic obstructive Cardio myopathy Endocarditis
Andere Medikamente: SOME OF THESE SHE WAS TAKING AND SOME SHE MAY NOT HAVE BEEN, List is from 2016. Metoprolol Omeprazole Duloxetine Valacyclovir Trazadone Tramadol HCL Cyclobenzaprine Augmentin
Allergien: No/Unknown
Vorherige Impfungen: -

VAERS 1068884

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 02.03.2021
Impfdatum: 08.02.2021
Beginn: 22.02.2021
Tage bis Beginn: 14,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cardioversion Death Dyspnoea Endotracheal intubation Hypotension Intensive care Pulseless electrical activity Respiratory distress Resuscitation Sepsis

Symptomtext

DEATH Narrative: Presented to ED via EMS c/o increasing shortness of breath, O2 sat mid to high 80s on 4L. When EMS arrived , pt was in distress, intubated by EMS and transported to ED. Pt had a PEA arrest en route but resuscitated w/ return of spontaneous circulation after receiving a dose of epinephrine and chest compressions. Pt was hypotensive on arrival to ED. He was started on sepsis protocol , volume resuscitation and empiric antibiotics. Once stabilized, he was admitted to icu at hospital. Removed from respirator 2/22/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1063464

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: MA
Alter: 55,0
Geschlecht: M
Eingang: 01.03.2021
Impfdatum: 19.02.2021
Beginn: 26.02.2021
Tage bis Beginn: 7,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Deep vein thrombosis Dyspnoea Pain in extremity Pulmonary embolism

Symptomtext

Patient had the first dose of the Pfizer COVID vaccine (LOT# EL9264) on 1/29/21 at the vaccination center at Medical Center (set up in Hotel). He had the second dose on 2/19/21 (LOT# EN6201) at 12:30pm, and reported leg pain and difficulty breathing on 2/26/21 as he was going to bed. He presented to the ER at Hospital that day, and was diagnosed with a deep venous thrombosis and pulmonary embolism. He is currently taking Xarelto, and will schedule an appointment with Hematology, as he has no family or personal history of clotting disorder.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Living-donor kidney transplant recipient CKD stage G2/A1, GFR 60-89 and albumin creatinine ratio <30 mg/g HTN (hypertension) Hyperlipidemia, unspecified hyperlipidemia type Hyperkalemia Gout Iron deficiency Condyloma acuminata Gastroesophageal reflux disease, esophagitis presence not specified
Andere Medikamente: Amlodipine Besylate 2.5 MG Tablet 2 tablets Orally Once a day Atorvastatin Calcium 20 mg Tablet 1 tablet Orally Once a day Famotidine 20 MG Tablet 1 tablet at bedtime as needed Orally Once a day Ferrous Gluconate 324 (38 Fe) MG Tablet 1
Allergien: None
Vorherige Impfungen: -

VAERS 1059001

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: HI
Alter: 91,0
Geschlecht: F
Eingang: 26.02.2021
Impfdatum: 21.01.2021
Beginn: 22.02.2021
Tage bis Beginn: 32,0
Dosis: 2
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Decreased appetite Fatigue Mobility decreased

Symptomtext

Patient had declining health for the past 6 months, dementia and unable to walk. Patient had decreased appetite starting 1/1/21. After 1st vaccine shot patient appetite decreased further. After 2nd vaccine shot patient fatigue increased to the point where she could not get out of bed and had minimal appetite. Patient passed away 10 days after receiving 2nd shot on 2/22/21. Patient did not go to ED and was not hospitalized.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Had declining health for the past 6 months, dementia, unable to walk. Decrease appetite after 1/1/21.
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1058379

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 79,0
Geschlecht: M
Eingang: 26.02.2021
Impfdatum: 23.02.2021
Beginn: 25.02.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebral haemorrhage Fall Neurologic neglect syndrome Sensory loss

Symptomtext

1st dose vaccine 2/23/21; EMS called after pt fell at home 2/25/21; taken to ED and admitted to hospital DX: 1. Right-sided nontraumatic intracerebral hemorrhage, unspecified cerebral location (CMS/HCC) I61.9 431 2. Long term (current) use of anticoagulants Z79.01 V58.61 3. Sensory neglect (left sided) R41.4 781.8 currently still admitted to hospital at the time of this report

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Multiple; see chart
Vorgeschichte: -
Andere Medikamente: -
Allergien: Motrin
Vorherige Impfungen: -

VAERS 1058221

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: KY
Alter: 81,0
Geschlecht: M
Eingang: 26.02.2021
Impfdatum: 21.02.2021
Beginn: 24.02.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Asthenia Hypoxia Pleural effusion Pneumonia

Symptomtext

1st dose vaccine 2/21/21; developed weakness and went to ED via EMS on 2/26/21 and admitted to Hospital from ED DX: Acute respiratory failure with hypoxia ; Pleural effusion, left; Community acquired pneumonia of right lung, unspecified part of lung currently admitted to hospital during time of this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DM; HTN; Pancreatitis; Kidney stone; COPD; GERD; Anemia
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 1058192

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: NE
Alter: 90,0
Geschlecht: M
Eingang: 26.02.2021
Impfdatum: 18.02.2021
Beginn: 24.02.2021
Tage bis Beginn: 6,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction Alanine aminotransferase increased Aspartate aminotransferase increased Asthenia Blood creatinine increased Blood lactic acid increased Blood potassium increased Blood urea increased Death Electrocardiogram abnormal Fall Procalcitonin increased SARS-CoV-2 test negative Troponin normal Urine analysis

Symptomtext

2/24/21 Patient Died. 02/23/21. Patient came to ED for weakness/falls. Patient had fallen on 02/21 and 02/23. UA was done in LTC, and he was started on ciprofloxacin 02/22/21. Treatment was to put patient on comfort cares (morphine + lorazepam)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: 02/23 Labs. EKG: NSTEMI. Respiratory BioFire Negative, SCr 2.12 (baseline is 1.25-1.5), K 6.1, BUN 62, Troponin 0.182, AST 101, ALT 94, Lactate 3.7, procal 0.17.
Aktuelle Erkrankungen: UTI on 02/21. 02/23 ED visit: AKI, HTN, Fall/weakness, NSTEMI, sepsis with hypoxic resp. failure.
Vorgeschichte: Obstructive bladder, GERD, HTN, Hypothyroidism, Malignant neoplasm of prostate, hyperlipidemia, Type 2 DM, Vit D deficiency, osteoarthritis, peripheral edema, Diabetic neuropathy.
Andere Medikamente: Xanax, Vitamin d2, levothyroxine, Tylenol, ciprofloxacin, doxazosin, furosemide, Duo-Neb, melatonin metoprolol, pantoprazole, artificial tears, potassium chloride.
Allergien: etodolac. reaction unknown.
Vorherige Impfungen: -

VAERS 1047571

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WA
Alter: -
Geschlecht: F
Eingang: 22.02.2021
Impfdatum: 10.02.2021
Beginn: 11.02.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident Death

Symptomtext

Death after stroke .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1045972

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: -
Alter: 78,0
Geschlecht: F
Eingang: 22.02.2021
Impfdatum: 06.02.2021
Beginn: 16.02.2021
Tage bis Beginn: 10,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

patient passed away within 60 days of receiving a COVID vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1036989

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CA
Alter: 80,0
Geschlecht: F
Eingang: 17.02.2021
Impfdatum: 16.02.2021
Beginn: 16.02.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute myocardial infarction Angina unstable Anxiety Catheterisation cardiac Chest X-ray Chest discomfort Chest pain Cold sweat Electrocardiogram Hyperhidrosis Intensive care

Symptomtext

This person received the 1st dose COVID-19 vaccine Pfizer @ 08:13am. Then @0930 am, c/o "feeling something on top of her chest, heaviness of chest", sweaty hands, clammy, chest pain. Rapid Response Team called at 09:35 am. Transferred to Emergency Room. In ED: Diagnosis included but not limited to STEMI, NSTEMI, unstable angina, anxiety. At 10:04am- based on EKG, code STEMI was called. Consultation with cardiologist. Then the patient was sent emergently to Cath Lab. The patient was admitted to ICU, intensive care, following Cath Lab

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: EKG, Chest X Ray, Cath Lab procedure
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 1036182

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: CO
Alter: 80,0
Geschlecht: M
Eingang: 17.02.2021
Impfdatum: 12.02.2021
Beginn: 12.02.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Agonal rhythm Areflexia Coma Coma scale abnormal Computerised tomogram head abnormal Cough Death Hunt and Hess scale Intracranial aneurysm Intracranial pressure increased Intraventricular haemorrhage Mechanical ventilation Ophthalmoplegia Posthaemorrhagic hydrocephalus Posturing Pupillary light reflex tests abnormal Pupillary reflex impaired Ruptured cerebral aneurysm

Symptomtext

Patient received 2nd dose of the COVID-19 Pfizer vaccine, was observed in office x 15+ minutes, and released home. Pt and his son exited the building and when they got to the car, the pt shouted out "oh no!" and collapsed to the ground. The patient was unconscious experiencing agonal respirations, and unresponsive to painful stimuli. There is an Emergency Room at the same location. Their staff came out and helped to transfer the pt to the ED for further evaluation. It was found that the patient had a known Anterior communicating artery aneurysm (7/28/2017) that seemed to have ruptured. The patient was stabilized and transported to our local hospital and upon arrival, he was effectively comatose with a GCS 3. CT Head notated an extensive subarachnoid and intraventricular hemorrhage most probably related to a bleeding anterior communicating artery aneurysm. Neuro-Interventional Radiologist dictation reads "Hunt Hess 5 Fisher grade 4 extensive subarachnoid hemorrhage with intraventricular hemorrhage and early hydrocephalus secondary to rupture of a known anterior communicating artery aneurysm. Initial ICP after EVD placement noted to be in the 120s now 68 treatment complicated by aneurysm rerupture after admission and increased volume of blood although large volume of hemorrhage was seen on initial scan and no change in the patient's clinical exam on her scale was noted due to this rerupture. Patient's exam and prognosis are poor giving extensor posturing lack of extraocular movements to doll's maneuver and weak pupillary reflex as well as cough and gag. Follows no commands or instructions at this time with no spontaneous movement on ventilator set at 12 overbreathing at 14-16 at this time without any sedation." The family opted to discontinue any further treatment to include surgical intervention given the findings. The patient was given comfort care with son and daughter at the bedside. The patient was extubated and expired at 1545h on 2/13/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Coma
Hospital-Tage: 1,0
Labordaten: CT Head w/o contrast - extensive subarachnoid & intraventricular hemorrhage most probably related to a bleeding anterior communicating artery aneurysm.
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Not verified. Problem list in EMR includes: Cerebellar ataxia Noted 7/28/2017, Parkinson's disease Noted 10/11/2019, Peripheral polyneuropathy Noted 7/29/2017, Lumbar radiculopathy Noted 10/29/2020, Throat clearing Noted 1/22/2018, Oropharyngeal dysphagia Noted 10/11/2019, Aortic ectasia Noted 10/6/2019, Anterior communicating artery aneurysm Noted 7/28/2017, Essential hypertension Noted 7/28/2017, Constipation Noted 10/23/2019, Nocturia Noted 10/11/2019, Dupuytren's disease of palm of both hands Noted 10/11/2019, Alcohol intake above recommended sensible limits with complication Noted 7/29/2017, Major depressive disorder, single episode, mild Noted 10/11/2019, Hoarseness Noted 1/22/2018.
Andere Medikamente: Not verified. EMR states 1/4/2021 SINEMET 25-100 mg tablet.
Allergien: NKA
Vorherige Impfungen: -

VAERS 1026270

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

kritisch

Staat: WI
Alter: 90,0
Geschlecht: F
Eingang: 12.02.2021
Impfdatum: 11.02.2021
Beginn: 11.02.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Resuscitation Unresponsive to stimuli

Symptomtext

At 10:33 am Patient pushed her pendant for staff, staff arrived to her apartment and Patient was found unresponsive in her bathroom. Patient received her second COVID-19 Pfizer vaccine about 75 minuets prior to this, she had no adverse reaction's within the first hour of receiving the second dose. CPR was started until paramedics arrived, they took over and tried to resuscitate. Patient was pronounced dead at 11:33 am at scene.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: primary hypertension Mitral Valve regurgitation COPD Osteoporosis Kyphoscoliosis deformity of spine Rheumatoid factor positive GERD history of cellulitis of leg history of C-diff post ATB therapy Monoclonal gammopathy Iron deficiency anemia, unspecified Hypothyroidism, unspecified Hyperlipidemia, unspecified Coronary atherosclerosis due to lipid rich plaque Nonrheumatic tricuspid valve disorder, unspecified Chronic atrial fibrillation Allergic rhinitis, unspecified Barrett's esophagus without dysplasia Other specified urinary incontinence
Andere Medikamente: Albeterol Inh Soln 0.083 % Calcium 600mg + D 400 IU One Daily Woman 50 + tablet Cetirizine HCL 10 mg Tablet Digozin 0.125 mg Tablet Levothyroxine 100 mcg tablet Metoprolol Tartrate 50 mg Tablet Esomeprazole Mag. Dr 40 mg Capsule Nitroglyc
Allergien: Ceftin, Cefuroxine, Sulfa
Vorherige Impfungen: -

VAERS 1024343

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6201

kritisch

Staat: HI
Alter: 75,0
Geschlecht: F
Eingang: 11.02.2021
Impfdatum: 05.02.2021
Beginn: 09.02.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac arrest

Symptomtext

PATIENT ARRIVED TO ED ON 2/9 IN FULL CARDIAC ARREST

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: LUPUS
Andere Medikamente: HYDROXYCHLOROQUINE MONTELUKAST METOPROLOL XL PANTOPRAZOLE
Allergien: ERYTHROMYCIN
Vorherige Impfungen: -

VAERS 2686430

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: TX
Alter: 55,0
Geschlecht: M
Eingang: 26.09.2023
Impfdatum: 12.02.2021
Beginn: 30.01.2022
Tage bis Beginn: 352,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 COVID-19 pneumonia Cough Dyspnoea Intensive care Pneumonia Respiratory failure Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Presented with SOB, cough, congestion; + covid 1/26/22; dx resp failure d/t covid bilat PNA; required transfer to PCU as requiring more O2; eventually weaned to 4 LPM NC; Tx: Decadron, Remdesivir, maxipime, zinc, Vit C, Vit D3, lovenox, Singulair; home on O2

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2668875

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: TX
Alter: 74,0
Geschlecht: F
Eingang: 10.08.2023
Impfdatum: 24.02.2021
Beginn: 18.01.2022
Tage bis Beginn: 328,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 COVID-19 pneumonia Dizziness Fall Head injury Loss of consciousness SARS-CoV-2 test positive

Symptomtext

Chief Complaint: Fall (has been having repeated falls at home, tested COVID +, uknown LOC, hit head, - thinners, dizziness present). COVID-19 pneumonia- currently on room air - tested positive on 01/10/2022 - no treatment warranted at this time. discharged to SNF.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2629227

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 60,0
Geschlecht: M
Eingang: 09.05.2023
Impfdatum: 24.02.2021
Beginn: 09.08.2021
Tage bis Beginn: 166,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Bacteraemia Partial seizures

Symptomtext

FOCAL MOTOR SEIZURE 10/15/2021 BACTEREMIA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Partial seizures
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624665

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 70,0
Geschlecht: F
Eingang: 02.05.2023
Impfdatum: 05.03.2021
Beginn: 11.09.2021
Tage bis Beginn: 190,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Ischaemic stroke

Symptomtext

I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 9/11/2021 PALLIATIVE CARE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ischaemic stroke
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2618713

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: WA
Alter: 73,0
Geschlecht: F
Eingang: 20.04.2023
Impfdatum: 18.02.2021
Beginn: 11.04.2023
Tage bis Beginn: 782,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiomyopathy Electrocardiogram abnormal Myocarditis

Symptomtext

4/11/2023 myocarditis, cardiomyopathy

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: MCG (multifunctional cardiogram) 4/11/2023 myocarditis, cardiomyopathy
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 2613987

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 78,0
Geschlecht: M
Eingang: 12.04.2023
Impfdatum: 04.03.2021
Beginn: 11.05.2021
Tage bis Beginn: 68,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anaemia Anal fistula Bladder squamous cell carcinoma stage unspecified Chronic kidney disease Coagulopathy Deep vein thrombosis Haematuria

Symptomtext

COAGULOPATHY, UNSPECIFIED TYPE 10/2/2021 ANEMIA ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 10/8/2021 ANEMIA COAGULOPATHY, UNSPECIFIED TYPE 10/2/2021 ANEMIA ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 10/8/2021 ANEMIA COAGULOPATHY, UNSPECIFIED TYPE 10/2/2021 HEMATURIA ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 10/8/2021 HEMATURIA COAGULOPATHY, UNSPECIFIED TYPE 10/2/2021 CKD STAGE 3B (GFR 30-44) ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 10/8/2021 CKD STAGE 3B (GFR 30-44) COAGULOPATHY, UNSPECIFIED TYPE 10/2/2021 ANEMIA ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 10/8/2021 ANEMIA COAGULOPATHY, UNSPECIFIED TYPE 10/2/2021 SQUAMOUS CELL CARCINOMA, BLADDER, UNSPECIFIED SITE ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 10/8/2021 SQUAMOUS CELL CARCINOMA, BLADDER, UNSPECIFIED SITE COAGULOPATHY, UNSPECIFIED TYPE 10/2/2021 RECTAL FISTULA ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 10/8/2021 RECTAL FISTULA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2585553

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

schwer

Staat: IN
Alter: 77,0
Geschlecht: F
Eingang: 22.02.2023
Impfdatum: 23.02.2021
Beginn: 21.02.2023
Tage bis Beginn: 728,0
Dosis: 2
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Alanine aminotransferase normal Anion gap Aspartate aminotransferase normal Asthenia Bacterial test positive Basophil count decreased Basophil percentage decreased Bilirubin urine present Blood albumin normal Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium normal Blood chloride decreased Blood creatinine normal Blood folate Blood glucose normal Blood potassium normal Blood pressure increased

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on February 21, 2023 15:49 EST Verified By: MD on February 21, 2023 15:49 EST Encounter Info: Hospital, Observation, 02/21/23 - * Final Report * Document Has Been Revised History of Present Illness/Subjective This is a 79-year-old female with past medical history of asthma, type 2 diabetes, hyperlipidemia, anemia and hypothyroidism presented with complaints of extreme fatigue that has been happening since last couple of months. To the point that it is difficult for her to get up from the bed the patient had her appointment with primary care physician Dr. She endorsed having chest pressure cough and shortness of breath due to which she was referred here. The patient had a recent ED visit on 02/11/2023 at that time she was treated with bronchitis and UTI. Patient tells me that she does not smoke but everyone around her smokes. She has been drinking a lot of fluid. She lives with her son and usually takes care of her her blood pressure is noted to be slightly elevated from the vitals. She is saturating 93% on room air. Her white count is mildly elevated to 11.2. EKG showed lateral leads T wave inversion troponins are slightly 25-29. Her BNP is 318 and she does not have an echocardiogram in the system X-ray suggestive of edema/atypical infection or interstitial lung disease. Review of Systems 13 point review systems negative except for what is mentioned above Physical Exam/Objective Vital Signs (most recent and range for last 24 hours) Temp (CEL) 36.2 (36.2-36.2) Temp (FAHR) 97.2 (97.2-97.2), BP 142/79 (135-165)/(62-83), HR 97 (80-108), RR 20 (20-33), O2Sat 93 (92-93) Patient Weight Current Daily Weight: 52.2 kg 02/21/23 Patient Height Current Height: 154.9 cm 02/21/23 Constitutional: No acute distress, Eyes: PERRLA, EOMI, normal conjunctiva, no scleral icterus ENMT: Moist oral mucosa Neck: Supple, non-tender, intact range of motion Respiratory: Slight expiratory wheezing Cardiovascular: Regular rate and rhythm Gastrointestinal: Soft, non-tender, non-distended Musculoskeletal: No joint swelling, no deformity, intact ROM, no edema Integumentary: Intact, warm, dry no rashes Neurologic: Alert & Oriented Psychiatric: Cooperative, appropriate mood and affect Assessment/Plan #Lethargy - the patient has chronic anemia, i don't see a colonoscopy in the system. - anemia workup, b12, thyroid profile, folate, - needs more PT ???????#chest pain - mild trop elevation, - ekg lateral t wave inversion - follow trops q 6 until downtrending - echo cardiogram , she does have risk factors #Asthma - her home meds, - duonebs PRN #Hypertension -resume home meds #Type 2 diabetes - resume home meds #Hypothyroidism -thyroid profile , given weakness #Pneumonia - she has recently been treatment, i will continue treatment for now - obtain pneumonia workup #Passive smoking - monitor for withdrawal can give lung changes #Diabetic nephropathy - noted 1. Asthma J45.909 2. Diabetes mellitus type 2, uncontrolled E11.65 3. Hypertension I10 4. Hypothyroidism E03.9 5. Microalbuminuric diabetic nephropathy E11.21 6. Normocytic anemia D64.9 Dyspnea R06.00 Weakness R53.1 Code Status None Recorded Chronic Problem List Asthma Diabetes mellitus type 2, uncontrolled Encounter for medication management Gout Hyperlipidemia Hypertension Hypothyroidism Major depression Microalbuminuric diabetic nephropathy Normocytic anemia Procedure/Surgical History ?Diabetic retinal eye exam (01/02/2019) ?back surgery Medications Home Medications (11) Active allopurinol 100 mg oral tablet 100 mg = 1 Tablet, Orally, Daily amLODIPine 5 mg oral tablet 5 mg, Orally, Daily atorvastatin 40 mg oral tablet 40 mg = 1 Tablet, Orally, QHS cyanocobalamin 1000 mCg oral tablet 1,000 mCg = 1 Tablet, Orally, Daily DME Spacer for MDI Not Applicable, Other, Unscheduled glipiZIDE XL 2.5 mg oral tablet, extended release 2.5 mg = 1 Tablet, Orally, Daily levothyroxine 125 mCg (0.125 mg) oral tablet 125 mCg = 1 Tablet, Orally, Daily lisinopril 40 mg oral tablet 40 mg = 1 Tablet, Orally, Daily ProAir HFA 90 mCg/inh inhalation aerosol 1 Puff, PRN, Inhalation, 4 Times Daily Requip 0.5 mg oral tablet 0.5 mg = 1 Tablet, Orally, QHS sertraline 100 mg oral tablet 100 mg = 1 Tablet, Orally, Daily Active Scheduled Inpatient Medications None Reported One-Time Medications Given 02/20/23 00:00:00 TO 02/21/23 15:49:19 Sodium Chloride 0.9% (Sodium Chloride 0.9% - ED Bolus), Infusion, 500 mL, IVPB, ONCE, (1 DOSE 02/21/23 09:51:00) PRN Medications (0600 - 0559) from 02/20 - 02/21 None Reported Allergies NKA Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Substance Abuse Denies Tobacco Tobacco Use: Never (less than 100 in lifetime). Family History Heart attack: Mother. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 11.2 k/cumm High (02/21/23 09:39:00) RBC: 4.16 million/cumm (02/21/23 09:39:00) Hgb: 10.4 GM/dL Low (02/21/23 09:39:00) Hct: 33.7 % Low (02/21/23 09:39:00) MCV: 81 fL (02/21/23 09:39:00) MCH: 25.1 pg Low (02/21/23 09:39:00) MCHC: 31 GM/dL Low (02/21/23 09:39:00) RDW: 14.8 % High (02/21/23 09:39:00) Platelet: 379 k/cumm (02/21/23 09:39:00) MPV: 7.8 fL (02/21/23 09:39:00) Neutrophils %: 76 % (02/21/23 09:39:00) Lymphocytes %: 14 % (02/21/23 09:39:00) Monocytes %: 8 % (02/21/23 09:39:00) Eosinophils %: 3 % (02/21/23 09:39:00) Basophils %: 0 % (02/21/23 09:39:00) Absolute Neutrophil: 8.5 k/cumm High (02/21/23 09:39:00) Absolute Lymphocyte: 1.5 k/cumm (02/21/23 09:39:00) Absolute Monocyte: 0.8 k/cumm (02/21/23 09:39:00) Absolute Eosinophil: 0.3 k/cumm (02/21/23 09:39:00) Absolute Basophil: 0 k/cumm (02/21/23 09:39:00) Chemistry: Sodium SerPl QN: 134 mmol/L Low (02/21/23 09:39:00) Potassium SerPl QN: 4 mmol/L (02/21/23 09:39:00) Chloride SerPl QN: 97 mmol/L Low (02/21/23 09:39:00) Carbon Dioxide SerPl QN: 29 mmol/L (02/21/23 09:39:00) Anion Gap: 8 mmol/L (02/21/23 09:39:00) BUN SerPl QN: 13 mg/dL (02/21/23 09:39:00) Creatinine SerPl QN: 0.81 mg/dL (02/21/23 09:39:00) Estimated GFR (CKD-EPI, no race): 74 mL/min/1.73m2 (02/21/23 09:39:00) Estimated CRCL (CG): 44 mL/min Low (02/21/23 09:39:00) Glucose SerPl QN: 194 mg/dL High (02/21/23 09:39:00) Calcium Total SerPl QN: 9.7 mg/dL (02/21/23 09:39:00) Alkaline Phos SerPl QN: 80 Units/L (02/21/23 09:39:00) ALT SerPl QN: 20 Units/L (02/21/23 09:39:00) AST SerPl QN: 34 Units/L (02/21/23 09:39:00) Bilirubin Total SerPl QN: 0.6 mg/dL (02/21/23 09:39:00) Total Protein SerPl QN: 7.9 GM/dL (02/21/23 09:39:00) Albumin SerPl QN: 3.6 GM/dL (02/21/23 09:39:00) Troponin-I High Sensitivity: 29 ng/L High (02/21/23 09:39:00) BNP Pl QN: 318 pg/mL High (02/21/23 09:39:00) Urine Studies: Color: Yellow (02/21/23 10:16:00) Clarity: Clear (02/21/23 10:16:00) Specific Gravity: 1.010 (02/21/23 10:16:00) pH: 6.5 (02/21/23 10:16:00) Protein: >=300 Abnormal (02/21/23 10:16:00) Glucose: NEGATIVE (02/21/23 10:16:00) Ketones: NEGATIVE (02/21/23 10:16:00) Bilirubin: SC Small Abnormal (02/21/23 10:16:00) Hgb Ur: NEGATIVE (02/21/23 10:16:00) Nitrite: NEGATIVE (02/21/23 10:16:00) Urobilinogen: NormalUro (02/21/23 10:16:00) Leukocyte Esterase Ur: NEGATIVE (02/21/23 10:16:00) WBC: 0-5 (02/21/23 10:16:00) RBC: None Seen (02/21/23 10:16:00) Bacteria: TRACE. (02/21/23 10:16:00) Squamous Epithelial: NONE (02/21/23 10:16:00) Mucous: PRESENT. (02/21/23 10:16:00) Hyaline Casts: 3-5 (02/21/23 10:16:00) All Other Labs: COVID 19 Specimen Source: Nasal (02/21/23 10:06:00) Coronavirus SARS-CoV2 Rapid: Not Detected (02/21/23 10:06:00) Diagnostics Radiology Results - Last 24 hours Across Visits 02/21/2023 09:24 - XR Chest PA or AP IMPRESSION:Slight interval improvement in extensive bilateral interstitialchanges when compared to 11/20/2023. This may still be edema,atypical infection and/or interstitial lung disease or somecombination of the above. Signature Line Electronically Signed on 02/21/23 15:49 EST ________________________________________________________ MD Electronically Signed on 02/21/23 15:50 EST ________________________________________________________ MD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2581133

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: TX
Alter: 77,0
Geschlecht: F
Eingang: 14.02.2023
Impfdatum: 24.02.2021
Beginn: 24.02.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Presyncope

Symptomtext

This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 77-year-old female patient received BNT162b2 (BNT162B2), on 24Feb2021 as dose 2, single (Lot number: EN6201) at the age of 77 years for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (ongoing); "hyperthyroid" (ongoing); "Fibromyalgia" (ongoing). The patient took concomitant medications. Vaccination history included: BNT162b2 (Dose 1, lot EL9262), administration date: 27Jan2021, when the patient was 77-year-old, for Covid-19 immunisation. The following information was reported: DIZZINESS (non-serious) with onset 24Feb2021, outcome "unknown"; PRESYNCOPE (non-serious) with onset 24Feb2021, outcome "unknown", described as "almost passed out". Additional Information: The patient had high blood pressure diagnosed long time ago; don't know when this was diagnosed but she went to her doctor on Tuesday for a regular check up and it was low and was 112 over 60 something, thyroid condition hyperthyroid; was diagnosed a long time ago and she has been taking thyroid medicine for quite a while. 2nd shot she got, she had almost an immediate reaction to that but did not realize that is what it was until later and the reaction was that she got dizzy, had to be driven home and was in a chair at the store; she had gone to physical therapy and went and almost passed out and someone had to come get her.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Blood pressure high; Fibromyalgia; Hyperthyroidism
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2554578

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: NY
Alter: 82,0
Geschlecht: F
Eingang: 09.01.2023
Impfdatum: 09.06.2022
Beginn: 23.10.2022
Tage bis Beginn: 136,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest X-ray normal Hypoxia Loss of consciousness Oxygen saturation decreased Pickwickian syndrome SARS-CoV-2 test positive White blood cell count increased

Symptomtext

10/23/2022- Presents to Ed, passed out while on toilet. Covid + test. WBC-16.2. CXr- no infiltrates. Desat to 88% placed on 4L NC Admit acute hypoxia in setting of obesity hypoventilation. Started decadron. 10/24/2022-No events on tele., on RA now. Normal CXR. Given betelovimab 10/25/2022-VSS. om RA. WBC- 13.4 d/c to SNF.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Osteoathritis, afib, Obesity and HTN
Andere Medikamente: -
Allergien: Narcotics
Vorherige Impfungen: -

VAERS 2546467

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: OH
Alter: 61,0
Geschlecht: F
Eingang: 30.12.2022
Impfdatum: 25.02.2021
Beginn: 01.03.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Embolism Full blood count Platelet count Platelet count decreased

Symptomtext

thromboembolic events; She had the Pfizer mRNA Covid vaccine in Feb2021. In Mar2021 her platelets were at 135,000; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient. A 62-year-old female patient received BNT162b2 (BNT162B2), on 25Feb2021 as dose 2, single (Lot number: EN6201) at the age of 61 years intramuscular, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Date and Time of Start of Drug: 04Feb2021, Batch/lot number: EZ9265, one time intramuscular injection right arm, Pharmaceutical form (Dosage form): Suspension), administration date: 04Feb2021, when the patient was 61-year-old, for COVID-19 immunization. The following information was reported: PLATELET COUNT DECREASED (caused and prolonged hospitalization, medically significant) with onset Mar2021, outcome "not recovered", described as "She had the Pfizer mRNA Covid vaccine in Feb2021. In Mar2021 her platelets were at 135,000"; EMBOLISM (caused and prolonged hospitalization, medically significant) with onset Mar2021, outcome "unknown", described as "thromboembolic events". The patient underwent the following laboratory tests and procedures: Full blood count: (unspecified date) decreased platelet, notes: had a CBC with differential and that is how they discovered the decreased platelet; Platelet count: (2020) 187,000, notes: In 2020 before any vaccine at her physical her platelets were 187,000; (Mar2021) 135,000, notes: decreased; (unspecified date) Unknown results. Clinical course: Reported that in 2020 before any vaccine at her physical her platelets were 187,000. She had the Pfizer mRNA Covid vaccine in Feb2021 had two doses three weeks apart. In Mar2021 her platelets were at 135,000. In Dec2021 she had the first booster. Any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was none reported. There was investigation assessment. For thromboembolic events with thrombocytopenia: Yes had a CBC with differential and that was how they discovered the decreased platelet. It was first noticed at her physical. Initially, they were not specifically looking for it. They also did titrated platelet level. Antibody test to platelet factor IV was none reported.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the reported event of platelet count decreased and embolism and BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Embolism
Hospital-Tage: -
Labordaten: Test Name: CBC with differential; Result Unstructured Data: Test Result:decreased platelet; Comments: had a CBC with differential and that is how they discovered the decreased platelet; Test Date: 2020; Test Name: platelets; Result Unstructured Data: Test Result:187,000; Comments: In 2020 before any vaccine at her physical her platelets were 187,000.; Test Date: 202103; Test Name: Platelets decreased; Result Unstructured Data: Test Result:135,000; Comments: decreased; Test Name: titrated platelet level; Result Unstructured Data: Test Result:Unknown results
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Other Conditions: No
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2410804

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

schwer

Staat: OH
Alter: 62,0
Geschlecht: F
Eingang: 30.12.2022
Impfdatum: 16.12.2021
Beginn: 01.03.2022
Tage bis Beginn: 75,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram head Full blood count Head injury Loss of consciousness Platelet count Platelet count decreased

Symptomtext

Passed out when platelets were low; hit head when platelets were low; Platelets decreased; This is a spontaneous report received from a contactable reporter(s) (Pharmacist), Program ID: (Unknown). The reporter is the patient. A 62-year-old female patient received BNT162b2 (BNT162B2), on 16Dec2021 as dose 3 (booster), single (Lot number: PJ8757) at the age of 62 years intramuscular, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Date and Time of Start of Drug: 04Feb2021, Batch/lot number: EZ9265, Dosage text: unknown dose one time intramuscular injection right arm), administration date: 04Feb2021, when the patient was 61-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 2, SINGLE, Date: 25Feb2021 Time: Not provided Anatomical Site of injection: right arm. Route of Administration: intramuscular; if other, please specify: Batch/Lot number: EN6201), administration date: 25Feb2021, when the patient was 61-year-old, for COVID-19 Immunization, reaction(s): "She had the Pfizer mRNA Covid vaccine in Feb2021. In Mar2021 her platelets were at 135,000". The following information was reported: PLATELET COUNT DECREASED (hospitalization, medically significant) with onset Mar2022, outcome "not recovered", described as "Platelets decreased"; LOSS OF CONSCIOUSNESS (hospitalization, medically significant) with onset 07Apr2022, outcome "recovered with sequelae" (07Dec2022), described as "Passed out when platelets were low"; HEAD INJURY (hospitalization) with onset 07Apr2022, outcome "recovered with sequelae" (07Apr2022), described as "hit head when platelets were low". The patient was hospitalized for platelet count decreased, loss of consciousness, head injury (start date: 07Apr2022, discharge date: 08Apr2022, hospitalization duration: 2 day(s)). The events "platelets decreased", "passed out when platelets were low" and "hit head when platelets were low" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Computerised tomogram head: (07Apr2022) Unknown Results; Full blood count: (unspecified date) Unknown Results; Platelet count: (unspecified date) 187,000, notes: In 2020 before any vaccine at her physical her platelets were 187,000; (Mar2021) 135000; (Mar2022) 57; (2022) 54; (unspecified date) Unknown results. Therapeutic measures were taken as a result of platelet count decreased, loss of consciousness, head injury. Clinical course: It was reported that, source of assessment was Primary Source Reporter, Method of assessment was Global Introspection and Result of Assessment was provided as Yes. No Other Conditions and Other Products. Patient who mentioned that she wanted to report an adverse event for Pfizer Covid 19 vaccine. Did not specify the adverse event. Clarified that she was the patient. In 2020 before any vaccine at her physical her platelets were 187,000. She had the Pfizer mRNA Covid vaccine in Feb2021 had two doses three weeks apart. In Mar2021 her platelets were at 135,000. In Dec2021 she had the first booster. Her platelets in Mar2022 went down to 57. Repeated the lab the next week and they were down to 54. Was referred to a hematologist and had been treated by them since then. Clarified the booster as Pfizer booster. Event details: Platelets decreased: Confirmed are still decreased. Treatment: Hematologist puts her on Prednisone when the platelets went down below 30 due to the vaccine and she would be on it to bring them up and it would bring them up. Cannot stay on Prednisone indefinitely. The Hematologist would take her off Prednisone for a few weeks and the platelets will continue to go down so this was not a temporary situation. Was hooked up to an 30 day event monitor to monitor to cardiac activity. No further details provided. Outcome: When probed for details she initially stated it would not stabilize without Prednisone so would say it worsened. Later stated, had recovered but her platelets are still down. Unable to clarify outcome further. Passed out when platelets were low: Happened twice once at house and after her head CT on 07Apr2022. Onset Date was 07Apr2022 Onset Time 10:00 for Passed out when platelets were low and Hit her head when platelets were low. No further details provided about her head CT. Had recovered but her platelets are still down. Treatment: None, was seeing the hematologist five days later when treatment was set. Later clarified no treatment. Hit her head when her platelets were low: Happened on 07Apr2022. Had recovered but her platelets are still down. Treatment: None, was seeing the hematologist five days later when treatment was set. Later clarified no treatment. Prior Vaccinations (within 4 weeks): If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was None. Specific Relevant Test: For Thromboembolic Events with Thrombocytopenia: Yes had a CBC with differential and that was how they discovered the decreased platelet. It was first noticed at her physical. Initially, they were not specifically looking for it. They also did titrated platelet level. Test: Antibody test to platelet factor IV was None. Adverse Events: Note: For Thromboembolic Events with Thrombocytopenia Include specific relevant test above; Sender's Comments: Based on available information and the temporal association, a possible contributory role of Comirnaty vaccine cannot be excluded for the reported events of "PLATELET COUNT DECREASED ","LOSS OF CONSCIOUSNESS " and "HEAD INJURY . The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 2,0
Labordaten: Test Date: 20220407; Test Name: Head CT; Result Unstructured Data: Test Result:Unknown Results; Test Name: CBC with differential; Result Unstructured Data: Test Result:Unknown Results; Test Name: Platelets decreased; Result Unstructured Data: Test Result:187,000; Comments: In 2020 before any vaccine at her physical her platelets were 187,000.; Test Date: 202103; Test Name: Platelets decreased; Result Unstructured Data: Test Result:135000; Test Date: 202203; Test Name: Platelets decreased; Result Unstructured Data: Test Result:57; Test Date: 2022; Test Name: Platelets decreased; Result Unstructured Data: Test Result:54; Test Name: titrated platelet level; Result Unstructured Data: Test Result:Unknown results
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Other Conditions: No
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2407005

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: MD
Alter: -
Geschlecht: M
Eingang: 10.08.2022
Impfdatum: 05.02.2021
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anaphylactic reaction

Symptomtext

the patient experienced an anaphylactic reaction; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2022NVX-US-000002628 (Novavax). A male patient received BNT162b2 (BNT162B2), on 05Feb2021 as dose number unknown, single (Lot number: EN6201) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANAPHYLACTIC REACTION (medically significant), outcome "unknown", described as "the patient experienced an anaphylactic reaction". Clinical course: On 14Jul2022, it was reported that a patient started treatment on 05Feb2021 with Pfizer BioNTech COVID-19 vaccine at an unreported dose/frequency for an unreported indication. It was reported the patient experienced an anaphylactic reaction. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2318546

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: TN
Alter: 73,0
Geschlecht: M
Eingang: 14.06.2022
Impfdatum: 24.02.2021
Beginn: 28.10.2021
Tage bis Beginn: 246,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Arthralgia Cardiomyopathy Computerised tomogram Dyspnoea Gait disturbance Hypoaesthesia Investigation Magnetic resonance imaging Paraesthesia Pulmonary oedema SARS-CoV-2 test

Symptomtext

an episode of inability to breathe; cardiomyopathy; pulmonary edema; lose feeling in my lower extremities; My hips begin to hurt; both legs go numb; unable to walk for more than 200 feet; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 73-year-old male patient received BNT162b2 (BNT162B2), on 24Feb2021 at 08:15 as dose 2, single (Lot number: EN6201) at the age of 73 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "high cholestrol" (unspecified if ongoing); "atherosclorsis" (unspecified if ongoing); "Penicillin Allergy" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: pfizer (Dose Number: 1, Batch/Lot No: EN5318, Location of injection: Arm Left, Vaccine Administration Time: 08:00 AM), administration date: 03Feb2021, for Covid-19 Immunization. Patient did not receive any other vaccines within 4 weeks prior and received unspecified other medications 2 weeks prior to the COVID vaccine. The patient was not tested positive for covid 19 prior to vaccination and tested post vaccination. The following information was reported: ARTHRALGIA (disability) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae", described as "My hips begin to hurt"; DYSPNOEA (hospitalization, disability, life threatening) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae", described as "an episode of inability to breathe"; HYPOAESTHESIA (disability) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae", described as "both legs go numb"; CARDIOMYOPATHY (hospitalization, disability, medically significant, life threatening) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae"; PARAESTHESIA (disability) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae", described as "lose feeling in my lower extremities"; PULMONARY OEDEMA (hospitalization, disability, medically significant, life threatening) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae", described as "pulmonary edema"; GAIT DISTURBANCE (disability) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae", described as "unable to walk for more than 200 feet". The patient was hospitalized for dyspnoea, cardiomyopathy, pulmonary oedema (hospitalization duration: 5 day(s)). The events "an episode of inability to breathe", "cardiomyopathy", "pulmonary edema", "lose feeling in my lower extremities", "my hips begin to hurt", "both legs go numb" and "unable to walk for more than 200 feet" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Computerised tomogram: (unspecified date) Unknown results; Neurological tests: (unspecified date) Unknown results; Magnetic resonance imaging: (unspecified date) Unknown results; SARS-CoV-2 test: (28Oct2021) Negative, notes: Nasal Swab. Therapeutic measures were taken as a result of dyspnoea, cardiomyopathy, pulmonary oedema, paraesthesia, arthralgia, hypoaesthesia, gait disturbance. Clinical course: No other vaccine on same date. It was reported that, approximately 2 months after the second dose, he began to lose feeling in his lower extremities. His hips begin to hurt and then both legs go numb. This started in April, 2021. This problem continues to present with no explanation after numerous MRIs, cat scans and neurological tests. He was unable to walk for more than 200 feet without legs going numb. In October he experienced an episode of inability to breathe. After a week in the hospital, he was diagnosed with pulmonary edema and cardiomyopathy. This occurred in October2021. Ae resulted in: [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage]. Ae treatment: Various from cat scans to MRI's to medications.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: 5,0
Labordaten: Test Name: CT scan; Result Unstructured Data: Test Result:Unknown results; Test Name: Neurological tests; Result Unstructured Data: Test Result:Unknown results; Test Name: MRI; Result Unstructured Data: Test Result:Unknown results; Test Date: 20211028; Test Name: Nasal Swab; Test Result: Negative ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Atherosclerosis; Cholesterol; Hypertension; Penicillin allergy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2309676

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 05.06.2022
Impfdatum: 01.03.2022
Beginn: 03.06.2022
Tage bis Beginn: 94,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Agitation Computerised tomogram head normal Endotracheal intubation Respiratory distress Seizure Unresponsive to stimuli

Symptomtext

Patient was staring off at Skilled Nursing Facility, patient then had a seizure in ER - requiring intubated for respiratory distress. Patient's cause of seizure is of unclear etiology per Neuro Critical Care Physician Note. MRI pending, patient still intubated, not following commands and not answering orientation questions despite being all small dose of sedation for agitation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory distress
Hospital-Tage: 2,0
Labordaten: CT head 6/3/2022 - Showed no new findings other than old CVA territory. MRI pending 6/5
Aktuelle Erkrankungen: Diabetes Type 2, Parkinson's Disease, COPD (on home O2)
Vorgeschichte: -
Andere Medikamente: -
Allergien: Pencillin and Blue Dye
Vorherige Impfungen: -

VAERS 2280458

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: CA
Alter: 73,0
Geschlecht: F
Eingang: 22.05.2022
Impfdatum: 19.11.2021
Beginn: 19.11.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Angina pectoris Arthralgia Blindness Blood test Cardiac disorder Balance disorder Chest pain Cognitive disorder Diastolic dysfunction Disorientation Dizziness Dyspnoea Dyspnoea exertional Echocardiogram abnormal Electric shock sensation Fatigue Feeding disorder Headache

Symptomtext

Woke up that night in excruciating pain, body aches, rigid muscles, swollen joints (could not form a fist). Extreme fatigue and disorientation; headache, slight fever; shortness of breath; painful chest and heart; high blood pressure, then disregulated blood pressure after that; smell and taste off; significant weight loss from 132 to 120 lbs in two weeks; could not eat; shortness of breath on exertion is still bad at 6 months post-booster. Neuropathy (shooting electric shocks). Temperature not regulated (over-heat). Cognitive impairment; dizziness and balance problems; had either a TIA or ocular migraine April 2022 when I lost vision, and impaired vision; vision regained; ECHO ultrasound (May 2022) shows left v left ventricle diastolic dysfunction, Stage II. I had no prior heart condition or heart damage before the booster shot last November. At 6 months or so post-booster I am essentially disabled. Cannot perform normal living duties (home or garden). Shortness of breath, chest discomfort. I cannot sustain mental work - get fatigued and cognition is not good. PULS blood test for unstable cardiac lesions showed a 27% risk of ACS (5-yr). I am recovering some functions (smell, taste).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: ECHO ultrasound April 2022 PULS blood tests March and May 2022
Aktuelle Erkrankungen: none
Vorgeschichte: asthma, arthritis, electrosensitive
Andere Medikamente: Hydrochlorothiazide 12.5 mG; Wixeka (Advair)
Allergien: caynne pepper (red)
Vorherige Impfungen: -

VAERS 2277718

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 83,0
Geschlecht: F
Eingang: 14.05.2022
Impfdatum: 22.02.2021
Beginn: 14.03.2022
Tage bis Beginn: 385,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Asthenia Computerised tomogram head Corneal reflex decreased Electroencephalogram Endotracheal intubation Gaze palsy Klebsiella infection Muscular weakness Seizure Urinary tract infection

Symptomtext

Patient has been in hospital since 3/14/2022 for klebsiella UTI. 5/9/2022 While on the unit, she began having a seizure and experienced gaze preference with limb weakness. While getting a STAT Head CT patient had another seizure and was intubated on arrival to NCC. Continuous EEG was started. Patient is still intubated at this time and still has weakness, impaired corneal reflexes and a upward gaze preference.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 60,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 2270903

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 88,0
Geschlecht: M
Eingang: 11.05.2022
Impfdatum: 15.02.2021
Beginn: 16.02.2022
Tage bis Beginn: 366,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Respiratory distress SARS-CoV-2 test positive

Symptomtext

02/16/22 presents to ED for "Respiratory Distress". PMHx of "COPD on chronic 15 L high flow nasal cannula therapy at home, right-sided heart failure"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory distress
Hospital-Tage: -
Labordaten: 02/16/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2266036

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: PA
Alter: 35,0
Geschlecht: M
Eingang: 06.05.2022
Impfdatum: 23.01.2021
Beginn: 13.04.2022
Tage bis Beginn: 445,0
Dosis: 2
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Deep vein thrombosis Ultrasound Doppler abnormal

Symptomtext

Blood clot (DVT) left leg. Prescribed blood 30 Mg of blood thinners daily for life.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 1,0
Labordaten: Ultrasound 4/17/22 at Hospital.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2234200

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: CT
Alter: 65,0
Geschlecht: M
Eingang: 14.04.2022
Impfdatum: 01.10.2021
Beginn: 13.02.2022
Tage bis Beginn: 135,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Atrioventricular block complete Cardiac pacemaker insertion Cardiac stress test normal Dyspnoea Electrocardiogram abnormal Electrocardiogram normal Intensive care Nausea Syncope X-ray

Symptomtext

On 2/13, I fainted while sitting on the couch. Went to see Dr on 2/17 who found an abnormal EKG. On 2/18 and 2/23 I had an ECG and Chemical Stress test. Both were normal On 2/27 I woke up during the night unable to breathe, and became nauseous. We were at our daughters in another state at the time. My wife accompanied me to Medical Ctr, where I was found to be in complete heart blockage. My BP on admittance was 156/90 and a pulse of 21. I was put on an external pacemaker immediately and a permanent one was implanted on Monday, 2/28. We flew back to CT on Friday 3/4. I have since followed up with Dr., Dr. (Cardiologist) and will see Dr. on 5/5

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 2,0
Labordaten: Multiple EKGs, XRays related to ER visit first, then admittance to the CCU post implant
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetic, environmental allergies, allergic asthma
Andere Medikamente: Trulicity, Jardiance, Metformin, Pravastatin, Paroxetine, Benezapril, Omeprazole
Allergien: Codeine if injected
Vorherige Impfungen: -

VAERS 1288429

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: CA
Alter: 54,0
Geschlecht: F
Eingang: 04.04.2022
Impfdatum: 29.03.2021
Beginn: 29.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time prolonged Angiogram Anticoagulant therapy Asthenia Chills Anaemia Anorectal operation Blood test abnormal Condition aggravated Crohn's disease Computerised tomogram abdomen abnormal Computerised tomogram intestine Decreased appetite Deep vein thrombosis Dyspnoea Endoscopy Fatigue Diarrhoea

Symptomtext

The inflammation in my intestines that the vaccine triggered is now causing me to have the large intestine and rectum removed by surgery. I am having protococolectomy to reduce inflammatory burden. I continue to have partial bowel obstruction and dysfunction. The doctors have tried entyvio infusion (biologic) and prednisone. The inflammation has increased.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 8,0
Labordaten: CTE on the night of the 13th. Morning of the 14th they did a full endoscopy, the ileostomy, sigmoidoscopy and those confirmed I was having active Chrons flair. Recently, I had CTE on 2-22-2022 and Ileoscopy on 3-22-2022. On 3-18-2022, I had a complete blood panel which showed continued anemia.
Aktuelle Erkrankungen: Multiple Sclerosis, Crohn's Disease with Ileostomy, Chronic Shingles
Vorgeschichte: Multiple Sclerosis, Crohn's Disease with Ileostomy, Chronic Shingles
Andere Medikamente: VALACYCLOVIR, Gabapentin, Percocet, Diazepam, Diflucan
Allergien: Remicade, Stelara, Budesonide, Dilaudid, Iron infusion (causes clot), diary, gluten intolerance.
Vorherige Impfungen: -

VAERS 1288429

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

schwer

Staat: CA
Alter: 54,0
Geschlecht: F
Eingang: 04.04.2022
Impfdatum: 29.03.2021
Beginn: 29.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time prolonged Angiogram Anticoagulant therapy Asthenia Chills Anaemia Anorectal operation Blood test abnormal Condition aggravated Crohn's disease Computerised tomogram abdomen abnormal Computerised tomogram intestine Decreased appetite Deep vein thrombosis Dyspnoea Endoscopy Fatigue Diarrhoea

Symptomtext

The inflammation in my intestines that the vaccine triggered is now causing me to have the large intestine and rectum removed by surgery. I am having protococolectomy to reduce inflammatory burden. I continue to have partial bowel obstruction and dysfunction. The doctors have tried entyvio infusion (biologic) and prednisone. The inflammation has increased.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 8,0
Labordaten: CTE on the night of the 13th. Morning of the 14th they did a full endoscopy, the ileostomy, sigmoidoscopy and those confirmed I was having active Chrons flair. Recently, I had CTE on 2-22-2022 and Ileoscopy on 3-22-2022. On 3-18-2022, I had a complete blood panel which showed continued anemia.
Aktuelle Erkrankungen: Multiple Sclerosis, Crohn's Disease with Ileostomy, Chronic Shingles
Vorgeschichte: Multiple Sclerosis, Crohn's Disease with Ileostomy, Chronic Shingles
Andere Medikamente: VALACYCLOVIR, Gabapentin, Percocet, Diazepam, Diflucan
Allergien: Remicade, Stelara, Budesonide, Dilaudid, Iron infusion (causes clot), diary, gluten intolerance.
Vorherige Impfungen: -

VAERS 2127848

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: IL
Alter: 72,0
Geschlecht: F
Eingang: 30.03.2022
Impfdatum: 16.11.2021
Beginn: 06.12.2021
Tage bis Beginn: 20,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Asthenia Balance disorder Dizziness Electronystagmogram abnormal Syncope Fall Nausea SARS-CoV-2 test Vertigo Vomiting

Symptomtext

Within 7 days of vaccine I experienced dizziness and imbalance. On Dec 6; I collapsed to the floor with vomiting and extreme dizziness. I was taken by ambulance to a local Hospital. Treated with zofran; Valium and meclazine. Symptoms continued at home. I was treated by a Home Health service~6 weeks. Primary care: Dr prescribed 50mg prednisone x5 days ENT: Outpatient therapy at a HCF

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 1,0
Labordaten: Available upon request VNG 66% weakness right ear
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma well controlled; anxiety and depression
Andere Medikamente: Trelogy ellipta, Singular; Albuterol; Zoloft; CoQ10; Crestor, Calcium; Ibuprofen
Allergien: Macrodantin; Tramadol
Vorherige Impfungen: -

VAERS 2194585

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: TX
Alter: 66,0
Geschlecht: F
Eingang: 23.03.2022
Impfdatum: 23.02.2021
Beginn: 13.09.2021
Tage bis Beginn: 202,0
Dosis: 2
Route/Site: IM / OT

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia COVID-19 COVID-19 pneumonia Chronic obstructive pulmonary disease Cough Dyspnoea Endotracheal intubation Intensive care Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

Presented with weakness, 2 weeks dry cough/SOB; + covid in ED; Admitted 9/13 to medical with Covid PNA/COPD exacerbation; 9/13 zithromax, maxipime, rocephin, singulair, steroid protocol, remdesivir, zinc started; 9/14 symbicort started; 9/16 Tigecycline, merrem started; 9/17 actemra; O2 requirements: initially on Bipap (due to High CO2), 9/15 HF NC O2; 9/16 back to Bipap and then intuabted, tx to ICU; 9/19 extubated to 5 LPM NC 9/20 out of ICU; to SNF at DC, remains on AirVo 50/60

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2162571

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: OH
Alter: 73,0
Geschlecht: M
Eingang: 07.03.2022
Impfdatum: 28.11.2021
Beginn: 25.01.2022
Tage bis Beginn: 58,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory distress syndrome COVID-19 Chest X-ray abnormal Cough Dyspnoea Oropharyngeal pain Pneumonia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Patient tested positive for Covid on 01/17/2022. Admitted to hospital on 01/25/2022 with symptoms: runny nose, sore throat, cough, shortness of breath. Patient develop pneumonia and was in acute respiratory distress. Patient did have an abnormal chest xray. Patient has multiple underlying health conditions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory distress syndrome
Hospital-Tage: 7,0
Labordaten: SARS-CoV-2 Antigen tested positive 01/17/2022
Aktuelle Erkrankungen: diabetes, cardiovascular disease, hypertension
Vorgeschichte: diabetes, cardiovascular disease, hypertension
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2148563

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: MN
Alter: 81,0
Geschlecht: M
Eingang: 28.02.2022
Impfdatum: 18.02.2021
Beginn: 27.02.2022
Tage bis Beginn: 374,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Intensive care SARS-CoV-2 test positive

Symptomtext

admission date 2/27 There is no acute sign at this time. He did screen positive for COVID-19. There is no symptoms of pneumonia or other complicated illness from infection at this time. He will proceed to the medical ICU for further management. dose 3 (pfizier) given 9/28/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2132201

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: KY
Alter: 73,0
Geschlecht: F
Eingang: 22.02.2022
Impfdatum: 29.09.2021
Beginn: 04.02.2022
Tage bis Beginn: 128,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time shortened Alanine aminotransferase normal Albumin globulin ratio normal Angiogram pulmonary abnormal Anion gap Arteriogram coronary abnormal Aspartate aminotransferase normal Basophil count normal Basophil percentage Blood albumin normal Blood alkaline phosphatase increased Blood bilirubin normal Blood calcium normal Blood chloride normal Blood creatinine normal Blood glucose normal Blood magnesium normal Blood potassium normal

Symptomtext

2/4/22 74-year-old white female who presents to the emergency department with a chief complaint of "having all the symptoms of a heart attack". The patient has a history of prior myocardial infarction and states she began having all the same symptoms tonight. She complains of left-sided chest pressure that radiates to the left side of the neck and left shoulder region that began around 12:30 AM tonight while working as a cashier. The pain is resolved at the time of my evaluation, lasting roughly an hour. The pain was associated with shortness of breath, nausea, and diaphoresis. She had no vomiting. She felt lightheaded and near syncopal but did not lose consciousness. She denies any exacerbating or relieving She denies any exacerbating or relieving factors, stating that her relief was spontaneous. She denies any recent fever, sore throat, or runny nose. She states she has a chronic cough. She denies lower extremity pain and swelling. She denies abdominal pain, diarrhea, and bloody stools. Review of Systems Constitutional: Negative for chills and fever. HENT: Negative for congestion, sore throat and sinus pressure. Eyes: Negative for redness and itching. Respiratory: Positive for cough (Chronic) and shortness of breath. Cardiovascular: Positive for chest pain. Negative for leg swelling. Gastrointestinal: Negative for abdominal pain, diarrhea, nausea and vomiting. Genitourinary: Negative for dysuria and hematuria. Musculoskeletal: Negative for back pain. Skin: Negative for rash. Neurological: Positive for light-headedness. Negative for syncope and headaches. Hematological: Negative for adenopathy. Psychiatric/Behavioral: Negative for confusion. All other systems reviewed and are negative. Discharged Condition: stable Hospital Course: 74-year-old female presented to emergency department with complaint of chest pain and shortness of breath that began while she was at work as a cashier at a convenience store. She endorsed associated nausea, diaphoresis, and lightheadedness. She has a history of myocardial infarction and was concerned symptoms were that of another MI. Vital signs on presentation were unremarkable: Temp 97.7, pulse 88, BP 145/91, respiratory rate 20, SPO2 100%. Laboratory studies were unremarkable. Troponins were flat x4. Covid testing is positive and CTA chest did reveal extensive bilateral groundglass opacities typical of COVID-19 virus infection. Following presentation she required supplemental O2 to maintain oxygen saturation greater than 90%. Respiratory status is stable on 2 L O2 BNC, SPO2 96%. No increased work of breathing conversational dyspnea. She was started on dexamethasone and vitamin supplementation. Initial CRP was 0.4. We suspect presenting chest pain and shortness of breath are related to COVID. The patient was monitored with continuous telemetry following her admission and no arrhythmias were detected. Fortunately the patient's respiratory status remained stable for her brief hospital course. She was maintaining adequate oxygen saturations on 2 L O2. She will be set up for supplemental O2 BNC, to be delivered to her room prior to her discharge today. She will be followed on an ongoing basis by the hospital. She already has a pulse oximeter at home and she will be provided with a BP cuff.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: 1,0
Labordaten: 2/4/22 COVID-19 Result Detected Abnormal CBC w/Diff Collection Time: 02/04/22 1:48 AM Result Value Ref Range White Blood Count 7.97 4.5 - 11.0 10*3/uL Red Blood Count 4.57 4.0 - 5.2 10*6/uL Hemoglobin 14.2 12.0 - 16.0 g/dL Hematocrit 43.6 36.0 - 46.0 % Mean Corpuscular Volume 95.4 80.0 - 100.0 fL Mean Corpuscular Hemoglobin 31.1 26.0 - 34.0 pg Mean Corpuscular HGB Conc 32.6 31.0 - 37.0 g/dL Red Cell Distribution Width-CV 13.5 12.0 - 16.8 % Platelet Count 274 140 - 440 10*3/uL Mean Platelet Volume 11.6 8.4 - 12.4 fL Diff Type Hospital CBC w/AutoDiff (arb'U) Neutrophils % 68.9 45 - 80 % Lymphocyte % 21.6 15 - 50 % Monocyte % 7.2 0 - 15 % Eosinophil% 1.5 0 - 7 % BASO% 0.5 0 - 2 % Immature Granulocyte% 0.3 0.0 - 1.0 % Nucleated RBC % 0 0 /100(WBC) Neutrophil Abs 5.50 2.0 - 8.8 10*3/uL Lymphocyte-Absolute 1.72 0.7 - 5.5 10*3/uL Monocyte Absolute 0.57 0.0 - 1.7 10*3/uL EOS-Absolute 0.12 0.0 - 0.8 10*3/uL Basophil Abs 0.04 0.0 - 0.2 10*3/uL Immature Granulocyte Abs 0.02 0.00 - 0.10 10*3/uL Comprehensive Metabolic Panel(CMP) Collection Time: 02/04/22 1:48 AM Result Value Ref Range Sodium 138 136 - 145 mmol/L Potassium 3.5 3.5 - 5.1 mmol/L Chloride 102 98 - 107 mmol/L Carbon Dioxide 19 (L) 22 - 29 mmol/L Anion Gap 17 (H) 5 - 13 (arb'U) Glucose 175 (H) 74 - 99 mg/dL Blood Urea Nitrogen (BUN) 15 10 - 20 mg/dL Creatinine-Blood 0.95 0.55 - 1.02 mg/dL BUN/Creatinine Ratio 15.8 RATIO Estimated GFR 58 (L) >60 /1.73 m2 Estimated GFR if African-American >60 >60 /1.73 m2 Total Protein 7.4 6.2 - 8.0 g/dL Albumin 3.8 3.2 - 4.6 g/dL Globulin 3.6 1.5 - 4.5 g/dL Albumin/Globulin Ratio 1.1 1.1 - 2.5 RATIO Calcium 9.7 8.4 - 10.2 mg/dL Total Bilirubin 0.9 0.2 - 1.2 mg/dL AST/SGOT 28 5 - 34 U/L ALT/SGPT 32 0 - 55 U/L Alkaline Phosphatase 135 40 - 150 U/L B-Type Natriuretic Peptide Collection Time: 02/04/22 1:48 AM Result Value Ref Range B-Type Natriuretic Peptide 38.2 3 - 160 pg/mL Magnesium Collection Time: 02/04/22 1:48 AM Result Value Ref Range Magnesium 1.8 1.6 - 2.6 mg/dL Troponin Collection Time: 02/04/22 1:48 AM Result Value Ref Range Troponin 0.018 0.000 - 0.034 ng/mL D-Dimer,Quantitative Collection Time: 02/04/22 2:25 AM Result Value Ref Range D-DIMER 982 (H) <500 ng/mL FEU Protime-INR Collection Time: 02/04/22 2:25 AM Result Value Ref Range Prothrombin Time 11.7 10.3 - 13.3 s INR 1.0 INR Partial Thromboplastin Time Collection Time: 02/04/22 2:25 AM Result Value Ref Range Partial Thromboplastin Time 29.0 25.1 - 36.5 s Repeat Troponin 2 Hours after the Initial Troponin is drawn Collection Time: 02/04/22 4:13 AM Result Value Ref Range Troponin 0.022 0.000 XR Chest 1 Vw 2/4/22 IMPRESSION: Cardiomegaly CT Angiogram Chest For PE 2/4/22 IMPRESSION: 1. No pulmonary embolism. 2. Cardiomegaly. 3. Heterogeneous groundglass opacities are seen, correlate with edema. Infectious process not excluded.
Aktuelle Erkrankungen: -
Vorgeschichte: Anxiety o Asthma o Benign essential HTN o COPD (chronic obstructive pulmonary disease) o Coronary artery disease o Heart attack o Hyperlipidemia o Myocardial infarction 6/18/14 Anterior o Obstructive sleep apnea o Pneumonia o Stroke o Urinary tract infection
Andere Medikamente: albuterol (ACCUNEB) 1.25 MG/3ML nebulizer solution, Take 1 ampule by nebulization every 4 (four) to 6 (six) hours as needed for Wheezing or Shortness of Air. o albuterol (ACCUNEB) 1.25 MG/3ML nebulizer solution, Take 3 mLs by nebulization
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2084920

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: MI
Alter: 73,0
Geschlecht: M
Eingang: 03.02.2022
Impfdatum: 30.09.2021
Beginn: 27.01.2022
Tage bis Beginn: 119,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anaemia Arthralgia Aspiration joint Asymptomatic COVID-19 Blood culture negative Blood sodium decreased Blood test abnormal Blood uric acid decreased Bone disorder C-reactive protein increased Chest pain Condition aggravated Echocardiogram normal Embolism Gait inability Haemofiltration Hyponatraemia Hypotension

Symptomtext

Hospitalized 01/27/2022; COVID-19 positive 1/4/2022 (no documentation just stated in d/c summary) documented COVID-19 positive 01/27/2022; fully vaccinated plus booster Admission Date: 1/27/2022 Discharge Date: 02/01/2022 Admitting Physician: PRIVACY Attending Physician: PRIVACY Discharge Clinician: PRIVACY Primary Care Provider at Discharge: PRIVACY Hospital Course: Patient is a 73 y.o. male with past medical history significant for CHF, A. fib, s/p redo AVR due to Strep. Group B endocarditis 12/3/21, anemia, CAD, HTN who presented to ED with complaints of R knee pain and swelling. Patient had recent prolonged admission 11/26-12/30 for chest pain, hypotension and renal failure requiring CRRT. He was on vent and pressors but was eventually weaned off both. Developed Strep. Group B endocarditis for which he completed course of Rocephin through 1/14. Was discharged to MFB for rehab. While at hospital he had a positive COVID test on 1/4 though was asymptomatic. Was d/c back home about a week ago. About 3 days PTA he started having R knee pain and swelling. The pain in his right knee became more severe to the point where he could not ambulate secondary to the pain. He notes that he was also unable to bend his knee secondary to the pain. He was also having R foot pain. He does have chronic distal phalanx thromboembolism of bilateral toes. Denies any drainage or foul smell from wounds. Notes that his wife changes his dressings and puts iodine on his wounds daily. Upon arrival to the ED, patient had low grade fever but vitals were otherwise stable. Baseline blood work was obtained showing WBC 14.7, elevated ESR/CRP, minor hyponatremia of 131, stable chronic anemia. INR 1.9. Covid test persistently positive. Blood cultures were obtained. US RLE negative for DVT. XR R knee showing subtle new irregularity about lateral aspect of lateral tibial plateau w/ enlarged joint effusion. Ortho performed bedside arthrocentesis in ED. They did not feel it was consistent with septic arthritis at this time. Cultures negative, no crystals in fluid, blood uric acid low. Patient treated with Vanc for 3 days (MRSA screen negative) and Zosyn for 5 days. CRP improved from 169.1 to 68.8. Echocardiogram from 1/26 did now show any valvular vegetations. Evaluated by PT/OT who initially recommended acute rehab. PMR recommended home with home therapy. He is established with services already and this was verified

Weitere VAERSDATA-Felder

Praegender Schweregrund: Embolism
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension CAD (coronary artery disease) Bioprosthetic Aortic insufficiency CHF (congestive heart failure), NYHA class IV, acute, combined Ventricular ectopy Endocarditis Obesity Liver dysfunction Unspecified severe protein-calorie malnutrition Postoperative anemia due to acute blood loss AKI (acute kidney injury) BPH (benign prostatic hyperplasia) Hypercholesterolemia DM (diabetes mellitus), type 2 S/P AVR (aortic valve replacement), 3/2012; with redo AVR and root homograph placement 12/3/2021. Ischemic toe ulcer
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet ALPRAZolam (XANAX) 0.25 MG tablet ascorbic acid (VITAMIN C) 500 MG tablet aspirin 81 MG chewable tablet atorvastatin (LIPITOR) 10 MG tablet enoxaparin sodium (LOVENOX) 120 MG/0.8ML SOLN guaifenesin (HUM
Allergien: Codeine Hydrocodone-acetaminophen Vicodin [Hydrocodone-acetaminophen}
Vorherige Impfungen: -

VAERS 2647081

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: NC
Alter: 79,0
Geschlecht: F
Eingang: 25.01.2022
Impfdatum: 28.01.2021
Beginn: 24.12.2021
Tage bis Beginn: 330,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Back pain COVID-19 Carditis Chest X-ray normal Chest pain Echocardiogram Electrocardiogram Pericarditis X-ray limb normal

Symptomtext

had COVID mid September before received booster shot. chest and backpain 12/24/2021. Hopitalized 12/26/201 - 12/27/2021 with inflammation around the heart, diagnosed with pericarditis. Hospitalized again 1/6-1-7/2022 with chest pains, same diagnoses. Taking heart med for 90 days and then I will be reevaluated to see long term affects or effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 4,0
Labordaten: numerous EKG's, ECHO's, xrays of legs and lungs for blood clots (none) 12/26-27/2021 & 1//6-1/7/2022
Aktuelle Erkrankungen: none
Vorgeschichte: kidney disease, high blood pressure, high cholesterol
Andere Medikamente: simvastatin, cavedilol, losartan, amlodipine, vit. d, multi-vi
Allergien: codene
Vorherige Impfungen: -

VAERS 2051526

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: IL
Alter: 88,0
Geschlecht: F
Eingang: 20.01.2022
Impfdatum: 02.03.2021
Beginn: 12.01.2022
Tage bis Beginn: 316,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Atelectasis COVID-19 COVID-19 pneumonia Cardiac failure Cardiac failure congestive Chest X-ray abnormal Gastrointestinal haemorrhage Haematochezia Haematocrit Haemoglobin Inappropriate schedule of product administration Pleural effusion Pulmonary oedema SARS-CoV-2 test positive

Symptomtext

REceived Pfizer vaccine on 03/02/21, 3/30/21 and 10/26/21. COVID positive and presented to ER on 1/12/22. was admitted on 01/12/2022 for COVID-19 pneumonia and decompensated CHF. Patient was treated with remdesivir and dexamethasone therapy per COVID-19 treatment protocol Empiric antibiotic therapy with ceftriaxone and azithromycin was also offered. There was a suspicion for a GI bleed given blood streaked stools; her anticoagulation therapy was put on hold and H&H monitored and currently stable. Protonix was also given for GI prophylaxis. The patient improved clinically and was ultimately discharged back to a nursing home residence. She will follow up with the PCP within 1 week. Discharged on 1/19/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: 7,0
Labordaten: 1/12/22 COVID 19: positive 1/12/22 chest xray: Findings suggest CHF with mild pulmonary edema and small bilateral pleural effusions with adjacent airspace disease, likely atelectasis. These findings are not significantly changed from the previous study performed today.
Aktuelle Erkrankungen: -
Vorgeschichte: Arthritis, Carcinoma, Carotid disease, bilateral, Coronary artery disease, Depression, Diverticular disease of colon, Diverticulitis, Fatty liver, Heart disease, HTN (hypertension), Hypercholesterolemia, Hyperglycemia, IBS (irritable bowel syndrome), Lumbar foraminal stenosis, Pulmonary sarcoidosis, PVD (peripheral vascular disease), Spinal stenosis, Thrombocytopenia, and Transfusion history. She also has no past medical history of Breast cancer, Breast lump, or Colon cancer.
Andere Medikamente: Acidophilus/L-Sporogenes Tabs 1 Tablet, Oral, DAILY ALPRAZolam 0.5 MG Tabs Commonly known as: XANAX 0.5 mg, Oral, NIGHTLY ascorbic acid 500 MG Tabs 500 mg, Oral, DAILY atorvastatin 80 MG Tabs Commonly known as: LIPITOR 80 mg, Oral, NI
Allergien: iodine dye, paroxetine, tape
Vorherige Impfungen: -

VAERS 2043178

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: MI
Alter: 46,0
Geschlecht: F
Eingang: 18.01.2022
Impfdatum: 01.03.2021
Beginn: 21.04.2021
Tage bis Beginn: 51,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Antinuclear antibody increased Arteriogram carotid normal Blood pressure increased Cardiac monitoring Computerised tomogram head normal Double stranded DNA antibody positive Electrocardiogram ST segment depression Electrocardiogram normal Facial paralysis Facial paresis Fatigue Hypertension Laboratory test normal Neurological symptom Palpitations Stress echocardiogram abnormal Supraventricular tachycardia Tachycardia

Symptomtext

The patient was found to have an elevated ANA as well as double stranded DNA on her recent testing. 11.4.21 Patient present to ED on 4.27.21-for TIA symptoms of left sided facial weakness with drooping, elevated blood pressure 181/91, fatigue & tachycardia 119. Facial drooping-resolved-possible neurological side effect from vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: 2,0
Labordaten: Ongoing palpitations requiring cardiac follow up as well as a Zio patch monitor, labs & Stress echocardiogram In the emergency room the patient presented hypertensive at 181/91 and tachycardic at 119. Stroke work-up was initiated, laboratory studies and EKG were unremarkable. CT of head and CTA of head and neck were done and were also unremarkable. 4.24.21. The patient was found to have an elevated ANA as well as double stranded DNA on her recent testing. 11.4.21 Stress echo-SVT's & ST depression
Aktuelle Erkrankungen: -
Vorgeschichte: Asthma Chronic pain syndrome-Degeneration of intervertebral disc of lumbar region Anxiety
Andere Medikamente: albuterol sulfate Claritin Mobic Flexeril
Allergien: Codeine
Vorherige Impfungen: -

VAERS 2043094

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 18.01.2022
Impfdatum: 27.01.2021
Beginn: 25.12.2021
Tage bis Beginn: 332,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Syncope

Symptomtext

12/25/21 presents to EC ED for "syncope". PMHx of "afib on Eliquis, HTN, CHF, CVD "

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: 12/25/21 SARS-CoV-2 (COVID-19) detected.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2024895

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: CT
Alter: 26,0
Geschlecht: F
Eingang: 11.01.2022
Impfdatum: 12.02.2021
Beginn: 25.05.2021
Tage bis Beginn: 102,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Contraception Deep vein thrombosis Fibrin D dimer Pain in extremity Pelvic venous thrombosis Skin warm Swelling Ultrasound Doppler abnormal Venous occlusion Wisdom teeth removal

Symptomtext

Patient began complaining of some right calf pain on 5/25/2021. This reporter is patient's mom, legal guardian, as well as an RN. After some home treatment patient reported the pain was feeling better. However, when she continued to complain of pain and then developed some other symptoms consistent with a DVT (slight swelling, increased warmth to touch behind her knee) I took her to the ER for evaluation on 6/2/2021. Her Doppler report notes state, ?+ evidence of DVT in right lower extremity seen from mid femoral vein to Post Tibial vein (1 occluded, 1 patent). No Baker?s cyst seen * Occlusive.? To fairly note other possible contributing factors: Patient was taking birth control pills at time of DVT (for menses management). She also had 2 wisdom teeth removed in 5/2021. Also she had a period of time of extended sitting with her legs crossed on the night prior to her ED visit. Further clarification of above noted facts: Patient has been taking birth control medication since she has been a teenager, has had two other wisdom teeth removed in the past and has always sat cross legged for extended periods of time nearly her whole life. Additionally, Patient began complaining of leg pain prior to the time she was sitting cross legged. Although all of these other factors MAY contribute to the likelihood of a DVT occurring, they have never caused a DVT in the past either alone or combined. The only new possible link to DVT causal effect was the she received her 2nd Covid vaccine three months prior.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: 6/2/2021- Venous Doppler 6/2021- blood test to rule out genetic components/Cancer 7/2021- venous doppler 9/2021- D-diner/venous doppler
Aktuelle Erkrankungen: None Had two wisdom teeth removed in May, 2021
Vorgeschichte: Autism Anxiety Benign heart arrhythmia
Andere Medikamente: Birth control pill Zoloft Topiramate Multivitamin
Allergien: Pertussis vaccine
Vorherige Impfungen: Pertussis vaccine (DPT)- approximately 2 months old, became pale and extremely lethargic, difficult to arouse.

VAERS 2021267

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: FL
Alter: 83,0
Geschlecht: F
Eingang: 10.01.2022
Impfdatum: 21.01.2021
Beginn: 29.12.2021
Tage bis Beginn: 342,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 Condition aggravated Cough Diarrhoea Nausea Pyrexia SARS-CoV-2 test positive Syncope Vomiting

Symptomtext

12/29/2021- History of Present Illness: The patient presents with episode of syncope during physical therapy at the house PTA. Daughter denies patient hitting her head or trauma. Patient had vomiting and diarrhea. Yesterday patient was doing OK with no vomiting or diarrhea. Patient has had a dry cough starting today. Patient got COVID test for the cough for which she sometimes has. Patient had no fever at home. Per EMS: BP 62/38, 100.4 F, 1200 mL saline given. Patient says she is now feeling fine. Associated symptoms: nausea, vomiting, fever, denies chest pain, denies abdominal pain, denies headache, denies dizziness and denies back pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: 12/29/2021 SARS COV2 COVID 19 PCR--POSITIVE. 12/31/2021 SARS COV2 COVID 19 PCR--DETECTED.
Aktuelle Erkrankungen: Syncope, Shingles
Vorgeschichte: HTN, Hyperlipidemia, DM, HX TIA, Neuropathy
Andere Medikamente: Acyclovir, Amlodipine, ASA, Eliquis, Enalapril, Invokana
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2010637

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: MI
Alter: 90,0
Geschlecht: F
Eingang: 06.01.2022
Impfdatum: 15.02.2021
Beginn: 25.12.2021
Tage bis Beginn: 313,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Atelectasis COVID-19 Cardiomegaly Chest X-ray abnormal Confusional state Hilar lymphadenopathy Hypoacusis Hypoxia Lung opacity Lymphadenopathy mediastinal Neurodegenerative disorder Pleural effusion Pleural thickening Pulmonary imaging procedure abnormal Pulmonary mass Respiratory distress SARS-CoV-2 test positive

Symptomtext

This is a 91y.o. female with PMH of AAA, AVM, Caridomyopathy, CHFrEF 30%, Carotid artery disease, Chronic A-Fib s/p ablation, Colitis, CVA, Dementia, Depression, GERD, Glaucoma, hearing loss, HTN, HLD, hypothyrodism, hiatal hernia, mitral valve regurgitation s/p repair presenting to the ED for hypoxia respiratory distress. Patient was diagnosed with COVID on Tuesday. Patient was seen and evaluated in the ED. Patient is hard of hearing but AOx3-4. States she is feeling well. Denies fever, chills, nausea, vomiting, diarrhea, sob or chest pain. Seen and examined in the ER setting. Confused. Advanced age with degenerative brain syndrome. No increased work of breathing. Suspect she was not boostered She is a resident of a group home. Found with hypoxia, 85% at the facility. + Covid 12/24/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory distress
Hospital-Tage: 5,0
Labordaten: IMPRESSION: 1. No evidence for pulmonary embolism. 2. Circumferential lobulated thickening involving the right pleura and oblique fissure with multiple pleural based nodules along the horizontal fissure concerning for primary malignancy such as mesothelioma, metastasis felt to be less likely. 3. Small to moderate right-sided pleural effusion with associated passive atelectasis of the right lower lobe. 4. Right hilar and mediastinal lymphadenopathy, secondary to #2. 5. Cardiomegaly. CHEST 1 VIEW AP/PA Result Date: 12/24/2021 IMPRESSION: 1. Patchy airspace opacities in the right lung and small right pleural effusion 2. Postsurgical changes
Aktuelle Erkrankungen: ? AAA (abdominal aortic aneurysm) ? Arthritis ? AVM (arteriovenous malformation) ? Cardiomyopathy, nonischemic EF 30% ? Carotid artery disease ? Chronic a-fib s/p AV node ablation ? Colitis ? CVA (cerebrovascular accident) ? Dementia ? Depression ? Falls ? GERD (gastroesophageal reflux disease) ? Glaucoma ? Hearing loss ? Hiatal hernia ? HTN ? Hyperlipidemia ? Hypothyroidism ? Mitral valve regurgitation s/p repair with annuloplasty ring
Vorgeschichte: -
Andere Medikamente: apixaban (ELIQUIS) 2.5 mg, Oral, TWICE DAILY ? furosemide (LASIX) 40 mg, Oral, DAILY ? latanoprost (XALATAN) 0.005 % OPHTH Solution 1 Drop, EVERY NIGHT AT BEDTIME ? levothyroxine (SYNTHROID, LEVOTHROID) 50 mcg, Oral, BEFORE BREAKFAST, 2 ta
Allergien: Codeine Nausea and/or vomiting
Vorherige Impfungen: -

VAERS 1998041

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: NY
Alter: 20,0
Geschlecht: F
Eingang: 02.01.2022
Impfdatum: 13.04.2021
Beginn: 02.01.2022
Tage bis Beginn: 264,0
Dosis: 1
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Facial paralysis Hypoaesthesia

Symptomtext

Diagnosed with bells palsy Right side of face numb and droopy

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No
Vorgeschichte: Sub clinical hypothyroidism Anxiety Depression
Andere Medikamente: Baclofen Naproxan
Allergien: No
Vorherige Impfungen: -

VAERS 1967440

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 62,0
Geschlecht: M
Eingang: 21.12.2021
Impfdatum: 05.03.2021
Beginn: 03.12.2021
Tage bis Beginn: 273,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Blood sodium normal COVID-19 Cough Diarrhoea Dyspnoea Hyponatraemia Intensive care Nausea Positive airway pressure therapy Respiratory distress SARS-CoV-2 test positive Sputum discoloured Vomiting

Symptomtext

presented to the emergency room a tonight with the 2-3 day history of worsening shortness of breath associated with cough and brownish sputum production. He denies fever or chills. The shortness of breath progressively got was during this time frame. He also gives a 2-3 day history of nausea, vomiting and diarrhea and unable to keep for liquids or solids down. He denies abdominal pain, melena or hematochezia. He presented and respiratory distress on BiPAP support. He received intravenous Lasix 80 mg upon arrival to the emergency department. Subsequently live auricle investigations revealed a profound hyponatremia with a serum sodium of 111 and hence received 500 mL of... Tested positive on 12/03/2021 presented to the emergency room tonight with the 2-3 day history of worsening shortness of breath associated with cough and brownish sputum production. He denies fever or chills. The shortness of breath progressively got was during this time frame. He also gives a 2-3 day history of nausea, vomiting and diarrhea and unable to keep for liquids or solids down. He denies abdominal pain, melena or hematochezia. He presented and respiratory distress on BiPAP support. He received intravenous Lasix 80 mg upon arrival to the emergency department. Subsequently live auricle investigations revealed a profound hyponatremia with a serum sodium of 111 and hence received 500 mL of intravenous sodium chloride fluid challenge. He also received the duo neb. in view of the profound hyponatremia he is being evaluated to be admitted to the intensive care unit for closer monitoring. During his stay in the emergency department he has been weaned off the BiPAP support and currently on 3 L of oxygen via nasal cannula. Incidentally he claims that he was vaccinated for COVID-19, 6 months ago with 2 dose regimen but he is not sure what type of vaccine it was.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: hypertension, hyperlipidemia, insulin-dependent type 2 diabetes mellitus, history of TIA, morbid obesity, COPD/emphys, hypertension, hyperlipidemia, insulin-dependent type 2 diabetes mellitus, history of TIA, morbid obesity, COPD/emphysema, gout, depression, chronic GERD, peripheral neuropathy, resident of assisted living facility, functional paraplegia following back surgery and nicotine dependence
Andere Medikamente: nystatin topical
Allergien: Tramadol
Vorherige Impfungen: -

VAERS 1962000

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: CT
Alter: 69,0
Geschlecht: M
Eingang: 18.12.2021
Impfdatum: 08.10.2021
Beginn: 12.12.2021
Tage bis Beginn: 65,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: ja

Brain injury Computerised tomogram Endotracheal intubation Ischaemic stroke Magnetic resonance imaging Thrombectomy

Symptomtext

Ischemic stroke leading to hospitalization for 4 days. Needed thrombectomy and intubation. The stroke affected the area within right frontal lobe and area between right parietal-temporal lobe. No known residual deficits. There is some brain damage.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ischaemic stroke
Hospital-Tage: 4,0
Labordaten: 12/12 CT and MRI
Aktuelle Erkrankungen: -
Vorgeschichte: Mild dyslipidemia, osteoarthritis, history of prostate cancer post prostatectomy, allergies, asthma
Andere Medikamente: Lovastatin, nasonex, timolol eye drops, latanoprost eye drops
Allergien: Penicillins
Vorherige Impfungen: -

VAERS 1951959

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: MN
Alter: 79,0
Geschlecht: M
Eingang: 15.12.2021
Impfdatum: 17.02.2021
Beginn: 30.08.2021
Tage bis Beginn: 194,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Diarrhoea SARS-CoV-2 test positive Syncope Vomiting

Symptomtext

hospitilization, syncope, diarrhea, vomiting, unknown symptom onset date 3rd dose Pfizer vaccine given 12/1/21, Lot # FJ8762, IM RUD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 2,0
Labordaten: 8/29/21 COVID positive by PCR
Aktuelle Erkrankungen: -
Vorgeschichte: cardiac, lung nodule
Andere Medikamente: -
Allergien: Penicillins, Cefadroxil, Griseofulvin
Vorherige Impfungen: -

VAERS 1923923

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: OK
Alter: 48,0
Geschlecht: M
Eingang: 05.12.2021
Impfdatum: 15.03.2021
Beginn: 01.03.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Blood test Computerised tomogram Dysarthria Eye disorder Facial paralysis Magnetic resonance imaging abnormal

Symptomtext

In March 2021, had stroke like symptoms and face started drooping, slurring of speech and can't close my eye and left side of my face is still impacted. Diagnosed Bell's palsy. Had it 15 years.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: MRI; CT scan; Blood work for stroke screening.
Aktuelle Erkrankungen: No.
Vorgeschichte: Hypertension; Non-Insulin Dependent Diabetes; Psoriatic Arthritis; COPD.
Andere Medikamente: No.
Allergien: Penicillin.
Vorherige Impfungen: -

VAERS 2563109

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 03.12.2021
Impfdatum: 12.02.2021
Beginn: 31.07.2021
Tage bis Beginn: 169,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal distension Adenocarcinoma of colon Aspiration Asthenia Blood urine present Bradycardia COVID-19 Chest X-ray abnormal Colectomy Colonoscopy abnormal Computerised tomogram thorax abnormal Exposure to SARS-CoV-2 Fatigue Lower respiratory tract infection Pollakiuria Presyncope Respiratory tract congestion Rhinorrhoea

Symptomtext

Narrative: COVID infections following completion of COVID vaccine series 01/22/21 COVID dose #1 02/12/21 COVID vaccine dose #2 05/19/21 Pt admitted for right hemicolectomy for adenocarcinoma identified by recent EMR colonoscopy 05/24/21 Pt recovering from surgery 05/25/21 Discharged from hospital 07/08/21 Pt presents to ER reporting increased urinary frequency, blood in urine, and feeling bloated x2-3; discharged home with rx for UTI with cephalexin and phenazopyridine 07/19/21 Pt presents to ED reporting loss of energy and weakness; CT chest atypical infection or aspiration; discharged with rx for augmentin, oxymetazoline nasal spray for possible lung infection, decreased metoprolol dose to 50 mg due to presenting bradycardia and near syncope 07/26/21 Pt's wife was positive; pt tested - COVID NEGATIVE 07/13/21 Pt tested again - COVID POSITIVE; reports asymptomatic; rx given ascorbic acid, cholecalciterol, zinc 08/01/21 Pt reports fatigue, runny nose 08/02/21 Pt reports worsening runny nose, congestion 08/03/21 Pt is improvingl met CDC guidelines for stopping isolation

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: 07/19/21 CXR atypical infection or aspiration 07/30/21 COVID POSITIVE
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2566444

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 30.11.2021
Impfdatum: 04.03.2021
Beginn: 16.08.2021
Tage bis Beginn: 165,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 Cough Dyspnoea Hypoxia Intensive care Malaise SARS-CoV-2 test positive

Symptomtext

Narrative: 82 yo male patient with comorbidities including CKD 3A, chronic pain, HTN, BPH, and unspecified HLD who presents with dyspnea and coughing. Really came to the hospital just for a swab but was noted to be hypoxic and was admitted. COVID positive test on 8/23/21 with symptom onset on 8/16/21. Patient was fully vaccinated with COVID vaccine (Pfizer in 2/11/21 and 3/4/21). Patient was initiated on Remdesivir and Dexamethasone but required transfer to ICU due to worsening hypoxia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1910462

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: ID
Alter: 78,0
Geschlecht: F
Eingang: 30.11.2021
Impfdatum: 10.02.2021
Beginn: 19.02.2021
Tage bis Beginn: 9,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Abdominal pain Atrial fibrillation Blood pressure increased Cardioversion Chest pain Computerised tomogram Cough Echocardiogram Magnetic resonance imaging Nausea Night sweats Pericarditis Vomiting

Symptomtext

On 02/19/20221 Reported to Primary Physician of increased blood pressure, night sweats and coughing. On 05/02/2021 reported to ER and reported Chest pain and vomiting, On 05/05/2021 reported back to ER for Acute Chest pain Acute Abdominal pain and nausea (diagnosed with Acute Pericarditis) tHrough out the last nine months she has been to the E.R. 10 times and Hospitalized 5 times under the care of Dr. also Pericarditis caused various bout of AFIB.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 13,0
Labordaten: TO numerous to mention but among them was CT Scans, MRI's, Echocardiograms , Electric shock to the heart.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Amlodipine, Busprione,Calcium, Fluoxetine,Levothyroxine, Omeprazole,Potassium Chloride, 2ltr Oxygen at night
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 1887806

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: NC
Alter: 78,0
Geschlecht: F
Eingang: 20.11.2021
Impfdatum: 16.02.2021
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram Echocardiogram Electrocardiogram Fatigue Pulmonary thrombosis Ultrasound scan

Symptomtext

She experienced a little bit of feeling tired with those.; blood clots in her lungs; This is a spontaneous report from a Pfizer. A contactable 79-year-old female consumer (patient) reported for herself that: A female patient of 79-year-old received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 16Feb2021 (Lot Number: EN6201) (at the age of 78-year-old) as DOSE 2, SINGLE for covid-19 immunization. The patient had no medical history. The patient previously took BNT162B2 (first dose, lot number:EL9263) administrated in arm left on 28Jan2021 for covid-19 immunization and experienced with tired. Concomitant medications included levothyroxine (LEVOTHYROXINE) 50 ug taken for thyroid disorder. The patient experienced blood clots in her lungs on 2021 with outcome of recovering and felt a little bit of feeling tired on an unspecified date with outcome of unknown. Patient did a CT scan, ultra sound, echocardiogram, and EKG. Everything looked fine. Event required an emergency room visit and a physician office visit. Therapeutic medication oxygen was taken for blood clots in her lungs.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: -
Labordaten: Test Date: 2021; Test Name: CT Scan; Result Unstructured Data: Test Result:Everything looked fine; Test Date: 2021; Test Name: Echocardiogram; Result Unstructured Data: Test Result:Everything looked fine; Test Date: 2021; Test Name: EKG; Result Unstructured Data: Test Result:Everything looked fine; Test Date: 2021; Test Name: Ultrasound; Result Unstructured Data: Test Result:Everything looked fine
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
Andere Medikamente: LEVOTHYROXINE
Allergien: -
Vorherige Impfungen: -

VAERS 1867729

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: CO
Alter: 37,0
Geschlecht: F
Eingang: 13.11.2021
Impfdatum: 06.03.2021
Beginn: 20.08.2021
Tage bis Beginn: 167,0
Dosis: UNK
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Computerised tomogram abdomen abnormal Echocardiogram abnormal Intracardiac thrombus Splenic infarction Splenic thrombosis

Symptomtext

Upper left quadrant abdominal pain several months post 2nd vaccine dose. Underwent many medical procedures including CT scans to find blood clots in spleen and heart. Clot in spleen caused an untreatable splenic infarct. Spent 5 days in the hospital. Unable to find cause of blood clots.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Splenic thrombosis
Hospital-Tage: 5,0
Labordaten: 8/20/21 CT scan of abdomen - Clot in spleen, splenic infarct 8/22/21 Echo - Clot in heart
Aktuelle Erkrankungen: Common cold
Vorgeschichte: Crohn?s Disease
Andere Medikamente: Prenatal Vitamin
Allergien: Tramadol
Vorherige Impfungen: -

VAERS 1860941

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: KY
Alter: 39,0
Geschlecht: M
Eingang: 11.11.2021
Impfdatum: 03.03.2021
Beginn: 08.11.2021
Tage bis Beginn: 250,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hospitalisation

Symptomtext

hospitilization

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hospitalisation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: obesity, short gut syndrome, ILJV thrombosis
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2574790

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 10.11.2021
Impfdatum: 08.02.2021
Beginn: 16.07.2021
Tage bis Beginn: 158,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Base excess Blood bicarbonate normal Blood gases Blood pH normal COVID-19 COVID-19 pneumonia Carbon dioxide normal Cardiomegaly Chills Computerised tomogram thorax abnormal Dizziness Dyspnoea Fatigue Hypotension Intensive care Muscular weakness Nausea Oropharyngeal pain

Symptomtext

Narrative: COVID INFECTION after COVID vaccine series 01/18 COVID vaccine dose #1 02/09 COVID vaccine dose #2 07/16 started with fever, chills, fatigue, nausea, rhinitis, sore throat 07/19 seen in outside ED, diagnosed with COVID pneumonia 07/20 c/o dizziness, shortness of breath, muscle weakness and tremors 07/21 c/o worsening cough, low BP 07/22 c/o mild, infrequent, productive cough w/ clear sputum, fatigue, fever 07/23 reports o2 sat 72-73% w/ pulse of 71, hands cold and discolored, 30 minutes later, o2 sat 69%, BP 90/58, HR 60, admitted thru ED to ICU; CT showed bilateral pneumonia; o2 sat improved to 93% on non-rebreather mask, received cefepime, doxycycline, IV steroids during admission 08/13 clinically resolved infection 08/18 discharged from hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: 07/20/2021 outside COVID POSITIVE LAB RESULTS: Date Test Name Result 08/06/2021@11:45 SARS-CoV-2 IgG (ABBOTT) 3.17 07/23/2021@09:05 COVID-19 DIAG (ORL) DETECTED Date Test Name Result 08/06/2021@11:45 SARS-CoV-2 IgG (ABBOTT) 3.17 I-STAT ABG+ ARTERIAL BLOOD Collection time: Jul 23, 2021@08:50 Test Name Result Units Range --- ------ ------ ----- ----- i-pH 7.44 7.35 - 7.45 i-PCO2 37.2 mmHg 35 - 45 i-PO2 54L* mmHg 80 - 105 i-HCO3 25.1 mmol/L 22.0 - 26.0 i-BE (BASE EXCESS) 1 mmol/L (-2) - (+3) i-TCO2 26 mmol/L 23 - 27 i-sO2 89L % 95 - 98 07/23 CT chest w/ IV contrast; impression: No pulmonary embolus. Bilateral pneumonia that can be compatible with viral pneumonia. Cardiomegaly.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1849261

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: IL
Alter: 75,0
Geschlecht: M
Eingang: 07.11.2021
Impfdatum: 17.02.2021
Beginn: 10.03.2021
Tage bis Beginn: 21,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Atrial fibrillation Bladder cancer Bladder catheterisation Bladder irrigation Bladder neoplasm Blood urine Computerised tomogram abnormal Condition aggravated Cystoscopy abnormal Haematuria Neoplasm prostate Prostate cancer Prostatic specific antigen increased Pulmonary mass Thrombosis

Symptomtext

Patient has a history of metastatic prostate cancer that had been well controlled for nearly a decade after prostatectomy in 2010. In conjunction with first vaccination dose, PSA was measured reported 2/17/21 at 2.32 ng./mL. PSA had been measured at 1.72 in 11/18/2020, and 1.80 on 8/19/2020. Shortly thereafter, patient began to experience significant blood clots and blood in the urine. CT scan taken 3/12/21 reported growing tumor in prostate region and bladder. "Multiple new bilateral <8mm solid pulmonary nodules concerning for metastasis," and "possible metastatic progression in nodes and ?lungs". Within 45 days after 2nd shot, patient had multiple ER trips/hospitalizations for gross hematuria, necessitating catheterization and irrigation, as well as clot retention at one admission. Subsequent cystoscopy confirmed prostate cancer invasion into bladder. By 6/23/2021, PSA had increased to 2.93 ng/mL, and by 8/18/2021, PSA increased to 6.65 ng/mL. Constant urinary bleeding. Patient experienced a-fib, was admitted to hospital for more urinary bleeding. Patient underwent 20 days of radiation in-hospital to attempt to address the tumor/bleeding.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 31,0
Labordaten: See above. Chart is 100+ pages long post-February 2021 detailing multiplicity of problems.
Aktuelle Erkrankungen: none
Vorgeschichte: Prostate cancer
Andere Medikamente: Alogliptin, 25 mg tab daily; amlodipine besylate, 5 mg tab, atorvastatin calcium 40 mg tab daily, plus dosing of Leuprolide (Eligard) 22.5 mg under the skin every 3 mos injected. Calcium, multivitamin.
Allergien: not aware
Vorherige Impfungen: -

VAERS 1837151

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: MN
Alter: 90,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 19.02.2021
Beginn: 31.10.2021
Tage bis Beginn: 254,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asymptomatic COVID-19 SARS-CoV-2 test positive Syncope

Symptomtext

Received Pfizer vaccines on 1/29/21, 2/19/21, 10/20/21. Tested positive by PCR for COVID 19 on 10/31/21 admitted to hospital on 10/31/21 d/t syncope, asymptomatic for COVID 19

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1818489

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: MI
Alter: 65,0
Geschlecht: M
Eingang: 26.10.2021
Impfdatum: 12.05.2021
Beginn: 17.10.2021
Tage bis Beginn: 158,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anticoagulant therapy Arthropathy Asthenia Blood lactic acid increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Haematemesis Haemoglobin normal Hepatic steatosis Hyperbilirubinaemia Hypoxia Lung opacity Magnetic resonance imaging spinal abnormal Nausea Presyncope SARS-CoV-2 test positive Spinal osteoarthritis

Symptomtext

Hospitalized 10/17/2021; COVID-19 positive 10/17/2021; fully vaccinated BRIEF OVERVIEW: Hematologist/Oncologist: No care team member to display Admission Date: 10/17/2021 Discharge Date: 10/21/21 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19 HOSPITAL COURSE: No notes on file This is a 66 y.o. patient with a past medical history significant for HTN, CAD, Atrial Fibrillation, Depression, DM type II, neuropathy associated with MM, HLD and Multiple myeloma who presented with symptoms of weakness and near syncope at home per spouse at bedside 10/17/21. In the ED, patient was found to be hypoxic and nauseous, and improved with 2 L NC and Zofran. A CXR revealed patchy diffuse bilateral airspace opacities, compatible with COVID 19 pneumonia and his lactic acid ws slightly elevated, covid swab was positive. Patient was admitted for further tx. ID followed. Patient was placed on dexamethasone 6 mg daily, Remdesevir, and monoclonal antibodies given 10/18/21. Weaned off 2L to RA. MRI of lumbar/sacrum 10/18/21 no aggressive focal lesions, no fracture or mass. Mild progressive facet arthropathy L3-4. Multilevel lumbar spondylosis. PT/OT evaluated while inpatient. Patient also had coffee - ground emesis 10/18/21, GI followed. Protonix gtt started -- transitioned to PPI PO BID for 8 weeks, then will have EGD on outpatient basis when covid pna resolves. Eliquis initially held, then restarted as hgb stayed stable. Also noted hyperbilirubinemia 10/17 of 1.9 and had RUQ US which showed hepatic steatosis and mild splenomegaly, no biliary tree dilation. While inpatient team followed and adjusted insulin tx.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: OSA (obstructive sleep apnea) AF (paroxysmal atrial fibrillation) CAD (coronary artery disease) Hypertension Sustained SVT PVC's (premature ventricular contractions) Orthostatic hypotension Class 1 obesity due to excess calories with serious comorbidity and body mass index (BMI) of 33.0 to 33.9 in adult Constipation due to opioid therapy COVID-19 Kappa light chain Multiple myeloma Cancer related pain Neuropathy associated with multiple myeloma Syncope, unspecified syncope type Dyslipidemia Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin Steroid-induced hyperglycemia
Andere Medikamente: acyclovir (ZOVIRAX) 400 MG tablet apixaban (ELIQUIS) 5 MG tablet ascorbic acid (VITAMIN C) 500 MG tablet Cholecalciferol (VITAMIN D3 PO) DARATUMUMAB IV dexamethasone (DECADRON) 4 MG tablet empagliflozin (JARDIANCE) 10 MG tablet FLUoxetine (
Allergien: NKA
Vorherige Impfungen: -

VAERS 1804350

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: CO
Alter: 74,0
Geschlecht: M
Eingang: 21.10.2021
Impfdatum: 12.03.2021
Beginn: 31.08.2021
Tage bis Beginn: 172,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Arthralgia Chest pain Pain in extremity Pericarditis

Symptomtext

Mild chest pain,, under left arm and in shoulder starting morning of 08/31/2021. Diagnosis = idiopathic pericarditis. Treatment = high dose aspirin + colchicine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: Pasturella & bacterioids infection from cat bite
Vorgeschichte: Congenital spherocytosis, polycythemia vera, chronic atrial fibrillation, high blood pressure, high cholesterol, BPH, asplenia, history of DVTs & PE, coronary artery disease, TIA when withholding warfarin to prep for colonoscopy, kidney stones, ventricular tachycardia, ascending aorta dilation, obstructive sleep apnea, central sleep apnea, inflammatory arthritis in fingers, type II dinettes (A1C = 6.4 on 08/31/2021)
Andere Medikamente: Metformin, Metoprolol, Losarttan, Warfarin Sodium, Aspirin, Simvastatin, Vitamin D3, Tamsulosin, Finasteride, Glucosamine/MSM/chondritin
Allergien: Erythromycin, morphine, codeine
Vorherige Impfungen: -

VAERS 1277463

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: PA
Alter: -
Geschlecht: M
Eingang: 16.10.2021
Impfdatum: 30.04.2021
Beginn: 30.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic reaction Asthenia Chills Confusional state Dizziness Blood test normal Body temperature increased Dyskinesia Electrocardiogram normal Fall Dyspnoea Fatigue Flushing Hyperhidrosis Injection site erythema Electrocardiogram Feeling hot Full blood count

Symptomtext

kind of almost seizures like,body makes involuntary muscle spasms like jerky moments.; passing out/was unconscious; Tingling sensation in the arm where I got my shot; Almost seizures like your body makes involuntary muscle spasms; body temperature was getting very hot; sweating; Allergic reaction; fell down off my chair; face kind of turned green; This is a spontaneous report from a contactable consumer (patient). A 35-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EN6201 and expiration date: not reported), via an unspecified route of administration, in Arm on 30Apr2021, as DOSE 1, SINGLE for covid-19 immunization. The patient had no medical history and concomitant medications. On 30Apr2021, after vaccination, while waiting in the observation area, the patient felt like tingling sensation in the arm where he got shot. About five minutes, patient fell down off chair. The patient was kind of passed out. The patient face kind of turned green. The patient further stated that he had a kind of almost seizures like, his body makes involuntary muscle spasms like jerky moments. The body temperature was getting very hot, and patient was sweating. So, they gave patient an EpiPen in his thigh. The patient had an allergic reaction. But at that time patient was unconscious. The patient would like to know if he should get a second dose of the vaccine after the side effect from his first dose. The patient underwent lab tests and procedures which included full blood panel test with the results normal and electrocardiogram with unknown results. Therapeutic measures were taken as a result of kind of events included EpiPen. The outcome of the events was unknown at time of report. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: Test Name: blood panel test; Result Unstructured Data: Test Result:results normal; Test Name: ECG; Result Unstructured Data: Test Result:Unknown results
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1277463

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: PA
Alter: -
Geschlecht: M
Eingang: 16.10.2021
Impfdatum: 30.04.2021
Beginn: 30.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic reaction Asthenia Chills Confusional state Dizziness Blood test normal Body temperature increased Dyskinesia Electrocardiogram normal Fall Dyspnoea Fatigue Flushing Hyperhidrosis Injection site erythema Electrocardiogram Feeling hot Full blood count

Symptomtext

kind of almost seizures like,body makes involuntary muscle spasms like jerky moments.; passing out/was unconscious; Tingling sensation in the arm where I got my shot; Almost seizures like your body makes involuntary muscle spasms; body temperature was getting very hot; sweating; Allergic reaction; fell down off my chair; face kind of turned green; This is a spontaneous report from a contactable consumer (patient). A 35-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EN6201 and expiration date: not reported), via an unspecified route of administration, in Arm on 30Apr2021, as DOSE 1, SINGLE for covid-19 immunization. The patient had no medical history and concomitant medications. On 30Apr2021, after vaccination, while waiting in the observation area, the patient felt like tingling sensation in the arm where he got shot. About five minutes, patient fell down off chair. The patient was kind of passed out. The patient face kind of turned green. The patient further stated that he had a kind of almost seizures like, his body makes involuntary muscle spasms like jerky moments. The body temperature was getting very hot, and patient was sweating. So, they gave patient an EpiPen in his thigh. The patient had an allergic reaction. But at that time patient was unconscious. The patient would like to know if he should get a second dose of the vaccine after the side effect from his first dose. The patient underwent lab tests and procedures which included full blood panel test with the results normal and electrocardiogram with unknown results. Therapeutic measures were taken as a result of kind of events included EpiPen. The outcome of the events was unknown at time of report. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: Test Name: blood panel test; Result Unstructured Data: Test Result:results normal; Test Name: ECG; Result Unstructured Data: Test Result:Unknown results
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1277463

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: PA
Alter: -
Geschlecht: M
Eingang: 16.10.2021
Impfdatum: 30.04.2021
Beginn: 30.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic reaction Asthenia Chills Confusional state Dizziness Blood test normal Body temperature increased Dyskinesia Electrocardiogram normal Fall Dyspnoea Fatigue Flushing Hyperhidrosis Injection site erythema Electrocardiogram Feeling hot Full blood count

Symptomtext

kind of almost seizures like,body makes involuntary muscle spasms like jerky moments.; passing out/was unconscious; Tingling sensation in the arm where I got my shot; Almost seizures like your body makes involuntary muscle spasms; body temperature was getting very hot; sweating; Allergic reaction; fell down off my chair; face kind of turned green; This is a spontaneous report from a contactable consumer (patient). A 35-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EN6201 and expiration date: not reported), via an unspecified route of administration, in Arm on 30Apr2021, as DOSE 1, SINGLE for covid-19 immunization. The patient had no medical history and concomitant medications. On 30Apr2021, after vaccination, while waiting in the observation area, the patient felt like tingling sensation in the arm where he got shot. About five minutes, patient fell down off chair. The patient was kind of passed out. The patient face kind of turned green. The patient further stated that he had a kind of almost seizures like, his body makes involuntary muscle spasms like jerky moments. The body temperature was getting very hot, and patient was sweating. So, they gave patient an EpiPen in his thigh. The patient had an allergic reaction. But at that time patient was unconscious. The patient would like to know if he should get a second dose of the vaccine after the side effect from his first dose. The patient underwent lab tests and procedures which included full blood panel test with the results normal and electrocardiogram with unknown results. Therapeutic measures were taken as a result of kind of events included EpiPen. The outcome of the events was unknown at time of report. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: Test Name: blood panel test; Result Unstructured Data: Test Result:results normal; Test Name: ECG; Result Unstructured Data: Test Result:Unknown results
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1785659

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: NV
Alter: 84,0
Geschlecht: M
Eingang: 14.10.2021
Impfdatum: 12.02.2021
Beginn: 14.02.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Atrial fibrillation Blood test normal Cardiac disorder Cardiac fibrillation Computerised tomogram thorax Echocardiogram Myocardial necrosis marker Pulmonary oedema SARS-CoV-2 test negative

Symptomtext

I went to the emergency room on the 27th. i was cardio fibrillated on the 25th, heart complications. and pulmonary edema, I lost 15lb of fluid. I went to Afib. I was discharged on march the 1st. I gave Lasix and it made me lose a lot of water.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: 3,0
Labordaten: I had a blood test , and they did a couple of covid test. Those were negative. They ran enzymes to see if i had a heart attack , ct scan and ultrasound of the heart . From the 27th of Feb to 1st of march
Aktuelle Erkrankungen: None at the time
Vorgeschichte: I had Afib. Type 2 diabetes, Obesity , I also have sleep apnia.
Andere Medikamente: I take Dofetilide 500mcg twice a day Enalapril 20mg twice a day Eliquis 5 mg twice a day elopuneral predezone varied, it was a mini taper from 20 to 10mg coltezine 0.6mg Metorolopo 25mg twice a day vitamin c 500mg once a day vitamin
Allergien: I don't tolerate epidural
Vorherige Impfungen: Dengi, it made my arm sole up , back when I was in the service back in May 2003

VAERS 1782338

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: MN
Alter: 85,0
Geschlecht: M
Eingang: 13.10.2021
Impfdatum: 03.02.2021
Beginn: 08.10.2021
Tage bis Beginn: 247,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Consciousness fluctuating Cough Diarrhoea Dyspnoea exertional Loss of consciousness Malaise Presyncope Respiratory symptom SARS-CoV-2 test positive Skin abrasion Syncope Vomiting

Symptomtext

CHIEF COMPLAINT/REASON FOR VISIT Weakness - Generalized HISTORY OF PRESENT ILLNESS An 86-year-old gentleman history of coronary artery disease status post CABG, abdominal aortic aneurysm, hyperlipidemia, chronic kidney disease, hypertension, history of prostate cancer, central sleep apnea. He lives alone and independently. He is brought to the emergency department by EMS with concerns of generalized weakness with a syncopal event today. Patient reports that for the past week he has been feeling generalized malaise, weakness, and upper respiratory symptoms including a cough. He has had 3 episodes of diarrhea in the past week which have been nonbloody. He has been tolerating food and fluids, though admits he has not been hydrating well because he did not feel good. Earlier today the neighbors him taken him to the clinic for outpatient COVID testing given his persistent symptoms. These results are pending. When he was returning back to his home in walking up the stairs he had a near syncopal episode where he collapsed. He denies preceding lightheadedness or palpitations at the time His neighbor assisted him to the ground in the only injury he sustained was an abrasion to the left elbow. However the neighbor states that he was in and out of consciousness for about a minute while he was on the ground. The neighbor also reports that he has noticed that the patient breathe severe with any amount of exertion though the patient himself denies shortness of breath. The patient denies any chest pain, fever. He reports that his cough has been nonproductive. No abdominal pain or headache. Denies preceding nausea and vomiting but did state that he vomited once in the ambulance EN route and was given 4 mg Zofran and started on 1 L of IV fluids.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: SARS Coronavirus 2, PCR Rapid, V Symptomatic DETECTED 10/8/2021
Aktuelle Erkrankungen: -
Vorgeschichte: Hospital Hyperlipidemia Aneurysm Abdominal Aortic Without Rupture Coronary Artery Disease Without Angina Pectoris History Of Falling Retention Urinary Central Sleep Apnea Syndrome Personal History Of Malignant Neoplasm Of Prostate Anemia Macrocytic Coronary Arterial Bypass Graft Status Post Personal History Insomnia Debility Dysfunction Diastolic Weakness General Non-ST Elevation Myocardial Infarction COVID-19 Infection Non-Hospital Hypertensive Heart With Heart Failure And Chronic Kidney Disease (CKD) Stage 3a Glomerular Filtration Rate (GFR) 45 To 59 (HCC) Fracture Rib Multiple Subsequent With Routine Healing Right Chronic Kidney Disease Stage 4 Glomerular Filtration Rate 15-29 Pneumonitis Due To Inhalation Of Food And Vomit Loss Weight Primary Osteoarthritis Hand Left Gout Percutaneous Transarterial Coronary Angioplasty Status Post Radiculopathy Lumbosacral Rotator Cuff Disorder Left Hypernatremia Edema Lower Extremity Tinea Pedis Repeated Falls Bradycardia
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 1776290

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: KY
Alter: 32,0
Geschlecht: F
Eingang: 11.10.2021
Impfdatum: 19.02.2021
Beginn: 09.10.2021
Tage bis Beginn: 232,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Intensive care

Symptomtext

hospitalization (ICU)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1759358

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 04.10.2021
Impfdatum: 19.02.2021
Beginn: 02.10.2021
Tage bis Beginn: 225,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Malaise Syncope

Symptomtext

generally felt ill, had a syncopal episode

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1750566

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

schwer

Staat: MS
Alter: 44,0
Geschlecht: F
Eingang: 30.09.2021
Impfdatum: 31.03.2021
Beginn: 01.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Chest pain Deep vein thrombosis Illness Influenza like illness Pain in extremity Pyrexia Respiration abnormal Superficial vein thrombosis

Symptomtext

After the first dose I was sick as expected with a sore arm, fever, etc... After the second dose I got really sick. I had flu like symptoms for about a week or so. Then I had issues breathing , chest pains, and my legs were really sore. I had developed new blood clots in both legs, superficial and deep vein. I did not have a heart related chest pain though. I continue to have these issues right today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 1,0
Labordaten: 4/8/2021 4/8/2021 Vascular 4/8/2021 4/19/2021 4/27/2021 5/3/2021 5/20/2021 Vascular 6/11/2021 ER and Hospitalization 7/2/2021 7/16/2021 7/20/2021 8/24/2021 Vascular
Aktuelle Erkrankungen: N/A
Vorgeschichte: IVC filter for blood clots since 2011 High blood pressure GERD Migraines Edema
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1723139

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: NV
Alter: 84,0
Geschlecht: M
Eingang: 22.09.2021
Impfdatum: 11.02.2021
Beginn: 25.02.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anticoagulant therapy Cerebral thrombosis Computerised tomogram head abnormal Computerised tomogram normal Fall Full blood count abnormal Haemoglobin decreased Hypoaesthesia Intensive care Laboratory test Pain Speech disorder

Symptomtext

He got the vaccine, had no reaction other than slight soreness. Then 2 weeks later he fell to the ground, was rushed to the hospital and had CT scan that told that he had a blood clot on the left side of his brain. Had slow drip for 2 hours and then started getting feeling back in right side of his body and speech started coming back. Was admitted to the ICU at Medical Center. The next day did another CAT scan and there was no sign of the blood clot. He is now on Plavix, heart pills, as well as Lasix. His blood counts have been low since this and still being monitored to that. Blood count 129 3 months ago, and 104 the other day. Hemoglobin is low as well. Went to the ICU to a regular room and then released. Due for the 2nd vaccine while in the hospital and then had it subsequently on 3/9/21. He did not have any reactions from that vaccine other than some soreness. Lot #EL3302. Before moving 22 years ago he did have a stroke and was hospitalized for 9 days, and has not had any problems until after the vaccine. He believes that it is more than coincidence that for over 23 years he has been fine, and that he had it 2 weeks after the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral thrombosis
Hospital-Tage: 3,0
Labordaten: Multiple while in the hospital and ongoing.
Aktuelle Erkrankungen: None.
Vorgeschichte: High blood pressure, 4 MI's, CABG x 3 vessels at age 44.
Andere Medikamente: Heart medications, BP medications.
Allergien: Sulfa.
Vorherige Impfungen: -

VAERS 1307177

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: VA
Alter: 17,0
Geschlecht: M
Eingang: 22.09.2021
Impfdatum: 01.05.2021
Beginn: 02.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Adenovirus test Bell's palsy Bordetella test COVID-19 Chlamydia test Facial paresis SARS-CoV-2 test negative Coronavirus test Enterovirus test Headache Human metapneumovirus test Human rhinovirus test Influenza A virus test Influenza B virus test Mycoplasma test Respiratory syncytial virus test SARS-CoV-2 test SARS-CoV-2 test positive

Symptomtext

Bell's palsy--Left side. Associated c HA 12 hrs before. Woke up c L facial weakness. Seen in ED 5/4/2021. Treatment: Artificial Tears ophthalmic solution: See Instructions, 2 drops in left eye, QID, # 30 mL, 0 Refill(s), Start Date/Time 05/05/21 1:50:00 EDT, Acute, 103.1 acyclovir 400 mg oral tablet: 400 mg = 1 tab(s), PO, 5 times/day, # 50 tab(s), 0 Refill(s), Start Date/Time 05/05/21 2:18:00 EDT, Maintenance, 103.1 ocular lubricant ophthalmic ointment: See Instructions, Eye, Left prior to bedtime and eye taping, # 7 gm, 0 Refill(s), Start Date/Time 05/05/21 2:07:00 EDT, Maintenance, 103.1 predniSONE 20 mg oral tablet: 60 mg = 3 tab(s), PO, Daily, with food or milk, X 7 day(s), # 21 tab(s), 0 Refill(s), Start Date/Time 05/05/21 1:51:00 EDT, Acute, 103.1. Improved but still very asymmetric.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: RP2-PCR: No Adenovirus, Coronavirus 229E ,Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, Human Metapneumovirus, Human Rhinovirus/Enterovirus, Influenza A H1, Influenza B Parainfluenza Virus 1 ,Parainfluenza Virus 2 ,Parainfluenza Virus 3, Parainfluenza Virus 4, Respiratory Syncytial Virus, Bordetella pertussis, Bordetella parapertussis, Chlamydia pneumoniae, Mycoplasma pneumoniae, or SARS-CoV-2 detected.
Aktuelle Erkrankungen: None
Vorgeschichte: Remote Hx asthma--Last event 10 yrs old
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1689779

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: CA
Alter: 40,0
Geschlecht: F
Eingang: 10.09.2021
Impfdatum: 14.02.2021
Beginn: 11.08.2021
Tage bis Beginn: 178,0
Dosis: N/A
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Cardiac failure Electrocardiogram Myocarditis

Symptomtext

Symptoms related to myocarditis. EKG determined portion of heart has failed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: EKG and blood testing - 09/10/2021
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1688925

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: TN
Alter: 42,0
Geschlecht: M
Eingang: 10.09.2021
Impfdatum: 31.03.2021
Beginn: 02.07.2021
Tage bis Beginn: 93,0
Dosis: 2
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anaphylactic reaction Arthropod bite Chest X-ray Chest pain Electrocardiogram Eye swelling Lip swelling Peripheral swelling Pharyngeal swelling Urticaria

Symptomtext

On July 2 I was stung on the left shoulder by an unknown insect. Within 2-3 minutes I started having Anaphylaxis reaction. Swelling on lips, eyes, throat, fingers and feet. I had chest pains and hives broke out on my back. It should be noted that I have been stung many times throughout my life, by many different types of bees and insects and I have NEVER once had an Anaphylaxis reaction. I was stung in the leg in 2020, three times in the same incident by yellow jackets and I did not have a reaction. My sting on July 2 2021 resulted in being rushed to the Emergency room where I was treated with Antihistamine, steroid and Epinephrine. I was released after 2 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: Chest x-ray July 2 2021 EKG
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1678955

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: GA
Alter: 80,0
Geschlecht: M
Eingang: 07.09.2021
Impfdatum: 27.02.2021
Beginn: 28.02.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Laboratory test Syncope

Symptomtext

had a couple of fainting episodes after first vaccine, but collapsed and was hospitalized 2 days after second dose

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 12,0
Labordaten: Many can be provided if requested. Was in the hospital so they did many tests multiple times daily
Aktuelle Erkrankungen: diagnosed with covid when brought to hospital
Vorgeschichte: heart, diabetes, high blood pressure
Andere Medikamente: allopurinol 100 MG Oral Tablet (Allopurinol) 100 Mg TABLET Active 100 MG PO Daily aspirin 81 MG Delayed Release Oral Tablet (Aspirin Ec) 81 Mg TABLET.DR Active 81 MG PO Daily 30 30 March 25th, 2021 10:08am carvedilol 12.5 MG Oral Tab
Allergien: none
Vorherige Impfungen: -

VAERS 1678829

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: MN
Alter: 83,0
Geschlecht: F
Eingang: 07.09.2021
Impfdatum: 29.01.2021
Beginn: 04.09.2021
Tage bis Beginn: 218,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 Diarrhoea General physical health deterioration Presyncope

Symptomtext

Pt is a 84 y.o. female with history of hypertension, hyperlipidemia, coronary artery disease s/p stenting, heart failure with reduced ejection fraction (48%), TIA s/p right carotid endarterectomy, CKD stage 3, mild cognitive impairment who is brought in by her daughter for worsening functional decline, diarrhea, and a near syncopal episode. She has limited ability to provide history and her history was provided by her daughter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Coronavirus 2 PCR Detect, V symptomatic POSITIVE
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1651692

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: HI
Alter: 63,0
Geschlecht: F
Eingang: 28.08.2021
Impfdatum: 06.02.2021
Beginn: 06.02.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Electric shock sensation

Symptomtext

light headed after injection; brain felt like it was vibrating; buzzing sensation in head.it was not painful but quite annoying.; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 06Feb2021 at 09:00 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, osteoporosis and fibromyalgia. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1686) via an unspecified route of administration in the right arm on 06Feb2021 at 08:45 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Feb2021, the patient experienced light headed after injection. About 1 to 1-1/2 hours later brain felt like it was vibrating/ buzzing sensation in head which was not painful but quite annoying. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event brain felt like it was vibrating/ buzzing sensation in head was recovered on 07Feb2021; while that of light headed after injection was recovered on an unknown date in Feb2021. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Fibromyalgia; Osteoporosis; Rheumatoid arthritis
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1647125

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: MN
Alter: 55,0
Geschlecht: F
Eingang: 28.08.2021
Impfdatum: 11.02.2021
Beginn: 28.06.2021
Tage bis Beginn: 137,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest X-ray Echocardiogram Electrocardiogram Pericarditis

Symptomtext

This is a spontaneous report from a contactable consumer. A 55-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in left arm at the age of 55 years old on 11Feb2021 11:00 (Batch/Lot Number: EN6201) as dose 2, single for covid-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient previously took first dose of bnt162b2 (lot number: EK9231) on 21Jan2021 at 11:00 AM administered at left arm for COVID-19 Immunization. No reaction reported. The patient also took amoxicillin and experienced allergies. On 28Jun2021, the patient experienced pericarditis and it was a possible diagnosis at an ER visit that ruled out any life-threatening events. SED rate test with value of 75 confirmed pericarditis on 22Jul2021. Echocardiogram, EKG, electrocardiogram, chest XR were done and all indicate healthy heart. Prednisone was prescribed after 22Jul2021. The outcome of the event was not recovered. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: Test Name: Chest XR; Result Unstructured Data: Test Result: indicate healthy heart; Test Name: Echocardiogram; Result Unstructured Data: Test Result: indicate healthy heart; Test Name: EKG; Result Unstructured Data: Test Result: indicate healthy heart.
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1632933

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

schwer

Staat: CA
Alter: 55,0
Geschlecht: M
Eingang: 25.08.2021
Impfdatum: 29.03.2021
Beginn: 29.04.2021
Tage bis Beginn: 31,0
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angiogram Cardiomyopathy Chest pain Computerised tomogram Magnetic resonance imaging Myocarditis Palpitations

Symptomtext

chest pains, cardiomioposy, myocarditis, heart palpitations

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: mri- ct scan- angiogram-
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: penicillin
Vorherige Impfungen: -

VAERS 1632194

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: KY
Alter: 78,0
Geschlecht: F
Eingang: 25.08.2021
Impfdatum: 19.02.2021
Beginn: 19.02.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anaphylactic reaction Flushing Infection Rhinorrhoea

Symptomtext

When the young lady put the needle in my arm I had face flushing and my nose starting running and I couldn't stop it. It was called a mild anaphylactic reaction. The following week I had a bacterial or viral infection that lasted 5 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: No
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: No
Allergien: No
Vorherige Impfungen: -

VAERS 1591934

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: VA
Alter: 40,0
Geschlecht: F
Eingang: 20.08.2021
Impfdatum: 16.02.2021
Beginn: 16.02.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal X-ray Anxiety Blood test normal Endoscopy Epistaxis Eyelid ptosis Facial paralysis Hypoaesthesia oral Laboratory test Menstrual disorder SARS-CoV-2 test negative Spinal X-ray normal Thrombosis

Symptomtext

I developed palsy in my face within an hour of the injection. My eye was drooping, I had numbness and my mouth was drooping. By that evening, I started experiencing clotting. I blew my nose and had a golf ball sized clot come out. The palsy lasted to the next day. I didn't go to get care at the ER right away because of my worries with COVID. I kept having regular nose bleeds and then clotting which made me go get care. I received care from my ENT twice in one week. They did an outpatient endoscopy to stop the bleeding in my nose. I still had to go to the ER because I was still experiencing other ways of bleeding. I started my menstrual cycle and it was not normal for it to start when it did. At the ER, they performed multiple tests. I was passing a lot of clots during my cycle. My neurologist recommended that I should not get the booster shot because of what has happened. I did have these same reactions after the first dose, except they were milder.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: I had X-Ray's of my back, my abdomen, blood work and a COVID-19 test. Everything came back normal.
Aktuelle Erkrankungen: I did not have any illness.
Vorgeschichte: I have a history of stroke and challenges with blood clots related. I have mild paralysis because of my history of strokes.
Andere Medikamente: I was taking progesterone (the mini pill/birth control) and Allegra.
Allergien: I am allergic to sulfa and penicillin.
Vorherige Impfungen: -

VAERS 1587366

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 30,0
Geschlecht: F
Eingang: 19.08.2021
Impfdatum: 06.03.2021
Beginn: 12.03.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Pain in extremity Pericarditis

Symptomtext

Patient stated that after both shots she had server pain in her Arms. After a week after the second Vaccination she started having chest pain. She went to the ER three times with in 5 weeks after having the vaccine. Patient stated that she finally went to a better hospital and was diagnosed with Peracarids. She is still experiencing bad chest pains.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Auto Immune and nervous System
Andere Medikamente: -
Allergien: Cranberry pills Mextione Macro Bid Macro Dentin
Vorherige Impfungen: -

VAERS 1578080

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 78,0
Geschlecht: F
Eingang: 17.08.2021
Impfdatum: 09.02.2021
Beginn: 16.08.2021
Tage bis Beginn: 188,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Azotaemia Blood lactic acid COVID-19 Condition aggravated Decreased appetite Electrolyte imbalance Endotracheal intubation General physical health deterioration Hypotension Intensive care Leukocytosis Mechanical ventilation Mental status changes Respiratory distress SARS-CoV-2 test positive Troponin increased

Symptomtext

70-year-old female from an assisted facility tested positive today for COVID-19 was brought in by EMS with worsening altered mental status, hypotensive and respiratory distress. The nursing facility stated she has been declining for two weeks, anorexia, bed bound and not participating, but was COVID negative. They test them every 2 days. They reported 2 days of worsening symptoms prior to arrival and a positive COVID-19 (8/16/2021) swab at her facility. Pfizer vaccination dates were 1/19 and 2/9. The patient was intubated immediately on arrival placed on mechanical ventilation and is not requiring sedation. She tested positive for COVID-19 and was found to be in acute renal failure, hypernitremia, leukocytosis, with elevated lactic acid, electrolyte abnormality and elevated troponin. The patient presented to the ICU intubated and on vasopressors. Husband is at home, and the daughter, is listed as the emergency contact and is the first call. She is communicating with husband and sister and will be the person communicating with the critical care team. She states her husband said the patients wishes would be to be a DNR, a partial DNR was completed since the patient is already intubated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: worsening altered mental status, hypotensive and respiratory distress
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1520274

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: WA
Alter: 67,0
Geschlecht: F
Eingang: 02.08.2021
Impfdatum: 12.02.2021
Beginn: 27.07.2021
Tage bis Beginn: 165,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Feeling abnormal Impaired work ability Loss of personal independence in daily activities Muscle strength abnormal

Symptomtext

This was the Phitzer - second dose on 06/06/2021. On July 27th i developed Bells Palsey. I have not been sick or had any virus. I have not have COVID at all. I was unaware the vaccine could cause this. Very miserable. Affecting my job and life.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Medical tests done at clinic - tested strength, breathing. Examined and diagnosis as Bels Palsey. Could be 3- 6 months before I am back to normal. I am a very healthy 68 year old with no health problems. (or was)
Aktuelle Erkrankungen: None
Vorgeschichte: none
Andere Medikamente: aspirin Triametrene _ sp
Allergien: none
Vorherige Impfungen: -

VAERS 1516533

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: PA
Alter: 37,0
Geschlecht: F
Eingang: 30.07.2021
Impfdatum: 26.01.2021
Beginn: 16.06.2021
Tage bis Beginn: 141,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Aphasia Arthralgia Blood test Cognitive disorder Cognitive test Dyskinesia Dyspnoea Facial paralysis Feeling abnormal Gait disturbance Magnetic resonance imaging head Memory impairment Migraine Mobility decreased Myalgia Pyrexia Speech disorder

Symptomtext

Day of vaccine troubles allowing. Next day migraines everyday, severe muscle and joint pain that I could barely move and fever. I am having uncontrollable movements throughout my entire body and facial drooping. I am having trouble with brain fog, memory and cognition. I did not do well on my neurological MOCA test. I am having trouble breathing. These things have gotten much worse since my second vaccine. I have been to the ER because I was barely able to walk and was not able to speak. My speech is severely impaired at times.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: Brain mri Lots of bloodwork
Aktuelle Erkrankungen: Osteoarthritis diagnosed 12/20
Vorgeschichte: No
Andere Medikamente: Topomax 100mg B-complex Lamictal 200 Lamictal 25x2 Cymbalta 60 Cymbalta 20 Caltrate Tylenol Arthritis Imitrex Voltaren Gel Icy hot D3 50 Wellbutrin xl 300
Allergien: Unknown food allergy herb, chemical or spice
Vorherige Impfungen: -

VAERS 1513202

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 84,0
Geschlecht: F
Eingang: 29.07.2021
Impfdatum: 15.02.2021
Beginn: 23.07.2021
Tage bis Beginn: 158,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Ischaemic stroke

Symptomtext

I63.9 - Acute ischemic stroke (CMS/HCC) I63.9 - Ischemic stroke (CMS/HCC)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ischaemic stroke
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1510186

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: -
Alter: 46,0
Geschlecht: M
Eingang: 28.07.2021
Impfdatum: 21.02.2021
Beginn: 25.05.2021
Tage bis Beginn: 93,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Asthenia Atrial fibrillation Condition aggravated Dizziness Loss of consciousness

Symptomtext

Increase of Atrial Fibrillation (Afib) events and severity. For the 20 years preceding the Covid shot, I had 1-2 Afib events in low severity about every 8 months and only one severe event in 2008. Since getting the Covid shot, I've had 1 event every week with 2 severe events and 2 emergency room visits. Three cardiologists have confirmed my condition and verified my event history and the increase in frequency. My workouts have been relatively the same for 3 years. Now, after any workout that I push to failure, onset of Afib occurs approximately 4-6 hours later with a medium to high severity. Afib Severity: Low; occasional light headed when exerting. Medium; weakness, need to sit. Severe; semi/or unconscious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1510090

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: PA
Alter: 67,0
Geschlecht: F
Eingang: 28.07.2021
Impfdatum: 04.03.2021
Beginn: 15.03.2021
Tage bis Beginn: 11,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Asthenia Bacterial infection Blood test Chronic inflammatory demyelinating polyradiculoneuropathy Condition aggravated Electromyogram Feeling abnormal Gait inability Guillain-Barre syndrome Magnetic resonance imaging head Mobility decreased Movement disorder Pain in extremity Ultrasound liver

Symptomtext

So weak could not turn in bed, hands went fuzzy, stabbing pains developed in hands, Hospitalized 4 days to treat bacterial infection, did MRI of brain, went to rehab for 6 weeks to learn to walk again and gain use of hands. Now is diagnosed with either Guillen-Barre Syndrome or CIDP. Neurologist is not certain which it is but is beginning infusions beginning Aug2 thru Aug6 to help her.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: -
Labordaten: IV drip antibiotics for bacterial infection 3/27 - 3/29,many blood tests ulta sound of liver and MRI Brain Scan - 3/29 EMG - 7/13
Aktuelle Erkrankungen: BACTERIAL INFECTION (ecoli) diagnosed a few days later.
Vorgeschichte: Diabetes Type 2, Heart (Bypass surgery done in 2010)
Andere Medikamente: Etezimibe 10mg, Losartan Potassium 25mg, Jentadueto XR 5mg/1000mg, Baby Aspirin, fish oil, Centrum Multi Vitamin, Calcium and Vitamin D
Allergien: Thimerosol
Vorherige Impfungen: -

VAERS 1501872

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: OH
Alter: 72,0
Geschlecht: F
Eingang: 26.07.2021
Impfdatum: 24.02.2021
Beginn: 28.04.2021
Tage bis Beginn: 63,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Antiacetylcholine receptor antibody Diplopia Headache Magnetic resonance imaging normal VIth nerve paralysis Vision blurred

Symptomtext

Headache right after 2nd shot lasted 1 month and at that time, sixth nerve palsy began in left eye. Was present for about 3 months, now sequential sixth nerve palsy in right eye. Still have double and blurred vision.

Weitere VAERSDATA-Felder

Praegender Schweregrund: VIth nerve paralysis
Hospital-Tage: -
Labordaten: Negative MRI (4/2021) Negative mysthenia gravis (6/2021)
Aktuelle Erkrankungen: none
Vorgeschichte: hypertension high cho high triglycerides high h1c (6.1)
Andere Medikamente: Losartan postassium 100mg Lexapro 20 mg Vitamin D3 2000U Metoprolol 100mg Atorvastatin 20mg Leutein 20mg Vascepa 4g Felodopine 5mg
Allergien: none
Vorherige Impfungen: -

VAERS 1371455

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: CA
Alter: 54,0
Geschlecht: F
Eingang: 20.07.2021
Impfdatum: 08.03.2021
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diarrhoea Diplegia Fatigue Movement disorder Pain in extremity Endoscopy Neuralgia Sigmoidoscopy Ultrasound joint Seizure

Symptomtext

I had terrible diarrhea; Symptoms of neuralgia; This is a spontaneous report received from a contactable consumer. A 54-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EN6201) via an unspecified route of administration in right arm on 08Mar2021 at 04:00 as dose 1 single (at the age of 54-year-old) for COVID-19 immunization. Medical history included Multiple sclerosis, Ileostomy, Blood clot in my arm back in 2014, Crohn's Disease. Concomitant medications included gabapentin 100 mg capsule, valaciclovir hydrochloride (VALTREX) 1 g, 3 times a day, diazepam 2.5 mg tablet, 3 times a day, ondansetron (ZOFRAN MELT), oxycodone 7.5 g, tablet 4 times a day, lansoprazole (PREVACID) 20 mg, once a day, vedolizumab (ENTYVIO) 300 mg for Crohn's disease. It was reported that (after first dose) patient experienced terrible diarrhea and symptoms of the neuralgia and then she was lucky enough to have her Entyvio 300 mg for Crohn's and it helped somewhat diarrhea. Patient received second dose of BNT162b2 on 29 of the March. It was reported that coming out the second dose on 29th immediately was really bad like pain and shortness of breath and she have had a back surgery so and she always feel bad so I did not think anything of it but then she ended up after the second dose into ER and discovered that my Crohn's had caused really bad flare up. Her foot was looking strange but she just was too tired and left ER. She went back to the hospital and couple days later they told me that actually she had deep vein thrombosis now in her legs. She also had superficial clot in that left leg that was the pain began on the edges through eventually the vaccine is basically started and that it's started the Crohn's flare up and now on but I always trying to get back on a shorter time period of Entyvio and she was also on blood thinners now for a blood clot. She have had a blood clot in my arm back in 2014 and also have had it before. So she was kind of fine now because which is she don't know, you know what to do but I just want to make sure it just got reported because I have seen Johnson & Johnson and other getting reports of products. Consumer stated, Because of diarrhea and Crohn's problem she was down to 91 and now in hospital they gave me Prednisone 40 mg, Tablet so the things are coming up. I am just above 100 right now but I have been in the hospital for 5 days now with the clot and Crohn's Flare. Consumer stated, Yes I had Multiple Sclerosis and I have Crohn's disease with ileostomy and I have an ileostomy where I no longer use my large intestine, I just use a bag. So, I just have the small intestine and I have a flare. When probed if still experiencing the events, Consumer stated, Yes she was still experiencing, the arm is much better now. You know that's not really sore. Crohn's is terrible and the blood clot they have me on the Xarelto. She was getting a bit tired and the pain it's pretty bad and Neuralgia is still pretty bad. The diarrhea was getting better so I am just trying to get healthy enough to leave the hospital. So, I can get on Entyvio because her insurance won't allow them to do the Entyvio in the hospital. So it's kind of frustrating but she was also experiencing extreme shortness of breath, extreme fatigue she couldn't get any oxygen to her muscles. She was realizing that was the blood clot. Consumer further stated, She was just wondering had you been hearing any reports of blood clots from the BioNTech Pfizer at all. The patient underwent lab tests and procedures which included endoscopy: nil, sigmoidoscopy: nil, Ultrasound of legs: nil on an unspecified date. The outcome of the event terrible diarrhea was unknown and outcome of the event neuralgia was not recovered. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: Test Name: Endoscopy; Result Unstructured Data: Test Result:Nil; Test Name: Sigmoidoscopy; Result Unstructured Data: Test Result:Nil; Test Name: Ultrasound; Result Unstructured Data: Test Result:Nil
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Clot blood; Crohn's disease; Ileostomy; Multiple sclerosis
Andere Medikamente: GABAPENTIN; VALTREX; DIAZEPAM; ZOFRAN MELT; OXYCODONE; PREVACID; ENTYVIO
Allergien: -
Vorherige Impfungen: -

VAERS 1371455

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6201

schwer

Staat: CA
Alter: 54,0
Geschlecht: F
Eingang: 20.07.2021
Impfdatum: 08.03.2021
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diarrhoea Diplegia Fatigue Movement disorder Pain in extremity Endoscopy Neuralgia Sigmoidoscopy Ultrasound joint Seizure

Symptomtext

I had terrible diarrhea; Symptoms of neuralgia; This is a spontaneous report received from a contactable consumer. A 54-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EN6201) via an unspecified route of administration in right arm on 08Mar2021 at 04:00 as dose 1 single (at the age of 54-year-old) for COVID-19 immunization. Medical history included Multiple sclerosis, Ileostomy, Blood clot in my arm back in 2014, Crohn's Disease. Concomitant medications included gabapentin 100 mg capsule, valaciclovir hydrochloride (VALTREX) 1 g, 3 times a day, diazepam 2.5 mg tablet, 3 times a day, ondansetron (ZOFRAN MELT), oxycodone 7.5 g, tablet 4 times a day, lansoprazole (PREVACID) 20 mg, once a day, vedolizumab (ENTYVIO) 300 mg for Crohn's disease. It was reported that (after first dose) patient experienced terrible diarrhea and symptoms of the neuralgia and then she was lucky enough to have her Entyvio 300 mg for Crohn's and it helped somewhat diarrhea. Patient received second dose of BNT162b2 on 29 of the March. It was reported that coming out the second dose on 29th immediately was really bad like pain and shortness of breath and she have had a back surgery so and she always feel bad so I did not think anything of it but then she ended up after the second dose into ER and discovered that my Crohn's had caused really bad flare up. Her foot was looking strange but she just was too tired and left ER. She went back to the hospital and couple days later they told me that actually she had deep vein thrombosis now in her legs. She also had superficial clot in that left leg that was the pain began on the edges through eventually the vaccine is basically started and that it's started the Crohn's flare up and now on but I always trying to get back on a shorter time period of Entyvio and she was also on blood thinners now for a blood clot. She have had a blood clot in my arm back in 2014 and also have had it before. So she was kind of fine now because which is she don't know, you know what to do but I just want to make sure it just got reported because I have seen Johnson & Johnson and other getting reports of products. Consumer stated, Because of diarrhea and Crohn's problem she was down to 91 and now in hospital they gave me Prednisone 40 mg, Tablet so the things are coming up. I am just above 100 right now but I have been in the hospital for 5 days now with the clot and Crohn's Flare. Consumer stated, Yes I had Multiple Sclerosis and I have Crohn's disease with ileostomy and I have an ileostomy where I no longer use my large intestine, I just use a bag. So, I just have the small intestine and I have a flare. When probed if still experiencing the events, Consumer stated, Yes she was still experiencing, the arm is much better now. You know that's not really sore. Crohn's is terrible and the blood clot they have me on the Xarelto. She was getting a bit tired and the pain it's pretty bad and Neuralgia is still pretty bad. The diarrhea was getting better so I am just trying to get healthy enough to leave the hospital. So, I can get on Entyvio because her insurance won't allow them to do the Entyvio in the hospital. So it's kind of frustrating but she was also experiencing extreme shortness of breath, extreme fatigue she couldn't get any oxygen to her muscles. She was realizing that was the blood clot. Consumer further stated, She was just wondering had you been hearing any reports of blood clots from the BioNTech Pfizer at all. The patient underwent lab tests and procedures which included endoscopy: nil, sigmoidoscopy: nil, Ultrasound of legs: nil on an unspecified date. The outcome of the event terrible diarrhea was unknown and outcome of the event neuralgia was not recovered. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: Test Name: Endoscopy; Result Unstructured Data: Test Result:Nil; Test Name: Sigmoidoscopy; Result Unstructured Data: Test Result:Nil; Test Name: Ultrasound; Result Unstructured Data: Test Result:Nil
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Clot blood; Crohn's disease; Ileostomy; Multiple sclerosis
Andere Medikamente: GABAPENTIN; VALTREX; DIAZEPAM; ZOFRAN MELT; OXYCODONE; PREVACID; ENTYVIO
Allergien: -
Vorherige Impfungen: -

VAERS 1464826

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: KY
Alter: 47,0
Geschlecht: F
Eingang: 12.07.2021
Impfdatum: 17.02.2021
Beginn: 17.02.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blepharospasm Dizziness Facial discomfort Facial paralysis Facial paresis Facial spasm Nausea

Symptomtext

A few minutes after the vaccine, I was talking normally and relaxed and then suddenly had a strange sensation on one side of my face. The right side of my mouth and right eye and cheek felt strange, like a sudden muscle cramp in my face. I was with my daughter and asked her if my face looked funny and tried to smile and she noticed one side (my right side) wasn?t smiling. I got dizzy and nauseous and had to lie down. Clinic staff brought sprite and crackers. After about 30 minutes I was able to sit up and the facial weakness started to subside. However, I continue 5 months later to have occasional facial weakness and eyelid twitching on the right side. It comes and goes. The weakness is gradually improving, but after seeing the story about the J&J vaccine, although I had Pfizer, I thought I should report this.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: None. I reported it to my doctor in a telemedicine visit and she advised me not to get a second dose.
Aktuelle Erkrankungen: None
Vorgeschichte: IBS-C, ADD
Andere Medikamente: Vyvanse 30 mg
Allergien: Penicillin, cephalosporin, sulfa, raglan, macrodantin, shellfish
Vorherige Impfungen: Fainted following a flu vaccine once.

VAERS 1457685

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: CA
Alter: 45,0
Geschlecht: F
Eingang: 08.07.2021
Impfdatum: 08.03.2021
Beginn: 24.06.2021
Tage bis Beginn: 108,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anaemia Blood test Syncope

Symptomtext

I passed out

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: blood test showed anemia
Aktuelle Erkrankungen: n/a
Vorgeschichte: anemia
Andere Medikamente: albuterol, astepro, montelukast, pro-air
Allergien: n/a
Vorherige Impfungen: -

VAERS 1446560

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6201

schwer

Staat: WA
Alter: 34,0
Geschlecht: F
Eingang: 04.07.2021
Impfdatum: 23.01.2021
Beginn: 19.06.2021
Tage bis Beginn: 147,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Foetal placental thrombosis Placental disorder Premature delivery SARS-CoV-2 test negative White blood cell count increased

Symptomtext

First pregnancy, low risk under midwife care, no genetic anomalies detected, due date oct 4 2021, spontaneous delivery on June 19 2021. Birth weight 790g, survived and receiving care at NICU.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Foetal placental thrombosis
Hospital-Tage: -
Labordaten: Maternal COVID test negative at time of delivery. No signs of infection in baby. Slightly elevated white blood cell count (14) on mom. Placenta showed acute subchorionitis grade 1 stage 1 and chorionic villi with hypomature villious morphology.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Prenatal vitamins, loratafine
Allergien: Nka
Vorherige Impfungen: -

VAERS 1443649

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: WA
Alter: 26,0
Geschlecht: F
Eingang: 02.07.2021
Impfdatum: 05.03.2021
Beginn: 08.03.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Antinuclear antibody positive Atrial fibrillation Blood test Decreased appetite Dizziness Headache Heart rate increased Migraine Pain Presyncope Pyrexia Tachycardia Vision blurred

Symptomtext

Near syncope following vaccination followed by 2 days of HA, elevated HR and blurry vision. March 8th, symptoms worsened. Went to ED and was told she had a fib. 3/25- reported to clinic for continued fevers, blurry vision, poor appetite, HA, dizziness, body aches and increased HR. Returned to clinic on 3/29, 4/8 and 4/15 with a similar constellation of symptoms. 5/11- seen in the ED for migraine. 5/12- Seen again in the clinic with autoimmune panel run. Seen again on 5/17 in the clinic and in the ED on 5/30 for ongoing tachycardia and dizziness that worsens throughout the day. Additional neuro and cardiology work ups requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Multiple. Of note, positive ANA with possibility of Lupus discussed. MRI and MRA pending. Cardiology referral pending.
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: none
Vorherige Impfungen: -

VAERS 1433128

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: OH
Alter: 71,0
Geschlecht: M
Eingang: 29.06.2021
Impfdatum: 02.02.2021
Beginn: 09.06.2021
Tage bis Beginn: 127,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chest tube insertion Chills Cough Diarrhoea Dyspnoea Intensive care Mechanical ventilation Neuromuscular blockade Pneumomediastinum Pneumothorax SARS-CoV-2 antibody test SARS-CoV-2 test positive Sedation

Symptomtext

Patient developed dyspnea, diarrhea, chills and cough. Presented at the ED on 06/11 and was found to be COVID-19 positive. Admitted to ICU Despite maximal medical intervention; including deep sedation, NMB, flolan, intermittent pronation, steroids, a second round of Remdesivir, multiple pressors, and full vent support, the patient continued to decline and remained with increasing pressor requirements. He suffered severe pneumomediastinum and bilateral pneumothoraces requiring bilateral chest tubes

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: Nasal pharyngeal swab positive for COVID-19 SARS CoV-2 Antibody IgG positive SARS-CoV-2 positive 6/13 x 2, 6/18
Aktuelle Erkrankungen: -
Vorgeschichte: NIDDM2, HTN, HLD, A. Fib
Andere Medikamente: Albuterol 90mcg/actuation Q6HPRN ASA EC 81mg QD Docusate sodium 100mg po PRN Dulaglutide (Trulicity) 1.5mg/0.5ml pen SC weekly Losartan-HCTZ (Hyzaar) 100-25 po QD Metformin-XR 500mg #2 po BID Metoprolol succinate (Toprol-XL) 100mg po BID Wa
Allergien: NKA
Vorherige Impfungen: -

VAERS 1419952

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: IN
Alter: 75,0
Geschlecht: M
Eingang: 23.06.2021
Impfdatum: 09.02.2021
Beginn: 09.02.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy

Symptomtext

Bell's palsy; This is a spontaneous report from a contactable consumer (patient). A 75-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left (left shoulder) on 09Feb2021, early afternoon 15:20 (Batch/Lot Number: EN6201) as single dose for COVID-19 immunisation. Medical history included Bell's Palsy in the past, but not for years. He doesn't know, but probably 15 years since he last had it. Family Medical History Relevant to AE(s) included his brother had Bell's Palsy after his COVID shot. His brother had Bell's palsy before also. There were no concomitant medications. The patient had no history of previous immunization with the Pfizer vaccine considered as suspect. The patient had no additional vaccines administered on same date of the pfizer suspect. The patient did not receive any prior Vaccinations (within 4 weeks). He normally doesn't take vaccines. The patient had no AE(s) following prior vaccinations. Patient wanted to report Bell's Palsy is directly caused by Pfizer COVID shot. Caller clarified that he is the patient that experienced Bell's Palsy. He understands that Pfizer has denied that. He was not sure of the date. It was the date he got the shot. It happened the same date got first COVID shot. He did not get second COVID shot. Facility called him today to follow up because he didn't get second shot and they told that's what it was and gave him Pfizer's phone number. When caller got his vaccination card, he states the date was 09Feb2021 that he got the shot and developed Bell's Palsy. Immediately afterwards, the patient experienced Bell's Palsy. The next day his wife noticed it. The patient clarified the date Bell's Palsy started was 09Feb2021. It was bad enough the next day, 10Feb2021, that his wife noticed it. The patient just went directly to the doctor and did not go to ER. He would have gone to the ER to get the thing he needed for Bell's Palsy, but he went to the doctor instead. The doctor gave him the medication he needed. He went to the doctor because the doctor had treated his brother. His brother had the same reaction. That is how caller knows it was caused by the Pfizer COVID shot. Caller clarified that his brother got Bell's Palsy immediately too but didn't recognized it until after he had the second shot. That is how they know for sure it was caused by Pfizer COVID shot. The outcome of the event was not recovered. Follow-up attempts are needed, Other additional information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021725674 similar report from same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Bell's palsy (Verbatim: History of Bell's Palsy his brother also had Bell's Palsy after his COVID shot.)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1071223

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: CA
Alter: 49,0
Geschlecht: F
Eingang: 23.06.2021
Impfdatum: 26.02.2021
Beginn: 26.02.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram pulmonary Chest discomfort Dizziness Dyspnoea Echocardiogram Anxiety Blood thyroid stimulating hormone decreased Bronchial hyperreactivity Chest pain Computerised tomogram thorax Dysphagia Echocardiogram normal Electrocardiogram Hypoaesthesia oral Erythema Incomplete course of vaccination Joint swelling Laboratory test

Symptomtext

Within 5 minutes of injection, I started feeling faint and light headed, my skin was bright red with a rash that was burning and itching. My throat and tongue were swelling. I also had tightness in my chest and difficulty breathing. At the vaccination site I was given Benadryl and about 10 minutes after that, they administered an Epi-pen. I was taken to the hospital and was treated with Mythlprednisolone sod suc (Soul-Medrol) and Famotidine. I was given an RX of Benadryl and Prednisone (Deltasone) that I took for the next week. For a couple weeks, I continued to have a rash and itchy skin and severe swelling of ankles and feet. On 4/22/21, I believe I was diagnosed with another reaction from the vaccine, Pericarditis. I spent 3 days in the hospital and I'm still taking Colchicine and Indomethcin from this event. I have been told I can not take the second dose of the vaccine at this time, but look back into this after September. I am also taking Alvesco and Combivent.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 3,0
Labordaten: 4/22/21 - I had several lab tests done while in the ER prior to being diagnosed with Pericarditis. EKGs, Chest CT angiogram, Echocardiogram
Aktuelle Erkrankungen: Hashimoto's Thyroid disease
Vorgeschichte: Hashimoto's Thyroid disease
Andere Medikamente: Vit d3, Cyclobezaprine, Gabapentin, Armour, Cytomel
Allergien: Medicines - Azithromycin, Asprin, Doxycycline, Ibuprofen, Levothryroxine, Penicllin, Percocet, Sulfa Food - Gluten, guava, pineapple, squash, lactose Other - dust, pollen, flowers, airbornne chemicals and polutants
Vorherige Impfungen: -

VAERS 1413290

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: CA
Alter: 48,0
Geschlecht: F
Eingang: 20.06.2021
Impfdatum: 14.02.2021
Beginn: 14.04.2021
Tage bis Beginn: 59,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Aspiration pleural cavity Cardiac tamponade Intensive care Pericardial drainage Pericardial effusion Pleural effusion

Symptomtext

April 14, 2021 Seen at emergency room symptoms of pericardial effusion however were mild and no echocardiogram performed to confirm, but now believe this was occurring although resolved on own. June 2, 2021 Admitted to ICU for Cardiac Tamponade and Pleural Effusion. Remained at ICU for 3 days after procedures to remove effusion and tamponade June 11, 2021 Seen at emergency room for repeat symptoms of pericardial and pleural effusion. Mild pericardial effusion confirmed - rest at home June 14, 2021 Taken to ER for increased pericardial effusion and pleural effusion. Remained in hospital through June 19, 2021 for testing and treatment

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 9,0
Labordaten: There are too many tests to list here. I am otherwise very healthy and Doctors have found no reason for this to have happened to me. I never get sick. I strongly believe this to be the results of the Pfizer Covid 19 Vaccination.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Lexapro 7mg Adderal 30mg
Allergien: Mold
Vorherige Impfungen: -

VAERS 1410240

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6201

schwer

Staat: TN
Alter: 77,0
Geschlecht: M
Eingang: 18.06.2021
Impfdatum: 18.02.2021
Beginn: 01.06.2021
Tage bis Beginn: 103,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Peripheral artery thrombosis Stent placement Surgery

Symptomtext

lARGE BLOOD CLOT IN ARTERY FEEDING RIGHT LEG - OCCURRED AT A BEND IN THAT ARTERY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Peripheral artery thrombosis
Hospital-Tage: 6,0
Labordaten: THREE SURGERIES PLUS INSERTION OF A STINT TO LESSON THE AMOUNT OF THE BEND AT THE CLOT SITE
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Simvastatin, Duloxathene, Centrum Silver for men
Allergien: Codiene
Vorherige Impfungen: -